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Limited financial resources and an increase in demand for access present challenges to policy 
makers wishing to address people s need for sexual and reproductive health services (SRHS). 
The potential of pharmacies to take pressure off healthcare systems and deliver SRHS is being 
increasingly recognised. The aim of this PhD project was to explore the attitudes, experiences 
and utilisation of pharmacy-based SRHS to develop recommendations for service optimisation.  
Methods 
A mixed methods approach was used. A retrospective quantitative study was conducted to 
describe the utilisation of a large range of SRHS delivered through the health provider Umbrella 
in Birmingham (England). A systematic review was carried out to summarise what is known about 
pha mac  e  and aff e pe ience  of SRHS. Qualitative semi-structured interviews were 
conducted with pharmacy staff and pharmacy users to explore their experiences with pharmacy-
based SRHS in Birmingham. The results of all three studies were synthesised and 
recommendations developed based on the discussion of the integrated findings. 
Results 
People using the pharmacy for SRHS found pharmacies convenient to use and overall had a 
positive experience interacting with pharmacy staff. However, key barriers to access included not 
being able to access pharmacy staff of the preferred sex, not having staff trained in SRHS delivery 
available, a lack of privacy at the counter, difficulties with self-sampling kits testing for sexually 
transmitted infections, and a lack of awareness for services. While pharmacy staff were generally 
motivated to deliver SRHS, added workload was experienced as stressful, particularly when 
staffing levels were low.  
Conclusion 
The thesis developed recommendations on the optimisation of pharmacy-based SRHS. Barriers 
to access and usability need to be addressed in order to exploit pha macie  full potential. The 
thesis developed recommendations on the optimisation of pharmacy-based SRHS, some of which 
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1.1. Chapter overview 
The research conducted for this PhD project was based at Warwick Medical School in Coventry 
(West Midlands, England) and was funded by Umbrella which is part of the University Hospitals 
Birmingham NHS Foundation Trust. More information about Umbrella is provided in a later section 
of this chapter (section 1.7). 
The introduction serves to provide the reader with important background information to 
understand the context of the current PhD thesis. It starts by explaining what is meant by sexual 
and reproductive health (SRH), and sexual and reproductive health services (SRHS) in general. It 
also outlines how SRH and SRHS are defined for the current thesis. Thereafter, the importance of 
services related to contraception and sexually transmitted infections, two areas of SRH, is 
demonstrated. It then explains how SRHS are commissioned in general, with a focus on services 
in England. Subsequently, the pharmacy service and funder of this project Umbrella is introduced 
and an overview of all their pharmacy-based SRHS provided. Next, the focus of this PhD project 
is outlined and the aims and objectives of this thesis presented. Following this, an overview of the 
thesis structure and the research design is presented. Finally, the research team members who 
supported the conduct of this project are introduced. The chapter closes with a brief chapter 
summary.  
1.2. Sexual and reproductive health and related services 
Definitions for terms such as SRH are important to ensure a collective understanding of the term 
when discussing it (W. M. Edwards & Coleman, 2004). The first internationally accepted definition 
of sexual health was published by the World Health Organisation (WHO) in 1975 (W. M. Edwards 
& Coleman, 2004). It was based on the generic definition of health which was developed by the 
WHO after World War II (W. M. Edwards & Coleman, 2004). Almost twenty years later in 1994, 
reproductive health was first defined at the International Conference on Population and 
Development in Cairo (Cottingham et al., 2019). While the usage of the term reproductive and 
sexual health was proposed at this conference in Cairo, he e m e al  a  d opped d e o 
objections from many governments. Although sexual health has unique aspects, it is closely linked 
to and overlaps with reproductive health (Viner et al., 2012). Recently, Starrs et al. (2018) 
developed an integrated and comprehensive definition of SRH and sexual and reproductive rights, 
which is presented in Figure 1.  
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Sexual and reproductive health is a state of physical, emotional, mental, and social wellbeing 
in relation to all aspects of sexuality and reproduction, not merely the absence of disease, 
dysfunction, or infirmity. Therefore, a positive approach to sexuality and reproduction should 
recognise the part played by pleasurable sexual relationships, trust, and communication in 
the promotion of self-esteem and overall wellbeing. All individuals have a right to make 
decisions governing their bodies and to access services that support that right. Achievement 
of sexual and reproductive health relies on the realisation of sexual and reproductive rights, 
which are based on the human rights of all individuals to: 
x have their bodily integrity, privacy, and personal autonomy respected; 
x freely define their own sexuality, including sexual orientation and gender identity and 
expression; 
x decide whether and when to be sexually active; 
x choose their sexual partners; 
x have safe and pleasurable sexual experiences; 
x decide whether, when, and whom to marry; 
x decide whether, when, and by what means to have a child or children, and how many 
children to have; 
x have access over their lifetimes to the information, resources, services, and support 
necessary to achieve all the above, free from discrimination, coercion, exploitation, 
and violence. 
FIGURE 1 DEFINITION OF SEXUAL AND REPRODUCTIVE HEALTH AND RIGHTS BY STARR ET AL. (STARRS ET 
AL., 2018, P. 2646) 
Starrs et. al. also developed a comprehensive definition of essential SRHS which are needed to 
meet public health and human rights standards (Starrs et al., 2018). The essential services 
recommended by Starrs et al. are presented in Figure 2.  
The sexual and reproductive health services should include:  
x accurate information and counselling on sexual and reproductive health, including 
evidence-based, comprehensive sexuality education; 
x information, counselling, and care related to sexual function and satisfaction;  
x prevention, detection, and management of sexual and gender-based violence and 
coercion; 
x a choice of safe and effective contraceptive methods; 
x safe and effective antenatal, childbirth, and postnatal care; 
x safe and effective abortion services and care; 
x prevention, management, and treatment of infertility; 
x prevention, detection, and treatment of sexually transmitted infections, including HIV, 
and of reproductive tract infections; and 
x prevention, detection, and treatment of reproductive cancers 
FIGURE 2 ESSENTIAL SEXUAL AND REPRODUCTIVE HEALTH SERVICES (STARRS ET AL., 2018, P. 2646) 
Starrs et al. (2018) definition shows that SRHS comprise many different areas. As not all of these 
SRHS are focussed on in this PhD thesis, the next section will outline how SRHS are defined for 
the current PhD project.  
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1.3. Definition of Sexual and reproductive health services for this thesis 
The previous section has shown that SRHS encompass many different components. However, 
the current PhD project will only focus on those SRHS ela ing o he p e en ion, de ec ion, and 
ea men  of e all  an mi ed infec ion  (STIs) and afe and effec i e con aceptive 
me hod .  
More specifically, the following services which relate to the prevention, detection and treatment 
of STIs will be explored: condoms, chlamydia treatment and self-sampling kits testing for five 
different STIs (chlamydia, gonorrhoea, syphilis, HIV and hepatitis B).  
With ega d  o afe and effec i e con acep i e me hod , he follo ing e ice  ill be 
explored: condoms, ongoing contraception (progesterone-only-pill and combined pill; 
contraceptive injection), hormonal emergency contraception (emergency contraceptive pills) and 
non-hormonal emergency contraception (copper coil).  
An overview of the services defined as SRHS for this thesis is presented in Table 1.  
The range of services explored in this thesis was defined by the services that Umbrella, a sexual 
health provider in Birmingham (England), currently provides through pharmacies (as of 2020). 
The rationale for defining the range of services to match Umbrella s pharmacy services is justified 
at a later point (section 1.7), where Umbrella and its services are introduced more thoroughly.  
TABLE 1 DEFINITION OF SEXUAL AND REPRODUCTIVE HEALTH SERVICES FOR THIS PHD THESIS 
Definition of sexual and reproductive health services for this PhD thesis 
Services related to the prevention, detection, and treatment of STI 
Services related to the prevention of STIs x Condoms 
Services related to the detection of STIs x STI self-sampling kits testing for five 
different STIs: chlamydia, gonorrhoea, 
syphilis, Human Immunodeficiency 
Viruses (HIV), hepatitis B 
Services related to the treatment of STI x Chlamydia treatment 
Services related to contraception 
Safe and effective contraceptive methods x Condoms 
x Ongoing contraception 
(progesterone-only-pill and combined 
pill; contraceptive injection) 
x Hormonal emergency contraception 
(emergency contraceptive pill)  
x Non-hormonal emergency 
contraception (copper coil) 
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The next section outlines why services related to safe and effective contraception and services 
related to the prevention, detection and treatment of STIs are important. Since the field work for 
this PhD project was conducted in England, evidence on the importance of contraception and STI 
services from England will be provided alongside global figures.  
1.4. Importance of services related to contraception and STI  
SRH is an important part of both individual health and well-being but also an important aspect of 
public health (Henry, 2019). Although improvement in both individual and public health outcomes 
associated with SRH have been observed (Henry, 2019), many challenges related to SRH remain. 
This is demonstrated in the following section. 
1.4.1. Importance of services related to contraception 
Contraceptives are ways to prevent pregnancy and there are many different methods of 
contraception available. Rates of unmet need for contraception, unintended pregnancy and 
unsafe abortion are high (Viner et al., 2012). According to data from 41 countries, between 20% 
and 25% of married adolescents have an unmet need for contraception (Barroso, 2014). 
Furthermore, an estimated 44% of all pregnancies worldwide are unintended and about 45% of 
abortions between 2010 and 2014 were unsafe (Starrs et al., 2018). This is problematic, as 
unintended pregnancies have been shown to lead to poor mental health outcomes in later life 
(Herd et al., 2016). It is also associated with death or significant morbidity following childbirth (L. 
Michie & Cameron, 2020). Further, where the termination of unintended pregnancy is done by 
untrained and unauthorised people, it can have disastrous outcomes. According to the WHO, 
every eight minutes a woman from one of the developing nations will die of complications of an 
unsafe abortion (Akpanekpo et al., 2017). Moreover, stigma associated with abortions can lead to 
diminished well-being of women (O Donnell e  al., 2018).  
It is estimated that more than 200 million women who want to avoid pregnancy do not use modern 
high-quality contraception (Starrs et al., 2018), defined as a product or medical procedure that 
interferes with reproduction from acts of sexual intercourse  (Hubacher & Trussell, 2015, p. 420). 
Instead, many women around the world rely on non-modern contraceptives such as abstinence, 
withdrawal, fertility awareness approaches or lactational amenorrhea (Hubacher & Trussell, 
2015).  
In the United Kingdom (UK), unintended pregnancies are estimated to have cost health services 
more than £1 billion in 2011 (C. M. Thomas & Cameron, 2013). Further, young English people 
between 15 and 25 years continue to have poor sexual health including inconsistent contraceptive 
use (Aranda et al., 2018) and although abortion rates have started to fall in the UK, the use of 
effective contraception to prevent unintended pregnancy remains a challenge (Aranda et al., 
2018). 
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1.4.2. Importance of services related to STIs 
STIs affect the health and lives of people worldwide (Rowley et al., 2019). The WHO estimated 
that 376 million new curable STIs occurred in 2016 alone (M. M. Taylor & Wi, 2019) and that one 
million new urogenital STIs are acquired each day worldwide (Stulpin & Marrazzo, 2019).  
STI numbers are also increasing in England (Aranda et al., 2018). In 2018, there were 447,694 
new diagnoses of STIs made in England, which was a 5% increase since 2017 (Public Health 
England, 2018). This would suggest that this is a growing problem, that needs to be addressed. 
There are more than 30 bacteria, viruses and parasites that spread through sexual contact  
(Newman et al., 2015; Starrs et al., 2018). Of these the following five: HIV, chlamydia, gonorrhoea, 
syphilis, and hepatitis B are outlined in more detail as they are relevant to this thesis. A bacterial 
cure is possible with syphilis, gonorrhoea and chlamydia. With HIV and hepatis B a viral cure is 
not possible  however, early prevention can halt the disease progression and will favour a better 
quality of life (Starrs et al., 2018).  
Human immunodeficiency virus (HIV) 
The epidemic caused by the human immunodeficiency virus (HIV), was first recognised in the 
United States of America (USA) in the early 1980s and shortly after throughout the world (Wing, 
2016).  
HIV can be transmitted through sexual intercourse and through blood. In three quarters of all 
cases, HIV is transmitted through intercourse between men and women (Basavarajaiah & Murthy, 
2020). It can also be transmitted from mother to child during the pregnancy and delivery and 
through breastfeeding (Basavarajaiah & Murthy, 2020). HIV can lead to Acquired Immune 
Deficiency Syndrome (AIDS). This is the stage of HIV where the immune system becomes too 
weak to fight off certain infections and cancers. Although HIV can be prevented by the use of 
condoms and by taking pre-exposure prophylaxis (PreP) (J. Jones et al., 2019), nearly two million 
people worldwide become infected with HIV every year (Starrs et al., 2018). As of 2017, 36.9 
million people were estimated to be living with HIV worldwide (Bbosa et al., 2019). The majority 
of these infections were in sub-Saharan Africa (Bbosa et al., 2019). However, recent research has 
shown that Eastern Europe and Central Asia (EECA) are the only regions worldwide where annual 
HIV infections rates are growing (Pape, 2019).  
Since no curative therapy is available, HIV remains a lifelong infection (J. Jones et al., 2019). 
However, the introduction of combination antiretroviral therapy (cART), which first became 
available in the 1990s (Wing, 2016), has been one of the great public health successes (Katz & 
Maughan-Brown, 2017). It has led to increased survival in people living with HIV and shown to be 
effective in reducing viral loads and extending the life span of people living with HIV (M. T. May et 
al., 2014).  
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The importance of providing services to address the HIV epidemic is recognised by the United 
Nations, who have set a goal to end the AIDS epidemic by 2030 (J. Jones et al., 2019). Despite 
significant progress in controlling the epidemic and saving lives over the past two decades, HIV 
remains a major public health threat (Starrs et al., 2018).  
Moreover, further highlighting the importance of providing appropriate provision for SRHS, in the 
UK, the life expectancy for HIV-positive individuals treated with cART improved by 16 years 
between 1996 and 2008 (M. May et al., 2011). Most patients with HIV treated with cART live with 
their disease successfully (Wing, 2016). However, the mortality figures and life expectancy of 
people with HIV is driven by many factors including achieving effective virological suppression 
and the stage of disease at diagnosis (Wing, 2016).  
In the UK, the decline in annual number of new HIV diagnoses has continued, with 4453 people 
diagnosed in 2018 (Public Health England, 2019). This is a 6% decline from previous year (2017) 
in which 4761 new HIV diagnoses were made (Public Health England, 2019). However, it is 
estimated that there are more than 100,000 people living with HIV in the UK (as of 2018) and 473 
deaths among people living with HIV have been recorded in 2018 (Public Health England, 2019). 
A problem with reducing the spread of HIV is that many people are unaware of their infection (S. 
Bell et al., 2019). It is estimated that there are more than 13,000 people living with HIV without 
knowing it in the UK (Kirwan et al., 2016).  
Chlamydia  
Chlamydia trachomatis is the leading cause of bacterial STIs worldwide (Filardo et al., 2019) and 
the most common bacterial STI in the UK (Draeger, 2019a). There are more than 130 million cases 
per year worldwide (Newman et al., 2015) and more than 200,000 new diagnoses in 2017 in 
England (Draeger, 2019a).  
Chlamydia trachomatis is transmitted primarily through penetrative sex (Draeger, 2019a) but can 
also be transmitted during pregnancy or delivery (Rowley et al., 2019). It infects the urethra and 
endocervix (Draeger, 2019a). Acute chlamydia urogenital tract infections are often asymptomatic 
in both women and men (Draeger, 2019a). However, they commonly have a deleterious effect on 
the reproductive health of men and women and is associated with subfertility, ectopic pregnancy, 
and chronic pain (Grillo‐Ardila et al., 2020; Schuchardt & Rupp, 2018). Chlamydia can also infect 
the throat and the rectum, and in some cases the surface of the eye (the conjunctiva) (Draeger, 
2019a). It is highly infectious, with a concordance of up to 75% between sexual partners (Draeger, 
2019a).  
Gonorrhoea 
The bacterium Neisseria gonorrhoeae causes the STI called gonorrhoea (Unemo et al., 2019). It 
is estimated that there are 86.9 million adults infected with gonorrhoea worldwide (Unemo et al., 
2019) and the rates are rising particularly among men who have sex with men (MSM) (WHO 
Department of Reproductive Health and Research, 2018).  
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Gonorrhoea rates have been rising in England, with a 26% increase in reported infections between 
2017 and 2018, when 56,259 cases were recorded (Draeger, 2019b). This is the highest number 
of cases since 1978 (Draeger, 2019b). Gonorrhoea is nowadays the second most common 
bacterial STI diagnosed in England (O B ien e  al., 2018). Not only globally but also in England, 
this is driven by infections by MSM. Between 2008 and 2017, the number of gonorrhoea 
diagnoses in MSM in England increased eight fold (Whittles et al., 2019).  
Gonorrhoea can present as urethritis in men, cervicitis and urethritis in women and can also occur 
in extragenital sites such as pharynx, rectum, conjunctiva and rarely systematically, in both women 
and men (Unemo et al., 2019). There is no gonococcal vaccine available, which is why preventing 
and detecting gonorrhoea is highly important (Unemo et al., 2019). Single-dose systemic therapy 
with an injectable ceftriaxone plus oral azithromycin, is the recommended first-line treatment 
(Unemo et al., 2019). However, a major public health concern worldwide is that Neisseria 
gonorrhoeae is becoming more antimicrobial resistant (AMR) (Unemo et al., 2019). This poses a 
threat to the effectiveness of available gonorrhoea treatment (Unemo et al., 2019). Due to the 
global spread of resistance to every antibiotic historically used against it, the WHO has classified 
Neisseria gonorrhoeae as a priority bacterial pathogen (Whittles et al., 2019). The remaining 
treatment, ceftriaxone, is now the first and last line treatment, with worrying signs that it may also 
fail to treat gonorrhoea soon (Eyre et al., 2018; Fifer et al., 2016).  
Syphilis 
Syphilis is a chronic bacterial infection caused by the spirochaete bacterium Treponema pallidum 
(Hook, 2017). It is estimated that there are 18 million people infected with syphilis worldwide and 
that there are 5.6 million new cases per year (Lithgow & Cameron, 2017). In England, the number 
of syphilis cases has increased between 2016 and 2017 by 20% (from 5955 to 7137 infections) 
(Iacobucci, 2018).  
Syphilis is endemic in low-income countries and occurs at lower rates in middle-income and high-
income countries (Hook, 2017). In addition to its direct morbidity, it can increase the risk of HIV 
infection and cause long-term morbidity in children born to infected mothers (Hook, 2017). It is 
estimated that 1.36 million pregnant women are infected with syphilis worldwide each year, with 
more than 500,000 of these pregnancies resulting in adverse outcomes (Lithgow & Cameron, 
2017). Syphilis can lead to stillbirth, neonatal death, premature delivery or severe disability 
(Rowley et al., 2019). 
If left untreated, syphilis can progress through a series of clinical stages and lead to irreversible 
neurological or cardiovascular complications in adults (Hook, 2017). It is an ancient disease that 
has been recognised by clinicians and the public for hundreds of years. Principles of management 
have been established for many decades. However, it still remains a challenge.  
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In Western Europe and North America, disease rates have been fluctuating periodically. Over the 
past decade, the incidence of syphilis has increased dramatically in MSM, particularly in those 
with coexistent HIV infection (Hook, 2017), living in western Europe and North America. The main 
drug recommended for syphilis is penicillin. Treatment for patients who cannot receive penicillin 
and management of patients who do not have an adequate serological response to treatment are 
common clinical problems (Hook, 2017). To date, there is no syphilis vaccine available and with 
only one main treatment, preventing, detecting and treating syphilis is highly important (Lithgow 
& Cameron, 2017).  
Hepatitis B  
Hepatitis B is one of the most common viral liver infections (Davitkov & Falck-Ytter, 2019). Over 
257 million people worldwide are chronically infected with the hepatitis B virus and it is estimated 
that there are four million acute cases per year (Davitkov & Falck-Ytter, 2019) and that one million 
people die from hepatitis B each year (Davitkov & Falck-Ytter, 2019). 
Hepatitis B can cause chronic hepatitis and cirrhosis. Further, chronic hepatitis B causes almost 
40% of cases of hepatocellular carcinoma (Stanaway et al., 2016). Hepatocellular carcinoma is a 
common primary liver cancer and a leading cause of cancer-related mortality worldwide (Balogh 
et al., 2016).  
Hepatitis B can be transmitted through infected blood, sexual intercourse and mother-to-child 
transmission. There is no virological cure for hepatitis B (Razavi-Shearer et al., 2018). However, 
existing therapies can control viral replication, an effective vaccine is available and prophylaxis 
can minimise mother-to-child transmission making elimination of hepatitis B feasible (Razavi-
Shearer et al., 2018). People with chronic hepatitis B may require long-term or lifelong therapy 
(Lok et al., 2017).  
The WHO has recommended vaccinating children for hepatitis B since the 1990s (Yang et al., 
2016). Since then, many countries have gradually adopted national immunisation programs (Yang 
et al., 2016). The hepatitis B vaccination, if used for primary prevention, can significantly lower the 
risk of infection (Yang et al., 2016). Nevertheless, a large proportion of adult populations remain 
unvaccinated (Yang et al., 2016). Another problem with hepatitis B is that most individuals with 
chronic hepatitis B are asymptomatic and ignorant of their infection status (Yang et al., 2016). 
1.5. Provision and commissioning of contraception and STI services 
The previous section illustrated that sexual and reproductive health is a major public health 
concern and highlighted the importance of services related to contraception and STIs. This 
section focuses on the provision and commissioning of SRHS. Although a global perspective will 
be provided, the focus will be on the commissioning of SRHS in England, where the field work for 
the current PhD was conducted.  
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1.5.1. Global perspective  
The burden of sexual and reproductive ill health can only be reduced if access to affordable 
services that deliver high-quality SRH care becomes universal (Glasier et al., 2006). Whether SRH 
needs are addressed depends on several factors including societal attitudes but also on legal and 
polic  afeg a d  ha  en e people  acce  o he info ma ion and e ice  he  need 
(Cottingham et al., 2019). 
In 1994, world leaders agreed to provide universal access to reproductive health services by 2015 
as part of a package for improvemen  of people  heal h and ellbeing, ed c ion of pop la ion 
growth, and promotion of sustainable development (Glasier et al., 2006). Although universal 
access has not been achieved there has been momentum in implementing SRHS in many 
countries around the world (Mazur et al., 2018). For example, over the past three decades, many 
countries have implemented family planning services (Askew & Berer, 2003). The services have 
been relatively well-financed and supported by high levels of expertise (Askew & Berer, 2003). 
The declining level of unwanted childbearing worldwide has been largely attributed to these 
services (Askew & Berer, 2003). The investments in family planning services have successfully 
led to an increase in contraceptive use in many countries (Glasier et al., 2008).  
However, there is still resistance to provide SRHS in many parts of the world (Cottingham et al., 
2019) and many people have insufficient access to a full set of SRHS, and their sexual and 
reproductive rights are not respected or protected in many countries (Starrs et al., 2018). It is 
estimated that 4.3 billion people of reproductive age worldwide will experience inadequate SRHS 
in their life (Starrs et al., 2018). 
1.5.2. Perspective from England (UK) 
Commissioning is the planning and purchasing of services to meet the needs of the population (I. 
F. Walker et al., 2016). In England, recent changes in commissioning arrangements for SRHS have 
been made and are documented in the Health and Social Care Act of 2012 (I. F. Walker et al., 
2016). These changes resulted in a reduction in the overall budget for SRHS provision in many 
parts of the country (Ashby et al., 2019). The provision of SRHS is relatively expensive with about 
a fifth of the public health spend, about £600 million, being used for contraception services and 
services related to STI (White, 2017). In total, 18% of the budget for sexual and reproductive 
health services have been cut between 2014-15 and 2018-19 (Finch, 2018).  
Since 2013, most SRHS are now provided by local authorities and clinical commissioning groups 
(CCGs). Charity and voluntary sector organisations are also involved in the delivery of some SRHS 
(Aranda et al., 2018). Hence, the commissioning of SRHS in England is highly complex.  
 
Local authorities take responsibility for planning, purchasing and monitoring most SRHS including 
the prevention and testing for HIV and the testing and treatment of sexually transmitted infections, 
including the National Chlamydia Screening Programme, and contraception (Ashby et al., 2019; 
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D. of Health, 2013; I. F. Walker et al., 2016). However, HIV treatment services are commissioned 
separately by NHS England and abortion services are commissioned by General Practitioner-led 
CCGs (S. Walker et al., 2016). Local authorities are also responsible for organising partner 
notification, an important part of STI management (Hind, 2013). Partner notification involves 
actively contacting all sexual partners of patients who test positive for an STI. The way in which 
partner notification or contact tracing is conducted largely varies in practice, ranging from brief 
advice to infected people to inform their sexual partners to more robust service provider-initiated 
tracking and tracing (G. Bell & Potterat, 2011). Table 2 provides an overview of the commissioning 
responsibilities of SRHS in England (from April 2013) (Hind, 2013).  
While regulations require local authorities to provide SRHS, they are free to decide how the 
services should be provided (Hind, 2013). There are no regulations on the number of services a 
local authority should have in an area, opening hours, waiting times, staffing levels, where services 
are located, whether services are walk-in or appointment only and which providers should be 
commissioned to provide which services (Hind, 2013). 
The changes in the delivery of SRHS has been challenging for local authorities but also provided 
a unique opportunity for SRHS to be re-designed and further developed (I. F. Walker et al., 2016). 
For example, STI testing and treatment and contraception used to be available in different settings 
but in many areas these services have become integrated meaning that people only need to visit 
one site for their SRHS (D. of Health, 2013; PHE & DH, 2018). Policymakers hoped that the 
integration of SRHS would improve patient outcomes, while also being more cost-effective for 
commissioners (D. of Health, 2013).  
With local authorities now procuring SRHS using tender processes (Ashby et al., 2019) many 
different providers have become involved in providing SRHS including: general practices, 
dedicated sexual health clinics, social enterprises, community interest companies (COC) and 
pharmacies.  
In summary, this section showed that the commissioning and provision of SRHS varies across 
countries. In England, local authorities are responsible for commissioning most SRHS and deliver 
the services through different health providers including pharmacies. 
The next section provides an introduction into pharmacies and their role in the provision of SRHS.  
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TABLE 2 SEXUAL AND REPRODUCTIVE HEALTH COMMISSIONING RESPONSIBILITIES SINCE APRIL 2013 (HIND, 
2013, P. 17) 
Commissioning of sexual and reproductive health services in England 
Local authorities 
commission 
x Comprehensive sexual health services, including: 
contraception, including LESs (implants) and NESs 
(intrauterine contraception) including all prescribing 
costs  but excluding contraception provided as an 
additional service under the GP contract  
x STI testing and treatment, chlamydia testing as part 
of the National Chlamydia Screening Programme 
and HIV testing; notification of sexual partners of 
infections persons 
x Sexual health aspects of psychosexual counselling  
x Any sexual health specialist services, including 
young people's sexual health and teenage 
pregnancy services, outreach, HIV prevention and 
sexual health promotion work, services in schools, 
colleges and pharmacies 
Clinical Commissioning 
Groups Commission 
x Most abortion services  
x Sterilisation 
x Vasectomy 
x Non-sexual health elements of psychosexual health 
services 
x Gynaecology, including any use of contraception for 
non-contraceptive purposes. 
The NHS Commissioning 
Board commissions 
x Contraception provided as an additional service 
under the GP contract 
x HIV treatment and care, including post-exposure 
prophylaxis after sexual exposure 
x Promotion of opportunistic testing and treatment for 
STIs, and patient requested testing by GPs 
x Sexual health elements of prison health services 
x Sexual Assault Referral Centres 
x Cervical screening 
x Specialist foetal medicine 
 
1.6. Pharmacies and their role in the provision of sexual and reproductive 
health services 
The practice of pharmacy as it is known today dates back to the 18th century (Meyerson et al., 
2013). A pharmacy is not simply a drug store but a place where licensed pharmacists oversee the 
dispensing of medicines after receiving a valid prescription or drug order by a legal prescriber 
(Kelly, 2018). Pharmacies directly serve the public (Meyerson et al., 2013) and have the purpose 
to help patients to make the best use of their medication (Kelly, 2018). Pharmacies can be 
independent or chains and be freestanding buildings (pharmacy stores) or be located in other 
places such as chemists, supermarkets, medical buildings and hospitals (Goode et al., 2019; Kelly, 
2018; Meyerson et al., 2013).  
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This thesis focuses on community pharmacies which serve the general public, in contrast to 
hospital pharmacies which mainly deal with inpatients. Community pharmacies are the most 
visited health-care destination and community pharmacists are the third largest health care 
professional group after physicians and nurses. In England, a four year Master of Pharmacy 
course and one pre-registration year with a registration examination set by the General 
Pharmaceutical Council are required to become a pharmacist (Altman et al., 2018). Pharmacists 
are registered by a board of pharmacy (Kelly, 2018). 
According to data from NHS digital, there were more than 11,500 pharmacies in England between 
2018 and 2019 (NHS Digital, 2020). Pharmacies offer accessibility, expertise in therapeutics, face-
to-face contact and skills in managing drug problems and adherence (Nazar et al., 2015). They 
are widely distributed covering a wide variety of geographical areas, often in areas of highest 
deprivation, and many have long opening hours (T. J. Brown et al., 2016). They also offer 
anonymity and have the potential to reach those in greatest need. Hence, pharmacy access can 
help overcome barriers for people who do not want to or cannot access services from other health 
care providers (Gonsalves & Hindin, 2017). Pharmacy-based services therefore may help to 
address socioeconomic inequalities (T. J. Brown et al., 2016).  
Pharmacies have been seen as underutilised and policymakers have started to recognise the 
importance of extending pharmacy staff roles to meet growing health-care demands. Several 
countries including Australia, Canada, New Zealand and the United States are funding public 
health services in pharmacies (Ali M.K. Hindi et al., 2018). Recent policies aim to extend 
pha maci  p ac ice (Altman et al., 2018) beyond dispensing into more clinical and patient-
centred roles (Altman et al., 2018). The expansion of pharmacists  role has been promoted by the 
WHO (Goode et al., 2019).  
Although there is a trend for pharmacists to take on a bigger role in the provision of care, the 
expansion of pharmacists into public health roles has developed inconsistently and the provision 
of services delivered by community pharmacies vary widely by country and even within countries 
(Goode et al., 2019). 
To facilitate addressing people  need , many community-based pharmacies are now adding 
semi-private counselling areas or private counselling rooms to deliver further services (Goode et 
al., 2019). However, providing further services presents challenges for pharmacies. These include 
the integration of technology into the pharmacy to document the delivery of services and keep 
e  heal h eco d  (Goode et al., 2019). Further, for pharmacists to expand their role, they need 
to continue their professional development and undergo additional training with a focus on user-
centred care (Goode et al., 2019). 
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The UK ha  been a  he fo ef on  of e panding pha maci  ole , and many pharmacies in the 
UK provide public health services such as: smoking cessation, lifestyle advice, substance misuse 
management and SRHS (Ali M.K. Hindi et al., 2018). SRHS has been identified as one area in 
which pharmacies could be more involved. 
Although pharmacies are unlikely to replace other SRHS providers, they can complement the 
provision of several services. In England, pharmacies have been involved in the provision of SRHS 
such as pregnancy tests and treatment for thrush for several years (B. Taylor, 2008). Providing 
access to further services has the potential to positively impact STI rates and unwanted pregnancy 
and thus to reduce the public health and other societal costs associated with these issues (D. of 
Health, 2013). Further, pharmacies allow more vulnerable groups to engage with SRHS (D. of 
Health, 2013).  
In England, the contribution of pharmacies in addressing SRH needs is variable across the 
country. While in some areas local authorities offer only a limited range of services through 
pharmacies, others have been more ambitious. The local authorities in Birmingham (England) 
have introduced a comprehensive range of services in pharmacies through their sexual health 
provider Umbrella. Umbrella and its pharmacy services are introduced in the next section. 
1.7. Umbrella and their pharmacy services 
As described in section 1.5.2, local authorities in England often put out a tender for SRHS. In 
Birmingham the commissioning parties, Birmingham City Council and Solihull Metropolitan 
Borough Council, put out a tender and University Hospitals Birmingham NHS Foundation Trust 
(UHB) de eloped a bid ba ed on he commi ione  i ion and c ea ed a no el app oach on ho  
SRHS could be delivered (Jewell et al., 2017). They were successfully awarded the tender in 
December 2014 and launched the SRHS under the name Umbrella. Umbrella, the service 
provider, has been delivering SRHS through several clinics, online provision, General Practices 
(GP) and community pharmacies since August 2015. Pharmacies which want to deliver Umbrella  
services have to fulfil certain criteria including having a private consultation room to deliver 
Umbrella s SRHS. More than 120 pharmacies across Birmingham are currently (as of 2020) 
delivering Umbrella SRHS.  
Umbrella s pharmacy services are prescription free and free of charge for the user. All costs for 
the pharmacy services are covered by the Birmingham City Council via Umbrella. Pharmacies 
receive a fixed fee for each SRHS based on the average amount of time required per consultation, 
plus the cost of any drugs or devices. 
Pharmacy staff record which Umbrella service is being used and collect data on all users of 
Umbrella  pha mac  e ice. Thi  da a i  o ned b  Umbrella. For service users under the age of 
18, a safeguarding assessment is carried out alongside the standard data collection to protect 
young people from potential harm (e.g. sexual exploitation). All pharmacy users are obliged to 
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provide their name, date of birth and a Birmingham postcode. However, no identify check is 
completed to verify pha mac  e  de ail . 
Pharmacies delivering Umbrella s SRHS ope a e a Tie  1  or a Tie  2  le el.  
Tie  1  pha macie  provide emergency contraception (EC) and condoms from available stock, 
dispensed directly to pharmacy users. They also dispense STI self-sampling kits (testing for 
chlamydia, gonorrhoea, HIV and syphilis, plus hepatitis B for men who have sex with men) that 
have been pre-ordered via Umbrella s website. STI self-sampling kits are the only service that can 
be pre-ordered from the Umbrella website and collected at any Umbrella pharmacy. Pharmacy 
aff o king a  Tie  1  pha macie  al o p o ide self-sampling kits testing for both chlamydia and 
gonorrhoea from available stock directly to women presenting for EC. 
In addition to the services offe ed b  Tie  1  pharmacies, Tie  2  pha macie  provide oral 
contraception, contraceptive injection and chlamydia treatment from in store stock. F he , Tie  
2  pha macie  ha e STI elf-sampling kits (testing for chlamydia, gonorrhoea, HIV, syphilis, plus 
hepatitis B for men who have sex with men) in stock and can provide them directly to all pharmacy 
e . Finall , Tie  2  pha macie  can offe  omen p e en ing fo  emergency contraceptive with 
one emergency contraception pill that they can take immediately and one that they can take away 
for future use (advance emergency contraception).  
The total number of pharmacies in Birmingham has decreased between August 2015 and August 
2018 from 301 to 285 (Birmingham Health and Wellbeing Board, 2018). The number of Umbrella 
pharmacies has also changed over time: between August 2015 and August 2018 the number of 
Tie  1  pha macie  dec ea ed f om 158 o 80. Ho e e , he n mbe  of pharmacies offering more 
e en i e Tie  2  e ice  inc ea ed f om 18 o 47.  
Hormonal contraception such as emergency contraception, oral contraception and the 
contraceptive injection are restricted to females only, but males can access the pharmacy for 
condoms, STI self-sampling kits and chlamydia treatment.  
All services except the STI self-sampling kits are accessible to users over the age of 13. The upper 
age limit for hormonal contraception is 60 years. For the remaining services there is no upper age 
limit. STI self-sampling kits can only be pre-ordered by over 16-year olds. However, women 
between 15 and 24 can be offered a chlamydia and gonorrhoea STI self-sampling kit when 
presenting for emergency contraception.  
An overview of Umbrella  pha macy services and the eligibility criteria is provided in Table 3.  
Umbrella services can only be provided by pharmacy staff who have undergone training and 
assessment by Umbrella s education team. Umbrella pharmacies have to ensure that at least 
ome of hei  pha maci  a e ained o deli e  he e ice . T aining fo  Tie  2  e ice  i  mo e 
comp ehen i e han Tie  1  e ice . Pharmacy healthcare assistants are only allowed to deliver 
condoms and STI self-sampling kits after they have obtained training from Umbrella s education 
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team. However, it is up to the pharmacy to decide whether they train their pharmacy healthcare 
assistants to deliver Umbrella s SRHS.  
TABLE 3 UMBRELLA'S PHARMACY SERVICES 
Umbrella s pharmac  ser ices and da a collec ion ools 
Type of Umbrella 
pharmacy 
service  
Umbrella  Pharmacy 
Services  





13-60 Women Tier 1 & Tier 2 
Referral or Appointment for 
the copper coil at closest 
sexual health clinic 
13-60 Women Tier 1 & Tier 2 
Oral Contraception  13-60 Women Tier 2 
Contraceptive Injection  13-60 Women Tier 2 
Condoms 13 Women and Men Tier 1 & Tier 2 
STI testing 
services  
Collection of pre-ordered 
STI self-sampling kits 
testing for up to five STI  
16 Women and Men Tier 1 & Tier 2  
STI self-sampling kits 
testing for up to five STI 
provided directly to 
pharmacy users 
16 Women and Men  Tier 2  
STI self-sampling kit testing 
for chlamydia & 
gonorrhoea  
15-24 Women Tier 2 
STI treatment 
service  
Chlamydia Treatment  13 Women and Men  Tier 2  
 
The SRHS that Umbrella offers will now be described in more detail.  
Emergency contraception  
Emergency contraceptive pills  
Hormonal emergency contraception in the form of emergency contraceptive pills (ECPs) can be 
used after sexual intercourse to prevent pregnancy (Black & Hussainy, 2017), but only where 
ovulation has not yet occurred. Emergency contraception is used in more than 148 countries 
worldwide (Mooney-Somers et al., 2019). 
In the 1980s a combined oestrogen-progesterone pill was specifically licenced as EC (Murphy & 
Pooke, 2019). The most common source of EC since its licensing was GPs, but EC could also be 
ob ained f om NHS comm ni  famil  planning clinic  o  o ng people  e al heal h centres. 
However, by the mid 1990s, evidence emerged that the provision was inadequate (Schenk, 2003), 
largely as a result of a reluctance to get EC from GPs, and there was a shortage of clinics open at 
appropriate times (Crosier, 1996; Gbolade et al., 1999; Peckham, 1997).  
In January 2001, pharmacy provision of levonorgestrel-only emergency contraception came into 
effect in the UK (Schenk, 2003), after France, the second European country to make emergency 
contraception available without prescription from pharmacists. In some European countries, 
PhD Thesis | Introduction | Julia Gauly 
16 
 
emergency contraceptive pills only became available much later: for example, in Germany it only 
became available without prescription from pharmacies in March 2015 (Said et al., 2019).  
According to a survey by Public Health England (PHE), the large majority of local authorities (93%) 
provide emergency hormonal contraception (EHC) through pharmacies (Public Health England, 
2017). It is the most commonly provided pharmacy-based SRHS provided by local authorities. 
Umbrella provides both ECPs containing levonorgestrel or ulipristal acetate. In Tie  2  
pharmacies, pharmacy users can also get advance EC meaning that they will be given an ECP for 
future usage. Pharmacists can additionally provide the user with a referral for the copper 
intrauterine device, which is introduced in the next section. 
Copper intrauterine device  
Copper intrauterine devices or copper coils have to be inserted by a trained healthcare 
professional. The copper intrauterine device is the most effective method of emergency 
contraception which contains no hormones. Its failure rate is less than 1% and in contrast to 
emergency contraceptive pills, it can also prevent implantation of the egg in case fertilisation has 
already occurred (Li & Gemzell-Danielsson, 2019). It can be inserted up to five days after ovulation 
(Black & Hussainy, 2017). In addition to its use as EC, the copper coil also provides ongoing 
contraception for up to 12 years (Kaller et al., 2020).  
Umbrella provides people presenting for emergency contraception with the option to get a referral 
or appointment for insertion of a copper coil at a sexual health clinic in Birmingham. According to 
a survey by PHE, only 3% of local authorities were providing any type of long acting reversible 
contraception through pharmacies and it is not specified whether the copper coil was amongst 
these contraception methods being offered (Public Health England, 2017).  
Umbrella also provides other contraceptive methods, which are outlined below.  
1.7.1. Ongoing oral contraception 
Combined oral contraception (COCs) use is highest in those in and around their late teens and 
early twenties, while progesterone-only pills tend to be taken more by older women (J. Gill & 
Taylor, 2017). Progesterone-only pills (POPs) avoid some of the contraindications associated with 
the intake of combined oral contraception. However, they also have disadvantages compared to 
the combined pill. For example, they have to be taken within three hours of the target time (as 
opposed to 12 hours for COCs) for their efficacy to be maximised (J. Gill & Taylor, 2017).  
Oral contraception (OC) is the most common form of contraception in Africa, Europe, and 
Oceania, and the most commonly used reversible contraception among married women or 
women in a partnership in America (Grindlay, Burns and Grossman, 2013).  
Ongoing oral contraception has been free of charge through the National Health Service (NHS) 
in the UK since 1974 (Boog et al., 2019). Due to cuts in funding, the advisory group on 
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contraception reported in 2017 that over the previous two years, contraceptive services in over 
one-third of English local councils had been closed or were under threat (Boog et al., 2019).  
The services where women traditionally get their contraception such as GPs and SRH clinics are 
facing cuts, resulting in reduced appointment numbers, longer waiting times and restricted 
opening hours (Boog et al., 2019). Making oral contraception easily accessible is important for 
women wishing to take OCs to prevent pregnancies by using oral contraception (Grindlay, Burns 
and Grossman, 2013). 
Providers are therefore concerned whether cuts in funding will lead to reduced access to 
contraception (Boog et al., 2019). Pharmacy contraception provision has therefore been 
highlighted as an area for development (Boog et al., 2019). In the UK, COCs and POPs are 
currently a prescription-only pills but can be supplied under instruction from a patient group 
direction (PGD) (Boog et al., 2019). A PGD is a legal mechanism enabling supply of a prescription 
only medication (Boog et al., 2019). The document allows specified healthcare professionals to 
supply a medicine directly to patients who fit into predefined criteria without needing a 
prescription or instruction from a prescriber (Boog et al., 2019). 
In Tie  2  Umbrella pharmacies, ongoing hormonal contraception (progesterone-only pills and 
combined pills) can be provided to users through the PGD without prescription. The survey from 
Public Health England showed ha  onl  3% of local a ho i ie  p o ide o he  con acep ion , 
which may include ongoing hormonal contraception, through pharmacies (Public Health England, 
2017). In addition to oral contraception, Umbrella also provides the contraceptive injection, which 
is the subject of the next section.  
1.7.2. Contraceptive injection 
The contraceptive injection is a reliable method of contraception for those who are able to receive 
regular doses in a timely fashion (Trussell, 2011). In the UK, there are two injections available: 
depot medroxyprogesterone acetate in the intra-muscular version (150 mg DMPA-IM given every 
12 weeks, Depo-ProveraVR) and the more recently licensed subcutaneous version (104 mg 
DMPA-SC given every 13 weeks, Sayana® PressVR). The latter one is easier to administer and 
can be self-administered (R. Heller et al., 2017). Same as oral contraception, the contraceptive 
injection can be provided through the pharmacy via a PGD (R. Heller et al., 2017).  
Research from a specialised contraceptive service in Scotland indicated that the option to receive 
injection from community pharmacies might improve the uptake of the contraceptive injection. 
(Rebecca Heller & Cameron, 2016). However, evidence on the delivery of the contraceptive 
injection through pharmacies to date is limited. Two small studies from the United States have 
shown that a pharmacy-based contraceptive injection is feasible (Maderas & Landau, 2007; 
Picardo & Ferreri, 2010), however only one study from the UK has looked at the feasibility of the 
contraceptive injection to date (R. Heller et al., 2017).  
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Only 3% of local authorities provide long-acting reversible contraception and it is not clear 
whether this includes the contraceptive injection (Public Health England, 2017).  
Umbrella provides the contraceptive injection Sayana® PressVR in Tie  2  pharmacies.  
1.7.3. Condoms 
The male condom is a barrier based means of contraception (J. Gill & Taylor, 2017). Condoms 
are a cost-effective contraceptive method (W. Evans et al., 2019) which can, when used correctly 
and consistently, not only prevent unwanted pregnancies but also STIs such as chlamydia, 
gonorrhoea, syphilis and HIV (Anstee et al., 2019; Ryder et al., 2015; Stone et al., 2018). The use 
of condoms is now higher than ever before and it is estimated that this has prevented 50 million 
HIV infections since the 1980s (W. Evans et al., 2019).  
In England, the first multicomponent condom distribution scheme, called C-Card, was developed 
in 1989. The nationwide C-Card scheme offers free access to condoms for individuals between 
13 and 25 years (J. Gill & Taylor, 2017). C-Card venues include pharmacies, youth voluntary 
organisations and education settings, General Practices, and sexual health clinics; but also work-
based learning providers, sports and leisure venues and supported housing providers (Public 
Health England, 2015). Condoms can also be purchased in community pharmacies and via 
vending machines and/or the internet (J. Gill & Taylor, 2017). 57% of local authorities provide 
condoms through pharmacies (Public Health England, 2017), including Umbrella pharmacies. 
Umbrella pharmacies also provide written condom instructions for pharmacy users.   
While condoms can prevent STIs, testing can help to detect STIs for early treatment. Information 
on STI self-sampling kits is described in more detail in the following section.  
1.7.4. STI self-sampling kits  
Case identification and treatment is an effective form of preventing onward transmission of STIs 
(Barnard et al., 2018). Self-sampling methods are novel approaches to screening where the 
sample for STI testing is collected by the patient rather than a health professional (Griner et al., 
2019).  
With the introduction of nucleic acid amplification tests (NAATs), which are the recommended test 
by the WHO for chlamydia and gonorrhoea (H. Wood & Gudka, 2018), asymptomatic patients can 
carry out self-sampling for STIs at home, also referred to as home-based testing. When screening 
for syphilis, HIV and hepatitis B, blood samples are needed.  
Chlamydia, gonorrhoea, and syphilis screening kits can be purchased from some pharmacies in 
the USA and in the UK. Gonorrhoea kits can also be purchased from selected pharmacies in 
Australia (H. Wood & Gudka, 2018). Some pharmacies in the UK also provide free screening kits 
for chlamydia and gonorrhoea over the counter (H. Wood & Gudka, 2018). To date, the National 
Chlamydia Screening Programme in the UK, implemented in 2008, is the only nationally 
coordinated screening initiative involving community pharmacies (H. Wood & Gudka, 2018).  
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HIV self-sampling kits, which require individuals to collect a specimen and send it to a laboratory 
for testing, have been available for some time in the UK and Belgium (Hoyos et al., 2018). 
Pharmacist-led hepatitis B screening has been trialled in England.  
While 73% of local authorities provide chlamydia screening in pharmacies, only 11% reported 
testing for other STIs, and only 6% indicated that they provide HIV testing (Public Health England, 
2017).  
Umbrella provides self-sampling kits testing for chlamydia, gonorrhoea, HIV, syphilis and hepatitis 
B. Chlamydia and gonorrhoea NAAT testing kits consist of either a vulvovaginal swab (for females) 
or a urine collection pot (for males) (Banerjee et al., 2018). Further, they include a lancet and 
blood-sample collection tube for HIV, syphilis and hepatitis B (Banerjee et al., 2018). Depending 
on the site of exposure, kits can also include rectal and oral swabs (Banerjee et al., 2018).  
Once people have completed their STI samples, they can post the STI self-sampling kits to the 
local laboratory for processing free of charge. All those who test positive for an STI receive an 
automated text message via their phone, usually within 10 working days. Depending on the 
permissions granted by the person who ordered the STI self-sampling kit, the text message is 
followed up by a health advisor from the sexual health clinic in Birmingham via telephone, or a 
letter to the patient or their GP. People with a positive test result are provided with treatment and 
asked to help by informing their sexual partners that they may be at risk of an STI. Umbrella s 
health advisors at the sexual health clinic in Birmingham can call sexual partners of the patient 
without revealing the patient  name. Al e na i el , he pa ien  can choo e o con ac  hei  e al 
partners themselves. While treatment for most STIs has to be obtained from the Umbrella clinic, 
Tie  2  pha macie  offe  chlam dia ea men . Thi  i  o lined in he ne  ec ion.  
1.7.5. Chlamydia Treatment  
Chlamydia infections are usually easily treated (Kalwij et al., 2010). More than 95% of those treated 
are negative for chlamydia after two weeks (Kalwij et al., 2010). No test of cure is needed if 
effective treatment has been taken, except in pregnant women (Kalwij et al., 2010). The 
recommended first-line treatment is doxycycline 100mg twice a day orally for seven days 
(Draeger, 2019a). In patients allergic to tetracyclines, azithromycin 1g is given as a single dose, 
then 500mg per day for two days (Draeger, 2019a). Umbrella uses a PGD to supply treatment for 
chlamydia through pharmacies (C. Anderson & Thornley, 2011). People attending for chlamydia 
treatment in the pharmacy do not need to prove that they tested positive for chlamydia, as some 
patients might have deleted the text for privacy reasons.  
Only 11% of local authorities indicated that they provide STI screening and treatment through 
pharmacies (Public Health England, 2017) and it is not clear how many local authorities provide 
chlamydia treatment.  
Only a few papers on pharmacy-based chlamydia treatment have been published to date (C. 
Anderson & Thornley, 2011; Baraitser et al., 2007; McClure & Cameron, 2016).  
PhD Thesis | Introduction | Julia Gauly 
20 
 
1.8. Focus of this project on pharmacy-based SRHS  
As shown in the previous section, the local authorities in Birmingham offer a large range of SRHS 
through Umbrella and provide more services than most other local authorities in England. This 
provided a unique opportunity to explore the delivery of an implemented and comprehensive 
pharmacy service in this PhD project.  
The focus of this project was to explore the experiences of pharmacy staff and users and also the 
utilisation of pharmacy-based SRHS. The reason for exploring experience and utilisation of 
pharmacy-based SRHS will be outlined in the following section. 
1.8.1. Importance of exploring user and staff experience  
Traditionally, health service design did not focus on people and experiences but on systems, 
resources and care services (DonHee Lee, 2019). However, user experience has been identified 
as important in a wide range of applications and has increasingly been recognised as an important 
indicator of healthcare quality (Doyle et al., 2013; S. of S. for Health, 2008). Evidence on user 
experience is often cited in health policies around the world (Baker, 2001; Gleeson et al., 2016). 
Healthcare organisations in England have to review patient experience as part of their quality and 
performance reporting, and sometimes funding is dependent on achieving improvement in patient 
experience (Gleeson et al., 2016). Patients themselves believe that their experience should be 
part of healthcare service design process and, in England, patient experiences are increasingly 
visible to the public through online resources such as NHS Choices (Gleeson et al., 2016).  
Patient experience is the result of human-to-human interaction and exploring patient experience 
is therefore seen as part of a human- or patient-centred approach to service design (DonHee Lee, 
2019). Each pa ien  e pe ience i  niq e and depend  on he pa ien  personality, emotion, 
diversity and context (DonHee Lee, 2019). It is therefore a rich source of important information 
for designing healthcare services (DonHee Lee, 2019). Exploring patient experience can help to 
nde and pa ien  eq i emen  and also provides an opportunity to address problems and to 
learn from patients on how to improve care (K. A. Fisher et al., 2019).  
Improving patient experience is regarded as important in the UK and worldwide (Coombes, 2008; 
Coulter, 2005; Fund, 2008; S. of S. for Health, 2008; White, 2012). This is because positive patient 
experience has shown to have implications with regards to outcomes such as patient safety, 
clinical effectiveness, greater adherence to treatment recommendations, and lower use of 
additional healthcare such as repeat hospitalisations or overuse of primary care (Doyle et al., 
2013). Further, patient experience is associated with ease of acquisition, loyalty and the intention 
to revisit (DonHee Lee, 2019). To improve patient experience, it is important to capture patient 
experiences during care episodes or service delivery (Male et al., 2017).  
U e  e pe ience  ha e been p io i i ed o e  ho e of aff (Goodrich, 2018). However, staff 
experience should also be central in healthcare design. Exploring staff experiences can ensure 
that the right changes occur to improve staff work lives (Goodrich, 2018). Further, it is evident that 
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e  and staff experiences are intrinsically linked and improving staff experience has shown to 
consequently al o imp o e pa ien  e pe ience  (Goodrich, 2018). Exploring pharmacy staff 
experiences can also make them more engaged and motivated through being involved in making 
changes (Goodrich, 2018).  
The main focus of this PhD thesis was therefore to e plo e bo h e  and aff experiences as 
both can contribute to the identification of changes that would benefit both groups and hence, 
lead to the development of recommendations for service optimisation. In this thesis, people 
attending the pharmacy are referred to as pharmacy users rather than patients as they may be 
healthy.  
1.8.2. Importance of exploring service utilisation 
Healthcare utilisation can be defined as the quantity of healthcare services accessed by a 
population. Over the last decade, there has been growing enthusiasm for data analytics as well as 
growing appreciation of the potential usefulness of big data in transforming public health (Vayena 
et al., 2018). At the institutional level, the analysis of electronic health records may greatly expand 
the capacity to generate new knowledge (Vayena et al., 2018). It is commonly acknowledged that 
health-related data routinely collected as part of everyday practice have great potential to improve 
pa ien  ca e, ci i en  li e  and p ofe ional e ice  (K. H. Jones et al., 2017). Understanding 
patient profiles enables interventions and policies to be more strategically targeted.  
Internationally, there has been considerable debate about the role of data in supporting quality 
improvement in health care (J. Greenhalgh et al., 2018). The utilisation of health-care services 
depends on many factors including the quality of health-care, cultural beliefs and practices, and 
socio-economic factors such as age, sex, and ethnicity (Abera Abaerei et al., 2017) . It is important 
to quantify the degree to which individuals who are not well seek care from public health-care 
facilities such as pharmacies (Abera Abaerei et al., 2017). Despite potential benefits, the use of 
user profiles has not yet received much attention in health care informatics research (LeRouge et 
al., 2013). A recent study from the United States described associations between patient 
demographics and service utilisation at pharmacies and concluded that future research should 
explore how patient characteristics affect the use of pharmacy services to facilitate targeted 
marketing of expanded pharmacy services to different populations (Patterson & Holdford, 2019). 
Demographic characteristics have been found to be associated with patient preferences for health 
care providers. For example, in 2008, Franic et al. (2008) compared a number of patient 
characteristics across community pharmacy settings and reported differences in the mean age 
and the proportion of rural patients between different settings (Franic et al., 2008).  
Associations between demographic characteristics and utilisation of expanded pharmacy services 
have not been investigated systematically. A better understanding of these associations might 
provide insights into how pharmacy services provide value to specific demographic groups, 
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ultimately informing more effective and targeted development and marketing of pharmacist 
services to particular patient groups (Patterson & Holdford, 2019).  
Hence, the utilisation of a wide range of pharmacy-based SRHS was explored in the current PhD 
project.  
1.9. Thesis Aim and Objectives 
This section outlines the thesis aim and objectives. The overall aim of this PhD was to develop 
recommendations for optimisation of pharmacy-based SRHS. To achieve this goal, e  and 
staff experiences and the utilisation of pharmacy-based SRHS were explored as mentioned in the 
previous section.  
1.9.1. Aim 
x To develop recommendations for the service optimisation of pharmacy-based sexual 
and reproductive health services in England (UK)  
1.9.2. Objectives 
1. To describe the utilisation of pharmacy-based sexual and reproductive health services 
using a retrospective quantitative study  
2. To mma i e ha  i  kno n abo  pha mac  e  and pha mac  aff a i de  and 
experiences of pharmacy-based sexual and reproductive health services using a 
systematic review  
3. Based on the findings of the systematic review and retrospective quantitative study, to 
e plo e pha mac  e  and pha mac  aff a i de  and e pe ience  and to explore 
the implementation of pharmacy-based sexual and reproductive health services using 
semi-structured interviews  
4. To synthesise all findings to develop recommendations for service optimisation 
The methods used to address the objectives outlined above are justified in the subsequent 
chapter. 
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1.10. Research Design 
To achieve the overall research aim, two approaches were undertaken: firstly, exploration of 
experiences and secondly, exploration of utilisation of pharmacy-based SRHS.  
To explore the utilisation of pharmacy-based sexual and reproductive health services, a 
retrospective quantitative study was conducted. To explore experiences, a systematic review 
synthesising qualitative and quantitative evidence was initially conducted.  
Both the systematic review and the retrospective study informed the interview study, which is the 
heart of this PhD project. It involved the collection of primary data on e  and staff experiences 
with pharmacy-based SRHS.  
The results from all three components were synthesised. Based on the integrated findings, 
recommendations for service optimisation were developed. The research design is illustrated in 
Figure 3.  
 
FIGURE 3 RESEARCH DESIGN 
1.11. Thesis Structure 
The current thesis has ten chapters including this introduction chapter. Figure 4 provides an 
overview of the thesis structure and illustrates in which chapters the four thesis objectives are 
addressed.  
Chapter 2 provides background to the methodological stance and approach for this thesis. In this 
chapter, all methods used in this thesis are justified along the different thesis objectives. The 
methods themselves are explained in subsequent chapters.  
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The retrospective study is presented in chapters 3 and 4. The aim of this retrospective study was 
o de c ibe he ili a ion of pha mac -ba ed SRHS . Chap e  3 de c ibe  he me hod  of he 
retrospective study and chapter 4 provides the results and discussion of the retrospective study.  
Chapter 5 and Chapter 6 report the systematic review which addressed the second objective of 
the thesis which was o mma i e ha  i  kno n abo  pha mac  e  and pha mac  aff 
experiences of pharmacy-based sexual and reproductive health services . While chapter 5 
describes the methods used to conduct the systematic review, chapter 6 presents the results and 
discussion of the systematic review.  
Both the retrospective study (presented in chapter 3 and chapter 4) and the systematic review 
(presented in chapter 5 and chapter 6) inform the qualitative interview study, which is presented 
in the chapters 7 and 8. Chapter 7 outlines the methods used for the interview study and chapter 
8 presents the results and discusses the interview study findings.  
Chapter 9 and Chapter 10 address objective 4, which a  to synthesise all findings to develop 
recommendations for service optimisation . In chapter 9, the methods used to synthesise the data 
are explained, and the results of the data synthesis presented. In the final chapter (chapter 10), 
recommendations for service optimisation are then outlined based on the results of the data 
synthesis. Then, the strengths and limitations of the thesis are presented and the dissemination 
plan for the thesis findings and recommendations discussed. The thesis ends with the conclusion, 
which highlights the key contributions of this mixed methods project.  




FIGURE 4 OVERVIEW OF THESIS STRUCTURE 
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1.12. Research team members 
The PhD project was supported by several research team members. Both academic supervisors, 
Dr Helen Atherton (H.A.) and Prof Jonathan Ross (J.R.) supported the conduct of the whole 
project.  
Two medical students at Warwick Medical School, Isobel Hall (I.H.) and Irekanmi Soda (I.S.) 
supported the conduct of the systematic review. The review was further supported by the 
specialist librarian Samantha Johnson at Warwick University (S.J.) and Prof Xavier Armoiry (X.A.), 
a former researcher at Warwick Medical School. 
The retrospective study was supported by Dr Peter K Kimani (P.K.), Associate Professor in Medical 
Statistics at Warwick Medical School, and the interview study by Dr Jo Parsons (J.P.), a research 
associate at Warwick Medical School with extensive experience in qualitative research.  
Dr Amy Grove (A.G), co-developer of the Pillar Integration Process and Associate Professor at 
Warwick Medical School, provided advice on the conduct of the data synthesis.  
Since Dr Helen Atherton was on sick leave since April 2020, Prof Jeremy Dale co-supervised the 
write up of the PhD from April 2020 to September 2020.  
The individual contributions of the research team members are acknowledged in the relevant 
chapters.  
1.13. Chapter summary  
This chapter was the first of ten thesis chapters. It began by explaining what is understood by 
sexual and reproductive health (SRH) and sexual and reproductive health services (SRHS) in 
general. Afterwards, the definition of SRHS for this project was outlined. In this thesis, SRHS are 
defined as services relating to contraception and sexually transmitted infections. It was shown 
why these SRHS are important. Then, it was explained how SRHS are commissioned and provided 
around the world and in England (UK), in particular, and pharmacies and their role in delivering 
SRHS were introduced. Following this, an overview of the integrated and comprehensive 
pharmacy service Umbrella was provided as their services were explored in this PhD thesis. Next, 
the focus of this PhD project on experience and the utilisation of pharmacy-based SRHS was 
justified. Subsequently, the aim and objectives of this thesis and the research design were 
presented. Afterwards, an overview of the thesis structure was offered. Next, the research team 
members who supported the conduct of this PhD project were introduced. The following chapter 
(chapter 2) is the background to the methodological approach. In this chapter, the methodological 
stance of the thesis is explained, and a rationale presented for all methods used in this PhD thesis. 
Descriptions of the methods for each sub-study are provided in subsequent chapters.  
  
PhD Thesis | Background to the methodological approach | Julia Gauly 
27 
 
2. Background to the methodological approach 
2.1. Chapter overview 
This chapter outlines the background to the methodological approach for this thesis. It begins by 
reiterating the aim and objectives of the thesis. Then, the methodological stance of the thesis is 
presented. Afterwards, the different research methods used to address each objective of the 
thesis are discussed. The methods themselves are described in subsequent chapters.  
2.2. Thesis Aim and Objectives 
2.2.1. Aim 
x to develop recommendations for the service optimisation of pharmacy-based sexual and 
reproductive health services in England (UK)  
2.2.2. Objectives 
1. To describe the utilisation of pharmacy-based sexual and reproductive health services 
using a retrospective quantitative study  
2. To mma i e ha  i  kno n abo  pha mac  e  and pha mac  aff a i de  and 
experiences of pharmacy-based sexual and reproductive health services using a 
systematic review  
3. Based on the findings of the systematic review and retrospective quantitative study, to 
e plo e pha mac  e  and pha mac  aff a i de  and e pe ience  and to explore 
the implementation of pharmacy-based sexual and reproductive health services using 
semi-structured interviews 
4. To synthesise all findings to develop recommendations for service optimisation 
2.3. The methodological stance of this thesis 
A paradigm can be defined as a set of assumptions concerning reality (ontology), knowledge of 
reality (epistemology), and the particular ways of knowing that reality (methodology) (Guba, 1990). 
While both qualitative and quantitative approaches can inform policy and practice (Noyes et al., 
2019), they are based on different paradigms, which largely contrast in their ontological, 
epistemological and methodological positions (see Table 4). They are also based on different 
underlying philosophies. Whereas quantitative research is based on positivism, which implies that 
all phenomena can be studied objectively through empirical experimentation, qualitative research 
is based on interpretivism and constructivism, which imply that meaning is created by human 
actors.  
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However, that qualitative and quantitative approaches are based on different paradigms does not 
mean that multiple methods cannot be used in one research project (Sale et al., 2002). Instead, 
qualitative and quantitative approaches can be combined to complement each other (Sale et al., 
2002).  
The approach where both qualitative and quantitative methods are used is referred to as mixed 
methods (Schoonenboom & Johnson, 2017). Compared to monomethod research it has the 
potential to allow richer insights to be gained and therefore lead to superior research (R. B. 
Johnson & Onwuegbuzie, 2004). Acknowledging that sometimes phenomena cannot be fully 
understood by using only one approach (Venkatesh et al., 2013), the use of both types of evidence 
to address an overall research question has increased in popularity over the past years in many 
fields including health research (Bryman, 2006; Creswell, 2011).  
Mixed methods research can lead to a broader investigation of research questions and the 
development of high-quality guidelines for recommendations (Noyes et al., 2019; Roberts & 
Noyes, 2009).  
To achieve the level of understanding needed to answer the overall research question of this PhD, 
it therefore was decided to use both qualitative and quantitative methods. Hence, with regards to 
the methodological stance of this thesis, the research conducted for this PhD on pharmacy-based 
sexual and reproductive health services was neither solely positivist, nor anti-positivist. Instead, 
quantitative and qualitative methods were used for complementary purposes. 
Most important when designing a mixed methods study, is to plan a point of integration at which 
both quantitative and qualitative components are combined in some way (Schoonenboom & 
Johnson, 2017). The choice of method to integrate qualitative and quantitative findings is justified 
in section 2.7.  
  




TABLE 4 THE QUANTITATIVE AND QUALITATIVE PARADIGMS  
 Quantitative paradigm Qualitative paradigm 
Underlying philosophies  Positivism Interpretivism and 
constructivism  
Ontological position The truth is a representation 
of the objective reality that 
exists independent of human 
perception.  
There are multiple realities 
ba ed on one  con c ion 
of reality, which is socially 
constructed and hence, 
constantly changing.  
Epistemological position Since the investigator and 
the investigated are 
independent entities, 
phenomenon can be studied 
without influencing or being 
influenced by it.  
The investigator and the 
investigated are interactively 
linked; hence, the findings 
are mutually created within 
the context of the situation 
which shapes the inquiry. 
Methodological position Techniques such as 
randomisation, blinding, 
questionnaires with a limited 
range of predetermined 
responses are used to 
measure and analyse causal 
relationship between 
variables within a value-free 
framework. Large sample 
sizes are used to ensure that 
samples are representative. 
Techniques used in 
qualitative studies include in-
depth and focus group 
interviews and participant 
observation; purposive 
sampling is used. 
 
2.4. Justification for including a retrospective quantitative study 
One of the objectives of the current thesis was:  
Objective 1:  
x To describe the utilisation of pharmacy-based sexual and reproductive health services 
using a retrospective quantitative study  
Quantitative methods rely on numbers to obtain accurate and reliable measurements (Queirós et 
al., 2017; Schutt, 2019). Quantitative techniques focus on objectivity and are epistemologically 
positivist whereby it is presumed that the social world is knowable by observers who quantify its 
characteristics (Queirós et al., 2017; Schutt, 2019).  
Retrospective studies use secondary data, which is data that is available but was originally 
collected for other purposes (Hess, 2004; Johnston, 2017). Over time, the availability of previously 
collected data has increased and technological breakthroughs over the past two decades have 
simplified data analysis. Further, data is increasingly available electronically which makes the 
sharing of datasets easier (Doolan et al., 2017; Jorm, 2015). Consequently, retrospective studies 
have become more popular, particularly in health service research (Cole & Trinh, 2017).  
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In he e a of big da a , he e a la ge amo n  of heal h-related data is collected routinely by policy-
makers and healthcare providers as a by-product of health care delivery, the potential of routinely 
collected data has increasingly been recognised (Jorm, 2015). Routinely collected data can 
contribute towards the effectiveness and efficiency of health care systems (Jorm, 2015) and is 
commonly used to describe healthcare utilisation (Cappetta et al., 2020; Somers et al., 2016; 
Tunesi et al., 2019). Compared to the conduct of primary research, secondary data analysis is 
time and cost-effective (Johnston, 2017) and therefore should be utilised where new research 
questions can be answered by existing data sets (Doolan & Froelicher, 2009).  
Measures associated with health service utilisation include outcomes and volume of services (Da 
Silva et al., 2011). Moreover, studies on health service utilisation often give insight into socio-
demographic characteristics of health service users (Ben et al., 2017; Gerritsen & Devillé, 2009). 
Community pharmacies have a large amount of information, including patient records and 
information on over-the-counter sales (Wright & Twigg, 2016). If used appropriately, this 
information can be used to enhance the quality of services and patient care (Wright & Twigg, 
2016). Therefore, a retrospective study was used in this project, to describe the utilisation of 
pharmacy-based sexual and reproductive health services. The analysis can also provide important 
information on the qualitative study, which is justified in section 2.6.  
2.5. Justification for using systematic review methodology 
Objective 2:  
x To summarise what is kno n abo  pha mac  e  and pha mac  aff a i de  and 
experiences of pharmacy-based sexual and reproductive health services using a 
systematic review  
To be familia  i h ha  i  kno n  abo  a opic i  i  c cial o e al a e ha  ha  been died to 
date (Gough et al., 2017). For every research project, it is therefore important to conduct a 
literature review to clarify what is known from pre-existing research studies (Gough & Richardson, 
2018; Tranfield et al., 2003).  
The overarching goal of some types of literature reviews such as theoretical reviews and realist 
reviews is explanation building (Paré et al., 2015). In theoretical reviews, various evidence is 
brought together and a structured approach taken to identify patterns that facilitate the 
development of new theories or a conceptual framework (Baumeister & Leary, 1997; Webster & 
Watson, 2002). In realist reviews, evidence is synthesised in order to refine theory (Paré et al., 
2015) and mechanisms of how complex interventions work, or do not work, in particular contexts 
unpacked (Pawson et al., 2005). Since both, theoretical reviews and realist reviews, go beyond 
merely just summarising past work (Paré et al., 2015), they were not be deemed as appropriate 
to address the thesis objective.  
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Instead, literature reviews such as narrative reviews, scoping reviews, and systematic reviews can 
be used to summarise what has been written about a certain subject (Paré et al., 2015). Narrative 
reviews discuss important topics on a theoretical point of view (T. Greenhalgh et al., 2018; Jahan 
et al., 2016). The evidence reviewed suggests that search terms, databases used and inclusion 
and exclusion criteria are usually not reported in narrative reviews (Bernardo et al., 2004; Jahan 
et al., 2016; Paré et al., 2015). Consequently, narrative reviews may be vulnerable to subjectivity 
(Green et al., 2006; Pieper et al., 2012). It was therefore decided to choose a literature review 
design which involves the transparent reporting of the data search. Scoping reviews have a 
systematic approach in searching to select studies and are used to examine the extent, range and 
nature of research that has been conducted in an area (Paré et al., 2015). They are usually used 
to answer broad research questions (Armstrong et al., 2011). Since the current PhD project aimed 
to explore a relatively narrow research question, it was decided to conduct a systematic review 
rather than a scoping review.  
This decision was made on the one hand because systematic reviews are often used to explore 
attitudes and experiences in health research (Jennings et al., 2018; Johl et al., 2016; Rebafka et 
al., 2018; van Dongen et al., 2020). On the other hand, this type of review is well established and 
offers the highest level of evidence to inform decision making (Aromataris et al., 2015). Another 
strength of systematic reviews is that they can reveal research areas which require further 
exploration and inform the delivery of health care (M. Rodgers et al., 2009); this review could 
therefore inform the scope of this project while also helping to provide recommendations for 
practice. Further, systematic review findings are generated from a range of settings and 
populations increasing their robustness and generalisability (D. Evans, 2003). In contrast to 
narrative reviews (Green et al., 2006; Paré et al., 2015; Paré & Kitsiou, 2017) which may have an 
unstructured approach, evidence is summarised in systematic reviews through transparent and 
structured methods to search, screen, select, critically appraise and summarise findings (T. 
Greenhalgh et al., 2018). A systematic review was therefore considered as an appropriate method 
to address the thesis objective in question.  
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2.6. Justification for the conduct of qualitative research and the use of 
semi-structured interviews  
The third thesis objective was as follows:  
Objective 3:  
x Based on the findings of the systematic review and retrospective quantitative study, to 
e plo e pha mac  e  and pha mac  aff a i de  and e pe ience  and to explore 
the implementation of pharmacy-based sexual and reproductive health services using 
semi-structured interviews  
This section is broken down into four parts: The justification for taking a qualitative approach to 
address this objective; the justification for choosing interviews as qualitative method to explore 
experience; the justification for choosing semi-structured interviews; and the justification for using 
Normalisation Process Theory to explore the implementation of pharmacy-based sexual and 
reproductive health services.  
2.6.1. Using a qualitative approach to explore experience 
The third thesis objec i e a  o e plo e pha mac  e  and pha mac  aff a i de  and 
experiences and to explore the implementation of pharmacy-based SRHS. Traditionally, Likert 
scales, a rating system where each response category is assigned a numerical value have been 
used to measure attitudes and perceptions quantitatively (Carrasco & Lucas, 2015; Ho, 2017). 
Likert scales allow participants to choose from a range of possible responses to a specific question 
or statement. However, while Likert-type scales are economical and easy to analyse, the 
limitations of this approach to exploring attitudes have increasingly been recognised (Carrasco & 
Lucas, 2015; Ho, 2017). Likert scale results are inherently numerical and although they are 
statistically feasible, they can be difficult to interpret or translate into narrative form and apply in 
practice (Ho, 2017). Where research objectives cannot be explored through quantitative 
approaches, qualitative approaches can be used (Carrasco & Lucas, 2015). Qualitative research 
is a scientific approach to exploring human attitudes and experiences and to gaining greater 
understanding of factors influencing experiences (Gelling, 2015). In contrast to quantitative 
research, qualitative research is about the interpretation of nonnumeric data and aims to make 
sense of and identify patterns among nonnumeric data to develop a meaningful picture (Hoek et 
al., 2017; Leung, 2015). Findings from qualitative research have contributed to the advancement 
of health research and can change practice (Sandelowski, 2004). Since most qualitative research 
studies explore only a specific issue in a certain population, generalisability of the findings cannot 
be expected (Leung, 2015). However, through the collection of rich data, questions for which little 
is known can be answered in qualitative research (Nathan et al., 2018).  
It was therefore decided to take a qualitative approach to investigate pharmacy staff and pharmacy 
users  ie  and e pe ience . 
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2.6.2. Choosing the method to explore experiences  
Traditionally, qualitative research uses data collected through interviews, focus groups, or 
observations (Carr et al., 2019). More recently, new approaches such as the analysis of social 
media content, emails and instant messages have emerged in qualitative research (Carr et al., 
2019). Further, audio diaries and photovoice, a research method where photographs alongside 
narratives are used to elicit rich data, have increasingly been used in qualitative research (Carr et 
al., 2019). 
However, one-on-one Interviews, in which an in e ie e  in e iga e  pa icipan  e pe ience  
and attitudes in-depth, and focus groups, in which a researcher facilitates a group discussion 
between participants, are still the most commonly used qualitative methods (P. Gill & Baillie, 2018; 
Guest et al., 2017; Johnstone, 2017). When deciding whether to conduct interviews or focus 
groups with pharmacy users for this study it needed to be considered that sexual and reproductive 
health is a sensitive topic (Elam & Fenton, 2003). It might also be intrusive, meaning that it may 
be a topic that respondents do not like to discuss or find it difficult to talk about (Elam & Fenton, 
2003). While there is evidence to suggest that focus groups may be effective to discuss sensitive 
topics (Guest et al., 2017), a recent study found that individual interviews were more effective than 
focus groups to discuss sensitive topics (Kruger et al., 2019). Focus groups have also been found 
to lead to less valuable data collection if rapport and trust within a group cannot be established 
and that these issues of trust may be related to the sensitive nature of the topic (Carey & Asbury, 
2016). Further, where there is a risk of social stigmatisation, focus groups should be avoided as 
participants may not discuss their experiences and attitudes freely or may hesitate to engage in 
the discussion (Harrison et al., 2015; O. Nyumba et al., 2018). In asking pharmacy users about 
their experiences of pharmacy-based sexual and reproductive health services, it might have been 
that users and staff wanted to talk about their sexual lives, their relationship to the pharmacist, 
and other topics that pharmacy users may not have been comfortable to share in front of other 
people. Possibly, online focus groups could have been feasible as they provide more anonymity 
and might increase participation in a conversation on sensitive topics (D. W. Stewart & 
Shamdasani, 2017). However, computer malfunctions, problems with internet connectivity and 
cyber security breaches are issues that may arise in online focus groups (Hawkins, 2018).  
Interviews provide a more confidential setting for participants in comparison to focus groups 
(Carey & Asbury, 2016) and allow researcher to go deeper and highlight on personal issues 
(Adhabi & Anozie, 2017). It was therefore decided to conduct one-on-one interviews rather than 
focus groups o e plo e pha mac  e  e pe ience  and a i de .  
 
It was also considered to conduct focus groups with pharmacy staff; since staff were in the position 
of delivering rather than using the SRHS, the risk of inhibiting discussion due to a sensitive topic 
was lower; however, from a practical point of view, setting up focus groups can cause logistical 
problems (Tausch & Menold, 2016) as people have to be brought together in one place (D. W. 
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Stewart & Shamdasani, 2017) at a certain time. As pharmacy staff have time constraints and often 
also work in the evening and on weekends, focus groups may not have been feasible to conduct. 
Instead, it was decided to conduct one-on-one interviews with pharmacy users and pharmacy 
staff.  
2.6.3. Choosing the type of interviews 
There are different types of interviews: They can be structured, unstructured or semi-structured. 
Structured interviews are fully controlled by the interviewer and give the interviewee less room to 
be flexible and casual (Stuckey, 2013). Questions are kept short and it is expected that study 
participants answer with short and straightforward responses. In structured interviews, 
researchers have to adhere to the sequence of questions and question wording (Adhabi & Anozie, 
2017). While this rigid structure and uniformity increases the validity of interview findings, 
structured interviews also have disadvantages. For example, interviewees may not be able to 
provide appropriate context for their answers such as motivations, reasoning and further 
elaboration (Adhabi & Anozie, 2017). Structured interviews are therefore more commonly used 
to collect quantitative data, for example in survey research, rather than qualitative data (Stuckey, 
2013).  
In contrast, unstructured interviews are not based on an interview script and have broad 
objectives (Young et al., 2018). They are led by respondents  priorities and concerns (Pope & 
Mays, 2006) and questions by the interviewer are asked spontaneously (Bryman, 2016). They are 
used to unfold events from interview participants (Stuckey, 2013) and to explore new research 
questions (Sorsa et al., 2015). However, shortcomings include lack of consistency across 
participants and lack of advanced planning (Chauhan, 2019). In order to make it easier to draw 
compa i on  be een in e ie  pa icipan  e pe ience  hile ill allo ing pa icipan  o alk 
about what seems significant for them, it was decided to choose semi-structured interviews.  
Semi-structured interviews are those where a researcher has predefined questions but can probe 
f he  o p od ce da a hich can offe  in igh  in o pa icipan  e pe ience  and a i de  
(Peters & Halcomb, 2015). They also allow questions emerging from the conversation to be added 
and have no rigid adherence (Whiting, 2008). This allows the researcher the flexibility to ask more 
enhanced questions than initially planned (Adhabi & Anozie, 2017). Semi-structured interviews 
are the most common type of interview used in qualitative research (Stuckey, 2013) and are often 
used to explore experiences and attitudes (Englander et al., 2018; Laidsaar-Powell et al., 2016; 
Skinner et al., 2009). Semi-structured interviews were therefore deemed as appropriate to explore 
pharmacy e  and staff experiences for this PhD project.  
2.6.4. Choosing Normalisation Theory to explore the implementation of SRHS 
Closing the gap between research and practice is a problem in health service research which can 
be addressed by underpinning research with strong theoretical approaches (Murray et al., 2010; 
O Donnell e  al., 2017). If research lacks theoretical underpinning it is more difficult to fully 
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understand why implementations were or were not successful and to identify factors contributing 
towards or inhibiting successful implementation (McEvoy et al., 2014; Nilsen, 2015). Theory can 
further help to gain an understanding of the wider significance of qualitative research findings, 
(O'Donnell et al., 2017; Reeves, Albert, Kuper, & Hodges, 2008) and to translate processes that 
are beneath the visible surface and to gain knowledge of underlying principles for policy makers 
and healthcare providers (Reeves et al., 2008).  
There are several theories that can be applied to the healthcare setting. For example, agency 
theory has been used to explore relationships between doctors (Dranove & White, 1989) and the 
diffusion of innovation theory ha  been ed o d  indi id al  adop ion of ne  heal hca e 
information technologies (Cain & Mittman, 2002). However, both theories have originally been 
developed for other purposes: Agency theory has been developed to focus on reducing problems 
emerging through the separation of business owners and managers (Panda & Leepsa, 2017) and 
the diffusion of innovation theory has been used to explain how an idea or product spreads 
through a specific population (Kaminski, 2011).  
Instead, Normalisation Process Theory (NPT) has been specifically designed to assist researchers 
to understand the factors that promote and inhibit the routine implementation of complex 
healthcare interventions in practice (C. R. May et al., 2011). It is a relatively new theory (C. R. May 
et al., 2009), which provides a consistent framework that can be used to improve complex 
interventions (C. R. May et al., 2011). A recent qualitative systematic review found that NPT was 
applicable to a large range of interventions and service design, and that NPT was effective in 
aiding intervention development and in understanding implementation processes (C. R. May et 
al., 2018).  
Pharmacy-based sexual and reproductive health services are complex interventions based on the 
requirements defined by Guise et al. (2017): They have multiple components (collection of patient 
information; consultation; service delivery) and multiple causal pathways (workload, training, skills, 
clinical case) (Guise et al., 2017). NPT was therefore considered as well suited to interpret the 
interview study findings.  
NPT is concerned with understanding why and how new complex healthcare interventions 
become normal components of work as a result of people s actions (May and Finch, 2009). It was 
first iterated by May (2006) and then further developed. It consists of four main components: 
coherence (sense-making); cognitive participation (or engagement), collective action (actions 
done to enable the intervention to happen); and reflexive monitoring (formal and informal appraisal 
of the benefits and costs of the intervention) (Murray et al., 2010). All of the components can 
impact each other.  
NPT is a middle-range theory (C. R. May et al., 2009) which means that it is, compared to Grand 
Theories, less abstract as it addresses specific phenomena and concepts that can be tested and 
used to inform intervention development (O Donnell e  al., 2017). Since implementation is 
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complex and there are many causes of outcomes it is unlikely that one grand theory of 
implementation will be developed that can provide universal explanations (Nilsen, 2015).  
Two previously published systematic reviews showed that NPT was effective in evaluating the 
implementation of a diverse range of complex health interventions in several qualitative studies 
(C. R. May et al., 2018; McEvoy et al., 2014). Although many studies have only included service 
providers perspectives when applying NPT (McEvoy et al., 2014), it can be applied to both health 
professionals, such as pharmacy staff, but also service users, such as pharmacy users (C. R. May 
et al., 2011). This was advantageous as the aim of the qualitative study was to gain insight into 
both e  and staff perspectives.  
Some theories focus only on evaluating and understanding individual attitudes and intentions. For 
example, the theory of planned behaviour attempts to predict an individual s intention to engage 
in an action at a specific time or place and does neither take into account the environmental 
factors and nor consider change over time (Sommer, 2011). These types of theories which focus 
on individuals are less suitable for evaluating complex interventions where various confounders 
can impact behaviour (Murray et al., 2010). Instead, NPT addresses both what individuals and 
groups do (McEvoy et al., 2014) and seeks to understand the work that staff and users are 
engaging with rather than to understand the relationship between individual attitudes and 
intentions (McEvoy et al., 2014). Hence, unlike other theories NPT does not only consider 
behaviour in isolation but also context and the practical implementation of interventions in real 
settings. It provides an explanatory model of how interventions become embedded and 
normalised based on the things that individuals and groups do (C. R. May et al., 2011).  
In line with the diffusion of innovation theory, NPT addresses the legitimacy of the interventions 
and the roles of people involved and whether there is a trusting relationship between those 
involved in complex interventions (McEvoy et al., 2014). However, in contrast to the diffusion of 
innovation theory (Murray et al., 2010), which focuses only on whole systems, NPT also considers 
system components and additionally investigates processes impacting whether an innovation 
becomes routinely embedded in practice (McEvoy et al., 2014).  
Hence, NPT is different from other theories as it can look at all participants involved in 
implementation processes, look at the work that participants do individually and collectively, and 
also help to understand the processes that lead to interventions becoming normalised (McEvoy 
et al., 2014). It was therefore considered to be an appropriate approach to explore the 
implementation of pharmacy-based sexual and reproductive health services.  
 
Theories, including NPT, can be applied at different stages of the research process and in many 
different ways. For example, it can be used to design studies, structure them or as lens for 
interpretation (Wu & Volker, 2009). Pharmacy-based research has traditionally been lacking the 
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use of a theoretical lens, although it can aid data interpretation (D. Stewart & Klein, 2016). For this 
PhD project, NPT was therefore used as lens for interpretation of the qualitative interview findings.  
Several methodologists have highlighted the importance to describe clearly how theory has been 
applied (Bradbury-Jones et al., 2014; D. Stewart & Klein, 2016). Section 7.10  therefore describes 
in detail how NPT was applied to interpret the findings from the qualitative study.  
2.7. Approach for synthesising all findings to develop recommendations 
The fourth and final objective of the thesis was as follows:  
Objective 4:  
x To synthesise all findings to develop recommendations for service optimisation 
Data integration can be considered a  he cen epiece of mi ed me hod  e ea ch (O Ca hain, 
Murphy, & Nicholl, 2007), as it allows new insights and ensures the full exploitation of the available 
data (Bryman, 2006). Data integration can be done, for example, by using a framework to bind 
different datasets together (Creswell & Clark, 2017). Methods for synthesising mixed methods 
evidence have been developed (Noyes et al., 2019), however there are only a few well-articulated 
methods (R. E. Johnson et al., 2017).  
One app oach o n he i e q an i a i e and q ali a i e e idence i  Follo ing a h ead , 
developed by Moran-Ellis et al. (Moran-Ellis et al., 2006). However, it has not been used frequently 
in the literature and no specific steps for this technique are outlined (R. E. Johnson et al., 2017; 
O Ca hain e  al., 2010). It was therefore not chosen as the approach for the data synthesis. Another 
method considered to synthesise evidence was iang la ion ; triangulation is well suited for 
synthesising evidence that examines different aspects of an overall research question (O Ca hain 
et al., 2010). Triangulation can help to identify whether one set of findings confirms or disconfirms 
another set of findings (Noble & Heale, 2019; O Ca hain e  al., 2010) and can contribute to 
assessing the validity of research results (Farmer et al., 2006). It is a process of studying a 
phenomenon using different methods to gain a more in-depth understanding (Denzin, 2012; 
O Ca hain e  al., 2010). Triangulation as a methodological approach to combine qualitative and 
quantitative results has been criticised as little guidance on how to carry out triangulation had 
been published. However, this gap in the literature was addressed through the publication of the 
he iang la ion p o ocol , hich i  he mo  de ailed de c ip ion of ho  o cond c  iang la ion 
(Farmer et al., 2006).  
 
The iang la ion p o ocol  ha  been de eloped o ca  o  iang la ion fo  m l iple q ali a i e 
methods but can also be applied for mixed methods studies (O Ca hain e  al., 2010). However, 
according to the triangulation protocol, multiple investigators have to undertake independent 
applications of the triangulation protocol and compare results. Different perspectives on 
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convergence or dissonance of findings between the researchers have to be noted down. As the 
PhD candidate was the sole researcher and did not have a team with time available, it was not 
possible to adopt this approach effectively.  
In ead, he da a n he i  a  ba ed on he Pilla  In eg a ion P oce , p bli hed b  John on 
et al. (2017). This approach outlines four steps to integrate qualitative and quantitative data (R. E. 
Johnson et al., 2017). The advantage of the Pillar Integration Process is that it provides great 
flexibility in terms of the type of data that can be integrated (Quinton & Smallbone, 2010). 
However, there is no clear guidance on how and whether more than two datasets could be 
synthesised using the Pillar Integration Process (R. E. Johnson et al., 2017). In light of this, Dr Amy 
Grove, Assistant Professor at Warwick Medical School and co-developer of the Pillar-Integration-
Process, was consulted. The way in which the Pillar Integration Process can be adapted for more 
than two datasets was discussed in depth, and the methods used to triangulate the data 
developed, generating furthered knowledge on the Pillar Integration Process. The methods used 
to synthesise data using the adapted Pillar Integration Process are described in detail in the 
respective chapter for transparency (see chapter 9).  
2.8. Chapter summary 
In this chapter, the methodological stance of the thesis was explained and the background to the 
methodological approach for the thesis was outlined. The thesis  aim and objectives were 
reiterated. In section 2.4, it was justified why a retrospective quantitative study was used to 
describe the utilisation of pharmacy-based sexual and reproductive health services. A justification 
for using a systematic e ie  me hodolog  o mma i e ha  i  kno n abo  pha mac  e  
and pharmacy staff attitudes and experiences of pharmacy-based SRHS was provided in the 
subsequent section (2.5). Afterwards, it was explained why qualitative semi-structured interviews 
e e ed o e plo e pha mac  e  and pha mac  aff e pe ience  and why NPT was used 
to interpret the qualitative findings (2.6). In the final section of this chapter (2.7), it was justified 
why the Pillar Integration Process was used to guide the integration of all findings from this thesis. 
In the following chapter the methods of the retrospective study are described.  
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3. Retrospective Quantitative Study Methods 
3.1. Chapter overview 
This chapter outlines the methods for the retrospective quantitative study. Beginning with the 
aims, objectives and study design, it then explains how the routine pharmacy data analysed in the 
study was collected and processed. Inclusion criteria, analysis methods, ethical considerations 
and approvals are described. The chapter ends with a short chapter summary. 
3.2. Aim & Objectives for the retrospective study 
3.2.1. Aim  
x To describe the utilisation of pharmacy-based sexual and reproductive health services 
(SRHS) using a retrospective quantitative study 
3.2.2. Objectives 
x To describe the uptake of six SRHS encompassing contraception, testing and treatment 
for sexually transmitted infections 
x To describe the characteristics of those using pharmacy-based SRHS 
x To describe the attendance patterns of SRHS requests according to the day of the week  
x To describe the outcomes of pharmacy-based emergency contraception, oral 
contraception, condom provision and chlamydia treatment  
3.3. Study Design 
A retrospective quantitative study was performed to evaluate all SRHS requests made by users 
at Umbrella pharmacies between August 2015 and August 2018. The study was published in the 
journal Sexually Transmitted Infections on the 16th August 2020. A copy of this paper is provided 
in Appendix 1.  
3.4. Umbrella s pharmac -based SRHS  
As described in section 1.7, the sexual and reproductive health services (SRHS) branded as 
Umbrella was launched in Birmingham (England) in August 2015. Umbrella provides services 
related to sexually transmitted infections and contraception through several pathways, including 
pharmacies, free of costs for the users.  
Pharmacie  ope a e ei he  a  Tie  1  o  Tie  2  le el. The number of Umbrella pharmacies 
changed o e  ime: Be een A g  2015 and A g  2018 he n mbe  of Tie  1  pha macie  
decreased from 158 to 80.  
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However, the number of pharmacies offering more extensi e Tie  2  e ice  inc ea ed f om 18 
to 47. The services p o ided in Tie  1  and Tie  2  pha macie  are described in the following two 
sections (section 3.4.1 and 3.4.2). The eligibility criteria for Umbrella s pharmacy services are 
described in section 3.4.3. An overview of Umbrella s pharmacy services is provided in Table 5.  
3.4.1. Tie  1  pha macie  
Tie  1  pha macie  offe  p e c ip ion-free emergency contraception consultations. Possible 
outcomes of emergency contraception consultation include: advice only; supply of an emergency 
contraceptive pill (either containing levonorgestrel or ulipristal); supply of an emergency 
contraceptive pill and a copper coil referral or appointment at the closest sexual health clinic; or 
a coppe  coil efe al/appoin men  onl . Tie  1  pha macie  al o p o ide condom . As part of the 
consultation on condoms, pharmacy staff can offer and provide pharmacy users with instructions 
on how to correctly use condoms. Moreover, Tie  1  pha macie  di pen e STI elf-sampling kits 
testing for chlamydia, gonorrhoea, HIV and syphilis, plus Hepatitis B (for men who have sex with 
men) that have been pre-ordered by pharmacy users o a Tie  1  pha mac  or a sexual health 
clinic via the Umbrella website. Alternatively, users could also order an STI self-sampling kit to be 
posted to their home. Pha mac  aff o king a  Tie  1  pha macie  al o have STI self-sampling 
kits testing for chlamydia and gonorrhoea in stock and can provide them directly to young women 
(15-24-year olds) presenting for emergency contraception. 
3.4.2. Tie  2  pha macie  
Tie  2  pha macie  offe  all Tie  1  e ice  and in addi ion p e c ip ion-free oral contraception, 
contraceptive injection and chlamydia treatment. When providing oral contraception, pharmacy 
staff can either supply a progesterone-only pill (POP) or a combined pill, containing both 
oestrogen and progesterone (Casper, 2017). The contraceptive injection provided by Umbrella 
was Sayana® Press (Nai et al., 2020). Two different antibiotics, doxycycline (1st line treatment) or 
azithromycin (2nd line treatment), can be supplied to pharmacy users as chlamydia treatment.  
In con a  o Tie  1  pha macie , Tie  2  pha macie  not only have STI self-sampling kits testing 
for chlamydia and gonorrhoea but also STI self-sampling kits testing for chlamydia, gonorrhoea, 
HIV, syphilis and hepatitis B in stock and can provide them directly to pharmacy users. However, 
pharmacy users can also choose to pre-order a STI self- ampling ki  o a Tie  2  pha mac . Finally, 
Tie  2  pha macie  can offe  omen p e en ing fo  emergency contraception with one 
emergency contraceptive pill that they can take immediately and one that they can take away for 
future use (also referred to as advance emergency contraception). 
3.4.3. Eligibility criteria for Umbrella s services 
Umbrella s pharmacy services can be used by those who meet certain eligibility criteria (see Table 
5). Hormonal contraception such as emergency contraception, oral contraception and the 
contraceptive injection are restricted to females only, but males can access the pharmacy for 
condoms, STI self-sampling kits and chlamydia treatment.  
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All services except the STI self-sampling kits are accessible to users over the age of 13. The upper 
age limit for hormonal contraception is 60 years. For the remaining services there is no upper age 
limit. STI self-sampling kits can only be pre-ordered by over 16-year olds. However, women who 
are between 15 and 24 years old and presenting for emergency contraception can be provided 
with a STI self-sampling kit testing for chlamydia and gonorrhoea. 
3.5. Routine data collection 
Although recording pharmacy staff activities can be helpful, for example to monitor the workload, 
it is not routine practice (Wright & Twigg, 2016). However, Umbrella collects and owns data on all 
their pharmacy services and is licensed to use the data for any legitimate purpose in anonymised 
form.  
Data on Umbrella s pharmacy services is primarily recorded by pharmacy staff on behalf of 
Umbrella in order to receive payment for the Umbrella services provided. However, it is also 
collected for quality assurance, for example to ensure that young people can be safeguarded and 
to get an overview of who is reached by pharmacy-based sexual and reproductive health services.  
Data analysed in this study were available from two data sources. Information on the data sources 
used for the retrospective study is provided in the following section.  
3.5.1. Data sources 
The first data source used for this retrospective study was PharmOutcomes®, which is a secure 
web-based service record platform provided by Pinaccle Health Partnership LLP (R. Brown, 2018; 
Sabir et al., 2019). It allows pharmacies to store all information relating to the services delivered 
(R. Brown, 2018). Although PharmOutcomes® is not used universally across England 
(Mantzourani et al., 2020), it is used by more than 85% of pharmacies in England (R. Brown, 2018).  
The second data source was the Umbrella website, which was linked with STI self-sampling orders 
(Banerjee et al., 2018; Jewell et al., 2017). In order to request an STI self-sampling kit people had 
to complete a secure Online Patient Questionnaire placed on the Umbrella website (Umbrella, 
2020).  
When people attended an Umbrella pharmacy for emergency contraception, oral contraception, 
contraceptive injection, condoms or chlamydia treatment, they were taken into a consultation 
room by pharmacy staff, who then recorded demographic and clinical information on 
PharmOutcomes®.  
Data on those users who were provided with an STI self-sampling kit directly in the pharmacy 
(without having pre-ordered it on the Umbrella website) were recorded on PharmOutcomes® 
before the 6th of February 2018 and via the Umbrella website thereafter. Data on STI self-sampling 
kits that were pre-ordered online were consistently collected via the Online Patient Questionnaire 
on the Umbrella website.  
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The information that was collected and analysed for this study and the data sources for each 
Umbrella service is shown in Table 5.  
3.5.2. Data collection 
The day of the week and date of service request is automatically collected when pharmacy staff 
record an Umbrella service. While information on the day of the week those services were 
delivered was shared with the PhD candidate, the dates of service requests were not provided by 
Umbrella. 
Each user of an Umbrella pharmacy service was automatically assigned a patient identification 
number. If a user returned to the same pharmacy to use an Umbrella service, this was registered 
under the original patient identification number. However, if a pharmacy user subsequently visited 
a different Umbrella pharmacy, this was recorded under a new patient identification number. 
Hence, patient records were not integrated and since individuals could have been recorded under 
different patient identification numbers it was not possible to evaluate frequency of attendance for 
individual patients. 
Pharmacy staff recorded the type of Umbrella service that was provided to a pharmacy user and 
the consultation outcomes. If an individual used more than one of the Tier 1  or Tier 2  services 
(e.g. emergency contraception and condoms), this was recorded as separate requests. Because 
of this, and also because the dates of service requests were not provided to the PhD candidate, 
it was therefore not possible to evaluate whether multiple services were delivered at a single 
attendance or over several pharmacy visits. 
Service users are required to provide a name, their age and a Birmingham postcode to be able 
to get a service. However, since no proof of identify is required, service users who wished to 
remain anonymous could provide any name, age and Birmingham postcode of their choice.  
Pharmacy users are also asked for their gender and ethnicity but can choose not to disclose this 
information. When asked for their gender, users had the possibility to self-identify as female, male 
or transgender. Data on gender were reported in this study as recorded by Umbrella. Ethnicity 
data were collected consistently for all services except the STI self-sampling kits. Inconsistencies 
in the data collection meant that it was not possible to analyse ethnicity data on STI self-sampling 
kits. No ethnicity data were collected until March 2017 and subsequently different ethnic group 
categories were used. Ethnicity data were therefore only analysed for individuals accessing the 
other sexual health services: emergency contraception, oral contraception, contraceptive 
injection, condoms and chlamydia treatment. 
For the STI self-sampling kits that were pre-ordered online, the date that the kit was collected 
rather than pre-ordered was recorded. No data on the dates that STI self-sampling kits were pre-
ordered were recorded, so it was not possible to analyse how many days passed between users  
pre-order and collection of the STI self-sampling kits.  





TABLE 5 OVERVIEW OF UMBRELLA SERVICES, ELIGIBILITY CRITERIA, DATA SOURCE AND ASSOCIATED DATA INCLUDED IN ANALYSIS 
SRHS 
Provided 
Pharmac  Tier   Eligibility by Gender Eligibility by Age Data Source  Associated data included in this analysis 
Emergency 
Contraception 






x Weekday of attendance 










x Weekday of attendance 
x Consultation outcome 
Referral or 
Appointment 
for the copper 
coil at closest 
sexual health 
clinic 






x Weekday of attendance 
x Consultation Outcome 
Oral 
Contraception  






x Weekday of attendance 
x Consultation Outcome 
Contraceptive 
Injection 






x Weekday of attendance 
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testing for up 
to five STIs 





x Weekday of attendance 
STI self-
sampling kits 
testing for up 
to five STIs  
Tier 2  Females and Males 16 Pharmacy Electronic 
Patient Record 
(PharmOutcomes®) 



















Tier 1 and Tier 2 Females 15-24 Pharmacy Electronic 
Patient Record 
(PharmOutcomes®) 
until 6th Feb 2018 
and Online Patient 
Questionnaire 
(Umbrella Website) 




x Weekday of attendance 
Chlamydia 
Treatment 






x Weekday of attendance 
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3.6. Data processing 
User activity recorded on PharmOutcomes® and the Umbrella website were combined into a 
single dataset. Although National Statistical Institutes from various countries including the UK have 
proposed standardised categories to classify people into ethnic groups, there is no widely 
accepted protocol for the collection of ethnicity (Connelly et al., 2016). Based on the ethnic groups 
li ed b  UK  go e nmen  ebsite (GOV.UK, 2020), ethnicity was grouped from more than 20 
categories into five categories: White/White British, Black/Black British, Asian/Asian British, 
Mixed/Mixed British, Other Ethnic Group. Age plays an important role in health research as a 
pe on  age can indica e he he  omeone i  at a higher risk of a certain condition (Geifman et 
al., 2013). For example, while women and men of all ages can face challenges related to their 
sexual and reproductive health (Gonsalves & Hindin, 2017), adolescents are at higher risk of 
contracting STIs (Morris & Rushwan, 2015). Ages are often presented in groups in health research 
(Geifman et al., 2013). The age groups chosen for this retrospective study were informed by 
another study on pharmacy-based sexual and reproductive health services (Mantzourani et al., 
2019). They are as follows: 13-15, 16-19, 20-24, 25-29, 30-39 and 40+. The final dataset included:  
x PharmOutcomes® data on all user requests recorded for: emergency contraception, 
oral contraception, contraceptive injection, chlamydia treatment, and condoms between 
August 2015 and August 2018 
x PharmOutcomes® data (recorded between August 2015 and the 6th February 2018) 
and STI website data (recorded between the 7th February 2018 and August 2018) on all 
STI self-sampling kits that were provided directly to users  
x STI website data on all STI self-sampling kits that were ordered online and collected 
from a pharmacy between August 2015 and August 2018 
3.7. Inclusion Criteria 
As mentioned in the description of Umbrella and their pharmacy-based SRHS, individuals were 
eligible for an Umbrella pharmacy service if they fulfilled the inclusion criteria for the service in 
question:  
x The age of users requesting condoms or chlamydia treatment was 13 
x The gender of users of hormonal contraception was female 
x The age of females provided with hormonal contraception was 13 and ≤60 
x The age of users requesting STI self-sampling kits online was 16 
x The age of males who were provided with an STI self-sampling kit was 16 and the age 
of women provided with STI self-sampling kit was 15  
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Only those service records which met Umbrella s inclusion criteria were included in the analysis. 
This decision was based on the assumption that data entries which did not meet Umbrella  
inclusion criteria included errors that occurred when pharmacy staff were entering the data. 
However, it may be also be possible that services were provided to pharmacy users although they 
did not meet Umbrella  incl ion c i e ia. The system into which pharmacy staff input the patient 
data does not notify them if information outside of the inclusion criteria is entered.  
3.8. Data Analysis  
Descriptive statistics are often used in studies on health care utilisation (Burkard et al., 2019; 
Otterstatter et al., 2018). For this study, both categorical data and continuous data was used. 
Continuous variables are those that can be measured and theoretically take infinitely many values 
(Mayya et al., 2017). In this study, age was the only continuous data used. Categorical data are 
data which are not numerically measurable but can be allocated to different groups (Mayya et al., 
2017). Examples for categorical data used in this study include ethnicity, gender, age groups, and 
types of service. Frequency statistics such as counts and percentages were used to summarise 
categorical variables (Mishra et al., 2019). The con in o  a iable age  a  mma i ed b  
reporting the range, median and interquartile range in order to describe the spread of the data 
distribution (M. J. Fisher & Marshall, 2009). The range described the distance between the highest 
and lowest score, whereas the median described the middle score of a rank ordered distribution 
(M. J. Fisher & Marshall, 2009). While the median, mean and mode will have the same value if 
data is normally distributed, this is not the case in a skewed distribution (McHugh & Hudson‐
Barr, 2003). For this study, the median age rather than the mean age was reported as it is usually 
the most accurate indicator of central tendency skewed distributions (McHugh & Hudson‐Barr, 
2003). The interquartile range is reported together with the median as it can further help to 
describe the central tendency by showing the range within which the middle 50% of the scores 
fall (M. J. Fisher & Marshall, 2009; McHugh & Hudson‐Barr, 2003). 
To date there is little information on who the users of pharmacy-based SRHS are. Therefore, the 
distribution of age, ethnicity and attendance pattern by the day of the week were additionally 
analysed by gender. 
The date (day, month, year) of attendance was requested but was not available from the service 
provider, despite a number of requests, due to concerns regarding data confidentiality. This 
prevented the analysis of the uptake of services over time. Without having the date of service 
request, it was also not possible to analyse whether pharmacy users had been provided with 
several sexual and reproductive health services on the same day.  
The potential for further statistical analysis such as assessing statistically significant associations 
be een ca ego ical a iable  ing e  ch a  he K kal Walli  e  (Jaber et al., 2017), 
chi- q a ed e  (Zhu & Fang, 2016) o  ANOVA e  (Kim, 2017) was discussed with Peter K 
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Kimani (P.K.K.), Associate Professor in Medical Statistics at Warwick Medical School. However, 
this was not possible as all the named tests require independent groups (Jaber et al., 2017; Kim, 
2017; Zhu & Fang, 2016). Independent groups are groups in which the participants, in this case 
the pharmacy users, are different. However, pharmacy users may have requested the same SRHS 
repeatedly (e.g. emergency contraception) or obtained several SRHS (e.g. emergency 
contraception, STI self-sampling kits and condoms). Since pharmacy users are provided a new 
patient identification number whenever they enter a different Umbrella pharmacy, it was not 
possible to identify individuals in the dataset. Hence, independent groups could not be guaranteed 
as individuals could not be identified in the dataset and may have been in more than one group.  
The data analysis was conducted using IBM® SPSS Statistics software (SPSS®) version 24, which 
is a statistical package produced by IBM, Inc. (Cronk, 2019).  
3.9. Ethical Considerations and Approvals 
Ensuring data privacy and data security is an important part of research (Zhang, 2018). For this 
study, the information governance team of the University Hospitals Birmingham (UHB) NHS 
Foundation Trust helped to set the criteria for processing the information to ensure patient 
anonymity was maintained in all circumstances. Since the PhD candidate did not have an honorary 
contract with the UHB Trust and did not have an UHB email account, extra safety measures were 
taken. Fo  ea on  of p i ac  p o ec ion, pa ien  name  and add e e , and he da  and mon h 
of birth were deleted from the dataset. Although requested, no dates of service request were 
provided. A data sharing agreement between the University Hospitals NHS Foundation Trust and 
the University of Warwick was signed by both parties. The datasets were then sent to the 
researcher via email in a password-protected file. The password was communicated on the 
phone. All data from the study will be stored for 10 years (until 2029) in accordance with the 
Uni e i  Reco d  Re en ion Sched le. Elec onic da a ill con in e o be o ed on a ec e, 
password-protected device in password protected files. Access to the files is restricted to the 
research team members.  
There was a level of uncertainty whether NHS Ethical approval would be needed for the 
retrospective study. A Health Research Authority (HRA) assistant stated that the retrospective 
quantitative study was exempt from NHS Research Ethics Committee (REC) Review as only 
anonymised patient data was used. However, the Ethics Board from the University of Warwick 
advised to apply for NHS ethical approval for both the retrospective study and the interview study. 
Ethical considerations and issues regarding the interview study are discussed in the respective 
chapter (Chapter 7).  
We therefore obtained approval from the South Central  Oxford B Research Ethics Committee 
(REC) and from the Health Research Authority (HRA) (Rec Reference: 18/SC/0511). Further, 
approval from the University Hospitals Birmingham NHS Foundation Trust was obtained prior to 
the beginning of the study (Ref number: RKK6366).  
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3.10. Chapter summary 
This chapter presented the retrospective quantitative study methods. It started by presenting the 
aim and objectives of the retrospective quantitative study, the overall aim of the study being to 
describe the utilisation of pharmacy-based sexual and reproductive health services. It was then 
outlined that a retrospective study was used to address this aim. To provide context to the reader, 
information on Umbrella  pha mac -based sexual and reproductive health services were 
provided. Next, it was explained how, and which type of data was collected on behalf of Umbrella 
in the pharmacy. It was then outlined, that demographic characteristics (age, gender, ethnicity) 
as well as weekday of attendance and consultation outcomes were analysed for the retrospective 
study. It was then explained how data was processed. Once it was clarified that only data that met 
Umbrella s inclusion criteria were included in the analysis, it was explained that data was analysed 
descriptively for the retrospective study. At the end of the chapter, it was shown that NHS Ethical 
Approval, HRA approval as well as approval from the University Hospitals Birmingham NHS 
Foundation Trust was obtained prior to the beginning of the retrospective study. In the next 
chapter (chapter 4), the findings of the retrospective study will be presented and discussed.  
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4. Retrospective Study Results and Discussion 
4.1. Chapter overview 
This chapter provides the results and discussion of the retrospective quantitative study. The cases 
selected for analysis are presented and the findings on the service use, demographic 
characteristics, attendance patterns by day of week and consultation outcomes are outlined. The 
key findings are then summarised, and strengths and weaknesses of the retrospective study are 
discussed. A comparison of the findings with the existing literature is offered. Afterwards, the 
contribution of the retrospective quantitative study is outlined. The chapter closes with a short 
chapter summary. 
4.2. Results 
4.2.1. Cases selected for analysis 
Overall, there were 60573 data entries recorded between August 2015 and August 2018. Less 
than 1% of data entries (n=75) were excluded from the analysis as they did not meet the pharmacy 
service eligibility criteria: 
x User recorded as being under 13-year olds (n=13) 
x Hormonal contraception recorded as being accessed by men (n=59)  
x Hormonal contraception recorded as being accessed by women over the age of 60 
(n=3).   
The remaining 60498 data entries were included in the analysis. As mentioned in the methods 
section, no ethnicity data were available for the STI self-sampling kits. As pharmacy users had the 
option not to provide some personal details, data on the gender and ethnici  of pha mac  e  
a  ome ime  indica ed o be nkno n . Ho e e , da a on pha mac  e  age and he da  of 
service request were complete.  
4.2.2. Service Use 
Emergency contraception (50.4%, 30473/60498), condoms (33.1%, 19998/60498) and STI self-
sampling kits (9.6%, 5830/60498) accounted for more than 90% of all visits for Umbrella  
pharmacy services. The three least accessed Umbrella pharmacy services were the contraceptive 
injection (0.6%, 359/60498), chlamydia treatment (1.0%, 591/60498) and oral contraception 
(5.4%, 3247/60498).  
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4.2.3. Demographic Characteristics 
An overview of the demographic characteristics of Umbrella  e ice e  be een A g  2015 
and August 2018 is provided in Table 6. Information on the age-distribution, ethnicity-distribution, 
by gender can be found in Table 7.  
Gender 
As mentioned in section 3.5.2., pharmacy users could self-assign their gender as female, male, or 
transgender. Alternatively, they could choose not to disclose their gender. Gender is reported in 
this section as collected by Umbrella. Services were most likely to be requested by females 
(85.6%, 51780/60498). The majority of service requests were made by females for contraception 
(78.2%, 47354/60498). Males only accounted for 14.2% (8597/60498) of all service requests. 
Females also made up the majority of service requests for those services that were accessible for 
both sexes: condoms (females: 66.4% (13286/19998) versus males: 33.1% (6610/19998)), STI 
self-sampling kits (females: 69.4% (4044/5830) versus males: 30.5% (1781/5830)) and chlamydia 
treatment (females: 64.6% (382/591) versus males: 34.9% (206/591)). Females were more likely 
to be provided with an STI self-sampling kit directly from the pharmacy (60.6%, 2450/4044) rather 
than to order an STI self-sampling kit online (39.4%, 1594/4044). In total, 15 transgender people 
attended pharmacy-based sexual and reproductive health services between August 2015 and 
August 2018.  
Age 
People between 16 and 24 years accounted for more than 50% of all service requests. For all 
services consistently, 16-24-year-old females and males accounted for the largest number of 
service requests. 
The median age of service users across all services was 24 years [Interquartile range: 20-30]. The 
youngest users were 13 and the oldest 86 years old. The median age was lowest for users who 
were provided with STI self-sampling kits with 21 years [Interquartile range: 20-27] and highest 
for emergency contraception users with 25 years [IQR: 20-29].  
For all age groups the most frequent presentation at a pharmacy was for emergency 
contraception; with the only exemption being 13- to 15-year-olds, who most frequently accessed 
the pharmacy for condoms (50.86%, 296/582).  
  




As mentioned in the methods section, ethnicity data were not available for pharmacy users who 
requested a STI self-sampling kit (n=5830/60498) due to inconsistencies in the data collection. 
However, ethnicity data was available for all remaining service requests (n=54668/60498).  
Overall, pharmacy-based SRHS were most likely to be used by White/White British (43.3%, 
23742/54668) and Asian/Asian British people (23.1%, 12603/54668), followed by Black/Black 
British people (15.1%, 8278/54668), people from Mixed ethnic backgrounds (6.4%, 3490/54668) 
and other ethnic groups (2.0%, 1078/54668). 
4.2.4. Attendance patterns by day of week  
An overview of the attendance patterns by day of week is provided in Table 6. An overview of the 
weekday that the service was received by gender is provided in Table 7.  
All services except the contraceptive injection and chlamydia treatment were most frequently 
accessed on Monday, which was the most common day to present in a pharmacy for a SRHS 
overall (20.9%, 12657/60498). 
Service requests were lowest on a Saturday (12.2%, 7375/60498) and Sunday (5.0%, 
3013/60498). Most requests on Saturday (57%, 4206/7375), Sunday (67.6%, 2035/3013) and 
Monday (54.4%, 6894/12657) were made by women presenting for emergency contraception. 
Females were most likely to request emergency contraception, condoms and STI self-sampling 
kits on Mondays, and chlamydia treatment and the contraceptive injection on Wednesday. In 
contrast, males were most likely to obtain condoms and chlamydia treatment on Fridays and STI 
self-sampling kits on Tuesdays. 
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TABLE 6 UPTAKE, USER DEMOGRAPHICS, AND WEEKDAY OF ATTENDANCE OF PHARMACY-BASED SRHS 
Characteristics Service 
contacts 







Condoms STI self-sampling kit Chlamydia 












30473 (50.4) 3247 (5.4) 359 (0.6) 19998 (33.1) 5830 
(9.6) 
3324 (57) 2506 (43) 591 (1.0) 
Gender, n (% by column) 
Females  51780 
(85.6) 
30464 (100) 3245 (99.9) 359 (100) 13286 (66.4) 4044 
(69.4) 
2450 (60.6) 1594 
(39.4) 
382 (64.6) 
Males 8597 (14.2) - - - 6610 (33.1) 1781 
(30.5) 
869 (48.8) 912 (51.2) 206 (34.9) 
Transgender 15 (0) 2 (0) 1 (0) - 10 (0.1) 1 (0) 1 (100) - 1 (0.2) 
Unknown 106 (0.2) 7 (0) 1 (0) - 92 (0.5) 4 (0.1) 4 (100) - 2 (0.3) 





12383 (40.6) 1918 (59.1) 159 (44.3) 9003 (45) N/A N/A N/A 279 (47.2) 
Asian/Asian British 12603* 
(23.1) 
7478 (24.5) 450 (13.9) 33 (9.2)  4612 (23.1) N/A N/A N/A 30 (5.1) 
Black/Black British 8278* 
(15.1) 
4964 (16.3) 427 (13.2) 67 (18.7) 2715 (13.6) N/A N/A N/A 105 (17.8) 
Mixed/Multiple 
Ethnic Groups 





571 (1.9) 50 (1.5) 19 (5.3) 429 (2.1) N/A N/A N/A 9 (1.5) 
 
 
1 In total, 75 requests (0.1%, 75/60573) were excluded from the analysis because they did not meet the pharmacy service eligibility criteria 
 





2944 (9.7) 229 (7.1) 63 (17.5) 2130 (10.7) N/A N/A N/A 111 (18.8) 
Age (years) 
Range (Min-Max) 13-86 13-59 13-56 16-49 13-86 16-78 16-78 16-72 16-54 
Median (IQR) 24 (20-30) 25 (20-29) 24 (20-30) 25 (21-31) 24 (20-33) 22 (20-
277) 
21 (20-25) 24 (21-30) 23 (20-27) 
Age groups, n (% by column) 
13-15 582 (1.0) 267 (0.9) 19 (0.6) - 296 (1.5) - - - - 
16-19 11765 
(19.4) 
6223 (20.4) 542 (16.7) 43 (12.0) 3707 (18.5) 1130 
(19.4) 
735 (22.1) 395 (15.8) 120 (20.3) 
20-24 20834 
(34.4) 
10740 (35.2) 1156 (35.6) 117 (32.6) 6025 (30.1) 2535 
(43.5) 
1638 (49.3) 897 (35.8) 261 (44.2) 
25-29 11061 
(18.3) 
6209 (20.4) 645 (19.9) 85 (23.7) 2961 (14.8) 1034 
(17.7) 
467 (14) 567 (22.6) 127 (21.5) 
30-39 11786 
(19.5) 
5715 (18.8) 608 (18.7) 84 (23.4)  4550 (22.8) 767 
(13.2) 
334 (10) 433 (17.3) 62 (10.5) 
40+ 4470 (7.4) 1319 (4.3) 277 (8.5) 30 (8.4) 2459 (12.3) 364 
(6.2) 
150 (4.5) 214 (8.5) 21 (3.6) 
Day of week accessed, n (% by column) 
Monday  12657 
(20.9) 
6894 (22.6) 599 (18.4) 46 (12.8) 3935 (19.7) 1102 
(18.9) 
645 (19.4) 457 (18.2) 81 (13.7) 
Tuesday 10249 
(16.9) 
4952 (16.3) 588 (18.1) 63 (17.5) 3515 (17.6) 1049 
(18.0) 
602 (18.1) 447 (17.8) 82 (13.9) 
Wednesday  8999 (14.9) 4223 (13.9) 505 (15.6) 73 (20.3) 3268 (16.3) 828 
(14.2) 
449 (13.5) 379 (15.1) 102 (17.3) 
Thursday  8970 (14.8) 4043 (13.3) 586 (18.0) 71 (19.8) 3325 (16.6) 844 
(14.5) 
445 (13.4) 399 (15.9) 101 (17.1) 
Friday 9235 (15.3) 4120 (13.5) 591 (18.2) 63 (17.5) 3384 (16.9) 968 
(16.6) 
639 (19.2) 329 (13.1) 109 (18.4) 
Saturday 7375 (12.2) 4206 (13.8) 293 (9.0) 37 (10.3) 2021 (10.1) 719 
(12.3) 
440 (13.2) 279 (11.1) 99 (16.8) 
Sunday 3013 (5.0) 2035 (6.7) 85 (2.6) 6 (1.7) 550 (2.8) 320 
(5.5) 
104 (3.1) 216 (8.6) 17 (2.9) 
* Total number of (%) of service requests of all services except STI self-sampling kits.     N/A= not available 
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TABLE 7 AGE-DISTRIBUTION, ETHNICITY-DISTRIBUTION, WEEKDAY OF SERVICE RECEIVED BY GENDER 


















Monday  6893 (22.6) 
16-19 6223 (20.4) Asian/Asian 
British 





4964 (16.3) Wednesday 4223 (13.9) 
25-29 6208 (20.4) Mixed/Multiple 
Ethnic Groups 
2133 (7.0) Thursday  4040 (13.3) 
30-39 5713 (18.8) Other Ethnic 
Groups 
571 (1.9) Friday 4119 (13.5) 
40+ 1319 (4.3) Unknown 2941 (9.7) Saturday 4203 (13.8) 




13-15 19 (0.6) White/White 
British 
1917 (59.1) Monday  599 (18.5) 
16-19 541 (16.7) Asian/Asian 
British 
449 (13.8) Tuesday 587 (18.1) 
20-24 1156 (35.6) Black/Black 
British 
427 (13.2) Wednesday 505 (15.6) 
25-29 644 (19.8) Mixed/Multiple 
Ethnic Groups 
173 (5.3) Thursday  585 (18.0) 
30-39 608 (18.7) Other Ethnic 
Groups 
50 (1.5) Friday 591 (18.2) 
40+ 277 (8.5) Unknown 229 (7.1) Saturday 293 (9.0) 




13-15 -  White/White 
British 
159 (44.3) Monday  46 (12.8) 
16-19 43 (12.0) Asian/Asian 
British 
33 (9.2)  Tuesday 63 (17.5) 
20-24 117 (32.6) Black/Black 
British 
67 (18.7) Wednesday 73 (20.3) 
25-29 85 (23.7) Mixed/Multiple 
Ethnic Groups 
18 (5.0) Thursday  71 (19.8) 
30-39 84 (23.4) Other Ethnic 
Groups 
19 (5.3) Friday 63 (17.5) 
40+ 30 (8.4) Unknown 63 (17.5)  Saturday 37 (10.3) 
 Sunday 6 (1.7)  
Condoms 
(n=13286) 
13-15 109 (0.8) White/White 
British 
6425 (48.4) Monday  2777 (20.9) 
16-19 2427 (18.3) Asian/Asian 
British 
2923 (22.0) Tuesday 2343 (17.6) 
20-24 4370 (32.9) Black/Black 
British 
1755 (13.2) Wednesday 2145 (16.1) 
25-29 2227 (16.8) Mixed/Multiple 
Ethnic Groups 
825 (6.2) Thursday  2122 (16.0) 
30-39 3132 (23.6) Other Ethnic 
Groups 
217 (1.6) Friday 2083 (15.7) 
40+ 1021 (7.7) Unknown 1141(8.6) Saturday 1435 (10.8) 




13-15 - White/White 
British 
N/A Monday  779 (19.3) 
16-19 886 (21.9) Asian/Asian 
British 
N/A Tuesday 699 (17.3) 
20-24 1847 (45.7) Black/Black 
British 
N/A Wednesday 559 (13.8) 
25-29 656 (16.2) Mixed/Multiple 
Ethnic Groups 
N/A Thursday  578 (14.3) 
30-39 480 (11.9) Other Ethnic 
Groups 
N/A Friday 693 (17.1) 
40+ 175 (4.3) Unknown N/A Saturday 513 (12.7) 




13-15 - White/White 
British 
203 (53.1) Monday  56 (14.7) 
16-19 96 (25.1) Asian/Asian 
British 
13 (3.4) Tuesday 52 (13.6) 
20-24 179 (46.9) Black/Black 
British 
63 (16.5) Wednesday 71 (18.6) 
25-29 73 (19.1) Mixed/Multiple 
Ethnic Groups 
39 (10.2) Thursday  69 (18.1) 
30-39 27 (7.1) Other Ethnic 
Groups 
5 (1.3) Friday 68 (17.8) 
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40+ 7 (1.8) Unknown 59 (15.4) Saturday 57 (14.9) 




13-15 187 (2.8) White/White 
British 
2550 (38.6) Monday  1146 (17.3) 
16-19 1261 (19.1) Asian/Asian 
British 
1670 (25.3) Tuesday 1153 (17.4) 
20-24 1630 (24.7) Black/Black 
British 
951 (14.4) Wednesday 1102 (16.7) 
25-29 730 (11.0) Mixed/Multiple 
Ethnic Groups 
283 (4.3) Thursday  1189 (18.0) 
30-39 1373 (20.8) Other Ethnic 
Groups 
211 (3.2) Friday 1277 (19.3) 
40+ 1429 (21.6) Unknown 945 (14.3) Saturday 577 (8.7) 




13-15 - White/White 
British 
N/A Monday  323 (18.1) 
16-19 243 (13.6) Asian/Asian 
British 
N/A Tuesday 348 (19.5) 
20-24 686 (38.5) Black/Black 
British 
N/A Wednesday 268 (15.0) 
25-29 378 (21.2) Mixed/Multiple 
Ethnic Groups 
N/A Thursday  266 (14.9) 
30-39 285 (16.0) Other Ethnic 
Groups 
N/A Friday 274 (15.4) 
40+ 189 (10.6) Unknown N/A Saturday 205 (11.5) 




13-15 - White/White 
British 
76 (36.9) Monday  25 (12.1) 
16-19 23 (11.2) Asian/Asian 
British 
16 (7.8) Tuesday 30 (14.6) 
20-24 80 (38.8) Black/Black 
British 
42 (20.4) Wednesday 30 (14.6) 
25-29 54 (26.2) Mixed/Multiple 
Ethnic Groups 
18 (8.7) Thursday  32 (15.5) 
30-39 35 (17.0) Other Ethnic 
Groups 
4 (1.9) Friday 41 (19.9) 
40+ 14 (6.8) Unknown 50 (24.3) Saturday 40 (19.4) 
 Sunday 8 (3.9) 
N/A= Not available  
 
4.2.5. Consultation Outcomes 
An overview of the consultation outcomes of condoms, chlamydia treatment and emergency 
contraception consultations is presented in Table 8. Most people attending for chlamydia 
treatment were provided with the antibiotic doxycycline (76.8%, 545/591) rather than the antibiotic 
azithromycin (20.0%, 118/591). More people requesting oral contraception were provided with 
the progesterone-only-pill (54.3%, 1764/3247) rather than the combined pill (44.4%, 1442/3247). 
Most people attending for condoms were not provided with condom instructions (74.4%, 
14888/19998). The large majority of people presenting for an emergency contraception 
consultation were supplied with the emergency contraceptive pill (98.3%, 29961/30473). Only a 
small number of women had an additional copper coil referral or appointment (0%, 4/3247), or 
were only provided with a copper coil referral or advice only (0.1%, 8/30473).  
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TABLE 8 CONSULTATION OUTCOMES 
Overview of consultation outcomes 
Umbrella services and their outcomes Frequency (n) Percentage (%) 
Chlamydia Treatment 591 100 
Azithromycin  118 20.0 
Doxycycline  454 76.8 
Unknown  19 3.2 
Oral Contraception  3247 100 
Progesterone-Only-Pill 1764 54.3 
Combined Pill  1442 44.4 
Unknown  41 1.3 
Emergency Contraception Consultation 30473 100 
Emergency Contraceptive Pill 29961 98.3 
Emergency Contraceptive Pill and coil 
appointment  
4 0 
Emergency Contraceptive Pill and coil referral  87 0.3 
Advice Only 34 0.1 
Copper coil referral 8 0 
Unknown  378 1.2 
Condom Instructions 19998 100 
Yes  1331 6.7 
No  14888 74.4 
Unknown 3779 18.9 
 
Of all those who were provided with the emergency contraceptive pill (n=30052), most were given 
an emergency contraceptive pill containing levonorgestrel (57.4%, 17255/30052) rather than an 
emergency contraception containing ulipristal (42.6%, 12797/30052) (see Table 9).  
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TABLE 9 MEDICATION SUPPLIED FOR EMERGENCY CONTRACEPTION CONSULTATIONS 




Emergency Contraception consultation ending in supply of 
emergency contraceptive pill 
30052 100 
Supply of Levonorgestrel emergency contraceptive pills 17255 57.4 
Supply of Ulipristal acetate emergency contraceptive pills 12797 42.6 
 
  




In this retrospective study, data on the uptake, demographic characteristics, attendance patterns 
and consultation outcomes of pharmacy-based SRHS from the Umbrella service in Birmingham 
(England) were analysed for the time period August 2015 to August 2018.The pharmacy-based 
SRHS comprised: emergency contraception, oral contraception, contraceptive injection, STI self-
sampling kits and chlamydia treatment. 
4.3.1. Summary of the main findings 
In total, there were 60573 service requests recorded over a three-year period. Of these, 75 service 
requests were excluded from the analysis as they did not meet the inclusion criteria. The 
remaining 60498 service requests were included in the analysis.  
There was a higher rate of provision for emergency contraception, condoms and STI self-sampling 
kits than the rates of provision for oral contraception, contraceptive injection or chlamydia 
treatment. This was expected as the first three types of services (emergency contraception, 
condoms and STI self-sampling kits) were available in all Umbrella pharmacies (between 127  
176 Tie  1  and Tie  2  pharmacies between August 2015 and August 2018), whereas the latter 
three services (oral contraception, contraceptive injection and chlamydia treatment) were 
restricted to a limited number of pharmacies (between 18-47 Tie  2  pharmacies between August 
2015 and August 2018). 
The majority of service requests were made for contraception by females. They were also more 
likely than males to request pharmacy-based SRHS that were accessible to both females and 
males. Over the three years, 15 transgender people requested a SRHS at an Umbrella pharmacy. 
The majority of all service requests were made by people between 16 and 24 years and the 
median age across all services was found to be 24 years. 
There was no ethnicity data available for STI self-sampling kit requests. White/White British and 
Asian/Asian British accounted for the majority of service requests for the remaining services.  
Most service requests were made on Monday and the least common days to present at the 
pharmacy for a SRHS were Saturday and Sunday. Most service requests at the weekend and on 
Monday were made by women attending for emergency contraception.  
4.3.2. Strengths and weaknesses  
Although the evaluation of healthcare utilisation is important to identify barriers to health services, 
literature on the utilisation of pharmacy-based SRHS is scarce and limited to the delivery of 
individual SRHS. This was the first study evaluating data collected on a large range of pharmacy-
based SRHS over a prolonged period of time; this was timely given that pharmacies are 
increasingly providing sexual and reproductive health services. The current study made use of 
recent data on how pharmacy-ba ed SRHS a e ed in he eal o ld .  
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The main limitation of this study is that the findings are limited to a single health provider in 
Birmingham (England), and so may not be generalisable. Further, the analysis relied on routinely 
collected data which limited the possible analyses. The data analysed in the study was mainly 
collected by the health provider with the intention to support financial transactions between the 
funder and pharmacies rather than to conduct research. The use of routine data meant that data 
was limited in relation to completeness as pharmacy users had the option not to provide some 
personal details. Consequently, the dataset had missing data (captured in the results as 
nkno n ). Variations in the method of data collection also had implications for the analysis. For 
example, the uptake of STI self-sampling kits could not be described in terms of use by ethnic 
group. Further, although the integration of patient records is possible and is believed to provide 
rich data which can be used for research purposes to understand service and medication usage 
in pharmacies (Horsburgh et al., 2010; Wright & Twigg, 2016), patient records were not integrated 
and the lack of consistent patient ID number meant that an analysis at patient level could not be 
conducted. Further, it is possible that transgender people were not identified in the analysis, as 
they may have been recorded as male or female rather than transgender. Further, since the PhD 
candidate was unable to obtain an honorary contract with the University Hospitals Birmingham 
(UHB) and did not have an UHB email account, no dates for service requests were available due 
o conce n  abo  pha mac  e  anon mi . No  ha ing acce s to this information limited 
understanding of whether pharmacy users received several services at one visit, or to analyse 
service uptake over time. 
Despite these shortcomings, this study was the first to explore the utilisation of a large range of 
community pharmacy-based SRHS. Umbrella s novel and integrated pharmacy service 
encompasses more than 120 pharmacies serving a population over one million people and 
pharmacy users were from a wide range of ethnic and cultural backgrounds and the study findings 
can therefore provide useful background information to those planning and delivering pharmacy 
services elsewhere. Conducting this study also informed the design and delivery of the 
subsequent qualitative study, as will be outlined in section 4.3.4.  
4.3.3. Comparisons to the literature 
This study showed that females made up the majority of service requests, even for those services 
that are accessible to both women and men. That males were less likely than females to access 
the pharmacy for SRHS has also been found in previous studies on STI testing (C. Anderson & 
Thornley, 2011; Baraitser et al., 2007; Debattista et al., 2017). This would suggest that males face 
barriers to pharmacy-based SRHS. However, a study from almost two decades ago showed that 
men were generally less likely to access the pharmacy for health advice (Banks, 2001), suggesting 
that males face a barrier to pharmacy access generally. Pharmacy counter staff are predominantly 
female (Schafheutle et al., 2008) and several studies have shown that males prefer speaking to 
male staff (Amir et al., 2016; Letshwenyo-Maruatona, 2017).  
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Hence, the lower proportion of male users could be linked to the high proportion of female counter 
staff in pharmacies. However, when looking at males usage of other health providers, it seems 
that males are generally less likely than females to attend for healthcare (Galdas et al., 2005) and 
with regards to sexual and reproductive health, males have been shown to have a lower uptake 
of STI testing in settings such as primary care (Kong et al., 2011), sexual health clinics (Banerjee 
et al., 2018) and commercial venues (Williamson et al., 2007). Males also were found to be less 
likely to order and return STI self-sampling kits (Banerjee et al., 2018; Götz et al., 2005; Goulet et 
al., 2010; Macleod et al., 2005; Novak & Karlsson, 2006; Paudyal et al., 2015). Hence, the low 
uptake of pharmacy-based SRHS in men is most likely not specific to pharmacies.  
This study also found that only one person recorded as being transgender requested an STI self-
sampling kit through Umbrella within the three-year period. A previously published study analysed 
not only the uptake of Umbrella s STI self-sampling kits that were distributed through pharmacies 
but also those STI self-sampling kits that were collected from Umbrella s sexual health clinic and 
en  o people  home  over a six-month period. This study found that 14 people recorded as 
transgender acquired a STI self-sampling kit within six months (Banerjee et al., 2018). This 
suggests that transgender people may be less likely to collect an STI self-sampling kit from a 
pharmacy than to either get it sent to their home or collect it from a clinic. A recent study found 
that community pharmacists felt that discrimination and lack of provider knowledge were barriers 
to pharmacies for transgender people, and the low uptake of services by transgender people may 
support this finding (C. Leach & Layson-Wolf, 2016). However, it is also possible that more 
transgender people did e pha mac  e ice  b  e e eco ded a  female, male o  p efe  no  
o a  (cap ed in hi  d  a  nkno n ). Further, it may that transgender people prefer to 
access SRHS at different settings. 
Censuses record data, including ethnicity data, about the population of a country. In the UK, the 
census takes place every ten years. The first census in the UK was conducted in 1801 and the 
most recent one was conducted in 2011 (Duke-Williams, 2017). When comparing the ethnicity 
data in this study with the 2011 Census data from Birmingham, ethnic groups utilising SRHS in 
pha macie  e e ep e en ed app o ima el  in p opo ion o hei  p e alence in Bi mingham  
population (Birmingham City Council, 2011)  White/White British (census: 57.9% cf. study 
population: 43.4%), Asian/Asian British (census: 23.7% cf. study population: 23.1%), Black/Black 
British (census: 7.2% cf. study population: 15.1%), Mixed/Mixed British (census: 4.4% cf. study 
population: 2.0%) and other ethnic groups (census: 6.7% cf. study population: 5.8%). In 
compa i on o Bi mingham  pop la ion, i  eem  ha  Black/Black people a e o e epresented in 
the dataset. Black people in developed countries experience worse health across almost all 
domains, including sexual and reproductive health (Assari, 2018; Fenton, 2001). The finding 
possibly suggests that pharmacies reach those associated with poor sexual health outcomes.  
However, when comparing the available ethnicity data from the pharmacies with 2018 sexual 
health clinic data from Umbrella (Umbrella, 2018), a higher proportion of clinic visits were made 
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from Black/Black British people compared to pharmacy visits (sexual health clinic: 25% cf. 15.1%). 
Further, people from Mixed or other ethnic groups were less likely to attend the pharmacy rather 
than the clinic (sexual health clinic: 14% cf. pharmacies: 7.8%). However, a similar proportion of 
White/White British people used pharmacies and clinics (sexual health clinic: 43% cf. pharmacy: 
43.4%). In comparison to the clinic data, Asian/Asian British people appeared to be more likely to 
attend pharmacies rather than sexual health clinics (sexual health clinic: 18% cf. pharmacy: 
23.1%). This would suggest that people from different ethnic backgrounds prefer different setting 
for SRHS. However, 10% of the available ethnicity data from the pharmacies is unknown, either 
because it was not recorded or because people preferred not to state their ethnicity. Further, 
available data could not capture the number of individual pharmacy users but only the number of 
service requests. Hence, it was unclear how many different individuals from each ethnic group 
had accessed the pharmacy for a SRHS in the analysed time period. With regards to the 
comparison between the study population and census data, it should also be considered that 
pharmacies are likely to be accessed by their local population, and so ethnicity data might need 
to be considered at local level rather than city level. However, since we did not have the postcodes 
of pharmacies by service requests, this could not be analysed. Hence, the findings and 
comparisons to census and clinic data have to be interpreted with caution. 
A recent systematic review suggested that young people are willing to use the pharmacy for SRHS 
(Gonsalves & Hindin, 2017). In support of this findings, this retrospective quantitative study 
showed that young people between 16 and 24 years were accounting for the majority of requests 
for SRHS. When comparing the findings from this retrospective quantitative study with people 
testing for STIs at a sexual health clinic in Birmingham, a higher proportion of pharmacy attendees 
were between 16-and 24-years old (3365/5530 [62.9%] cf. 9654/19193 [50%]) (Banerjee et al., 
2018). Young people are particularly vulnerable to worse sexual health outcomes (Slater & 
Robinson, 2014) and these findings suggest that pharmacies may be more effective than sexual 
health clinics in reaching young people who are in high need for SRHS. 
Emergency contraception, STI self-sampling kits and condoms were the most requested services. 
The analysis of attendance patterns by gender revealed that all those three services were most 
frequently requested on Mondays by females. It is likely that women requesting emergency 
contraception were also offered STI self-sampling kits (as they were at risk of contracting a STI) 
and condoms (for future use) by pharmacy staff when they attended. This would suggest that the 
concept of integrated services, where several services are provided in one visit, is working. 
However, since requests of several services in one attendance were recorded under separate 
service requests and the date of service request was not available, this cannot be verified.  
That males appear to obtain condoms before the weekend and emergency contraception is most 
requested by females on Mondays is possibly because sexual intercourse is more likely to occur 
at the weekend (Tan, 2020).  
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This study also showed that the number of requests for emergency contraception was highest on 
Mondays and lowest on Sundays. This is in line with several previous studies on pharmacy-based 
provision of emergency contraception (D. Greene et al., 2006; Killick & Irving, 2004; Mantzourani 
et al., 2019). This may indicate that there are barriers to Sunday access to the pharmacy for 
example because pharmacies are closed, have variable hours or do not have trained staff on 
Sundays. This assumption is supported by data provided by Umbrella on the current opening 
times of their pharmacies: In total, 76.7% (122/159) of their pharmacies collaborating with 
Umbrella in Birmingham are closed on Sunday (as of 2020). However, these opening times may 
have differed in the past and retrospective data on opening times is not available. To prevent 
unwanted pregnancy, emergency contraception has to be taken within a limited time period and 
therefore, timely access to emergency contraception is of high importance.  
In line with a previously published study, this study showed that more than 97% of emergency 
contraception consultations ended with the supply of emergency contraception pills (Mantzourani 
et al., 2019) and emergency contraception pills containing levonorgestrel were most commonly 
provided to service users. The reasons for this were not captured. However, it may be that 
ulipristal was less commonly provided because it is more expensive than levonorgestrel 
(McKeage & Croxtall, 2011). 
Although the copper coil can be used as emergency contraception while also providing highly 
effective contraception, less than 1% of people attending for emergency contraception were 
provided with a copper coil referral according to this study. This might be because of low interest 
in the copper coil as emergency contraception (Turok et al., 2011), maybe due to concerns about 
the long-acting nature and safety of intrauterine contraception (S. Walker et al., 2016). However, 
it may also be possible that there was a lack of clinical appointments available for the copper coil. 
This could not be captured in the dataset.  
It was shown that condom instructions were rarely provided or accepted. Since condom failure is 
a common problem (D. Greene et al., 2006), condom instructions may positively contribute to 
safer sex. A recent study from the US showed that discussing the usage of condoms made people 
feel embarrassed (Wilson, 2018); it is possible that people declined the condom instructions for 
these reasons. 
In our study, the antibiotic doxycycline was used more commonly to treat chlamydia infections 
than the antibiotic azithromycin. This stands in contrast to a study from England and Wales, which 
was conducted between 2006 and 2008 and where the majority of people (93.2%) were treated 
with azithromycin rather than doxycycline (C. Anderson & Thornley, 2011).  
However, between 2010 and 2015 the recommendation for first line treatment for chlamydia 
infections changed from azithromycin to doxycycline (Lanjouw et al., 2010; Nwokolo et al., 2016). 
This may explain the difference in proportion of supply of doxycycline and azithromycin.  
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4.3.4. Contribution of the retrospective quantitative study 
This was the first study to analyse the utilisation of a large range of pharmacy-based sexual and 
reproductive health services. The quantitative study showed the relevance of pharmacy-based 
sexual and reproductive health services: More than 60000 service requests were recorded within 
a three-year period, showing that there is a need and demand for pharmacy-based sexual and 
reproductive health services.  
Further, the quantitative study provides important background information for the qualitative 
study, which is described in chapter 7 and 8. Prior to the conduct of this study it was largely 
unknown who the users of pharmacy-based SRHS were in terms of age, gender and ethnicity. 
This information can inform and provide context to the sampling for the qualitative study. It allows 
understanding of whether the study participants in the interview study are likely to represent the 
users of pharmacy-based sexual and reproductive health services based on specific demographic 
criteria. 
Moreover, findings from the retrospective quantitative study can be used for comparison against 
the findings from the systematic review (presented in chapter 5 and chapter 6) and the interview 
study (presented in chapter 7 and chapter 8). It can be explored whether the qualitative findings 
can explain or support the findings from the other studies and vice versa. The integration of study 
findings using an adapted version of the Pillar Integration Process is addressed in chapter 9.  
4.4. Chapter summary 
In this chapter, the results of the retrospective quantitative study were presented and discussed. 
In total, 60498 SRHS requests, made between August 2015 and August 2018 at Umbrella 
pharmacies, were included in the analysis. The uptake of sexual and reproductive health services 
(SRHS) by service type was presented. Next, an overview of service requests by demographic 
characteristics (age, gender, ethnicity) and attendance patterns by the day of the week was 
provided. Further, the distribution of age, ethnicity and day of the week were analysed by gender. 
Afterwards, the outcomes following consultations for condoms, chlamydia treatment and 
emergency contraception were presented. The discussion started with a summary of the main 
findings and by outlining the strengths and weaknesses of the retrospective quantitative study. 
The findings were then discussed in relation to the existing literature. The chapter closed by 
explaining how the retrospective study contributes, particularly in context of this PhD thesis.  
In the next chapter, the systematic review methods are described.  
5. Systematic Review Methods 
5.1. Chapter overview 
This chapter reports on the conduct of a systematic review exploring what is known about 
pharmacy users  and pharmacy staff experiences of pharmacy-based sexual and reproductive 
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health services. It begins by presenting the aim and objectives of the systematic review. 
Afterwards, the research design is outlined. Next, the inclusion criteria are explained. 
Subsequently, the search methods and search strategy are described. Then, the study selection 
and data extraction methods are presented. Following this, the tool used to assess the quality of 
included studies is introduced. The chapter closes by presenting the method chosen for data 
synthesis. 
5.2. Aim & Objectives 
5.2.1. Aim 
x To mma i e ha  i  kno n abo  pha mac  e  and pha mac  aff a i de  and 
experiences of pharmacy-based sexual and reproductive health services using a 
systematic review  
5.2.2. Objective 
x To inform the qualitative interview study for this PhD project by exploring what is known 
abo  pha mac  e  and aff e pe ience  of pha mac -based sexual and reproductive 
health services using a systematic review  
5.3. Research Design 
Systematic reviews seek to draw together all existing evidence on a certain topic and are 
methodologically more robust than other types of review (Grant & Booth, 2009). However, their 
study design alone does not guarantee high quality (Garattini et al., 2016). The value of a 
systematic review depends on whether it was conducted in a rigorous way and on how well 
authors report their methods and findings (Page & Moher, 2017). This systematic review was 
conducted according to the PRISMA (Preferred Reporting Items for Systematic Reviews and 
Meta-Analyses) reporting framework (Moher et al., 2009). The PRISMA statement is a reporting 
guideline which was developed to allow better reporting and critical appraisal of reviews, and to 
increase the transparency and integrity of reporting systematic reviews (Hutton et al., 2016; Page 
& Moher, 2017). It has been used by researchers around the world since its publication in 2009 
(Hutton et al., 2016).  
There are many benefits of registering systematic reviews before they are conducted (Page et al., 
2018). For example, unintended duplication of systematic reviews can be avoided if researchers 
can access information on which systematic reviews are planned to be conducted (Gough et al., 
2012; Page et al., 2018).  
Further, stating the review methods in a review protocol without prior knowledge of results helps 
to reduce risk of bias (Kirkham et al., 2010). In 2011, he o ld  first international prospective 
register of systematic reviews (PROSPERO) was launched (Page et al., 2018). It is web-based and 
freely accessible to the public. To facilitate optimal transparency, the protocol for this systematic 
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review was therefore registered with PROSPERO in August 2018 under the registration number 
CRD4201810680 (see Appendix 2). The systematic review was published in the journal Sexually 
Transmitted Infections on the 17 July 2019. A copy of this paper is provided in Appendix 3.  
5.4. Criteria for considering studies for the review 
An overview of the inclusion and exclusion criteria for the review are provided in Table 10.  
5.4.1. Types of studies 
Traditionally, systematic reviews included only quantitative evidence (Hong et al., 2017). However, 
in the past 20 years, mixed methods have been increasingly been recognised as an alternative to 
quantitative or qualitative approaches (Teddlie & Tashakkori, 2009) . Since then, reviews of both 
qualitative and quantitative evidence are increasing in popularity (Hong et al., 2017; Sandelowski 
et al., 2006). Including different types of study designs and synthesising their results has the 
potential to provide greater strength and a richer understanding of phenomena compared to 
systematic reviews including only qualitative, quantitative or mixed methods studies (Harden & 
Thomas, 2005; Hong et al., 2017; Pearson et al., 2015). We therefore included quantitative, 
(randomised controlled trials, non-randomised controlled trials, cross-sectional studies, cohort 
studies), qualitative (interviews, focus groups, observational studies) and mixed methods studies 
in our systematic review.  
Consideration was given on whether to include studies in languages other than English. Including 
studies covering all languages may be more time consuming and potentially costly if translation 
costs occur (Jüni et al., 2002). However, excluding studies written in languages other than English 
introduces language bias and might lead to erroneous conclusion (Morrison et al., 2012). 
Therefore, no language restrictions were made in this systematic review. 
Pharmacy staff role and practices are changing fast due to policy changes and healthcare system 
reforms (S. Anderson, 2007; Mossialos et al., 2015). For this reason, the previous ten year period 
is often chosen as timeframe for systematic reviews (Di Sandro et al., 2018; Lu et al., 2019; 
Manzoni et al., 2008). It was also used as time frame in a previous systematic review in the field 
of pharmacy (Eades CE et al., 2011). It was therefore decided to restrict the time frame for the 
systematic review to the past ten years (as of 2018).  
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5.4.2. Types of participants 
A recent study comparing inquiries from mystery shoppers and real clients showed that there 
were systematic differences between them (Stokoe et al., 2020). For example, mystery shoppers 
did not produce social actions (e.g. service requests) in the same way as real clients (Stokoe et 
al., 2020). When applied to pharmacy-based sexual and reproductive health services, it may 
he efo e be ha  eal  e ice e s may experience services differently to mystery shoppers. 
Studies including mystery shoppers (studies utilising unannounced standardised patients to 
evaluate services) were therefore excluded from this review. Instead only studies exploring the 
experience of eal  e ice e  e e incl ded.  
Service user experience is strongly linked to staff experiences (Goodrich, 2018). It was therefore 
considered to be important to capture not only pharmacy users  e pe ience  but also providers  
experiences of pharmacy-based sexual and reproductive health services for this systematic 
review. No restrictions with regards to age, gender or ethnicity were made.  
5.4.3. Setting 
Community pharmacies located in countries listed as Organisation for Economic Co-operation 
and Development (OECD) member countries (as of 2018) were included in this review. OECD 
countries as a whole largely differ from non-OECD countries (W. Greene, 2004; Zimmermann et 
al., 2018). For example, the product availability at retail pharmacies in OECD countries is much 
higher than in non-OECD countries (Ballou-Aares et al., 2008).  
Whilst OECD member countries have different models of health care delivery and medical 
practices vary internationally (Corallo et al., 2014), they do have features in common. For example, 
most OECD countries have implemented universal health coverage for their population (Paris et 
al., 2016). Further, OECD countries face similar challenges such as dealing with the rising demand 
for quality health care surpassing the public health resources (Ozcan & Khushalani, 2017) and 
have therefore expanded their focus on community-based care (Ozcan & Khushalani, 2017). As 
of 2017, the average pharmacist to population ratio in OECD member countries is 8.2 pharmacists 
per 10,000 population (Alameddine et al., 2019). Evidence from non-OECD member countries 
therefore may not be effective in informing the field work in an OECD country such as the UK as 
they differ significantly. Studies from non-OECD member countries were therefore excluded from 
this systematic review. Instead, only research on pharmacy services from OECD member 
countries were included as these countries are more alike, allowing study findings to be more 
likely to inform field work in the UK.  
In 1999, Soma.com became the first online pharmacy (Mackey & Nayyar, 2016). Since then, 
online pharmacies have rapidly expanded with about 35,000 online pharmacies worldwide 
estimated to exist (as of 2016) (The Center for Safe Internet Pharmacies, 2016). Online service 
delivery models differs significantly to that in physical pharmacy stores (Orizio et al., 2011).  
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Instead of selling drugs including prescription-only drugs in a physical store, online pharmacies 
sell them through the internet and deliver pharmaceutical preparations through mail. 
Consequently, pharmacy users and staff therefore may have different experiences using an online 
pharmacy and physical pharmacy for sexual and reproductive health services. Studies looking at 
online pharmacies were therefore excluded from this study, except if they were used as a 
comparator to a physical community pharmacy.  
5.4.4. Types of Interventions 
As outlined in section 1.5.2 , most sexual and reproductive health services in England are provided 
by local authorities (Hind, 2013), who are free to decide where to locate the services. Whilst most 
local authorities provide emergency contraception and chlamydia screening through pharmacies, 
only few local authorities provide additional sexual and reproductive health services through 
pharmacies (Public Health England, 2017). Local authorities in Birmingham (England) were 
identified to provide a comprehensive range of sexual and reproductive health services. The 
services included in this review were therefore defined by the range of pharmacy-based sexual 
and reproductive health services that are provided by Bi mingham  local a ho i . It was 
important to define included services based on the range of services provided in England, as this 
is where the field work informed by this review took place. These services included: condoms, 
emergency contraception, pharmacy-based testing for sexually transmitted infections (such as 
chlamydia, gonorrhoea, syphilis, and HIV, hepatitis B), chlamydia treatment, contraceptive 
injection, and oral contraception. Further, any form of partner notification and hepatitis B 
vaccination were included for the systematic review. These two services have not been 
implemented by Umbrella pharmacies but were planned to be delivered in the future. Studies 
including at least one of those services were included in this review.  
5.4.5. Comparator 
Since the research also aimed to explore how users and staff experience pharmacy-based sexual 
health services compared to users and staff of other sexual health providers, studies comparing 
pharmacy services with other services (including Primary Care, Secondary Care, Sexual Health 
Clinics) were included in this systematic review. However, it was not necessary for studies to have 
a comparator to be included in the review.  
5.4.6. Types of outcomes 
For all reviews, it is important to define outcomes that are meaningful to patients and other key 
stakeholders (Pollock & Berge, 2018). The Cochrane Effective Practice and Organisation of Care 
(EPOC) group undertakes reviews of interventions aimed to improve health care delivery 
(Grimshaw et al., 2006). As the current review looked at health service delivery, the outcomes of 
interest for this review were based on the outcomes listed in the framework of the Cochrane EPOC 
group (Cochrane Institute, 2017).   
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The outcomes for this review were as follows:  
x Workload (pharmacy staff) 
x Impact (pharmacy staff; pharmacy users)  
x Advice (pharmacy staff; pharmacy users) 
x Enablers and barriers to service delivery (pharmacy staff; pharmacy users)  
x Quality of care (pharmacy staff; pharmacy users)  
x Satisfaction (pharmacy staff; pharmacy users) 
x Experience (pharmacy staff; pharmacy users)  
x Attitude (pharmacy staff; pharmacy users) 
 
Attitudes were only considered if they were based on actual experiences. The reason for this was 
that we aimed to explore e  and staff perspectives on implemented rather than planned 
pharmacy services.  
TABLE 10 SYSTEMATIC REVIEW: INCLUSION AND EXCLUSION CRITERIA 
Systematic Review: Inclusion and Exclusion Criteria  
Types of Studies  
Inclusion  x Qualitative studies (interviews, focus groups, ethnographies) 
x Quantitative studies (randomised controlled trials, non-randomised controlled 
trials, cross-sectional studies, cohort studies) 
x Mixed methods studies  
x Grey literature and dissertation theses  
Exclusion  x Service Evaluations 
x Conference Abstracts  
x Conference Proceedings 
x Poster Presentations 
x Literature Reviews and Systematic Reviews  
Types of participants  
Inclusion  x Pharmacy users of sexual health services 
x Pharmacy staff (pharmacists, pharmacy technicians, pharmacy healthcare 
assistants, locum pharmacists) providing sexual health services in pharmacies 
Exclusion  x Mystery shopper studies  
Setting  
Inclusion  x Pharmacies (community pharmacies; supermarket pharmacies) 
Exclusion  x Internet Pharmacies (or Online Pharmacies) and Hospital pharmacies 
x Pharmacies which are not located in countries listed as Organisation for 
Economic Co-operation and Development (OECD) member countries 
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Types of interventions  
Inclusion  x Condoms 
x Emergency hormonal contraception 
x STI self-sampling or testing kits for chlamydia, gonorrhoea, syphilis, and HIV 
x Chlamydia treatment 
x Oral contraceptive pill 
x Contraceptive injection 
x Hepatitis B vaccine 
x Any form of partner notification 
Exclusion  x Female condoms 
x Treatment for gonorrhoea, syphilis, HIV  
x Pre-exposure prophylaxis (or PrEP)  
Comparator  
Inclusion  x Any sexual health service provider other than those pharmacy-based (including 
Primary Care, Secondary Care, Sexual Health Clinics) 
x No comparator group 
Outcomes  
Inclusion  x Workload (pharmacy staff) 
x Impact (pharmacy staff; pharmacy users )  
x Advice (pharmacy staff; pharmacy users ) 
x Enablers and barriers to service delivery (pharmacy staff; pharmacy users )  
x Quality of care (pharmacy staff; pharmacy users )  
x Satisfaction (pharmacy staff; pharmacy users ) 
x Experience (pharmacy staff; pharmacy users )  
x Attitude (pharmacy staff; pharmacy users ) 
Exclusion  x Attitude - if prospective (pharmacy staff; pharmacy users ) 
 
5.5. Search Methods for identification of studies 
This section outlines the search methods and explains the search strategy.  
5.5.1. Electronic database searches  
Consideration was made as to the electronic databases searched for this review. When searching 
for relevant literature, the search of multiple databases is recommended (Bramer et al., 2017). 
Previous reviews on extended pharmacy services (Ali M.K. Hindi et al., 2019), pharmacy-based 
sexual and reproductive health services (Gonsalves & Hindin, 2017), STI screening (Paudyal et 
al., 2015), and contraception (Roberts & Noyes, 2009) were used to inform the choice of 
databases searched for this review. Additionally, evidence on literature searches were used to 
decide which databases to search. A recent study on literature searches showed that the 
combination of the databases Embase, Medline, Web of Science and PsycINFO was effective in 
identifying literature (Bramer et al., 2017). According to this study, Embase produced the most 
unique references but PsycINFO also added unique references to some reviews (Bramer et al., 
2017). Popline used to be one of the databases with greatest depth and breadth of evidence on 
family planning (Compton & Stenger, 1986) until it was retired on the first September of 2019. 
Considering the databases searched in previous reviews and research on literature studies, the 
following seven databases were chosen to identify relevant literature:  
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x Cochrane Central Register of Controlled Trials (CENTRAL, The Cochrane Library)  
x Embase (Classic + Embase)  
x Medline (OVID)  
x Popline 
x PsycINFO  
x Scopus  
x Web of Science  
All electronic databases were searched on the 17th September 2018.  
The previously published systematic review on pharmacy-based sexual health services 
(Gonsalves & Hindin, 2017; Gudka, Afuwape, et al., 2013) was used to inform the key words 
searched for this review. Further, the selection of keywords chosen for this systematic review was 
discussed with a specialist librarian (S.J.) and both academic supervisors (H.A. and J.R) who all 
have extensive experience in designing search strategies in health research. The search strategy 
was refined over time.  
Keywords from the research question ch a  pha mac  o  pha macie  e e mapped i h 
several search terms related to contraception services and STI services. The search strategy was 
adapted for each database. A combination of medical subject headings (MeSH) and multi-purpose 
set of fields (.mp), which searches in titles, abstracts and keywords, was utilised. A multi-purpose 
search was suggested by the librarian (S.J.) since it is slightly narrower than searching all fields 
( .af ). No language limits were applied and no search terms relating to specific countries were 
used to avoid limiting the search sensitivity. The detailed electronic search strategy for all 
electronic databases can be found in Appendix 4.  
According to a survey from 2013, the reference software EndNote (by Clarivate Analytics) was 
used by more than half of systematic reviewers (Lorenzetti & Ghali, 2013). For this review, 
EndNote X8 was also utilised. All references were imported into EndNote X8 and were de-
duplicated by the PhD candidate (J.G.) ing he EndNote  f nc ion Find D plica e  and b  
manual search.  
5.6. Data collection and analysis 
5.6.1. Study selection  
The PhD candidate (J.G.) screened all titles and abstracts identified against the inclusion criteria. 
As double screening of titles and abstracts is important as substantially more studies are missed 
when studies are only screened once (Waffenschmidt et al., 2019), two researchers (I.H and I.S) 
additionally acted as second screeners. Each of the two second reviewers (I.H. and I.S) screened 
50% of all titles and abstracts independently. Any discrepancies on whether to include a reference 
for full text screening were resolved through discussion with a further research (H.A. or J.R).  
After the screening of the titles and abstracts, the full texts of potentially eligible studies were 
retrieved. J.G. screened all full texts and, as outlined before, I.H. and I.S. acted as second 
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screeners. This time, a reason to exclude a paper from the review was recorded. Discrepancies 
on whether to exclude a full text paper were resolved through discussion with the academic 
supervisors (H.A. or J.R.).  
The reference list of all included articles was checked for further relevant articles. This process is 
often undertaken by researchers conducting a systematic review (Horsley et al., 2011) as it allows 
searching in a more comprehensive way than searching electronic databases alone (Badampudi 
et al., 2015) and can lead to the further identification of relevant evidence (Kugley et al., 2017).  
All studies could be accessed, and the last study was accessed on the 20th November 2018. 
5.6.2. Data extraction 
Data extraction is an important step in conducting systematic reviews as it builds the basis for the 
results. Based on the guidance provided by Boland et al. (2017) and templates provided by the 
academic supervisors, a data extraction sheet was developed by J.G. for this systematic review. 
It was piloted on a few randomly selected studies by the PhD candidate (J.G) and two researchers 
(I.H and I.S) to ensure the completeness of the sheet. After discussion, no changes were made. 
The data extraction sheet for this study can be found in Table 11.  
The data for all studies were extracted by the PhD candidate (J.G.). Since a previous study showed 
that prevalence of data extraction errors in systematic reviews are high, two further researchers 
(I.H. and I.S.) each extracted data for half of the studies to reduce the likeliness for errors to occur 
(Gotzsche et al., 2007). The three researchers (J.G, I.H. and I.S.) compared their data extraction 
and checked the references again in cases where authors had different data extracted.  
  




TABLE 11 DATA EXTRACTION SHEET 
Data Extraction Sheet for the Systematic Review - Version 1.0 (7 November 2018) 
Study Title  What is the title of the study? 
First Author What is the name of the first author? 
Date published  When was the study published? (Month/Year) 
Setting  Where and when did the study take place (Location/ Country) 
Study Design  What study design was used? (Qualitative study, quantitative study, mixed 
methods study) 
Study Methods Which methods were used to collect data? (e.g. interviews, focus groups, 
etc.) 
Research Question(s) or 
Research Objective(s)  
What is/are the research question(s) or research objective(s)?  
Number of participating 
pharmacies  
How many pharmacies participated in the study? 
Type of participating 
pharmacies  
What type of pharmacy participated in the study? (e.g. individual pharmacy; 
chain pharmacy) 
Population  Who are the study participants (e.g. pharmacists, pharmacy users etc.); 
What is participants age, gender, ethnicity and religion (where reported) 
Comparator  Was a comparator used in the study? If yes, which one? (e.g. GP) 
Sexual and reproductive 
health / Intervention 
Which sexual and reproductive health services did the study explore? (e.g. 
emergency contraception) 
Outcomes  What were the outcomes used in the study? (e.g. experience, attitude)  
Results What did the study find?  
Sponsorship/ Funding  Who funded or sponsored this study?  
 
5.6.3. Assessment of quality in included studies  
The most difficult source of bias in systematic reviews is to control for included studies of low 
methodological quality (Jarde et al., 2012). If included studies are flawed, the results of the 
systematic review cannot be trusted. Therefore, it is important to assess the quality of included 
studies (Jarde et al., 2012).  
When conducting a systematic review including qualitative and quantitative evidence, assessing 
the quality of studies is challenging due to the heterogeneity of studies (Hong, Gonzalez-Reyes, 
et al., 2018). Although some research suggests that studies that are reported poorly should be 
excluded from reviews (Carroll et al., 2012), it was decided to not exclude papers based on their 
reporting as they may still have been conducted adequately and provide valid and important 
findings. Instead, the quality assessment was used to offer context for the synthesised findings. 
While there are more than five hundred tools to critically appraise studies, most of them can only 
be applied for one specific research design (Pluye et al., 2019).  
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For this review, the Mixed Methods Appraisal Tool (MMAT)  Version 2018 was used for the quality 
assessment of included studies (Hong, Pluye, et al., 2018). It was chosen because it is a quality 
assessment tool for mixed methods reviews, allowing to assess the quality of evidence of all study 
designs, including mixed methods research designs (Crowe & Sheppard, 2011; Simera et al., 
2010).  
It has been found to be easy to use and comprehensive (Hong et al., 2018). It is also an 
increasingly popular method used to assess the quality of studies. Since its publication in 2009, it 
has been cited in more than one hundred systematic reviews (Hong, Gonzalez-Reyes, et al., 2018). 
MMAT, which was first published in 2009  (Pluye et al., 2019), consists of five sets of criteria for: 
qualitative, randomised, non-randomised, quantitative descriptive and mixed methods studies.  
The PhD candidate (J.G.) assessed the quality of all included studies. Additionally, I.H. and I.S. 
each assessed the quality of 50% of the papers. Disagreements were resolved by consensus or 
by the PhD supervisors (H.A. and J.R.). 
One of the MMAT criteria for quantitative descriptive studies asks whether the risk of nonresponse 
bias is low. Non-response bias may inhibit the generalisation of findings (Rupp et al., 2002). The 
Journal of the American Medical Association editorial policy states that response rates in surveys 
should generally be at least sixty percent in order to limit the impact of nonresponse bias on the 
validity of findings (Davern, 2013). Therefore, the risk of nonresponse bias was reported as low 
for this systematic review if the response rate was greater than or equal to sixty percent. 
The outcome of quality assessments can be summarised in an overall quality score (Lundh & 
Gøtzsche, 2008). A recent systematic review on quality assessment tools of non-experimental 
studies found that the majority of quality assessment tools have a summary score (Jarde et al., 
2012). As no guide for categorising studies into high, medium or low quality exists for MMAT, a 
guide for interpretation was developed by the PhD candidate. As it is important to explain how 
individual quality criteria are summarised (Viswanathan et al., 2012), studies included in the review 
were grouped into high, medium, or low quality. For qualitative and quantitative papers, for which 
five MMAT criteria exist, they were grouped into high, medium or low quality if they met 4-5, 3, or 
1-2 criteria respectively. For mixed methods studies, for which there are 15 (in one case 20) 
criteria, papers were divided into high, medium or low quality if they fulfilled 11-15 (12-20), 8-10 
(9-12), or 1-7 (1-8) criteria. 
5.6.4. Data synthesis  
There are many ways to synthesise qualitative and quantitative evidence in systematic reviews, 
some of which are interpretive and some of which are integrative (Dixon-Woods et al., 2005). 
Interpretive synthesis is concerned with the development of concepts or theories, whereas 
integrative syntheses focus on summarising data (Dixon-Woods et al., 2005). Examples for 
interpretive ways to synthesise qualitative and quantitative data include realist synthesis, 
grounded theory, and thematic analysis.  
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Realist synthesis is a theory-driven approach to synthesise evidence which can deal with evidence 
in many forms, including qualitative and quantitative data (Dixon-Woods et al., 2005).  
However, realist syntheses are only used in realist reviews. Grounded theory is an approach which 
is traditionally used for qualitative data analysis but could potentially deal with quantitative data by 
converting quantitative data into qualitative form (Dixon-Woods et al., 2005).  
Thematic analysis is an approach where analytical themes are identified in the data and 
conceptual frameworks can be developed (Hong et al., 2017). It is usually used with qualitative 
data but could also be used with quantitative data (Popay et al., 2006a).  
Ho e e , ince he objec i e of he c en  ema ic e ie  a  o o nde and ha  i  
kno n abo  pha mac  e  and pha mac  aff experiences of pharmacy-based sexual and 
ep od c i e heal h e ice , choo ing an in e p e i e app oach o ld ha e gone be ond 
summarising the data. Instead, an integrative approach was chosen to summarise the data.  
Narrative synthesis was identified to be the second most commonly used method to synthesise 
qualitative and quantitative evidence in systematic reviews after thematic analysis (Hong et al., 
2017). Evidence is integrated by a coherent textual narrative where diverse forms of findings are 
discussed side by side (Campbell et al., 2018; Dixon-Woods et al., 2005). The UK  Economic and 
Social Research Council funded guidance on how to conduct a narrative synthesis to increase 
the reproducibility and transparency of narrative synthesis. The guidance was published in 2006 
(Popay et al., 2006b). Elements of the guidance were used to guide the synthesis for this 
systematic review. Characteristics of included studies were summarised, and key findings of all 
studies were described as part of the data extraction process. Patterns across included studies 
were identified and described alongside the population type (Pharmacy Users/ Pharmacy Staff). 
Findings were presented in text and tables.  
5.7. Chapter summary 
The systematic review follows the PRISMA guidance. The aim of the review was to understand 
ha  i  kno n abo  pha mac  e  and pha mac  aff e pe ience of pha mac -based SRHS. 
The inclusion criteria were outlined in this chapter. Qualitative, quantitative and mixed methods 
studies, which focussed on pharmacy-based SRHS and were conducted in OECD countries in the 
past ten years, were included in this review. Next, the search methods were described. In total, 
seven databases were searched for this review. Afterwards, the methods to select studies were 
described. It was also outlined which data was extracted from included studies. The Mixed 
Methods Appraisal Tool was used to assess the quality of included studies and a narrative 
synthesis applied to analyse evidence. The results of the review and discussion of the findings are 
presented in the following chapter (chapter 6). 
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6. Systematic Review Results and Discussion 
6.1. Chapter overview 
This chapter begins by presenting the results of the literature search and by describing the studies 
included in the review. Then, the results of the quality assessment are outlined. Afterwards the 
findings of the systematic review are described. The results are presented by population type 
(pharmacy users and pharmacy staff). In the discussion, the key findings are summarised, and the 
strengths and weaknesses of the systematic review presented. Afterwards, the results are 
discussed in relation to the current literature. The chapter ends by outlining gaps in the literature 
on e  and staff experiences of pharmacy-based SRHS that the systematic review identified. 
6.2. Results of the literature search 
Figure 5 illustrates the number of papers that were identified, screened, excluded and included, 
based on the PRISMA guidelines (Moher et al., 2009). A total of 8965 studies were identified 
through the database searches. Following de-duplication, 4778 articles were screened for their 
titles and abstracts. Out of those 4778 articles, 110 articles were screened for their full text and 
20 articles, reporting on 16 different studies, were included in the review. A further three studies 
were identified through the screening of the reference lists of the included studies. The screening 
of the reference list of those three studies did not identify further studies. Hence, in total 23 articles 
reporting on 19 different studies were included in this systematic review.  




FIGURE 5 PRISMA FLOW DIAGRAM SHOWING SCREENING OF IDENTIFIED STUDIES 
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6.3. Description of included studies 
The 19 studies can be split into three different study designs: quantitative studies (n=7), qualitative 
studies (n=5) and mixed methods studies (n=7).  
Some studies looked only a  pha mac  aff pe pec i e  (n=11) o  pha mac  e  pe pec i e  
(n=4), while o he  looked a  bo h pha mac  aff and pha mac  e  pe pec i e  (n=4). Onl  
two studies looking at pharmacy staff included pharmacy healthcare assistants as study 
participants (Deeks et al., 2014; Parker et al., 2015; Ryder et al., 2015). To explore pharmacy staff 
and pharmacy use  e pe ience , e  (n=12), in e ie  (n=11) and foc  g o p  (n=2) e e 
used as methodologies in the included studies. Two included studies were found to have the same 
first author (Gudka et al., 2009, 2014; Gudka, Marshall, et al., 2013). Most studies only focussed 
on one type of intervention (n=16). Only three studies looked at two types of interventions (Gudka 
et al., 2009; Gudka, Marshall, et al., 2013; L. Michie & Cameron, 2020; G. Thomas et al., 2009) 
and no study explored more than two different interventions. The sexual and reproductive health 
services included in the selected studies are as follows: emergency contraception, oral 
contraception, contraceptive injection, chlamydia screening, HIV screening, and condom 
distribution.  
Six out of the eight studies that included pharmacy users only had women as study participants 
because they looked at services (e.g. emergency contraception, oral contraception or chlamydia 
screening after emergency contraception) which can only be accessed by females (Black et al., 
2008; Gudka et al., 2009, 2014; Gudka, Marshall, et al., 2013; R. Heller et al., 2017; L. Michie et 
al., 2016; Ragland, Battle, et al., 2015).   
T o q ali a i e and o q an i a i e die  compa ed pha mac  e  e pe ience  i h e  
who had obtained services from other settings including Family Planning Clinics and General 
Practices. 
Most studies originated from Australia (n=7), England (n=4) and the United States (n=4). Two 
studies were from Canada, one from New Zealand and one from Scotland.  
An overview of the characteristics of included studies is presented in Table 12.  
6.4. Quality of included studies  
The quality of the included studies was variable. In total, ten studies were of high, five of low and 
four of medium quality (see Table 12).  
Qualitative studies were more likely to be of good quality: Four qualitative studies were found to 
be of high quality and one of medium quality.  
The quantitative and mixed methods studies varied more in their quality: Out of the seven 
quantitative studies, three were of high, two of medium and one of low quality. Three of the mixed 
methods studies were of high quality, one of medium quality and three of low quality.  
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Most studies (n=18) had clear research questions and collected data in a way that allowed them 
to address their research questions (n=16). However, only three studies (Cooper et al., 2008; 
Ryder et al., 2015; Wong et al., 2017), which all were qualitative, fulfilled all of the MMAT  
assessment domains. 
All of the quantitative descriptive studies used appropriate measurements and statistical analysis 
to answer their research questions and all of the mixed methods studies employed a relevant 
sampling strategy to address the research questions. 
As outlined in the systematic review methods chapter, the response rate in surveys should at least 
be sixty percent for the non-response bias to be considered as low. However, none of the 
quantitative descriptive studies and only one of the seven mixed methods studies had a response 
rate higher than sixty percent, giving overall high risk of non-response bias. 
Further, most of the mixed methods studies (n=6) failed to adequately bring together results into 
an overall interpretation or to address divergences and inconsistencies between quantitative and 
qualitative results (n=4). 
For a mixed methods study to be of good quality, both the qualitative and quantitative components 
need to be of high quality according to the MMAT criteria. However, this was not the case in five 
out seven mixed methods studies included in the review.  
An overview of the criteria met, and the overall quality can be found in Appendix 5.  
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No Pharmacists (n=20) High 
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6.5. Pharmacy users: Experiences and attitudes 
The main findings on pha mac  e  e pe ience  and a i de  are summarised in Table 13. 
Th ee ke  a ea  ela ing o pha mac  e  e pe ience  and a i de  e e iden ified: privacy; 
convenience; and pharmacy staff as sexual and reproductive health providers.  
6.5.1. Privacy 
Privacy was a topic that was discussed in most studies (five out of eight) looking at pharmacy 
e  pe pec i e  (Black et al., 2008; Darin et al., 2015; Gudka et al., 2009, 2014; Gudka, 
Marshall, et al., 2013; Parker et al., 2015).  
In most studies, pharmacy users were directly asked about their experience of privacy at the 
pharmacy (Black et al., 2008; Gudka et al., 2009, 2014; Gudka, Marshall, et al., 2013; Parker et al., 
2015), whereas in one study the topic was brought up by pharmacy users without being prompted 
(Darin et al., 2015).  
The opic p i ac  a  no  iden ified in die  on condom  o  ongoing con acep ion b  onl  in 
studies on emergency contraception and STI testing (Black et al., 2008; Darin et al., 2015; Gudka 
et al., 2009, 2014; Gudka, Marshall, et al., 2013; Parker et al., 2015).  
Pha mac  e  e pe ience of p i ac  conflic ed i hin and be een dies: While some 
pharmacy users stated that privacy was something that they liked about the pharmacy (Darin et 
al., 2015; Gudka et al., 2009, 2014; Gudka, Marshall, et al., 2013) and that privacy at the pharmacy 
was not a concern for them, other pharmacy users were concerned about their privacy (Gudka et 
al., 2009, 2014; Gudka, Marshall, et al., 2013), particularly at the pharmacy counter (Darin et al., 
2015). Some pharmacy users even felt that lack of privacy was a barrier to service access. Fear 
of being overheard and being surrounded by other pharmacy users were reasons why pharmacy 
users did not want to discuss sexual and reproductive health over the counter and why privacy 
was important to pharmacy users (Darin et al., 2015; Parker et al., 2015). When compared to clinic 
users (98.9%; 82/83), pharmacy users were found to be significantly less likely (p≤0.001) to agree 
that adequate privacy had been provided to them (44%, 22/50) (Black et al., 2008).  
6.5.2. Convenience  
Convenience was one of the most highly valued features of the pharmacy amongst pharmacy 
users. In particular, physical accessibility of pharmacies was convenient for pharmacy users. They 
found it easy to a get to a pharmacy and liked that they did not have to travel a long distance to 
obtain a sexual and reproductive health service (Black et al., 2008; Darin et al., 2015; Gudka et 
al., 2014). In comparison, users found it easier to obtain a sexual and reproductive health service 
from a pharmacy than from a clinic (Black et al., 2008). Pharmacy users were also positive about 
the fast delivery of sexual and reproductive health services at the pharmacy (Darin et al., 2015). 
The walk-in nature of pharmacies was another feature that pharmacy users appreciated.  
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Some pharmacy users described that they had difficulties in the past to schedule an appointment 
for contraception in other settings and for some women this had put them off accessing 
contraception (Black et al., 2008; Darin et al., 2015; Deeks et al., 2014; Gudka et al., 2014; R. 
Heller et al., 2017; L. Michie et al., 2016; Parker et al., 2015). Pharmacy users therefore 
appreciated the fact that there was no need to make a plan or book an appointment before visiting 
the pharmacy (Deeks et al., 2014; Gudka et al., 2009; Gudka, Marshall, et al., 2013; L. Michie et 
al., 2016; Parker et al., 2015). In addition, pharmacy users liked that both sexual and reproductive 
health and other health issues could be dealt with in one visit. Pharmacies also offered the 
opportunity to get both the consultation and the medication in one attendance whereas General 
Practitioners typically can only provide the consultation but not the medication.  
However, there were also a few aspects that reduced the convenience of pharmacy access for 
sexual and reproductive health services. For example, some pharmacy users found that there 
were no trained pharmacy staff available to provide a sexual and reproductive health service (R. 
Heller et al., 2017). This meant that they had to return to the pharmacy at another time.  
Moreover, users who had accessed the pharmacy for STI testing found it inconvenient that they 
had to return the STI self-sampling kits to designated places and then wait for the test results. 
Having to call the hospital during working hours to receive the test results also did not suit some 
pharmacy users (Gudka et al., 2009; Gudka, Afuwape, et al., 2013).  
6.5.3. Pharmacy staff as sexual and reproductive health providers  
Pharmacy users commented on three different aspects of the pharmacy consultation: pharmacy 
staff communication and interpersonal skills; the information and advice provided to them; and on 
pharmacy staff competency in delivering the services.  
Pharmacy staff communication and interpersonal skills  
Pharmacy users generally had a positive consultation experience with pharmacy staff. Pharmacy 
staff were often described as nice, polite, friendly, kind, supportive and understanding. With 
exception of some young people, pharmacy users were largely comfortable discussing sexual and 
reproductive health with pharmacy staff (Darin et al., 2015; Deeks et al., 2014; Gudka et al., 2009, 
2014; Gudka, Marshall, et al., 2013; R. Heller et al., 2017; L. Michie et al., 2016; Parker et al., 2015; 
Ragland, Battle, et al., 2015; Ragland, Payakachat, et al., 2015) and found that they were 
professional during the consultation. They also felt that information was communicated clearly by 
pharmacy staff (Gudka et al., 2009; Gudka, Marshall, et al., 2013). 
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Pharmacy staff information and advice  
Overall, pharmacy users felt that appropriate advice was provided in the consultation and were 
highly satisfied with the consultation. However, consultations delivered by pharmacy staff 
appeared to be less comprehensive than consultations delivered by clinicians: For example, 
pharmacy users were less likely (82%; 41/50) than users of clinical services (95%; 78/83) to agree 
that adequate advice had been provided to them during the consultation (p=0.15) (Black et al., 
2008). Further, pharmacy users who attended for emergency contraception were less likely (28%; 
14/50) than users of clinical services (90.4%; 75/83) to receive advice on future contraception as 
part of the consultation (p≤0.001) (Black et al., 2008).  
Pharmacy users were also found to be less likely (n=87; mean ± SD: 3.6±0.6) than users of clinical 
services (n=116, mean ± SD:3.8±0.4) to agree that the information helped them to understand 
future use of emergency contraception better (p=0.034) (Ragland, Battle, et al., 2015; Ragland, 
Payakachat, et al., 2015), suggesting that this information was not provided or clearly 
communicated by pharmacy staff. 
Pharmacy staff competency in delivering the services 
Pharmacy users felt comfortable with pharmacists conducting the HIV rapid testing and stated 
that staff were able to obtain an adequate blood sample at the first attempt (Darin et al., 2015). 
There was also no significant difference between how comfortable users who had been to the 
pharmacy and users who had been to a GP felt receiving a HIV fingerstick test (Darin et al., 2015). 
While some pharmacy users who attended for the contraceptive injection had positive 
experiences, others found that staff appeared to be inexperienced with the method of delivery 
and needed several attempts to give the injection (R. Heller et al., 2017).  
6.6. Pharmacy staff: Experiences and attitudes 
One of the studies which explored pha mac  heal hca e a i an  pe pec i e , epo ed hei  
findings separately whereas the other two studies reported pha maci  and pharmacy 
heal hca e a i an  e pe ience  together without always making a distinction between the two 
groups (Downing et al., 2011; Ryder et al., 2015). Where differences between their views were 
noted, these will be highlighted in this section.  
In total, three key areas relating to pharmacy staff experiences and attitudes were identified: 
privacy; suitability of pharmacy as a venue to deliver sexual and reproductive health services; and 
pharmacy staff new role as sexual and reproductive health providers. The key findings are 
summarised in Table 13.  
  
PhD Thesis | Systematic Review Results and Discussion | Julia Gauly 
85 
 
6.6.1. Privacy  
Although pharmacy staff felt that some users, and particularly young users, did not seem 
concerned about their privacy (Deeks et al., 2014; Parker et al., 2015), they were aware that 
privacy was highly important for most pharmacy users requesting a sexual and reproductive 
health service (Downing et al., 2011).  
Pharmacy staff stated that discreetness enabled the delivery of sexual and reproductive health 
services (Ryder et al., 2015). Having a private consultation room therefore helped pharmacists to 
interact with users of sexual and reproductive health services (Gudka et al., 2009; Gudka, 
Marshall, et al., 2013). Pharmacy staff were concerned about having to explain sexual and 
reproductive health services outside a private area (Dabrera et al., 2011; Deeks et al., 2014; Parker 
et al., 2015) and felt that a lack of privacy interfered with their ability to provide a service (Whelan 
et al., 2013). When there was no designated private area or consultation room available, pharmacy 
staff tried to ensure confidentiality by seeking a quiet area away from the main counter and from 
other pharmacy users (Dabrera et al., 2011; Downing et al., 2011; Hussainy et al., 2011). Staff 
believed that city pharmacies offered greater anonymity compared to pharmacies located in more 
rural areas (Deeks et al., 2014; Parker et al., 2015), mainly because they felt it was less likely to 
meet an acquaintance in a large city compared to a rural area. Finally, pharmacy staff believed 
that fear of being seen by relatives when visiting the pharmacy was a barrier for young people to 
access pharmacy-based sexual and reproductive health services (Ryder et al., 2015). 
6.6.2. Suitability of pharmacy as a venue to deliver sexual and reproductive health 
services 
Both pharmacists and pharmacy healthcare assistants had a positive attitude towards the 
provision of sexual and reproductive health services through pharmacies (Dabrera et al., 2011; 
Downing et al., 2011; R. Heller et al., 2017; G. Thomas et al., 2009) and were supportive of the 
idea to further expand the range of sexual and reproductive health services delivered by 
pharmacies (Thomas et al., 2010; Heller, Johnstone and Cameron, 2017; Rodriguez et al., 2018).  
According to pharmacists, providing sexual and reproductive health services showed the public 
that the pharmacy was progressive and proactive (G. Thomas et al., 2009).   
Pharmacists felt that pharmacies were well placed to deliver sexual and reproductive health 
services because of their large clientele (G. Thomas et al., 2009) and because of their greater 
accessibility, longer opening hours and quicker appointments compared to other sexual and 
reproductive health providers such as General Practitioners and sexual health clinics (Cooper et 
al., 2008; R. Heller et al., 2017; Ryder et al., 2015). Pharmacy staff stated that in contrast to school 
clinics, pharmacies were also open during school holidays (Ryder et al., 2015). 
However, while most pharmacy staff felt that pharmacies are an appropriate place to offer services 
related to contraception (Dabrera et al., 2011; R. Heller et al., 2017) and sexually transmitted 
infections (Dabrera et al., 2011; G. Thomas et al., 2009), some pharmacy staff felt that pharmacies 
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might not be the right place for condom distribution since they were not necessarily accessed by 
young males (Ryder et al., 2015). These pharmacy staff thought that pharmacies might be 
perceived as an intimidating environment by young males for reasons such as perceived authority 
status of the pharmacist, or the need to discuss sexual and reproductive health issues with female 
pharmacy staff (Ryder et al., 2015). Therefore, pharmacy staff suggested that additional youth-
friendly condom collection points should be implemented (Ryder et al., 2015). A further concern 
of pharmacy staff was the provision of condoms to underage people without parental consent 
(Ryder et al., 2015). 
A difficulty for pharmacy staff was dealing with young pharmacy users presenting in groups 
(Deeks et al., 2014; Ryder et al., 2015). This was because staff felt that the presence of a group of 
youths made them and other customers feel uncomfortable. Amongst others they were concerned 
whether groups of youths would steal (Deeks et al., 2014).  
Further, staff were worried about pharmacy users having to wait longer to receive a service when 
it was busy in the pharmacy (Deeks et al., 2014; Parker et al., 2015). Other pharmacy staff did not 
think that waiting was an issue and stated that pharmacy users were usually prepared to wait 
(Deeks et al., 2014; Parker et al., 2015).  
6.6.3. Pharmacy staff new role as sexual and reproductive health provider 
Workload 
The large majority of pharmacy staff felt that the delivery of pharmacy-based sexual and 
reproductive health services was feasible within their practice and that time pressure did not 
prevent them from offering sexual and reproductive health services (Dabrera et al., 2011; 
Rodriguez et al., 2018; G. Thomas et al., 2009). Only a few pharmacy staff were anxious or 
concerned about not being able to meet the demand due to a lack of trained staff (G. Thomas et 
al., 2009; Whelan et al., 2013). Nevertheless, pharmacy staff agreed that offering additional 
services added to their workload (Deeks et al., 2014; Parker et al., 2015).  
Workload was mainly caused by administrative work ch a  eco ding pha mac  e  
information and the face-to-face consultation itself (Gudka et al., 2009; Gudka, Afuwape, et al., 
2013; Whelan et al., 2013). Although pharmacy staff felt that recording patient information was 
important, they reported that it was time-consuming and difficult (Gudka et al., 2009; Gudka, 
Marshall, et al., 2013; Whelan et al., 2013).  
They found that some questions in the protocol on emergency contraception included irrelevant 
and ambiguous questions and suggested the administrative work to be simplified and to be 
collected electronically (Gudka et al., 2009; Gudka, Marshall, et al., 2013; Hussainy et al., 2011).  
Pharmacy staff felt that the number of requests for emergency contraception had increased since 
it was available from the pharmacy without a prescription (Hussainy et al., 2011). Requests for this 
service were particularly high at the weekends and in the evenings, and pharmacy staff working 
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at these times reported difficulties with managing the administrative work and increased demand 
(Gudka et al., 2009; Gudka, Marshall, et al., 2013).  
While most pharmacists were willing to take on the extra workload as part of their routine work, 
pharmacy healthcare assistants expected to get financial recognition for their added workload 
(Deeks et al., 2014; Gudka et al., 2009; Gudka, Marshall, et al., 2013; Parker et al., 2015; G. Thomas 
et al., 2009).  
Motivation 
Pha mac  aff fel  ha  he  con ib ed o f eeing p doc o  ime b  aking on addi ional e al 
and reproductive health services (Deeks et al., 2014; R. Heller et al., 2017; Parker et al., 2015). 
They also found it motivating to know that they were increasing access to SRHS and helping to 
reduce unintended pregnancy (Rodriguez et al., 2018).  
Most pharmacy staff felt that their new role as sexual and reproductive health provider benefitted 
them personally. For example, they found that it enhanced their profession and aided them in 
developing their professional role as primary health provider (Cooper et al., 2008; Deeks et al., 
2014; Parker et al., 2015). Pharmacy staff also felt that the new role gave them the opportunity to 
get involved in real health issues, and allowed them to give health messages to pharmacy users 
(Deeks et al., 2014; Parker et al., 2015). Further, pharmacy staff stated that it allowed them to build 
rapport and engage in better communication with young people (Ryder et al., 2015).  
Interaction with pharmacy users  
Pharmacy staff generally felt comfortable to interact with pharmacy users who were presenting 
for a sexual and reproductive health service (Chaumont & Foster, 2017; Downing et al., 2011; 
Gudka et al., 2009; Gudka, Marshall, et al., 2013; Ryder et al., 2015; Wong et al., 2017). Some 
pharmacy staff felt that their ability to provide sexual and reproductive health services was on par 
with delivering other services (Chaumont & Foster, 2017). However, some pharmacy staff found 
it challenging to ask users for their weight but recognised that it was not appropriate to guess 
e  eigh  based on their appearance (Wong et al., 2017).  
Pharmacy staff were aware that being trained, confident and friendly had an impact on the 
interaction with pharmacy users (Ryder et al., 2015; Whelan et al., 2013; Wong et al., 2017).  
When interacting with pharmacy users, pharmacy staff wanted to make users feel comfortable 
and to be perceived as youth-friendly and non-judgemental (Downing et al., 2011; Ryder et al., 
2015; G. Thomas et al., 2009). 
Some pharmacy staff noted that pharmacy users had a preference regarding the sex of pharmacy 
staff. They felt that young males did not want to be counselled by female staff whereas women 
appeared to be less comfortable when being counselled by male staff (Ryder et al., 2015).  
While some pharmacy users seemed comfortable during the consultation according to pharmacy 
staff, others, and particularly young people, were quiet and nervous (Ryder et al., 2015). A difficulty 
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when interacting with pharmacy users was also that some users did not want to share their 
personal data and were not willing to send their STI screening samples to a separate agency 
(Debattista et al., 2017; Emmerton et al., 2011; Whelan et al., 2013).  
Service Delivery  
Although some pharmacy staff felt pressured by pharmacy users to provide services quickly 
rather than thoroughly (Wong et al., 2017), pharmacy staff generally agreed that having a 
consultation on sexual and reproductive health services was important to educate pharmacy users 
(Chaumont & Foster, 2017).  
This was particularly true for the emergency contraception. Pharmacy staff felt that a standardised 
consultation should be compulsory for the delivery of emergency contraception (Chaumont & 
Foster, 2017). Both pharmacists and pharmacy healthcare assistants were supportive of over the 
counter access for emergency contraception and of providing an additional pack of emergency 
contraceptive pills to users for future use (Downing et al., 2011). Documents such as protocols 
used by pharmacists to guide the delivery of emergency contraception were often only available 
in English (Hussainy et al., 2011). Pharmacists felt that this sometimes created a language barrier 
when delivering services to non-English speakers (Hussainy et al., 2011).  
Pharmacy staff opinions on which topic should be included in the counselling on emergency 
contraception varied. While most pharmacy staff felt that it was within their role to counsel on side 
effects, dosages, efficacy in relation to time since unprotected intercourse, and future 
contraception, views on whether to counsel on sexually transmitted infections were mixed 
(Downing et al., 2011; Hussainy et al., 2011).  
Pharmacy staff were less willing to provide emergency contraception to young people (Cooper et 
al., 2008; Downing et al., 2011; Hussainy et al., 2011) or to someone who was presenting for 
emergency contraception on behalf of someone else (Chaumont & Foster, 2017; Downing et al., 
2011; Hussainy et al., 2011). Further, pharmacy staff were concerned about approaching young 
users, married women and women in long-term relationships about chlamydia screening (Dabrera 
et al., 2011; G. Thomas et al., 2009). 









x Overall, 74% (37/50) pharmacy users and 83.1% (69/83) of users of 
clinical services found it easy to obtain EHC from the pharmacy 
(p=.163) 
x In total, 98.9% (82/83) of clinic users compared with only 44% (22/50) 
of pharmacy users agreed that adequate privacy had been provided 
(p≤.001) 
x Overall, 95% (78/83) compared to 82% (41/50) of pharmacy users felt 
that adequate advice was provided (p=.015) 







Key Findings of included studies 
x Only 28% (14/50) of pharmacy users compared to 90.4% (75/83) of 
clinic users reported that future contraception was discussed after 





x In total, 70.9% (134/189) of pharmacists were comfortable providing 
emergency contraception (as comfortable as providing other 
medications) 
x For 23.3% (10/43) of pharmacist the primary reason to refuse 
emergency contraception was that the person presenting was not 
the patient 
x The large majority of pharmacists felt that the consultation on 
emergency contraception should be mandatory and standardised 
x Emergency contraception should include asking for time of 
intercourse, previous emergency contraception usage 
x Most pharmacists were as comfortable providing emergency 
contraception as providing other medications (16.4% less 





x Some pharmacy staff were more likely give out emergency 
contraception to older users and were not willing to give emergency 
contraception to under 25-year olds  
x Perceived age and type of customer influenced some pharmacists  
decision on whether to dispense emergency contraception (some 
pharmacy staff were not willing to give emergency contraception to 






x Pharmacists were supportive of pharmacy-based chlamydia 
screening and found service provision feasible  
x Some pharmacists were concerned about privacy outside of a 
consultation room  
x Pharmacists were concerned about approaching young people 
(under 16 years) and found it more challenging to offer STI 
screening to users attending for non-sexual health complaints 
x Offering chlamydia was feasible within pharmacists  practice  
x Pharmacists felt that it was more challenging to offer STI screening 
when pharmacy users are attending for non-sexual health 
complaints  
Darin (2015) / 
Quantitative 
Study 
x Speed (22/52) and convenience (16/52) (easy to schedule; 
accessible, convenient) were the most favourable features of 
pharmacy users experience  
x Lack of privacy at the counter was something users (3 out of 15) did 
not like about the pharmacy, Private  and confidential  was 
something that users (7 out of 52) liked about the pharmacy 
x Most pharmacy users felt comfortable with the pharmacist 
performing the fingerstick test (similar to the proportion who felt 
comfortable with a physician taking the test) 
x Pharmacy users like that pharmacists are nice, polite, friendly, kind, 
understanding or supportive 
  










x While pharmacy staff were supportive of pharmacy-based chlamydia 
screening, some were concerned about the workload 
x Pharmacy staff reported that pharmacy user felt uncomfortable 






x Pharmacy users were highly satisfied with the pharmacy-based 
chlamydia screening service  
x With exception of some young users, most pharmacy users felt 
comfortable discussing chlamydia with pharmacy staff   
x Pharmacy users liked that they could attend the pharmacy for 
several health concerns at the same time and liked the one-site 
experience 
x Pharmacy users found pharmacy-based screening an easy and 
practical way to get screened 
x A lack of privacy in the pharmacy and talking to a pharmacist rather 
than a GP were stated as barriers by some participants 
x Further barriers to pharmacy-based chlamydia included: 
confidentiality (because of other people around; fear of being 
overheard) 
x Most young people felt that a community pharmacy is an appropriate 
place for chlamydia testing 
x Most pharmacy users felt that appropriate information was provided 
x Facilitators for chlamydia testing in pharmacies: Accessibility; one-
site experience; no need to book an appointment; no need to travel 
a long distance and pay  
x Pharmacy assistants felt that offering services increased their job 
satisfaction (felt like they were involved in real health issues and 
giving health messages; felt they were helping the doctor)  
x Pharmacy assistants felt they should get paid for extending their 
scope and for training and added workload  
x While some pharmacy users seemed to be concerned about privacy 
others, particularly young people, did not seem concerned  
x Pharmacy assistants were anxious about longer waiting times for 
users due to offering chlamydia screening  






x Pharmacy staff were aware of the importance of privacy and tried to 
seek a quiet consultation area away from the counter/other customers 
if no consultation room was available 
x Young age (65%; 28/43) and the person presenting not being the 
patient needing emergency contraception (32%/ 14/43) were reasons 
for staff refusing EC provision 
x 85% of pharmacists (109/128) and 72% of non-pharmacist staff 
(271/295) agreed that advice on STIs and future contraception 
should be provided after emergency contraception 
x Reasons to refuse EC dispense included young age 
x Pharmacy staff were supportive of pharmacy-based provision of EC 
x Pharmacy staff were supportive of giving a resource pack to 
customers when dispensing EC  




x 87% (79/91) of pharmacy users stated in a survey that they were not 
concerned about privacy; however, in a later survey, almost half of the 
same participants stated that they experienced a lack of privacy and 
in a focus group, users said that they would not feel comfortable 






discussing sexual health at the counter and preferred a private 
consultation area 
x Pharmacy users liked that the service was convenient to use, and no 
appointments needed to be booked 
x Pharmacy users felt that pharmacists handled consultations 
professionally and provided clear and concise information 
x Some pharmacy users found it inconvenient that they had to return 
their sample to a designated place and wanted a more convenient 
and simpler process; further, they found it inconvenient that the only 
way to get the test results was to call the hospital during working 
hours  
x Pharmacy users felt that pharmacists handled consultations 
professionally and provided clear and concise information (lay 
language)  
x Pharmacists were supportive of service provision; felt service 
provision was important and gave them the opportunity to participate 
in public health initiatives in sexual health 
x Pharmacists felt provision helped them to develop their professional 
role as primary healthcare provider  
x Pharmacists were supportive of service provision but felt that the 
administrative work and documentation of services was time 
consuming (particularly at weekends and evenings demand was 
higher which was demanding for pharmacists working at these 
times; found service implementation difficult at these times)  
x Pharmacists suggested to simplify the administrative work  





x Most women (69%; 73/113) found it very easy/ easy to get to the 
pharmacy and felt very comfortable/comfortable discussing 
emergency contraception with the pharmacist 
x In a questionnaire, 48% (54/113) of women stated to be 
unconcerned/very unconcerned about privacy in the pharmacy; 29% 
(33/113) were unconcerned/very unconcerned about privacy 




x Although most pharmacy users had a positive experience with the 
service delivery, some experienced difficulties (no trained staff 
available in chain pharmacies) 
x Pharmacy users found it easy to use the service and were supportive 
of pharmacy-based contraceptive injection 
x Pharmacists acknowledged that features of the pharmacy were 
appealing for users when compared to other providers and felt that 
the pharmacy was an appropriate place for contraceptive services 
x Some pharmacy users were concerned about pharmacist s ability to 
give the injection (apparently lacked familiarity; seemed anxious) 
x Pharmacists were anxious to provide injection (because of invasive 
nature of service and high responsibility to get it right) 
x Pharmacists acknowledged that convenient location, better opening 
hours and quicker appointments than general practices or sexual 
health clinics make pharmacies appealing  
x Pharmacists felt they contributed to public health care through 
freeing up  doctors and thus helping the health care system which is 
under pressure 
x Pharmacists were enthusiastic and willing to expand their role and 
believe that there is more that they can do; about half of pharmacists 
were pleased to deliver the contraceptive injection 
x Pharmacists felt that the pharmacy was an appropriate venue for 
contraceptive services and advice  
Hussainy 
(2011)/ 
x 59.7% (256/427) of pharmacists refused emergency contraception 
when the person presenting was not the person needing emergency 
contraception 





x 59.5% 2  of pharmacists preferred to counsel on EC in an area of 
pharmacy where confidentiality could be assured or in a separate area 
away from other pharmacy users  
x Most pharmacists counselled on EC side effects (90.2%), dosage 
(91.8%), efficacy in relation to time since unprotected sexual 
intercourse (88.8%); 81.9% (345/421) of pharmacists felt that it is 
their role to counsel on regular contraception but only 54.5% 





x Women used the pharmacy because they had difficulties accessing 
contraception elsewhere and did not want to plan an appointment in 
advance 
x Women felt that the information given to them about contraception 
was clear 
x Women were given information and had the opportunity to ask 
questions; some left with questions which they felt they were not 
able to ask at the time 
x Women felt that the information given to them about contraception 







x The majority of both clinic users (86.6%; 100/116) and pharmacy 
users (81.4%; 71/87) rated strongly agree  on being satisfied with 
counselling (p=0.523) 
x Pharmacy users (n=87; mean ± SD: 3.6±0.6) rated significantly 
lower (p=0.034) the statement that the counselling helped them 
understand EC use compared to clinic users (n=116, mean ± 
SD:3.8±0.4) 






x 87.6% of (106/121) pharmacists felt comfortable during counselling 
x The majority of pharmacists felt that contraception is feasible within 
their practice and that it improved their job satisfaction 
Ryder (2015)/  
Qualitative 
Study 
x According to pharmacists, young users were uncomfortable when 
requesting condoms  
x Pharmacy staff felt that dealing with groups of people together is 
problematic 
x Some pharmacy staff felt that young males do not use the pharmacy 
for condoms as the pharmacy might be seen as an intimidating 
environment due to having to talk to female staff   
x Many pharmacists felt that it was their duty to make the environment 
non-judgmental for youth 
x Pharmacy staff thought that the accessibility and long opening hours 
and no need to book an appointment, and accessibility during school 
holidays was appealing to young people 
x Pharmacy staff felt that offering services helped them to build 
rapport with young people 
x Pharmacy staff felt that dealing with groups is problematic (e.g. 
groups of youth laughing created an uncomfortable atmosphere for 
users)  
x Some pharmacy staff were concerned about handing out condoms 
to young people without parental consent 
x Pharmacy staff felt that rude, untrained or new staff could create a 
bad experience for pharmacy users  
 
 
2 Where percentages are presented without the numbers that they are derived from this is 
because they were not provided in the study manuscript. 
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x Pharmacy staff thought that not enough pharmacies taking part in 
the scheme was a barrier to service delivery  
x Pharmacy staff felt that young people being concerned that they 
may see a relative when visiting the pharmacy might be barrier to 
service delivery 
x Some pharmacy staff believed that cultural aspects might be a 





x Pharmacists were concerned to offer screening to older  individuals 
because they might be in a long-term relationship and might feel 
offended by being offered the service 
x No pharmacists wanted to approach clients in long-term relationships, 
married people or people with children (pharmacists perceived ethnic 
minorities to be more likely to be married and faithful) 
x Most pharmacists believed that pharmacies are well placed to 
deliver chlamydia screening because of their large clientele and felt 
that it was feasible within their practice; some pharmacists were 
concerned that increasing the use of locums could hinder service 
expansion since locums are often untrained 
x Pharmacists wanted users to like the service and feel comfortable  





x The factors interfering most with pharmacists  ability to provide EC 
were lack of privacy (46.1%; 195/422) and lack of staff (50.9%; 
219/422) 
Wong (2017)/  
Qualitative 
Study 
x Some pharmacists felt conflicted in their roles as a health care 
professional and a drug dispenser (pharmacists felt pressured by 
users to provide fast services rather than detailed counselling) 
x Most pharmacists were comfortable during counselling and believed 
that users were also comfortable 
x Pharmacists felt that it is difficult to ask users sensitive questions 
x Pharmacists strongly believed that EC counselling was important  
x Pharmacists asked pharmacy users whether they have had EC 
before and about the time that sexual intercourse had occurred; they 
also explained how to take EC and described possible side effects 
EC; often ongoing oral contraception was recommended  
x Most pharmacists were comfortable during counselling and believed 
that users were also comfortable; However, some pharmacists felt 
that women might feel uncomfortable being counselled by male 
pharmacists and if there is not enough privacy provided 
x Pharmacists felt that it is difficult to ask pharmacy users for their 
weight in counselling 
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6.7. Discussion  
First, the findings from this study are summarised. Afterwards, the strengths and limitations of this 
systematic review are discussed, before comparing these to the existing literature. At the end of 
the chapter, it is summarised how this study can inform the qualitative interview study, which is 
presented in chapter 7 and chapter 8.  
6.7.1. Summary of the main findings 
Thi  ema ic e ie  aimed o e plo e ha  i  kno n abo  pha mac  e  and pha mac  
staff experiences and attitudes relating to delivering a large range of sexual and reproductive 
health services.  
Nineteen studies were included in this review. Eleven studies only looked at pharmacy staff 
pe pec i e  (n=11) and fo  die  looked a  pha mac  e  pe pec i e . A further four 
die  looked a  bo h pha mac  aff and pha mac  e  pe pec i e  (n=4). Onl  o udies 
looking at pharmacy staff included pharmacy healthcare assistants as study participants.  
The majority of studies focussed on one type of intervention (n=16). Only three studies looked at 
two types of interventions and no study explored more than two different interventions. The sexual 
and reproductive health services in the included studies are as follows: emergency contraception, 
oral contraception, contraceptive injection, chlamydia screening, HIV screening, and condom 
distribution. 
The Mixed Methods Appraisal Tool was used to assess the quality of all included studies. Overall, 
ten studies were considered as high-, four as medium- and five as low-quality studies.  
The findings from the included studies were presented according to the population type: 
pharmacy staff and pharmacy users. Outcomes from the included studies were described to 
identify patterns within and between studies. 
Three areas of importance (privacy; convenience; and pharmacy staff as sexual and reproductive 
health providers) were identified for pharmacy users. For pharmacy staff, three areas of 
importance were also identified (privacy; suitability of pharmacy as a venue to deliver sexual and 
reproductive health services; and pharmacy staff new role as sexual and reproductive health 
providers).  
Pharmacy users had mixed experiences of privacy. While some were not concerned about their 
privacy, others were concerned about being overheard, particularly at the pharmacy counter. 
Compared to clinic users, pharmacy users were less satisfied with the level of privacy provided. 
Nevertheless, pharmacies were perceived as suitable for the delivery of sexual and reproductive 
health services, particularly because they were convenient to use. Pharmacy users liked that 
pharmacies were easy to get to and that no appointments needed to be scheduled.  
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However, some inconveniences with the pharmacy as sexual health provider were also identified: 
for example, not having trained staff available at all times and having to wait longer for STI test 
results were identified to be disadvantages of the pharmacy. While pharmacy users largely had 
positive experiences with pharmacy staff consultations, they were less satisfied with the 
consultation and information provided compared to individuals who were counselled by sexual 
health clinic staff or General Practitioners. Pharmacy staff were found to be capable of conducting 
a blood test, but some users perceived pharmacy staff as less competent to provide the 
contraceptive injection.  
Pharmacy staff were aware that privacy was important to many users and therefore tried to 
counsel in private areas and separate consultation rooms. Overall, pharmacy staff considered that 
pharmacies were suitable to deliver sexual and reproductive health services, although some staff 
questioned whether they were well placed to deliver condoms. Staff were largely comfortable 
counselling users but noted that counselling by a person of the same sex was important to many 
users. While the sexual and reproductive health service delivery was generally feasible, 
administrative work and consultation time added to staff workload and was sometimes 
challenging, particularly at times where the pharmacy was busy. Staff generally reported that they 
thought that providing a sexual and reproductive health consultation was important. However, 
they sometimes felt pressured by pharmacy users to deliver a service quickly rather than 
thoroughly. Finally, staff felt that a pharmacy delivered service could take pressure off other health 
providers, benefitted the pharmacy staff employability, and enhanced their job satisfaction.  
6.7.2. Strengths and Limitations  
This was the first systematic review providing an overview of the literature relating to pharmacy 
aff and pha mac  e  e pe ience  of a ide ange of pha mac -based sexual and 
reproductive health services. A strength of this review was that a systematic and robust approach 
was utilised. Further, including qualitative, quantitative and mixed methods approaches allowed a 
robust evaluation of all existing literature. Only studies from OECD member countries and those 
published after 2007 were included to ensure that the review findings were relevant and could 
inform the field work in the UK. Guidance on how to conduct a narrative synthesis was followed 
to increase the transparency and reliability of this review.  
The re ie  e cl ded m e  hoppe  die  a  he foc  a  on he eal  e pe ience of 
pharmacy users. However, in hindsight, it may have been useful to compare the experience of 
m e  hoppe  and eal  e  of pha mac -based SRHS to understand whether there are 
differences between the two groups.  
As discussed, the included studies were of variable quality and were not always reported in line 
with a recognised study reporting framework, having missing data and significant risk of bias. 
Findings were not weighed according to the quality assessment. This meant that the review 
finding  ma  no  p o ide a eliable mma  of e  and aff e pe ience . 
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The methods section of this review explained that studies which used mystery shoppers to explore 
pharmacy-based sexual and reproductive health services were excluded a  hi  g o p  
e pe ience  migh  ha e diffe ed f om eal  e . Ho e e , he incl ion of m e  hoppe  
studies may have added to the findings.  
Due to financial pressure many service providers and commissioners are looking towards 
alternative settings to provide sexual and reproductive health services. Therefore, the findings of 
this review are important for future service planning.  
6.7.3. Comparison with other studies  
Convenience was identified as a highly valued feature of pharmacies by both pharmacy users and 
pharmacy staff. This supports findings of previous reviews on pharmacy-based chlamydia 
screening (Gudka, Afuwape, et al., 2013), emergency contraception (C. Anderson & Blenkinsopp, 
2006) and STI screening (H. Wood & Gudka, 2018) but also reviews on pharmacy services other 
than sexual and reproductive health services (Ali M.K. Hindi et al., 2019), confirming that 
pharmacies are generally perceived as convenient venues to access a variety of healthcare 
services, including sexual and reproductive healthcare. 
While this was not true for all pharmacy users, many had privacy concerns and pharmacy staff 
were aware that privacy is important to users of sexual and reproductive health services. This is 
in line with a recent systematic review on extended pharmacy services (Ali M.K. Hindi et al., 2018) 
and studies on various other pharmacy services including cardiovascular screening (J. Taylor et 
al., 2012), advice for undiagnosed skin problems (Tucker & Stewart, 2015), vaccination or health 
checks (K. Wood et al., 2015), alcohol screening and advice services (Krska & Mackridge, 2014), 
and pharmacist prescribing services (D. C. Stewart et al., 2011). Particularly, young people were 
found to be concerned when accessing the pharmacy for contraception for privacy reasons 
(Zuniga et al., 2019). Hence, lack of privacy at the pharmacy does not seem to be a concern 
unique to users of sexual and reproductive health services.  
This review showed that pharmacy staff were less willing to provide emergency contraception to 
young women. This has also been shown in studies which used mystery shoppers to explore 
access to pharmacy-based emergency contraception. For example, one study from France 
showed that more than thirty percent of minors were refused pharmacy access to emergency 
contraception (Delotte et al., 2008). In another study from California, only thirty-six percent of 
young mystery shoppers were successful in obtaining emergency contraception (Sampson et al., 
2009). Adolescents experiencing difficulty obtaining emergency contraception was also shown in 
another study from the US (Wilkinson et al., 2014). Unintended pregnancy can pose several 
complications, particularly for teenagers, who have a higher risk of pre-term birth, pre-natal and 
post-partum depression (Kallner & Danielsson, 2016). The prevention of adolescent pregnancies 
is therefore of high importance (Kallner & Danielsson, 2016). Declining emergency contraception 
to adolescents may contribute to higher rates of teenage pregnancy.  
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Rather than denying young people access to sexual and reproductive healthcare, pharmacies 
should ensure that young people receive adequate safeguarding to assess risk and initiate 
disclosures of sexual exploitation and are provided with the help and healthcare they need. It is 
estimated that more than 16,000 children in England were at risk of sexual exploitation between 
April 2010 and March 2011 (Berelowitz et al., 2012). It is further predicted that teenage girls are 
at higher risk of sexual exploitation and teenage pregnancy due to the school closure during the 
COVID-19 pandemic (Burzynska & Contreras, 2020). Hence, pharmacies are likely to be an 
important point of contact for young people to seek help. Sexual and reproductive health providers 
should support pharmacies by providing safeguarding training and subsequent support to audit 
to ensure good practice is being implemented. 
Further, our review showed that while pharmacy staff felt that counselling on future contraception 
was important, fewer pharmacy users than clinic users of emergency contraception were 
provided with advice on future contraception. In line with this, a previous mystery shopper study 
showed that only a minority of pharmacy users presenting for emergency contraception were 
provided with advice on contraception (Glasier et al., 2010). Discussing future contraception is 
highly important to prevent subsequent unwanted pregnancy. 
The findings from the current review suggest that female users of pharmacy-based sexual and 
reproductive health services were more comfortable with a female staff member. Women  
preference for a same sex health care professional has been shown in different contexts. For 
example, females have found to prefer female gynaecologists-obstetricians  (Amer-Alshiek et al., 
2015) and gastroenterologists (Consedine et al., 2011). Preferences for a female healthcare 
p ofe ional ha e al o been iden ified in die  on omen  p efe ence  on b ea  geon  
(Groutz et al., 2016) and urogynecologists (Groutz et al., 2019). The latter study showed that the 
preference for a female healthcare professional were common among religious and university-
educated women compared to non-religious and high school or college graduates (Groutz et al., 
2019).  
Pharmacy staff in one of the included studies felt that the pharmacy may not be the ideal venue 
for condom distribution as young males do not use the pharmacy frequently. One concern was 
that males may not want to approach female staff for condoms due to embarrassment. Indeed, a 
cross-sectional probability sample survey showed that young males under 18 years were less 
likely than those over 18 years to obtain contraception from a retail setting including pharmacies 
(French et al., 2018). Men have generally been shown to be less likely than women to access 
health information from pharmacies (Banks, 2001). In line with this, previous studies have 
demonstrated that males also prefer same-sex health care professionals. For example, one study 
showed that males prefer male urologists (Amir et al., 2016). Further, a study from Botswana 
showed that particularly younger men preferred a male healthcare professional when presenting 
for services related to sexually transmitted infections (Letshwenyo-Maruatona, 2017). 
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It is likely that men have stronger preferences for the sex of the healthcare professional when it 
comes to health matters which they perceive as more sensitive (Letshwenyo-Maruatona, 2017). 
This review showed that pharmacy users were largely comfortable discussing sexual and 
reproductive health with the pharmacist. This was also found in a recent systematic review on 
patient and public perspectives of community pharmacies (Ali M.K. Hindi et al., 2018). In line with 
this, another study showed that patient-pharmacist interaction consistently met or exceeded the 
expectations of pharmacy users (Collum et al., 2013). 
Pharmacy staff in this review felt that they were contributing to the reduction of workload for 
General Practitioners. Taking work pressure from General Practices through the provision of 
extended services was also identified as a benefit by pharmacy staff in other studies (Agomo et 
al., 2016; Atkins et al., 2016). However, in a recent study, General Practitioners were not 
convinced that extended services provided by  pharmacies would reduce their workload (Ali M.K. 
Hindi et al., 2019).  
Relating to the topic of workload, pharmacists found that the service provision was feasible but 
that the delivery of sexual and reproductive health services such as emergency contraception 
added workload through the consultation time and the related administrative work. A separate 
systematic review showed that pharmacy staff in the UK felt that their workload levels were 
increasing and that increased workload added stress and lowered the job satisfaction (V. M. Lea 
et al., 2012). In a mo e ecen  d  on pha maci  pe pec i e  on p e c ibing ho monal 
contraception, workload was a concern for pharmacists (Wollum et al., 2020). Another review on 
extended services found that pharmacists experienced it sometimes as difficult to manage the 
delivery of extended services next to their dispensing duties (Ali M.K. Hindi et al., 2019). It has to 
be considered that the studies included in the current review only evaluated one or two sexual 
and reproductive health services. However, some pharmacies now provide a large range of sexual 
and reproductive health services and how staff manage the delivery of multiple services should 
be further explored.  
While pharmacists were less likely to demand remuneration for the additional time and work 
required to perform sexual and reproductive health services, some pharmacy healthcare 
assistants felt that they should get financial incentives to provide extra services. The review on 
extended pharmacy services found that pharmacists collectively agreed that the remuneration 
was insufficient for the added workload (Ali M.K. Hindi et al., 2019).  
6.7.4. Remaining gaps in the literature 
This systematic review clearly shows that there is scope for future research on pharmacy-based 
sexual and reproductive health services. Only 19 studies exploring pharmacy staff and/or users 
experiences of pharmacy-based sexual and reproductive health services exist. Only four of those 
studies were from England.  
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None of the included studies have investigated pharmacy services that provide more than two 
different sexual and reproductive health services. Further, no study has looked at chlamydia 
treatment, hepatitis B vaccination, partner notification and self-sampling kits testing for a large 
range of STIs (including syphilis, hepatitis B and gonorrhoea). 
This review also showed the lack of qualitative research in this area, particularly from England. 
Only five qualitative studies on the experiences of pharmacy-based sexual and reproductive 
health services were identified. While all five of these studies looked a  pha maci  e pe ience , 
only one also looked at pharmacy users experiences. The latter d  onl  looked a  omen  
experiences and consequently there was no qualitative study including male pharmacy users. 
Further, only one qualitative study included pha mac  heal hca e a i an  e periences of 
pharmacy-based sexual and reproductive health services. Only two of the five qualitative studies 
originated from England and only one of them was high quality. Hence, high-quality qualitative 
research on pharmacy-based sexual and reproductive health services from England is limited to 
onl  one d  e plo ing pha maci  ie  on eme genc  con acep ion.  
Therefore, the conduct of a qualitative study in England looking at pharmacists, pharmacy 
heal hca e a i an  and pha mac  e  e pe ience of a large of pharmacy-based sexual and 
reproductive health services was needed.  
6.8. Chapter summary 
This chapter summarised the findings from the systematic review results and discussed the 
findings. In total, nineteen studies were included in the review. Eleven studies included pharmacy 
staff, four included pharmacy users, and four both groups. Pharmacy users found services 
accessible and convenient and pharmacy staff found it feasible to deliver services. However, 
several barriers to the delivery of pharmacy-based SRHS were identified including lack of privacy 
for delivering services, lack of trained staff consistently available to deliver services and subjective 
judgements being made on who should be provided a service. Barriers to service delivery need 
to be addressed to use pharmacies full potential.  
The systematic review showed that there is a need for further exploration of pharmacy-based 
sexual and reproductive health services, and qualitative research from England in particular. This 
systematic review informed the qualitative study, which is presented in the following two chapters 
(chapter 7 and chapter 8). 
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7. Interview Study Methods 
7.1. Chapter overview 
This chapter reports on the conduct of the qualitative research study with pharmacy users and 
pharmacy staff in Birmingham. First, the aims and objectives of the interview study are presented, 
followed by the research study design, study setting and study population. Next, the sampling and 
participant numbers are discussed, and the recruitment strategies outlined. Afterwards, ethical 
concerns and all approvals obtained for the study are introduced and the data collection process 
described. It is then explained how the data was analysed and interpreted. The chapter closes 
with a chapter summary.  
7.2. Aim and objectives 
7.2.1. Aim 
x Based on the findings of the systematic review and retrospective quantitative study, to 
e plo e pha mac  e  and aff e pe iences of pharmacy-based sexual and 
reproductive health services and to explore the implementation of pharmacy-based 
sexual and reproductive health services  
7.2.2. Objectives 
x To e plo e pha mac  e , pha maci  and pha mac  heal hca e a i an  
experiences of pharmacy-based sexual and reproductive health services and to explore 
their implementation using semi-structured interviews 
7.3. Study Design, Study Setting & Study Population 
This qualitative study was set in community pharmacies in Birmingham (England). Semi-
structured interviews were conducted with the population of interest, which included pharmacists, 
pharmacy healthcare assistants and pharmacy users. 
Umbrella pha macie  ope a e a  a Tie  1  o  Tie  2  le el. Pha macie  offe ing he Tie  1  le el 
offer: emergency contraception, condoms and STI self-sampling kits. Tie  2  pha macie  offe  
Tie  1  e ice  and in addi ion he con acep i e injec ion, o al con acep ion and chlam dia 
treatment.  
Pharmacy staff, including locum pharmacists (pharmacists that are employed on a contractual 
basis through an agency), were invited to take part in a semi-structured interview if they fulfilled 
the following criteria: 
x be a pharmacist or pharmacy healthcare assistant working at an Umbrella pharmacy ( Tie  
1  o  Tie  2 ) at the time of the interview  
x have completed the necessary training allowing the participant to provide Umbrella s 
pharmacy-based sexual and reproductive health services 
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Pharmacy users wishing to participate in an interview were required to:  
x be at least 16 years old at the time of the interview 
x have used a sexual and reproductive health service provided by pharmacy staff in an 
Umbrella pharmacy 
x have the ability to adequately understand verbal explanations or written information in 
English 
x have the ability to consent for themselves 
The age when a child is deemed to be capable to consent to sex varies internationally (Ueffing et 
al., 2019). Although the legal age to consent to any form of sexual activity is 16 years in England, 
British adolescents under 16 years are sexually active (Scott et al., 2017) and therefore are at risk 
of STI o  n an ed p egnanc . Al ho gh i  i  impo an  o nde and child en  e pe ience  of 
pharmacy-based sexual and reproductive health services (Horgan, 2017), pharmacy users under 
the age of 16 years were not eligible to take part in an interview due to ethical and methodological 
issues. Under 16 year olds are legally not permitted to consent for their research participation but 
require parental consent (Roper et al., 2018). Obtaining parental consent may be difficult for 
indi id al  ho don  an  o admi  hei  e al ac i i  o hei  pa en . F he , cond c ing 
interviews with children can be difficult and may require the usage of specific methods appropriate 
for children (Winstone et al., 2014). Researchers should also have training in interviewing children 
and since this was not in place it was decided to exclude them from participation (S. Paul, 2017).  
Research involving adults lacking capacity requires a surrogate to provide consent on their behalf. 
However, this raises ethical and legal issues which often creates a barrier to the participation of 
people who lack decision-making capacity in research (Shepherd, 2016). Due to practical 
reasons, it was decided not to interview people lacking capacity. 
Studies in which language barriers exist between the researchers and the participant are referred 
o a  c o -lang age e ea ch  (Temple, 2002). While translators and interpreters can help to 
overcome language barriers, the quality of data translation remains a concern and can affect the 
accuracy of study findings (Squires, 2008). Hiring a translator or interpreter would have added 
costs and introduced ethical concerns. It was decided not to interview people with special 
communications needs (e.g. requiring a translator or interpreter) as this would have gone beyond 
the scope of this project. 
7.4. Sampling 
Consideration to the sampling method was given prior to recruitment and it was decided to adopt 
a purposive sampling framework in order to guide the recruitment. Purposive sampling is a non-
random technique (Etikan et al., 2016) that is typically used in qualitative research to identify and 
select information-rich cases (Patton, 2002). 
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There are numerous purposeful sampling strategies, some of which are used to narrow the range 
of variation (e.g. homogenous sampling, snowball sampling) and some of which are used to 
expand the range of variation (e.g. maximum variation sampling, extreme case sampling) (Palinkas 
et al., 2015).  
Previous research suggests that demographic characteristics such as ethnicity (Marlow et al., 
2009), age (Hussainy et al., 2011), gender (Hussainy et al., 2011) and religion (Cooper et al., 2008; 
Marlow et al., 2009; Mollen et al., 2008) ma  impac  people  a i de  o a d  e al and 
reproductive health services. With regards to pharmacy staff, the numbers of years working as a 
pha maci  ha  been ho n o impac  heal h p o ide  a i de  o a d  SRHS (Ibrahim et al., 
2013). It was therefore initially intended to maximally vary candidates according to a range of 
different parameters (e.g. ethnicity, age, gender and religion).  
However, sampling to large range of parameters would have required participants to provide 
personal information before being invited to take part in an interview. Given that sexual and 
reproductive health is a sensitive topic, it was considered that participants, and pharmacy users 
in particular, may not have been willing to share their demographic details before being invited to 
an interview. It was therefore decided, to purposively sample according to a range of other factors 
that would ensure important and relevant variety in candidates interviewed. 
Relevant parameters for pharmacy staff included:  
x Service level offered at Umbrella pharmacy employed at (Tier 1 or/and Tier 2) 
x Umbrella pharmacy store (e.g. independent/chain pharmacy; location of pharmacy) 
Relevant parameters for pharmacy users included:  
x Type SRHS requested at Umbrella pharmacy (emergency contraception, oral 
contraception, contraceptive injection, condoms, STI self-sampling kits, chlamydia 
treatment) 
x Umbrella pharmacy store (e.g. independent/chain pharmacy; location of pharmacy) 
As outlined previously (e.g. in section 1.7), Tie  1  and Tie  2  pha macie  offe  diffe en  pe  of 
e ice le el . While Tie  1  pha macie  deli e  eme genc  con acep ion, condom  and STI self-
ampling ki , Tie  2  pha macie  deli e  a ide  ange of e ice . In e ie ing aff i h 
e pe ience f om bo h Tie  1  and Tie  2  pha macie  a  he efo e deemed o be impo an  to 
understand whether and how delivering different service levels impacts staff experience. Since 
pharmacy stores vary in their layout, their clientele, their location and their staffing level, 
experiences of providing or being provided with a sexual and reproductive health services may 
vary between different pharmacy stores. It was therefore considered to be an important parameter 
for both pharmacy staff and pharmacy users.  
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This aim of this project was to explore experiences of a wide range of sexual and reproductive 
health services. Therefore, it was intended to interview pharmacy users who had access different 
types of Umbrella pharmacy services.  
Pharmacy staff and pharmacy users were asked to provide information on the relevant parameters 
above. Based on their answers, J.G. selected candidates that fitted the sampling frame. 
To provide the reader with context on whether perspectives from different groups were explored 
(Fossey et al., 2002; Tong et al., 2007) (Sifers et al., 2002), demographic information was collected 
on all study participants interviewed. Since evidence suggests that demographic questions may 
be best placed once rapport could be built (Teclaw et al., 2012), demographic information was 
obtained from study participants at the end of the interview (see section 7.7.3 for more detailed 
information).  
7.5. Participant numbers 
There is a lack of research exploring the optimal number of participant interviews and in many 
interview studies participant numbers are not reported and not justified (M. N. K. Saunders & 
Townsend, 2016). Saturation is commonly used as criterion for discontinuing data collection used 
in qualitative research (Glaser & Strauss, 2017). Ho e e , he e m a a ion  i  incon i en l  
applied (Malterud et al., 2016; B. Saunders et al., 2018).  
When using saturation to justify the discontinuation of data collection it is important to explain how 
data saturation was defined. In line with Grady (1998), data saturation was defined for this study 
as the point where no new themes were identified.  
7.6. Recruitment 
Recruiting participants for qualitative health research can be challenging, particularly for students 
who have limited experience, time, funds and established rapport with gatekeepers (Namageyo-
Funa et al., 2014). Further, recruiting participants for qualitative research on sensitive topics can 
be difficult (Namageyo-Funa et al., 2014). In health research, it is therefore common to employ 
several strategies to facilitate recruitment (Namageyo-Funa et al., 2014). Although multi-modal 
approaches require more time and effort compared to using a single recruitment method, they 
are beneficial as they can strategically balance the advantages and disadvantages of different 
recruitment methods (McRobert et al., 2018). Recruitment for this study lasted nine months 
(January 2019 to September 2019). The recruitment strategies are presented along the two 
different study populations: pharmacy staff and pharmacy users. An overview of all recruitment 
pathways is presented in Figure 6.  




FIGURE 6 RECRUITMENT PATHWAYS FOR PHARMACY STAFF AND PHARMACY USERS  
7.6.1. Recruitment of pharmacy staff 
Two recruitment strategies were employed to recruit pharmacy staff. First of all, they were 
recruited through flyers distributed through participating Umbrella pharmacies. Secondly, they 
were recruited face-to-face through training sessions and events.  
7.6.2. Recruitment through flyers 
Recruitment through flyers is a traditional recruitment method (Pedersen & Kurz, 2016) that has 
been used in previous studies on sexual and reproductive health services to recruit participants 
alongside other recruitment strategies (Chai et al., 2010; Darin et al., 2015).  
Letters inviting Umbrella pharmacies to support the recruitment of the study by distributing flyers 
to their staff were sent via email. Additionally, the PhD candidate (J.G.) attended meetings of the 
Local Pharmaceutical Committee in Birmingham and Umbrella pharmacy meetings to introduce 
the study and invite pharmacy representatives to spread flyers through their Umbrella pharmacy 
stores.  
Pharmacy representatives who were interested in supporting the recruitment of the study could 
approach Julia Gauly and provide their contact details. Pharmacies who decided to go forward 
with the support of the recruitment were then provided with a Schedule of Activities (SoA).  
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This is a document which can be used with participating organisations as a form of site agreement 
provided by the Health Research Authority (HRA). Pharmacies signed the SoA and sent it back to 
Julia Gauly. Julia Gauly then posted the flyers to the pharmacy or dropped them off in person. 
The flyers were aimed at both pharmacists and pharmacy healthcare assistants. Copies of the 
flyer are attached in Appendix 6. It was up to the pharmacy how to distribute the flyers. 
Some stated that they were giving them directly to their staff and others reported that they placed 
them in the common room for pharmacy staff.  
Only a small number of pharmacies (n=8) agreed to support the recruitment through flyers. It may 
be that pharmacies did not want to commit to handing out flyers due to time constraints. However, 
it could also be possible that pharmacies feared that interviews conducted with pharmacy staff 
might reveal negative experiences with the pharmacy and were concerned that this may reflect 
poorly on them. 
In order to be able to recruit pharmacy staff from a wider range of pharmacies, another 
recruitment method was added. This is described in the following section.  
7.6.3. Face-to-face recruitment 
Research has shown that people are more likely to participate in research when they are directly 
approached by researchers rather than when they have to approach the researcher to take part 
(Hewison & Haines, 2006). An advantage of face-to-face recruitment is that rapport can be built 
and misconceptions about the purpose and procedures of the study be addressed without delay 
(Badger & Werrett, 2005; Broyles et al., 2011). Although it is time-consuming, it was therefore 
decided to recruit pharmacy staff face-to-face.  
Pharmacy staff were recruited face-to-face from meetings with the Local Pharmaceutical 
Committee in Birmingham, Umbrella pharmacy meetings and Umbrella pharmacy staff training 
events. Training sessions were compulsory for pharmacists to attend and were conducted in 
function rooms in Birmingham by Umbrella  ed ca ion eam. In contrast, training sessions for 
pharmacy healthcare assistants were voluntary for them and completed within pharmacy stores 
during working hours by Umbrella  ed ca ion eam. When recruiting face-to-face, Julia Gauly 
introduced herself and her study and collected contact details from interested candidates. They 
were contacted the following day via text message, phone call or email and provided with the 
information sheets for the study. Interviews were scheduled with those who had considered the 
study information for at least 12 hours and agreed to take part.  
7.6.4. Recruitment of pharmacy users 
Originally, it was planned that pharmacy users would be recruited directly from the pharmacy; 
however, this was not approved by the ethics committee. This decision was made to protect the 
researcher  safety. Instead, pharmacy users were also recruited through flyers handed out to 
them by pharmacy staff at pharmacies who agreed to support the recruitment of pharmacy users. 
Additionally, pharmacy users were recruited online.  
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Recruitment through flyers 
All eight pharmacies that had agreed to distribute flyers to their pharmacy staff also agreed 
support the recruitment of pharmacy users (see section 7.6.2). Pharmacy staff working in these 
pharmacies were asked to hand out flyers to pharmacy users who had attended for an Umbrella 
service. A copy of the flyer aimed at pharmacy users is provided in Appendix 6. Pharmacy staff 
reported that they placed the flyers in their consultation room and behind the counter and handed 
them to users of Umbrella s services at the end of the consultation. Pharmacies were not asked 
how many flyers they had handed out to keep the added workload for pharmacy staff to a 
minimum. In order to recruit pharmacy users from a wider range of pharmacies, pharmacy users 
were also recruited online. This is outlined in the next section.  
Online Recruitment 
Online recruitment is cost effective and time-efficient (Batterham, 2014; L. S. Leach et al., 2017). 
It was therefore considered as suitable recruitment strategy for this study.  
With their increased popularity, researchers have realised the potential of utilising social media 
platforms for the recruitment of participants (Arigo et al., 2018). While Facebook is the most 
popular social networking site worldwide, Twitter is the most popular microblogging platform (Gu 
et al., 2016). It was therefore decided to use both platforms to recruit pharmacy users. 
Julia Gauly and Umbrella  comm nica ion  eam ed hei  T i e  and Facebook acco n s to 
raise awareness for the study. An example of a social media post is presented in Figure 7.  
 
FIGURE 7 EXAMPLE: SOCIAL MEDIA POST 
Additionally, a secure online pre-registration website was established by Umbrella  
communications team. Pre-registration websites have shown to be effective in the recruitment in 
health research (Hamilton et al., 2013; J. Paul et al., 2005), particularly in ensuring that participants 
meet the participant criteria (Fernández et al., 2004).  
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On the pre-registration site interested candidates were informed about the interview study. They 
were also informed that all participants would be given a £10 shopping voucher as thank you for 
their participation. To be considered for the study, interested candidates were asked to indicate 
the following information:  
x whether they had visited an Umbrella pharmacy 
x which Umbrella service(s) they had accessed 
x their contact details (either email address or phone number)  
When recruiting through websites it is important to target the relevant sites (Fernández et al., 
2004). The link to the pre-registration website was placed on four different locations of Umbrella  
website. First of all, the link to the pre- egi a ion eb i e a  placed on he con ac   ec ion 
of Umbrella  eb i e. Umbrella is part of the University Hospitals Birmingham and the link was 
therefore also placed on the site linking from the University Hospitals Birmingham website to 
Umbrella. Further, the link was placed on the overview about the pharmacy services on Umbrella 
website. Finally, the link was put on Umbrella  e ice loca o  fo  pha macie . The service locator 
page helps people to identify the nearest pharmacy offering the Umbrella service. People can 
enter the postcode on the site and are shown the closest pharmacy.  
The link to the pre-registration site was also posted on social media by Umbrella  
communications team as shown in Figure 8.  
 
FIGURE 8 EXAMPLE: SOCIAL MEDIA POST ADVERTISING PRE-REGISTRATION SITE 
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7.6.5. Ethical concerns and approvals 
Research has to be conducted in accordance with appropriate ethical standards (Pietilä et al., 
2020). This section highlights the main ethical concerns for this study.   
Informed consent 
Informed consent means that potential study participants receive all relevant study information, 
understand the information, know what it means for them and voluntarily agree to participate (C. 
Grady, 2018). The way that informed consent is gained, is a major ethical issue (Miller & Bell, 
2002). Providing sufficient time to consider participation is important as otherwise people might 
not be free in deciding whether they want to take part (Hallinan et al., 2016; Lynöe et al., 1991). 
Participants in this study were given at least 12 hours after the information sheet was provided to 
consider the information. The information sheets for pharmacy staff and pharmacy users are 
provided in Appendix 7. 
There should be flexibility in how consent can be obtained, hence, both written and verbal consent 
can potentially be used (Bhupathi & Ravi, 2017). If consent is taken verbally, it may be audio 
recorded (Lahman, 2017). Since all interviews in this study were conducted on the phone, audio 
recorded verbal consent was obtained from all study participants. Participants were sent the 
consent form in advance for their information. A copy of the telephone consent form is provided 
in Appendix 8. 
Withdrawal 
Research protocols often state that potential research participants can withdraw at any time from 
a study (S. J. L. Edwards, 2005). For trials this usually means that participants want to discontinue 
their participation in the data collection process (participant withdrawal); however, sometimes 
participants also want their previously collected data to be removed (data withdrawal) (Ye et al., 
2011). The current study consisted of one-off interviews and hence, participant withdrawal was 
not an issue; however, consideration for data withdrawal was given. Participants were given two 
weeks after the interview to request data withdrawal. Since the data would be anonymised, 
analysed and further synthesised for publication, an unlimited period of data withdrawal would not 
have been feasible. None of the participants requested data withdrawal.  
Data storage 
Secure storage of data is highly important (Ienca et al., 2018). The General Data Protection 
Regulation (GDPR) data privacy policy must be met in all European Union member countries, 
which currently (as of 2019) includes the UK (Conrad & Alghamdi, 2019).  
Only encrypted digital voice recorders were used to audio record the interviews. All electronic 
data from this study was securely stored on the shared drive of the University of Warwick. All 
paper versions were securely stored in a key-p o ec ed locke  in J lia Ga l  office. Only Julia 
Gauly had access to the keys. All data from the study will be stored for 10 years in accordance 
i h he Uni e i  Reco d  Re en ion Sched le.  
PhD Thesis | Interview Study Methods | Julia Gauly 
109 
 
When Julia Gauly leaves Warwick Medical School, all data in the form of paper versions will be 
safely stored at the data archive of Warwick Medical School. The electronic data will continue to 
be stored in a shared drive at the University of Warwick.  
Remuneration 
For this study, all study participants were provided with a shopping voucher worth £10 as an 
appreciation of their time. The availability of the voucher was planned to be put on all 
advertisement material as information for potential candidates. The ethics committee approved 
that vouchers could be provided to participants but initially declined the request to inform potential 
study participants about the voucher on advertising materials (e.g. flyers and social media posts). 
This decision was most likely made because some view the advertisement of the voucher as 
coercive and believe that it induces individuals to take part in research studies (Largent & Lynch, 
2017; Polacsek et al., 2017). However, taking part in an interview is time consuming and expecting 
the public to give their time without letting them know that they will receive an reimbursement has 
been described as unreasonable by some researchers (Draper et al., 2009). As recruitment 
without advertising the voucher was slow, an amendment was submitted after two months of 
recruitment to the ethics committee asking for permission to advertise the voucher on the study 
material and this was approved.  
Ethics committees have been found to lack policies informing their decision about payment 
(Largent et al., 2012), and more guidance about payment of participants needs to be provided to 
make decisions from ethic committees more consistent. 
7.6.6. Approvals for this study 
Ethical reviews are important to ensure that research meets ethical standards (Mooney-Somers 
& Olsen, 2017) and qualitative research involving humans must undergo ethics review and 
approval (Giacomini, Cook, & Group, 2000). This section outlines all approvals obtained for this 
study. 
Research studies that take place in an NHS setting require NHS Ethical approval. There was some 
level of uncertainty whether NHS Ethical Approval would be required for the interview study: On 
the one hand, pharmacy staff are not NHS employees and pharmacy users not NHS patients as 
pharmacies are independent businesses and not NHS institutions. This would suggest that no 
NHS Ethical Application would be required. On the other hand, the pharmacy-based sexual and 
reproductive health services aimed to be explored through interviews with pharmacy staff and 
users were provided by Umbrella, which is part of an NHS organisation (the University Hospital 
Birmingham NHS Foundation Trust). On the grounds that the sexual and reproductive health 
services to be explored were provided in conjunction with an NHS Trust it was advised by the 
study sponsor, the University of Warwick, to apply for NHS Ethical approval.  
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Ethics applications to key research approval bodies can now be made through a single UK-wide 
Integrated Research Application System (IRAS) which is provided by the Health Research 
Authority and Care Research Wales. The UK Research Ethics Service is independently from the 
Health Research Authority (G. D. Taylor & Rogers, 2019). Approval from the Health Authority in 
addition to approval from the Research Ethics Services is required since the 16th April 2018 for all 
research that is based in the NHS in England and Wales.  
Since all research carried out within the NHS requires a research sponsor in accordance with the 
UK Policy Framework for Health and Social Care Research (2017), sponsorship approval was 
obtained from the University of Warwick (Reference number: SC.40/17-18). Ethical approval was 
obtained from the South Central  Oxford B Research Committee (REC reference number: 
18/SC/0511) and from the Health Research Authority (HRA). Although HRA approval covers 
approvals of NHS Trusts, in e nal app o al f om he p ojec  f nde  Uni e i  Ho pi al 
Bi mingham NHS Fo nda ion  a  eq i ed befo e he da a collec ion and anal i  co ld be 
started. 
Only one substantial amendment was made to the NHS ethics application. The substantial 
amendment was made to get permission to advertise the voucher as outlined in a previous section 
(see section 7.6.5 remuneration ). The amendmen  a  app o ed b  he Re ea ch E hic  
committee and HRA. The amendment documents were forwarded to the University Hospital NHS 
Foundation Trust for their information.  
An overview of all amendments is provided alongside a reason for the amendment in Appendix 9. 
The approval process took eight months, measured from the time that the sponsorship application 
was submitted to the final approval from the University Hospitals Birmingham NHS Foundation 
Trust. A timeline offering an overview about all processes described in this section is provided in 
Appendix 10. 
7.7. Data collection 
Before the interview process is explained, considerations regarding the mode of interviews are 
discussed.  
7.7.1. Mode of interviews 
There are many different modes of interviews. For a long time, face-to-face interviews have been 
the norm for data collection and been held to be the gold standard whereas telephone interviews 
have often been dismissed as not being well suited for qualitative interviewing (Irvine, 2018; 
Oltmann, 2016). It has to be acknowledged that face-to-face interviews have several advantages 
over telephone interviews: For example, face-to-face interviews take place in a controlled 
environment (Seale, 2004) whereas there is a risk with telephone interviews that participants may 
get distracted and that background noise creates a problem. Further, social cues such as body 
language can be observed in face-to-face interviews and provide extra information (Barratt, 2012), 
whereas social cues in telephone interviews are limited to the pauses and tone.  
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Nevertheless, telephone interviews have increased in popularity in the past thirty years (Oltmann, 
2016) and there is increasing literature documenting the potential for telephone interviews to be 
a suitable method for conducting qualitative research (Drabble et al., 2016). Telephone interviews 
have also increased in importance during the COVID-19 pandemic (as of September 2020), where 
research methods which avoid face-to-face interactions with participants are needed. Telephone 
interviews are logistically convenient to conduct as both the interviewer and the participant do not 
have to travel (Rahman, 2015). This enables participants to be interviewed from a larger 
geographical area, reduces cost, increases interviewer safety and also provides greater flexibility 
to schedule interviews (Drabble et al., 2016). However, more importantly for this study, telephone 
interviews increase perceived anonymity and privacy, and have shown to be effective when 
interviewing participants on sensitive topics (Drabble et al., 2016). The anonymity of telephone 
interviews, where the interviewer is not physically present, may make participants more 
comfortable and encourage them to answer questions more truthfully (Musselwhite, Cuff, 
McGregor, & King, 2007). 
Since some participants might prefer telephone interviews over face-to-face interviews due to a 
higher level of confidentiality (Greenfield, Midanik, & Rogers, 2000), it was decided that 
participants could choose whether they wanted to be interviewed via phone or in person. This 
gave participants the freedom to select the mode of interview that they were most comfortable 
with.  
7.7.2. Topic Guide  
A topic guide or interview guide outlines the key topics to be explored with participants and aids 
the researcher to ensure consistency in the data collection while also giving room to explore detail 
relevant to the individual participant. The wording of questions on the interview topic guide can 
be adapted to each participant. Topics are developed after the relevant literature has been 
reviewed and research questions defined (Ritchie et al., 2013). For this study, the topic guide was 
developed by the PhD candidate based on the findings of the systematic review conducted for 
this project (Gauly et al., 2019). It was also informed by experts in the field (including the Chair of 
the local pharmaceutical committee, the academic supervisors and Umbrella employees). 
Separate topic guides for pharmacists, pharmacy healthcare assistants and pharmacy users were 
produced and iteratively developed based on the notes taken during and after the interviews. 
Different topic guides were required for the following reasons:  
Pharmacist and pharmacy healthcare assistants have different roles and responsibilities in the 
pharmacy. While pharmacists can deliver all of Umbrella  e ice , pha mac  heal hca e 
assistants are only allowed to provide condoms and STI self-sampling kits. Further, while 
pharmacists are often in the back of the pharmacy, pharmacy healthcare assistants are usually 
the first point of contact to pharmacy users and therefore may have different perspectives 
compared to pharmacists. Pharmacy users are receiving rather than providing services and 
therefore different questions needed to be asked.  
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The areas explored with pharmacy staff were as follows:  
x Experience of delivering the service  
x Views and experience of data collection when delivering sexual and reproductive health 
services  
x Role of pharmacy healthcare assistants in sexual and reproductive health service delivery 
x Views on how pharmacy-based sexual and reproductive health services can be further 
developed  
x Role of training in the delivery of sexual and reproductive health services 
The topic guide for pharmacy users covered the following areas:  
x Reasons they visited the pharmacy rather than other sexual and reproductive health 
provider 
x Experience of using the pharmacy for sexual and reproductive health services 
x Experience of providing personal information in the pharmacy 
x Views on how pharmacy-based sexual and reproductive health services could be further 
developed 
Open ended questions were used as they allowed for the exploration of topics in-depth (Weller et 
al., 2018). Further, prompt questions associated with the main questions were included in the 
topic guide to aid the researcher in guiding the interview and to get more information. Copies of 
the topic guides are provided in Appendix 11.  
7.7.3. Interview Process 
An overview of the telephone interview process is provided in Figure 9. Consideration was given 
to the length of the interview. Up to one hour is considered as appropriate for semi-structured 
interviews. However, one hour should not be exceeded to avoid fatigue of both the interviewer 
and the participant (Newcomer, Hatry, & Wholey, 2015). The advertisement material stated that 
the interview would last a maximum of 60 minutes. 
All interviews were conducted by Julia Gauly, a female researcher trained but without previous 
experience in qualitative interviewing. J lia Ga l  pe i o  (H.A.) and another researcher from 
Warwick Medical School (J.P.) reviewed the first number of interview transcripts in order to 
provide Julia Gauly with advice and guidance on the conduct of further interviews. 
At the beginning of the interview, Julia Gauly introduced herself, summarised the study 
information and gave the participant the opportunity to ask any questions. Next, oral consent was 
obtained. Following this, the semi-structured interview was conducted using the topic guide.  
 
 
PhD Thesis | Interview Study Methods | Julia Gauly 
113 
 
A  he collec ion of d  pa icipan  demog aphic  i  impo an  in o de  o in e p e  and d a  
conclusion from the results (Sifers et al., 2002), demographic information was then obtained from 
all study participants. In addition to the information collected on study participants prior to the 
interview (see section 7.4), the following demographic information was collected for each 
participant:  
x Gender 
x Ethnicity  
x Age 
x Religion 
P e io  e ea ch ho ed ha  pa icipan  age, gende , and e hnici  i  commonl  epo ed in 
research studies (Sifers et al., 2002). In the context of sexual and reproductive health services, 
previous research suggests that demographic characteristics such as ethnicity (Marlow et al., 
2009), age (Hussainy et al., 2011), gender (Hussainy et al., 2011) and religion (Cooper et al., 2008; 
Marlow et al., 2009; Mollen et al., 2008) ma  impac  people  a i de  o a d  e al and 
reproductive health services. Therefore, all participants were asked for this information. However, 
participants who preferred not to answer the questions on demographics and personal 
characteristics could still take part in the study.  
Pharmacy staff were also asked for the following information:  
x Number of years in pharmacy profession  
x Number of years in role at current pharmacy 
Numbers of years working as a pharmacist have also been collected in previous studies on 
pharmacy-based SRHS (Wong et al., 2017) and evidence suggests that it may impact health 
p o ide  a i de  o a d  SRHS (Ibrahim et al., 2013).  
These three parts of the interview (obtaining consent; semi-structured interview; obtaining 
demographic information) were audio recorded. The interview participant was informed every 
time when the encrypted audio recorder was turned on and off. As sharing qualitative research 
findings with participants is considered an ethical correct procedure (Goldblatt et al., 2011), study 
participants were asked at the end of the phone call whether they wanted to be provided with a 
study report. 
 




FIGURE 9 OVERVIEW OF TELEPHONE INTERVIEW PROCESS 
7.8. Data transcription 
As transcription work is a time-consuming part of qualitative research it was outsourced to an 
external transcription service. This is commonly done in qualitative research (Bokhove & Downey, 
2018). All interviews were anonymised and then transcribed verbatim by Appen, a professional 
transcription service, approved by the University of Warwick. Verbatim transcripts are considered 
to be the best way to capture the meanings of interviews (Cohen et al., 2007). The turnaround of 
the transcription was about ten working days. Once received, each transcript was checked for 
accuracy against the recording and read several times for familiarisation with the data by the PhD 
candidate.  
7.9. Data Analysis 
A commonly applied qualitative method to analyse data in health sciences studies is thematic 
analysis (Nowell et al., 2017). It is an approach to extract the meaning and concepts from data by 
identifying, analysing and reporting patterns in data (Bennett et al., 2019; Braun & Clarke, 2006).  
It is commonly used for several reasons. First of all, it is a highly flexible approach that fits most 
research questions (Cassell & Bishop, 2019). Further, no detailed theoretical knowledge is 
required. This means that thematic analysis can be learnt quickly, is straightforward (Herzog et 
al., 2019) and highly accessible, particularly for less experienced researchers (Braun & Clarke, 
2006). More importantly, thematic analysis is particularly suitable for analysing experiences 
(Herzog et al., 2019) and can be used to explore datasets of all sizes (Herzog et al., 2019) and to 
compa e imila i ie  and diffe ence  be een pa icipan  e pe ience  (King, 2004). Thematic 
analysis has also been found to be a flexible tool for exploratory research (Herzog et al., 2019). 
Since e plo ing and compa ing d  pa icipan  e pe ience  a  he main foc  of he 
interview study, thematic analysis was deemed appropriate for the data analysis.  
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To be able to evaluate whether the method of data analysis is credible, the method has to be 
described in detail (Nowell et al., 2017). Thematic analysis has received criticism in the past as 
there was no procedural advice published (Terry et al., 2017). However, since Braun and Clarke 
published their six phases of thematic analysis (Braun & Clarke, 2006), it has become a popular 
and reputable method of analysis. Thematic analysis is an iterative process (Braun & Clarke, 2019) 
and was carried out in parallel to the interview data collection. This approach also was taken to 
determine the point at which no new themes were identified in the data.  
For the analysis, the six phases of thematic analysis introduced by Braun and Clarke were followed 
(Braun & Clarke, 2006):  
1. Familiarisation with the data 
2. Generation of initial codes 
3. Searching for themes 
4. Reviewing themes 
5. Defining and naming themes 
6. Producing the report 
As interviews were conducted, interview transcripts were read several times by J.G. for 
familiarisation and initial codes were noted down. All transcripts were also read by another 
researcher (H.A.). Then, all interview transcripts were uploaded into the software programme 
NVivo v12 and initial codes were created. The codes were then grouped into categories and 
coding frameworks created for each participant group (Pharmacy Users, Pharmacists, and 
Pharmacy Healthcare Assistants). This process was repeated on paper: All codes identified in 
NVivo were printed and manually sorted into categories to create a coding framework. To reduce 
bias and increase the validity and value of the thematic analysis, analysis was supported by other 
researchers: A researcher from Warwick Medical School (J.P.), who is experienced in qualitative 
research, coded 30% of all interviews and also created her own version of a coding framework. 
J.G. and J.P. then discussed the coding framework for each group and adapted them where 
needed to produce one final coding framework. Afterwards, themes were identified within and 
across the three different participant groups. 
Mind maps were used to present the themes and subthemes. Different colours were used for the 
three different groups to ensure that it was visible which themes or subthemes resulted from 
which participant groups. The transcripts were also read by H.A. and the themes discussed, 
reviewed, defined and named in collaboration with H.A., J.R. and J.P. over time. Finally, the results 
were written up. Quotes were provided to substantiate analytic findings.  
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7.10. Interpretation of the Findings 
As explained in section 2.6.4, NPT was used as a lens for interpreting the findings from the 
qualitative interview study. It is now described how NPT was applied:  
In line with other qualitative studies which used NPT (McCrorie et al., 2019; Rostami et al., 2018), 
the results of the thematic analysis were mapped onto the four constructs of NPT: Coherence, 
Cognitive Participation, Collective Action and Reflexive Monitoring where applicable (see 2.6.4). 
Data was mapped only where the data fitted with a construct of Normalisation Process Theory.  
As done in other studies, the PhD candidate (J.G.) used the NPT toolkit to support this process of 
identifying specific points of relevance (C. H. D. Jone  e  al., 2016; O Donnell e  al., 2017). The 
toolkit is available online and presents sixteen statements related to the four constructs of 
Normalisation Process Theory. By sliding a bar, you can indicate how strongly the statement is 
true for the complex intervention in question according to the study findings. Once all statements 
are completed, radar plots illustrate the strengths assigned for the four concepts overall and for 
each single concept of NPT. While the NPT toolkit is not a scientific instrument but a subjective 
assessment, it can help users of the NPT to evaluate the different factors contributing or inhibiting 
complex interventions to become part of routine practice. Hence, it can assist the interpretation 
of the qualitative results. The PhD candida e  interpretation of the findings of the NPT was 
discussed with the research team (H.A., J.R. and J.P.). 
The findings of the interpretation using Normalisation Process Theory were adapted over time by 
J.G. and presented in text and a figure. 
7.11. Chapter summary 
This chapter presented the methods of the primary qualitative research study. It covered practical 
aspects such as recruitment, interview process and processing data, ethics and other approvals. 
It also covered factors that required decisions to be made on how the study would be conducted; 
eligibility criteria, sampling strategy, content of interviews and method of data analysis and 
interpretation were outlined. The following chapter 8 presents the findings and discussion of the 
interview study. 
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8. Interview Study Results and Discussion  
8.1. Chapter overview 
This chapter presents the results of the interview study, with accompanying interpretation and 
discussion of the findings. Firstly, an o e ie  of pa icipan  cha ac e i ic  i  described. Next, 
the themes and subthemes identified are presented and an interpretation of the results offered. 
In the discussion section, the main findings are reiterated, and the strengths and limitations 
presented, in relation to the approach, the setting, and the sample. Finally, the interview study 
findings are compared to the existing literature.  
8.2. Interviews  
In total, 15 pharmacy staff (nine pharmacists and six pharmacy healthcare assistants) and 15 
pharmacy users took part in a telephone interview between April and September 2019.  
8.2.1. Identification of interview participants 
In the end, no pharmacy staff members were recruited through flyers, suggesting that this strategy 
is not well suited to recruit this participant group. Research has shown that people are more likely 
to participate in research when they are directly approached by researchers rather than when 
they have to approach the researcher to take part (Hewison & Haines, 2006). Pharmacy staff might 
have been hesitant to contact Julia Gauly using the details provided on the flyer.  
However, the face to face recruitment of pharmacy staff proved to be effective. In total, 29 
pharmacists expressed an interest in taking part and interviews were scheduled with 13 of these. 
Of these, four did not answer the phone at the scheduled time. One of these explained that he 
had decided not to take part due to time constraints, whilst the others did not offer any explanation. 
Hence, nine pharmacists were interviewed in the end. Further, eight pharmacy healthcare 
assistants who attended Umbrella s training registered their interest in the study and six interviews 
were scheduled. Since data saturation was reached after these fifteen pharmacy staff interviews, 
no further interviews were scheduled. 
Two pharmacy users were recruited through the distribution of flyers and two pharmacy users 
expressed an interest in taking part as a result of social media promotion (one of these did not 
mee  he d  incl ion c i e ia and he o he  one decided no  o pa icipa e af e  being 
provided with the information sheet without giving a reason). In total, 196 pharmacy users 
registered their interest in taking part in an interview on the pre-registration site from Umbrella 
and 27 interviews were scheduled by the PhD candidate. Of these, two candidates cancelled the 
interview without giving a reason, five did not answer their phone at the scheduled time, one 
participant mistakenly thought it was a job interview, and four were found to be ineligible because 
they had used a sexual health clinic rather than a pharmacy. In total, 15 pharmacy users were 
interviewed, and data saturation was reached.  
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Emergency contraception pills can be purchased at a pharmacy or be provided for free through 
the Umbrella service to women between 13 and 60. One pharmacy user (age group: 25-29) 
interviewed was wrongly told by a pharmacy healthcare assistant that she had to pay to get the 
emergency contraceptive pill through Umbrella. The pharmacy healthcare assistant falsely stated 
that this was because she was not eligible for the free service due to her age. Technically, this 
pharmacy user had not used the Umbrella service because she was charged for the emergency 
contraceptive pill; however, since both the pharmacy healthcare assistant and the pharmacy user 
believed that the Umbrella service had been provided, her interview data was still included in the 
analysis. As this interview participant indicated that she would risk getting pregnant next time 
rather than having to pay for the emergency contraception pill, the incident was reported to 
Umbrella  b ine  manage  ho hen ai ed he i e i h he pha mac . 
8.2.2. Type of conducted interviews 
All participants chose to take part in telephone interviews rather than a face-to-face interview. 
On reflection, offering telephone interviews was crucial in conducting this study. Pharmacy staff 
were busy and difficult to get hold off, and they were not willing to travel for the interviews. Further, 
both staff and users were often interviewed outside working hours (early in the morning and late 
in the evening) and conducting interviews in person at these times would have been difficult. Both 
pharmacy staff and users often cancelled or rescheduled the interview last minute. If interviews 
would have taken place face-to-face, a lot of time would have been wasted for waiting or travelling 
unnecessarily.  
Previous research has shown that it can take some time to build rapport when conducting 
telephone interviews (Irvine, 2018). When reflecting on these interviews, it can be said that it took 
time to build rapport with some participants, and pharmacy users in particular. Pharmacy users 
tended to give short answers at the start of the interview. However, after a few minutes study 
participants seemed to get more trusting and to open up and all data required to address the 
research questions were collected.  
8.2.3. Interview lengths 
Excluding obtaining consent and asking demographic questions, interviews lasted between 15 
and 51 minutes (average: 29 minutes).  
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8.3. Description of sample  
8.3.1. Pharmacy staff 
An overview of pharmacy staff characteristics is provided in Table 14. 
TABLE 14 PHARMACY STAFF - PARTICIPANT CHARACTERISTICS 
Characteristic Pharmacists Pharmacy Healthcare 
Assistants 
Total number, n 9 6 
Gender 
Men 5 1 
Women 4 5 
Age 
<30 5 1 
30-39 3 2 
40-49 1 1 
50 - 2 
Ethnicity 
White/White British  1 4 
Asian/Asian British 6 2 
Black/Black British 2 - 
Religion 
Christianity - 2 
Islam 5 1 
Hinduism 1 - 
Sikhism 2 - 
No Religion 1 2 
Type of Umbrella pharmacy employed at 
Tier 1 3 2 
Tier 2 4 4 
Tier 1 and Tier 2 2 - 
Years in Profession 
<5 5 1 
5-9 1 2 
10-19 2 2 
20-30 1 1 
Years in current role 
<5 7 1 
5-9 2 2 
10-19 - 2 
20-30 - 1 
 
Pharmacists 
Umbrella pharmacies operate either at Tier 1  or Tier 2  level. Tier 1  pharmacies offer 
emergency contraception and condoms. They can also dispense pre-ordered STI self-sampling 
kits for up to five different STIs. Further, these pharmacies have STI self-sampling kits in stock 
that can be used to test women presenting for emergency contraception for chlamydia and 
gonorrhoea. Tier 2  pharmacies offer an even larger range of services: they additionally provide 
oral contraception, contraceptive injection, and chlamydia treatment. They also have all types of 
STI self-sampling kits in stock and can offer them to pharmacy users.  
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Further, they can provide women presenting for emergency contraception with another pack of 
emergency contraception for future use (advance emergency contraception).  
Out of the nine pharmacists interviewed, three worked at a Tier 1  and four at a Tier 2  pharmacy. 
Two locum pharmacists (pharmacists that are employed on a contractual basis through an 
agency), worked at both a Tier 1  and a Tier 2  pharmacy. All pharmacists interviewed worked at 
different pharmacy stores. In total, five out of nine pharmacists were male and four were female. 
Most pharmacists fell into the 25-29 age category (3/9), identified as Asian/Asian British (6/9) and 
stated that their religion was Islam (5/9). Most pharmacists had qualified as a pharmacist between 
0-5 years ago (5/9) and had been in their current role for less than five years (6/9).  
Pharmacy Healthcare Assistants 
Out of six pharmacy healthcare assistants interviewed, four worked at Tier 2  pharmacies and two 
at Tier 1  pharmacies. The six healthcare assistants worked at three different pharmacy stores. 
Overall, five out of six pharmacy healthcare assistants were female. Out of the six, two fell into the 
30-34 and two into the 50-54 age category. One pharmacy healthcare assistant was between 18 
and 24 and one was between 35 and 39 years old. Most pharmacy healthcare assistants (4/6) 
identified as White/White British. Two pharmacy healthcare assistants indicated Christianity and 
one Islam as their religion. Two pharmacy healthcare assistants stated that they were not religious. 
Pa icipan  experience as healthcare assistants and number of years in current role varied 
between one and twenty years. The pharmacy healthcare assistants recruited were working at 
three different pharmacies.  
8.3.2. Pharmacy Users 
An o e ie  of pha mac  e  cha ac e i ic  i  p o ided in Table 15.  
The large majority of pharmacy users were female (13/15); one of the females identified as a 
transgender woman. In total, 10 out of 15 participants fell into the 25-29 age group, 5 out of 15 
participants identified as Mixed/Multiple ethnic group (5 /15), and 8 out of 15 participants stated 
that they were not religious. 
Seven out of the 15 pharmacy users interviewed had used more than one Umbrella service in one 
visit (see Table 15). Six pharmacy users stated that it was their first time to visiting the pharmacy 
for an Umbrella service, whereas nine had previously used a pharmacy-based Umbrella service.  
In total, at fourteen different Umbrella pharmacies had been visited by participants.  
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TABLE 15 PHARMACY USERS - PARTICIPANT CHARACTERISTICS 
Characteristic Pharmacy Users 










White/White British 3 
Asian/Asian British 4 
Black/Black British 3 
Mixed/Multiple Ethnic Group 5 
Religion 




No Religion 1 
Umbrella services used 
Chlamydia treatment and condoms 1 
Oral contraceptive pill and emergency 
contraceptive pill 
1 
STI kit and condoms 1 
Condoms and emergency contraceptive pill 1 
STI kit and emergency contraceptive pill 2 
Condoms only  1 
Emergency contraceptive pill 4 
Oral contraception  1 
Contraceptive injection 1 
Chlamydia treatment 1 
Chlamydia treatment and oral contraceptive 
pill 
1 
PhD Thesis | Interview Study Results and Discussion | Julia Gauly 
122 
 
8.4. Overview of themes and their subthemes 
Four main themes and several subthemes were identified: 1. Pharmacy as a venue for sexual and 
reproductive health services (SRHS) (Need for physical privacy; need for trained staff; 
Convenience), 2. Staff-User interaction (Staff interpersonal skills; Sex of staff; Collection and use 
of personal information; Language and literacy), 3. Impact of delivering SRHS on pharmacy staff 
(Impact on Workload; Staff motivation to deliver services; Recognition for delivering services), 4. 
Implementing SRHS into pharmacies (Awareness of pharmacy services; Clinic support for 
pharmacies; Ease of use of STI self-sampling kits). An overview of all themes and their subthemes 
can be found in Figure 10.  
 




FIGURE 10 OVERVIEW OF ALL THEMES AND THEIR SUBTHEMES 
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8.4.1. Pharmacy as a venue for SRHS 
This theme captures aspects that are related to the pharmacy as a venue for SRHS. These 
included: need for physical privacy; convenience; and need for trained staff.  
Need for Physical Privacy 
Physical privacy was highly important to users when requesting or being provided with a SRHS 
in the pharmacy. Physical privacy for pharmacy users meant that no one could hear or observe 
which service they were presenting for or being provided with and that they were not personally 
recognised by users and staff.  
Stigma about using SRHS was identified as one reason for the high need of physical privacy by 
pharmacy users. For example, one pharmacy user stated she would use a separate pharmacy for 
sexual and reproductive health concerns as she feared that staff at her family pharmacy would 
judge her:  
 So that's why I didn t choose to go in there, because it s more of a 
judgement element to be honest, because, because I'm waiting for so 
long for the coil to, you know, get that appointment ... readily available 
.... I had to go into that pharmacy three weeks for the same thing 
(emergency contraception).  And that's not because I'm not, being 
careless, I'm using things, they're just not working.  [Pharmacy user, 
female, age group: 25-29, ID number: 1082] 
However, users were not only concerned about getting judged by pharmacy staff but also by other 
people using the pharmacy. While some users felt embarrassed to request a SRHS in front of 
o he  people, o he  claimed no  o ca e abo  o he  people  j dgemen :  
But there is definitely a feeling of judgement when you ve got people 
that are stood behind you in the queue and whatnot and you re asking 
for the morning after pill.  And you, you re sure that people are most 
likely judging you but for me it s kind of like, Whatever.  [Pharmacy 
user, female, age group: 25-29, ID:1049] 
Pha mac  e  e pe ience of ph ical p i ac  idel  diffe ed and a  depending on man  
different factors.  
Pharmacy users who had requested a service while attending an emptier pharmacy tended to 
have a more positive experience of privacy than those attending a busy pharmacy.  
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When there were other people around, including staff and other pharmacy users, this negatively 
impacted pha mac  e  experience of privacy:  
I don t think there was enough privacy because, obviously, if you re at 
the counter and there are, like, customers coming in as well and there 
was, like, other apprentice workers and some of the staff was around so 
I don t think it was private enough.  [Pharmacy user, female, age group: 
25-29, ID:1092] 
Having people around was impacting privacy as people could overhear the conversation. Instead, 
when the store was empty, pharmacy users had a better experience of privacy:  
The store was empty, nobody was waiting there, nobody could have 
overheard.  [Pharmacy user, female, age group 18-24, ID:1046] 
Some pharmacy users stated that they intentionally waited for the pharmacy to get empty before 
approaching pharmacy staff to request a SRHS as they did not want to be overheard:  
 Sometimes when I go into my other pharmacy I do have to wait until 
people have gone out, 'cause you don't necessarily wanna be 
discussing that in front of other people, do you know what I mean?  It s 
quite sensitive.  [Pharmacy user, female, age group: 25-29] 
This behaviour where pharmacy users were waiting for the pharmacy to be empty or quieter 
before requesting a service, was observed by pharmacy healthcare assistants:  
 If there s other people in the shop at the counter, they, they ll wait until 
there s nobody in there and then they ll come in.  [Pharmacy healthcare 
assistant, female, age group: <50, ID number:593] 
In order not to be overheard when requesting a SRHS, some users stated that they tried to speak 
very quietly at the counter:  
 I will usually just speak really quiet, like, I try to speak as quietly as 
possible.  But then I do recognise that, like, sometimes there are, like, 
about six or seven other people in there.  And then if someone s going 
to come up to you and say, Oh, what are you after?  you are going to 
have to say as, like, discreetly as possible. [Pharmacy user, female, age 
group: 25-29, ID number: 1056] 
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Whether pharmacy staff who were dealing with the service request were discreet or not further 
impacted how much privacy users experienced:  
 I just spoke to her when she was stocking shelves and I did it quietly 
and she replied quite quietly as well so there wasn t, I don t think people 
around heard or anything. [Pharmacy user, female, age group: 25-29, 
ID number:1092] 
The q e ing em in pha macie  al o infl enced pha mac  e  perception of physical 
privacy. One pharmacy user described that two parallel queues at the counter limited his feeling 
of privacy as people in the queue next to him could overhear him:  
Yeah, 'cause there was like, a queue behind, and there was .... like, two 
queues as well, so there was one to the left of me .... as well. And then, 
yeah, people walking past as well. It was, they, they were all right, just 
like I said, it was a bit embarrassing 'cause of the space.  [Pharmacy 
user, male, age group: 18-24, ID number: 1062] 
However, the layout of the pharmacy could also enable privacy. One pharmacy user described 
that the SRHS counter was in a separate area of the pharmacy, which provided her with privacy:  
They have a side bit with like a, a, it s like a privacy counter, so if I 
wanted I could have went to that counter to speak to somebody.  So no, 
even if it was busy, I know that I would have been speaking in 
confidence, I could have went to that counter. [Pharmacy user, female, 
age group: 18-24, ID number:1093] 
Those pharmacy users who did not want to be personally recognised, intentionally visited 
pharmacies at locations where they did not know the pharmacy staff and where they were unlikely 
to meet someone that they knew:  
That's probably one of the reasons as well why I did it closer to home, 
because I wouldn't ... I don't really know people living in my area .... as 
such.  So I wouldn't have necessarily bumped into anybody in there.  
[Pharmacy user, female, age group: 30-34, ID number 1047] 
The delivery of SRHS occurred in most cases in private consultation rooms within pharmacies. 
Most pharmacy users felt that being in a consultation room provided them with sufficient privacy 
during the service delivery.  
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However, one pharmacy user stated that the consultation room in which she was delivered a 
service was not soundproof, limiting her perceived privacy:  
 It wasn t soundproof ... 'cause I can hear people from outside.  I could 
hear them, so I assumed people could hear me from inside as well whilst 
we were having conversation sometimes.  [Pharmacy user, 
transgender woman, age group: 25-29, ID number:1023] 
Those pharmacy users who were provided with condoms or an STI self-sampling kit at the counter 
liked that the discreet packaging prevented other people from observing which services they were 
being provided with:  
 The product, it s, it s not, what s the word, it s not, noticeable, you 
know.  Only certain people would know, if they were to collect this, what 
it was, yeah... it s not labelled what it is. So it s in a, it s in a cardboard 
box and it s, you know, it s, there is privacy there.  [Pharmacy user, 
female, age group, 30-34, ID number:1088] 
In summary, whilst steps were taken to address physical privacy during the service delivery, with 
the use of private consultation rooms, pharmacy users often felt that privacy was insufficiently 
addressed when requesting a service at a pharmacy counter. This was largely because of the 
nature of the pharmacy setting, and the physical layout of the pharmacy which made it possible 
to overhear what pharmacy users were requesting. The level of discreetness of pharmacy staff 
also impacted the level of privacy. Stigma was identified to be a key reason why privacy was 
important to pharmacy users.  
Convenience  
When asked why pharmacy users had chosen to access the pharmacy for a SRHS, convenience 
was the most commonly reported reason. By convenience pharmacy users meant that 
pharmacies were accessible from a practical point of view. For example, pharmacy users liked 
that they could easily reach a pharmacy from their home or work:  
 Cause I get, I live down the road to that pharmacy ... so it s very 
convenient of me to go up there.  [Pharmacy user, transgender woman, 
age group: 25-29, ID number: 1023] 
Further, people found pharmacies accessible due to their long opening hours allowing them to 
access pharmacies after work:  
So I was still able to go to work and whatever. And it was open to, it s 
open 'til late as well, 'til 7 pm.  So that's pretty, that was pretty useful.  
[Pharmacy user, female, age group, 30-34, ID number:1047] 
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Short waiting times and no need to make an appointment were also reported as factors 
con ib ing o a d  pha macie  acce ibili : 
I went back to the same pharmacy and saw a female pharmacist, 
because both times it was just, just really straight forward, you didn t 
need an appointment, was seen really, really quickly, and the staff were 
nice, and it was just way more, I suppose convenient.  [Pharmacy user, 
female, age group, 18-24, ID number: 1027] 
In conclusion, pharmacy users collectively agreed that pharmacy-based SRHS are highly 
convenient to use.  
Need for trained pharmacy staff  
Pharmacies are offered free staff training by Umbrella  ed ca ion eam. While Umbrella services 
have to be delivered by trained staff, it is up to the pharmacy whether to train all staff they employ.  
Not having trained pharmacy staff in the pharmacy at all times was identified to be limiting the 
service availability. Pharmacy healthcare assistants stated that they often had to send people away 
as they did not have a trained pharmacist in the pharmacy. This was sometimes upsetting for 
pharmacy users who were desperately trying to access time sensitive services such as the 
emergency contraception pill:  
 I was like, I m really sorry, but we haven t got a pharmacist who can 
do that service for you.   And she got quite upset. You know, you know, 
she, she was, like, quite teary. And I m like, you know, If there was 
something I could do for you, I would.   But she was ... I think she was 
like, you know, she just felt she needed it there and then.  [Pharmacy 
Healthcare assistant, female, age group: 30-39, ID number: 497] 
Pharmacy healthcare assistants found it frustrating that they had to turn people away because a 
trained pharmacist was not available.  
So it just, it s frustrating we have to turn people away because we 
haven t got the right pharmacist in.  [Pharmacy Healthcare assistant, 
female, age group: 30-39, ID number: 497] 
In summary, according to pharmacy healthcare assistants, not having trained staff available at all 
times was identified as negatively impacting the service availability. 
8.4.2. Staff-User interaction  
In this theme all aspects relating to the interaction between pharmacy staff and pharmacy users 
are discussed. These included the subthemes: sex of staff; staff interpersonal skills; collection and 
use of personal information; and language and literacy.  
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Sex of staff 
While this was not true for all pharmacy users, many appeared to have a preference regarding 
the sex of the pharmacy staff delivering a SRHS to them. Several females expressed that they 
would feel more comfortable and prefer to be provided with a SRHS by female pharmacy staff.  
 I think I just feel more comfortable and for the some of the reasons 
that I ve gone and got the morning after pill in the past, probably seeing 
a man wouldn t make me happy.  So yeah, no, I probably would just 
prefer a female.  [Pharmacy user, female, age group: 25-29, ID 
number:1049] 
While some female pharmacy users stated that they would prefer female pharmacy staff but would 
still accept the service being delivered by a male member of staff, one pharmacy user expressed 
that she would probably not accept a male as provider of SRHS:  
 I dunno, I don t think I d just be, I don t think I d be comfortable. If there 
wasn t a lady working there I probably wouldn t go to that place.  
[Pharmacy user, age group: 25-29, ID number: 1092] 
That many females preferred to talk to a woman was described by several pharmacy staff 
members. They stated that some women would specifically ask for a female pharmacist and, in 
some cases, would wait for a female pharmacist to deliver the service:  
Yeah, I, I mean, personal experience, really, just speaking to a lot of 
females, because normally when they ll come in and they ll say, When 
is the female pharmacist …gonna be on?   Because, the, the pharmacy 
that I work in, me and the other pharmacist, we, we both offer the 
service, so he s there half the week and I'm there half the week.  So 
sometimes they will come back when I'm there, just to feel a little more 
comfortable, but a lot of people obviously when they need it, it s very 
time sensitive, so obviously they will have to have the consultation with 
either a male or female.  So it, it just depends on every situation.  
[Pharmacist, female, age group: <30, ID number: 47] 
Some pharmacy staff described strategies that they used to enable the delivery of services to 
those females who initially wanted to speak to a female pharmacist. For example, in some 
pharmacies, females were offered to be chaperoned by a female pharmacy healthcare assistant:  
But what, what we can do, we can have ... there s a, a lot of Healthcare 
Assistants there.  So they can chaperone with the pharmacist. If they re 
happy to go with the pharmacist then they can be chaperoned.  
[Pharmacy healthcare assistant, male, age group: 40-49, ID number: 
492] 
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In other pharmacies, male pharmacists let pharmacy healthcare assistants convince female 
pharmacy healthcare assistants to receive the service by a male pharmacist:  
I might get my Dispenser to speak to them, just for her to say to them 
that, This pharmacist is really friendly, is really approachable.   So 
that s, that s another technique I try to use as well, to, kind of, help them 
open up a little bit and be a bit less nervous about it.  [Pharmacist, male, 
age group: <30, ID number:24] 
While same sex delivery seemed to be preferred by many female , ie  on male  p efe ence  
regarding the sex of staff were mixed. Some pharmacy staff members felt that men were more 
comfortable talking to male pharmacy staff, while others felt they were more likely to approach 
female pharmacy staff:  
I feel that males are more comfortable speaking to a woman than they 
are to a man for some reason. Men don t really like speaking to men, do 
they?  Yeah, I, I feel they re a bit more open when it comes to speaking 
to a woman.  [Pharmacist, female, age group: 30-39, ID number: 71] 
One male pharmacy user interviewed indeed expressed that he preferred to be counselled by a 
female pharmacist because he was attracted to males:  
Cause I'm not attracted to females, if that makes sense?  So it s like, a 
bit weird saying it to the gender I'm attracted to, if that makes sense?  
[Pharmacy user, male, age group: 18-24, ID number: 1062] 
A pharmacist suggested that more information should be available for users to see whether a 
female or male pharmacist was working in a pharmacy.   
So where the, you ve got the pharmacy opening times, it d be nice, as 
well, maybe to have the main pharmacists, like, working in those 
pharmacies, whether they re male or female, and what times they would 
be available.  So that might be an idea.  [Pharmacist, male, age group: 
<30, ID number:24] 
This idea was supported by pharmacy users.  
In conclusion, many users had a preference regarding the sex of pharmacy staff and for some, 
not having the staff of the preferred sex created a barrier for pharmacy users. Staff tried to use 
different strategies to overcome these barriers. While same sex service delivery seemed to be 
important to many, preferences were not straightforward and could not be presumed. In one case, 
the preference appeared to be linked to he pha mac  e  e ali .  
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Staff Interpersonal skills  
Pha mac  e  e pe ience a  he pha mac  a  highl  dependen  on pha mac  aff 
interpersonal skills. The large majority of pharmacy users had a positive interaction with pharmacy 
staff whom they often described as friendly and sensitive.  
However, where pharmacy staff were not confident when delivering the service, this impacted on 
the pharmacy user, making them less comfortable:  
To be honest with you, the guy that was there, he seemed a bit ... like 
he kind of didn t know what he was doing. (…) He was really stuck, 
really, he wasn t ... I didn t, I didn t feel confident with him if I'm, if I'm 
honest with you.  [Pharmacy user, female, age group:25-29, ID number: 
1082] 
Pharmacy staff members were aware of the importance of being confident in delivering the 
services. While some pharmacy staff members found that the training provided them with 
confidence, some said that more training and roleplaying would have helped them to be more 
confident in delivering services:  
I think we could have done with a little bit more training and probably 
a bit more roleplaying.  And just to, yeah, I think they could have done 
with a little bit more training, just so that you are more confident in 
providing every service.  [Pharmacist, female, age group: <30, ID 
number:96] 
Further, it was important to users that pharmacy staff did not judge them, and most pharmacy 
users described staff as non-judgemental and friendly:  
They can give appropriate information for a variety of things. And the 
fact that they are so professional so it s not, you don t feel like it s a 
personal, like, you know, like you re being judged when you re in there. 
It s just very like, professional in that they help and they re very friendly, 
which is really nice.  [Pharmacy user, female, age group: 25-29, ID 
number:1056] 
However, two pharmacy users experienced stigma from pharmacy staff. One woman who had 
attended the pharmacy for chlamydia treatment was very upset by how she was treated by staff: 
They were just, like, This is what we ve got, take it, if it works it work 
... works, if it doesn t just come back,   But very abrupt and one of the 
healthcare workers said to me before, because I had an infection and 
then I d, I d had intercourse again and then there was a, there was a 
slip-up with the condom and then I had to go back.  
PhD Thesis | Interview Study Results and Discussion | Julia Gauly 
132 
 
And he s, and then, at the end of him seeing me, he said, I don t want 
to see you back here again. And that, that was a few years ago, but it 
always has stuck with me .... because that was really upsetting.  
[Pharmacy user, female, age group: 18-24, ID number: 1017] 
The other pharmacy user was a transgender woman who felt judged and discriminated by staff:  
And I think to myself, Is it because I m transgender?   And she was 
an Asian woman wearing a hijab, so I m just thinking to myself, Are you 
working in the right place?  Cause you shouldn t be in the sexual health 
care if you re gonna be upset about transgender people coming here.   
And she was very, quite, she was acting a bit funny as well.  And that s 
the thing, like, I don t think, again, and that s another thing, nobody 
should be discriminatory, especially the NHS, 'cause there s all sorts of 
people that are walking in there.  [Pharmacy user, transgender woman, 
age group: 25-29, ID number:1023] 
This pharmacy user suggested that Umbrella staff should have training on diversity, including 
training on the appropriate usage of pronouns when communicating to transgender people. 
Generally, the more respectful pharmacy s aff e e pe cei ed o be o a d  e  choice , he 
better was their experience:  
And he asked me about a long term contraceptive option, went through 
those options with me. But I made him aware that, like, I, I have, like, a 
health condition.  So before I made any decisions about going onto a 
long-term contraception I have to consult my, well I have to speak with 
my consultant to, because hormones can affect the condition and he 
was just very respectful of that.  [Pharmacy user, female, age group: 
25-29, ID number:1056] 
Conversely, where pharmacy users felt they pushed into using a service, they were more likely to 
feel uncomfortable:  
 I can't remember, but it was just, I just remember it being 
uncomfortable and awkward and thinking, Oh god, I just wanna get out 
of here.  This is just ...  It s more just based on the questions that are 
like, like, demanding, like, I felt like I was being pressured into getting 
the coil and I didn t, I didn t want that.  [Pharmacy user, female, age 
group: 25-29, ID number: 1082] 
Bad e pe ience  i h pha mac  aff e e no  fo nd o be a ocia ed i h pha mac  e  
ethnicity or age.  
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In summary, pharmacy users largely had a positive experience with pharmacy staff. Being 
e pec f l of e  choice , non-judgemental and confident were associated with a positive 
experience. However, where pharmacy users felt that pharmacy staff were not confident, 
judgemental or no  e pec f l of e  choice  hi  a  nega i el  pe cei ed b  pha mac  users. 
Collection and use of personal information  
For all Umbrella services, personal details (e.g. name, gender, ethnicity) and information (e.g. 
sexual history) is collected on service users. However, the services are confidential meaning that 
the data is only shared in cases where Umbrella is legally required to, for example where concerns 
about safety exist. Under 18-year olds are posed safeguarding questions, aiming to protect young 
people from harm.  
Experiences on having to provide personal information differed widely between pharmacy users. 
Some felt that all information collected was relevant:  
He was really informative and he asked me a lot of questions that I felt 
were relevant in providing me with the, the right service.  [Pharmacy 
user, female, age group: 18-24, ID number:1090] 
However, other pharmacy users felt uncomfortable with having to provide personal information 
for privacy reasons:  
 I just felt uncomfortable to be honest .... that's just me personally. I like 
to be a private person.  [Pharmacy user, female, age group: 25-29] 
While some pharmacy users were more willing to provide their details when pharmacists 
reassured them at the start of the consultation that the service was confidential, others, and 
particularly young people, remained reluctant and appeared to be put off by the questions:  
Sometimes you can see the youngsters, they don t, they don t really 
want to provide that information. They re a bit like, you know, if you 
reassure them, you know, you reassure them two or three times, or a 
bit, a bit more, you know, you say it doesn t go anywhere, it only goes 
to Umbrella.  And, you know, you are, it, you know, just for your safety, 
just, you know, when you, you can, you try to explain it in as much as 
you can.  But they re a bit reluctant to say why, and so that, that puts 
them off.  [Pharmacist, female, age group:30-39, ID number:71] 
According to pharmacy staff, some pharmacy users chose to buy emergency contraception rather 
than to use the free Umbrella service, as they did not want to provide their personal information, 
indicating how important data privacy was for some users:  
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I've actually had patients who won t go for the Umbrella service, just 
because of that, and they d ...prefer to buy it ... just ... Yeah, yeah, I've 
actually had customers, not many, but there are a few customers that, 
even after we reassure them that all this information is confidential, just 
don t like the idea of giving their names and date of births. [Pharmacist, 
male, age group: <30, ID number:24] 
Currently pharmacy staff are obliged to collect the name, postcode and date of birth of Umbrella  
service e . Ho e e , pha mac  e  can gi e an alia  if he  don  an  o p o ide hei  real 
name. Users are also asked additional q e ion  b  can op  o indica e P efe  no  o a . 
Pharmacists were aware that data privacy was a concern for many pharmacy users, and some 
felt that the data collected should be anonymised as much as possible:  
So, obviously, as long as we, I think, again, with the anonymising as 
much as we can, kind of, just taking the initials, for example; don t have 
to take their full names and surname. [Pharmacist, male, age 
group:<30, ID number:24] 
Some pharmacists expressed that they were already not asking users for their name and address:  
 I never take a patient s name and address.  [Pharmacist, male, age 
group:20-49, ID number 84] 
However, as outlined above, no  a king fo  pha mac  e  name i  again  he polic  (although 
users can provide an alias instead of their real name if they prefer). Some pharmacists believed 
that users did not want anyone else to have access to the data:  
So, again, I would be more comfortable if their, kind of, names were 
anonymised.  And then, just because it will, I feel like for the customer 
and the patient, they wouldn t want anybody else, other than the 
pharmacist, accessing that, that kind of data.  [Pharmacist, male, age 
group:<30, ID number:24] 
However, some pharmacy users expected that the data was shared amongst Umbrella 
pharmacies and clinics and were uncomfortable of being asked the same questions that they had 
already provided elsewhere. These users felt it would be better if the data was shared with other 
Umbrella providers:  
If they, if it was like, the clinic could share the information with the 
pharmacy it felt like it wouldn't be necessary, if that makes sense? You 
know, like, the database you keep all the information on? Like, if the 
pharmacy had access to that as well, it s just your name, date of birth 
and address, if that makes sense?  
PhD Thesis | Interview Study Results and Discussion | Julia Gauly 
135 
 
It would be less, well, anxious…..if that makes sense? [Pharmacy user, 
male, age group: 18-24, ID number:1062] 
In summary, data privacy was a concern and for some pharmacy users, even a barrier to 
accessing Umbrella  pha mac  ervices. This was despite attempts by pharmacy staff to 
convince users of the confidentiality of the services. Pharmacy staff felt that the data collection 
should be anonymised as much as possible. While staff believed that data should not be shared 
amongst different health providers as this might make users uncomfortable, some users were 
expecting that pharmacists had access to their health records and were surprised when they had 
to provide their data again. 
Language and literacy  
Several pharmacists expressed that they sometimes experienced difficulties in delivering services 
to people who were not native English speakers:  
There can sometimes be barriers, for example language barriers, if I 
cannot understand what somebody s saying, I cannot actually provide 
a service so I have signposted them back to the doctors or, you know, 
to a clinic where I can, somebody can, you know, get maybe an 
interpreter or something like that.  I have had a few incidents of that, as 
well.  [Pharmacist, female, age group: <30, ID number:47] 
While pharmacists tried to use Google Translate and Google Images to communicate the services 
to users, they sometimes needed to refer people on to the sexual health clinic (Whittall Street 
Clinic) in Birmingham when communication was difficult: 
Cause sometimes when they re a bit, have a bit of broken English it s 
a bit harder, and that s when I maybe refer them to Whittall Street, or 
something like that.  But I try and use Google Translate as much as I 
could, I can.  [Pharmacist, female, age group: 30-39, ID number:71] 
Some pharmacy staff suggested that having information leaflets in different language might be 
beneficial to overcome language barriers:  
Maybe if there were those questions written in different languages, like 
Polish for example, or Punjabi for example, so it s just easier for them.  
[Pharmacist, female, age group: 30-39, ID number:71] 
However, some pharmacy staff found that some users were illiterate and in these cases 
information leaflets were not helpful at all:  
So some, I would find that even though I am giving them the 
information leaflet, a lot of them say, Well we can t read so you might 
as well just put it in the bin.   
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So, okay, or you know, if they can t read or write, so in that sense 
providing them in different languages again wouldn t help them because 
they wouldn t understand.  [Pharmacist, female, age group: <30, ID 
number:6] 
In summary, pharmacy staff felt that language barriers and illiteracy were sometimes an issue and, 
in some cases, even a barrier to pharmacy-based services.  
8.4.3. Implementing sexual and reproductive health services into pharmacies 
Several aspects were identified as important regarding the implementation of SRHS into the 
pharmacies. These were as follows: awareness of pharmacy services; support through clinics; 
and ease of use of STI self-sampling kits.  
Awareness of pharmacy services 
Participants felt that lack of awareness of the range of services offered by Umbrella pharmacies 
was a barrier to service usage:  
I, I guess, I think some of the services a lot of patients will know about, 
so the free condom distribution.  But even then I think sometimes people 
might think that it s only for younger people whereas it s actually for 
everyone.  So I think that might be one of, one barrier, potentially, to do 
with, kind of, the awareness of the Umbrella scheme because, 
obviously, we do promote it in the pharmacy but I think maybe 
sometimes people ... a, a lot of the time people don t know about the 
initiation of contraceptives in the pharmacy, so will be really aware of 
the free condom distribution and the STI self-sampling kits that you can 
get online but they won t be as aware as, say, the initiation of the STI 
self-sampling kits.  A lot of patients are often surprised when we offer 
them that service or sometimes if it s the initiation of the 
contraceptives.  [Pharmacy healthcare assistant, female, age group: 
<30, ID number:566] 
Particularly, pharmacy staff from smaller pharmacies felt that people were not aware that they 
were offering Umbrella s services:  
But I just, I don't know, sometimes I think we get overlooked 'cause 
we re such a small pharmacy I think sometimes people think, Oh, no, 
we won't go there, they probably won t have it,  or, you know, it would 
be nice to be sort of put on the map for, for, you know, for everyone.  
[Pharmacy healthcare assistant, female, age group: 30-39, ID 
number:302] 
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Both pharmacy staff and users felt that more advertisement could lead to more people accessing 
the services:  
So the main thing I just, it needs better promotion, I think, and 
awareness.  That s the main thing we need, because at the moment, it s 
just going by word of mouth, mainly.  [Pharmacist, male, age group: 
<30, ID number:24] 
Even when interviewing pharmacy users who had already used an Umbrella service, it became 
clear that they were not really sure which services Umbrella were offering, where they were 
offering them, and who could access the services.  
Uncertainty of pharmacy users on who can access the services was found in interviews with both 
staff and users. For example, pharmacy staff stated that men often accessed the pharmacy to get 
emergency contraception for their female partners although hormonal contraception can only be 
provided to females in Umbrella pharmacies.  
No, it s, it s generally, the, the only difficulty we have is we ve noticed 
with Asian and, well, I don t even know if the others, they were kind of 
Romanian, I, I don t know, cause I ve never .... asked them, but they 
come in to get the morning after pill for their women, but obviously we 
can t do that.  [Pharmacy healthcare assistant, female, age group: <50, 
ID number 593] 
Pharmacy staff felt that they did not clearly advertise that only females could access hormonal 
contraception:  
That isn t clear, that isn t stated, no. I mean I, we ve got posters 
everywhere and information, and it doesn t actually say anywhere.  I 
mean, if it does, it s in the tiniest writing.  So it advertises what we do, 
but it doesn t sort of say, no, so that isn t made clear, no.  [Pharmacy 
healthcare assistant, female, age group: <50, ID number:593] 
One pharmacy user who attended an Umbrella service for emergency contraception was wrongly 
charged for the service by a pharmacy healthcare assistant who believed that Umbrella s services 
could only offer free emergency contraception to women within a certain age range. This indicates 
that pharmacy staff also were not clear about the eligibility criteria for the Umbrella service.  
I think, I can t really clearly remember but I think the lady said that the, 
the Umbrella service is only for people from 16 to 21 or something, so 
she said an age group definitely.  Then I wasn t in that age group, I was 
older than that 'cause I m, I m 27 now and I think I went, when I went I 
was, like, 26.  Yeah, so she said it s only for people that are 16 to 21, 
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something like that.  [Pharmacy user, female, age group: 25-29, ID 
number:1092] 
Further, pharmacy users described difficulties when trying to find out whether a certain Umbrella 
pharmacy was providing the service that they were interested in. Some users reported that it was 
difficult to find out on Umbrella s website which pharmacies offered which services.  
They also stated that they had difficulties reaching the pharmacies by phone and finding a 
pharmacy that had a trained pharmacist and offered the service:  
When I looked on the website it listed the, the ones that did have the 
Umbrella service, or that they offered the Umbrella, so I literally rang, 
rang them all, 'cause it was on a, I think it was like Sunday morning at 
like ten o clock or something, like, so I had to wait for opening times.  
But either they didn't answer or some of them said, Oh no,  they, like, 
they have to have a particular pharmacist or something.  [Pharmacy 
user, female, age group: 18-24, ID number:1027] 
Outdated information on the website also negatively impacted pharmacies  accessibility:  
Yes, because some of the pharmacies that are listed on the website, 
it s quite dated, so I gave a few a call and they said they no longer supply 
that, the Umbrella services, but those websites are still ... those 
pharmacies are still on the website. [Pharmacy user, female, age group: 
18-24, ID number 1017] 
That pharmacy users were calling in advance to make sure that there was a trained pharmacist 
available was noted by many pharmacy staff:  
No, it's just that usually we d get a phone call beforehand and they d 
ask you if you're … able to provide it and they ve already tried maybe 
another pharmacy and they're coming from a, a distance, so they want 
to make sure that the pharmacist is actually available to provide the 
service.  [Pharmacist, female, age group: <30, ID number 47] 
In summary, pharmacy staff and users felt that people were not aware of the range of services 
available due to a perceived lack of advertising. There was also confusion about who can access 
a service amongst both users and staff, creating a barrier to service in some cases. Finally, the 
available information (such as on the Umbrella website) was found to be incomplete and outdated 
by some users. 
Clinic support for pharmacies  
Pharmacy staff sometimes found themselves in difficult situations, such as pharmacy users 
repeatedly requesting services: 
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I ve had women come to me saying that they ve had sexual intercourse 
probably every single day for the past month and not had any regular 
contraception and they re not too sure whether they could be pregnant 
but they don t think they are.  
I ve had people had come in every day asking me for emergency 
contraception when I ve just supplied it the day before or the day prior 
to that, which again makes me feel a little bit uncomfortable.  And then 
I ve had patients who I know that are drug addicts coming in asking me 
for the morning after pill, which again makes me feel a little bit 
uncomfortable.  [Pharmacist, female, age group: <30, ID number 6] 
When unsure ho  o e pond o a pha mac  e s request, pharmacy staff used Umbrella s 
Clinical Advice Line. While pharmacy staff appreciated that the Clinical Advice Line was available, 
some pharmacy staff experienced difficulties to getting through to the support team:  
And another thing as well, have more people at the Clinical Help Desk 
as well, because I know from, I haven't had to call the Clinical Help Desk, 
but I know from colleagues that have rang, sometimes it s really difficult 
to get through to the Clinical Help Desk. And, especially on weekends, 
it can be really, really difficult to get through as well, and especially when 
you're not sure what to do in this situation, you need some guidance 
and the customer s waiting as well, it can be really, really frustrating.  So 
that might be something else as well.  [Pharmacist, male, age group: 
<30, ID number 24] 
Furthermore, staff stated Umbrella s support team could not always help and it was then up to 
pharmacy staff judgement to decide what to do; which was experienced as difficult for some 
pharmacists. While pharmacists felt that they were generally well trained, they were aware that 
they could not help every person presenting for a sexual and reproductive health concern. More 
complex clinical cases or pharmacy users presenting with STI symptoms needed to be referred:  
But when, when it comes to sexual health, the private part, I think that s 
when we tend to go, We re not trained to look at this, so you need to 
go to get some specialist help.  Go to your doctor or go to a clinic.  
[Pharmacist, female, age group: <30, ID number:6] 
At one sexual health clinic (Whittall Street Clinic) in Birmingham, pharmacy staff can schedule 
copper coil appointments for those women presenting to prevent unwanted pregnancy after 
unprotected intercourse. However, pharmacy staff stated that there were not sufficient 
appointments available for copper coil fittings and if they were available the appointment times 
were not always convenient for pharmacy users:  
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That s, 'cause when, we had one, for example, on, for example, on 
doing an STI initiation one on trying to provide someone with a STI kit, 
and one of the, when they answer one of the questions and they 
mention they have symptoms, it says, It s best for them to see someone 
at the Umbrella clinic straight away.  
So then I've gotta go on the computer and try and get them an 
appointment, and it s so difficult to ... find them an appointment, to the 
point where I'll be weeks away.  So that s another difficulty I face as well, 
just trying to get them an appointment at one of the Umbrella clinics.  
[Pharmacist, male, age group: <30, ID number: 24] 
Not having sufficient or convenient clinical appointments for pharmacy users created a barrier to 
service delivery in some cases. 
Pharmacists also commented on the appointment process and felt that it would be more practical 
if they could access the appointment system directly rather than having to call the clinic to 
schedule an appointment every time:  
I think maybe more appointments, or some kind of system where we 
can add an, add an appointment on, or something like that.  
[Pharmacist, female, age group: 30-39, ID number: 71] 
In summary, pharmacists felt that they did not get sufficient clinical support. They found that the 
clinical advice line was not always available and that a lack of clinical appointments created a 
barrier for women presenting for the copper coil.  
Ease of use of STI self-sampling kits  
Pharmacy users were satisfied with most Umbrella services.  
However, many pharmacy users expressed difficulties in conducting the blood test for the STI 
self-sampling kits: 
To be honest, it s just that I really found it hard to fill the tube up. So 
my blood stopped after just a couple of pushes. I had to use, like, all the 
pricks.  [Pharmacy user, female, age group: 18-24, ID number: 1093] 
Some people who were given a STI self-sampling kit in the pharmacy did not end up completing 
the samples because they felt they could not do it:  
The blood thing in the home testing, you have to, like, prick your finger 
then squeeze it to get the blood out …. and I just can t do it.  [Pharmacy 
user, female, age group: 25-29, ID number: 1049] 
Some users felt that not sufficient lancets were provided in the STI self-sampling kit:  
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It s awful, they don t put enough ... is it ... not lanyards (?) ... they don t 
put enough of the ... oh, what are those things called that you prick the 
finger with? They, they put three in there ... that s not enough.  
[Pharmacy user, female, age group: 18-24, ID number 1017] 
Due to these difficulties, several users stated that they preferred having the STI testing done by a 
healthcare professional in a clinic.  
Other than the blood test, one dyslexic pharmacy user stated having problems with the 
instructions for the STI self-sampling kit, and felt that clearer instructions and labelling would make 
the STI self-sampling kit easier to use:  
There s text in it…so with me I confuse which is which, because I don t 
understand what I m doing. And I don't know which one I m doing 
where, and what I m doing which, though.  If they specified that a little 
bit more better, then I might be able to continue using that service.  
[Pharmacy user, transgender woman, age group: 25-29, ID number: 
1023] 
Pharmacy staff were aware that users had difficulties with the blood test and felt that they could 
assist pharmacy users with it:  
But when it comes to, like, swabs and finger prick tests and that kind 
of thing, that s traditionally only done by kind of a healthcare 
professional. So I think they don t want to take that on themselves, they 
want someone else to do that for them.  Which I think a pharmacist is 
ideally placed to do so.  [Pharmacist, female, age group: <30, ID 
number: 6] 
This idea was supported by pharmacy users. 
Yeah, if, I think if you could train a pharmacist to give blood tests and 
then they d do it then it would be fine.  [Pharmacy user, female, age 
group: 25-29, ID number 1049] 
In summary, the blood test which is part of the STI self-sampling kits was found to be not feasible 
by many pharmacy users. Pharmacy staff and users felt that pharmacy staff could support 
pharmacy users with taking the blood sample in the pharmacy. 
8.4.4. Impact of delivering SRHS on pharmacy staff 
Three subthemes relating to the impact of delivering SRHS on pharmacy staff were identified: 
Impact on workload, staff motivation to deliver services and recognition for delivering services. 
PhD Thesis | Interview Study Results and Discussion | Julia Gauly 
142 
 
Impact on workload  
There was consensus amongst pharmacy staff that the consultation and recording of Umbrella  
services added workload. Some, but not all pharmacists, expressed that high workload was a 
burden and stressful. 
Linking back to the section Collection and use of personal information , some pharmacy staff 
members felt that the consultation was lengthy due to the data that had to be collected on 
pharmacy users. One pharmacist felt that one solution would be for pharmacy users to pre-
register themselves, which would not only speed up the consultation but also allow staff to use 
the consultation time o iden if  pha mac  e  need :  
And so if it could speed up the process of having them pre-registered 
on the system then that would cut the consultation down in half.  And 
then I could spend longer then actually, like I said, identifying maybe the 
patient s unknown needs rather than just the immediate concern.  
[Pharmacist, male, age group: 30-39, ID number: 86] 
One pharmacist also negatively commented on the complexity of the data collection on STI self-
sampling kits.   
The, the STI kits are ... going on the Umbrella website, logging in doing 
this, doing that, it s such a longwinded process. I think, I think in that 
way I think that could be made a lot less complex than what it is.  I mean 
I generally struggle because it s just such a longwinded process and I 
think there s no need for this. [Pharmacist, female, age group: <30, ID 
number: 6] 
Several pharmacists also felt that it took too much time to provide users with condoms:  
It takes five or ten minutes just to get condoms .... because we re 
asking for your name, your date of birth, where you live, whether you re 
allergic to latex ... did you put the leaflet in the bag?  Did you offer them 
this advice?  It s, it s, it s a bit much. [Pharmacist, male, age group: 30-
39, ID number:86] 
Pharmacy healthcare assistants can provide condoms and STI self-sampling kits to pharmacy 
users. As part of the service delivery they have to collect information on the pharmacy user using 
paper forms. Pharmacists are then required to enter the data collected by pharmacy healthcare 
assistants onto the web-based system PharmOutcomes®. Pharmacy staff described that having 
to enter the data collected by pharmacy healthcare assistants on PharmOutcomes® duplicated 
work and pharmacists stated that they sometimes needed to stay late in the pharmacy to complete 
this task:  
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I do feel the time pressure, yeah, yeah.  And sometimes also you d 
obviously have to stay late, then, won t you, to enter in the data and 
things like that, which I don t mind.  It s fine, but I think sometimes it can 
be an issue.  [Pharmacist, female, age group: 30-39, ID number 71] 
These pharmacists felt it would be more effective if pharmacy healthcare assistants could enter 
their data on the system themselves and pharmacists only had to check and sign off their data 
entries:  
I think that ll be a lot easier. That will save a lot of time for us as well.  
[Pharmacist, male, age group: <30, ID number: 24] 
Pharmacy healthcare assistants were also supportive of this idea:  
As long as the pharmacist has seen that, I don t see no problem 
whatsoever with us putting that data in.  [Pharmacy healthcare 
assistant, female, age group: >50, ID number: 567] 
In some pharmacies pharmacy healthcare assistants already entered data on the web-based 
system PharmOutcomes®, although they were not supposed to do this, to take pressure off the 
pharmacist:  
I mean, like we used to, to be honest.  We, we used to, when the 
pharmacist was in ... we would just say, Oh,  you know, we ve done 
this service.  Can we put it on PharmOutcomes?   The pharmacist 
would be, Yes,  you know. Yeah, that s fine.  Just go in and put it on.   
But again, I asked the question on the training.  And then I can t 
remember what her name was, but she said, It s probably best for the 
pharmacist to do it, cause it is under their registration number.  
[Pharmacy healthcare assistant, female, age group: 30-39, ID number: 
497] 
Some pharmacists stated that they faced time pressure. This was because the Umbrella service 
was only one of the jobs that they needed to manage:   
The only thing is sometimes it can be a little bit difficult with the time 
constraints, because obviously, you know, if we ve got ten different 
people waiting for prescriptions or consultations or you know, whatever, 
it can be a little bit difficult timewise.  [Pharmacist, female, age group: 
30-39, ID number: 71] 
Pharmacists described that they often had to multitask to complete all their different jobs:  
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But again like same thing, when, if I m in a Tier 2 pharmacy and they 
want an STI kit and then I get them to fill out the questions.  But 
obviously that s all confidential, I don t need to see that, so while they re 
filling out the questions for their free STI kit they should be eligible for, 
that s when again I just pop out.  So I just do my best really to try and 
multitask. [Pharmacist, male, age group: 40-49, ID number: 84] 
Pharmacy users negatively commented on pharmacists multitasking during consultations, as they 
did no  ha e he pha maci  f ll a en ion.  
I m there and then the phone goes, obviously he answers the phone.  
And then someone comes in cause they need a prescription, then he 
sorts that out, and I, I was just there for ages. And I was just thinking, 
So, can you just sort me out because I would really like to go back to 
my child.  [Pharmacy user, female, age group: 25-29, ID number: 1082] 
Pharmacy staff felt that workload was sometimes an issue because of low levels of staff:  
Especially if you re short staffed, for example, and a lot of people need 
your attention at the same time. Yeah, so that, that would be the, one of 
the most difficult things.  [Pharmacist, male, age group: <30, ID number: 
31] 
Pharmacists described that it was problematic if there was only one pharmacy healthcare 
assistant and one pharmacist in the store when someone presented for an Umbrella service:  
I think staffing is definitely an issue because if there s not much staff, I 
mean, for example, like, if it s just me and a counter staff and there s 
somebody coming for Umbrella, that means that I will have to obviously 
leave the main area of the pharmacy and be in the consultation room. 
So that s not always practical when there s more customers coming in, 
all that kind of thing, so I guess, yeah, staffing issues are definitely one.  
[Pharmacist, female, age group: <30, ID number: 47] 
It was reported as even more difficult for pharmacists who were alone in the pharmacy when 
someone attended for an Umbrella service because there was no one to look after the counter: 
Because, as a single pharmacist, sometimes, you find that it s very 
difficult to fit a consultation in.  For example, because I ve got a 
Dispenser, she ll work 37 and a half hours a week, so ..... she ll come in, 
for example, at half ten, she ll finish at seven.  But my pharmacy s open 
from nine til eight.  
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So if I get a customer, for example, coming in after seven o clock, when 
my Dispenser s gone, so I m by myself in the pharmacy at that ... time, 
that probably is the main challenge, trying to do that consultation. 
[Pharmacist, male, age group: <30, ID number: 24] 
Pharmacists felt that having more staff would be helpful but were aware that this was not possible 
due to financial reasons. One pharmacist said that he would ask the manager to come in the 
pharmacy if such a situation arose.  
Pharmacy staff were aware that there was no money to hire more pharmacy healthcare assistants:  
I think it s difficult to do, unless we get more dispensing staff, but this 
pharmacy might say, Well, we don t have the money for that . 
[Pharmacist, male, age group: <30, ID number: 24] 
Low levels of staffing were also a reason why some pharmacies could not deliver the larger range 
of pharmacy services ( Tier 2  e ice le el):  
But we re not staffed to a great level.  This is why ... somebody s always 
asked me, Why aren t you a Level, Tier 2 pharmacy?  and I tell them, 
It s because I, I couldn t just, I, I, I can t, I couldn t do that service in my 
pharmacy.  It ll take too much, there s too much time pressure and 
staffing pressures on, on my, on my staff that I wouldn t be able to run 
a Level 2 service, or Tier 2 service.   I have an interest in, in doing that.  
[Pharmacist, male, age group: 30-39, ID number: 86] 
Some pharmacists felt that shifting the workload to pharmacy healthcare assistants could help to 
take pressure off the pharmacist:  
I think, the only thing I can think of is, in community pharmacy, it can 
sometimes be obviously, a, a, a burden on pharmacists in terms of 
dealing with the service, taking the time out to, kind of, do a consultation, 
so I think if that kind of workload was a bit shifted onto other members 
of staff, that might be quite good.  [Pharmacist, female, age group:<30, 
ID number: 47] 
However, others felt it would not have a big impact because there were some parts of the role 
that had to be done by the pharmacist:  
It, it would, it would help a little bit more, but some things really do just 
need my attention only, as opposed to support staff.  [Pharmacist, male, 
age group: <30, ID number: 31] 
Moreover, some pharmacists were concerned that pharmacy healthcare assistants were not paid 
enough or not qualified enough to provide more complex services.  
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However, when pharmacy healthcare assistants were asked how they would feel about providing 
more services, most pharmacy healthcare assistants tended to be willing to take on a bigger role:  
But, like, say for example if we were allowed to do, like, the morning 
after pill, then, you know, we, we would happily do it.  [Pharmacy 
healthcare assistant, female, age group: 30-39, ID number: 497] 
With regards to the range of services offered, some pharmacists felt that it would not be feasible 
for them to offer more services, indicating that they were working already at their limit:  
So, I mean, offering a, a ten, 15 minute consultation is, is not a problem 
when it s a bit quieter but then if there were more, if there were another 
range of services, it might not always be practical, that s the only 
downfall.  [Pharmacist, female, age group, <30, ID number: 47] 
Some pharmacists felt that the nature of a pharmacy as walk-in service was challenging as 
consultations could not be planned in advance. These pharmacists were therefore supportive of 
introducing an appointment system:  
Well I think it would be great to, sort of, have a place where certain 
bookings were made, maybe, so it could be a more controlled process 
and it wasn t just that people are coming up on the day and saying that, 
We need to, you know, have this one (…) So, yeah, you know, like how 
they do in Umbrella clinics and they have to book appointments, so say 
if you want your contraception pill or you want your Sayana Press, you 
can just book in and then we ll, we can sort that out for you.  
[Pharmacist, female, age group:<30, ID number: 47] 
Workload did not appear to be dependent on whether pharmacists were working in a Tier 1  or 
Tier 2  pharmacy. Instead, workload issues were associated with the level of staff that pharmacists 
had available.  
In summary, added individual workload was an issue for some but not all pharmacy staff. 
Pharmacists were more affected by workload than pharmacy healthcare assistants. Integrating 
the workload caused through the delivery of sexual and reproductive health services into all other 
tasks, and low staffing levels were reported as challenging and stressful for pharmacy staff.  
Staff motivation to deliver services  
Pharmacy staff were generally highly motivated to provide Umbrella  e ice  and were overall 
positive about Umbrella:  
Well, with me, with me, I've often thought that with such a good service, 
Umbrella service is really good.  [Pharmacist, male, age group: 30-39, 
ID number: 86] 
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Pharmacy staff enjoyed taking on a bigger role through the provision of sexual and reproductive 
health services and many felt that their extended role increased their job satisfaction:  
Oh yeah, I do, I do definitely feel like it s improved my job satisfaction 
and just made me more clinically in check and just, just to basically have 
just more of a clinical responsibility for patients upfront, which is nice to 
have a consultation with them, and yeah, I think we re just, just providing 
a more meaningful service.  Yeah.  [Pharmacist, age group: <30, ID 
number: 96] 
Further, many pharmacy staff members stated that they were grateful to be able to help other 
people by offering the services:  
I think the best thing about delivering sexual health services is being 
able to be in the position to help somebody that is not happy about 
what s happened or maybe gets in an accident and they, they're quite 
worried, they're quite anxious, they don t know how to feel.  So when I 
see young women coming in like that asking for the emergency 
contraception pill, I do feel grateful that I'm in the position that I can 
encourage them and, kind of, reassure them that, It s okay.  You ve 
come in the right time.  You can actually have this pill, this will help you.  
And, you know, don t feel bad about your situation and you're gonna be 
absolutely fine. [Pharmacist, female, age group: <30, ID number: 47] 
Pharmacy staff were also found to be proud to be playing an important role and to take pressure 
off the healthcare system:  
And I think with providing the, kind of, condom distribution and things, 
it is also linked to whole, linked to STIs so, kind of, preventing unwanted 
pregnancies but then it s also preventing the spread of, like, sexually 
transmitted diseases. So ultimately, really, you re reducing the, kind of, 
strain of, on healthcare as well.  [Pharmacy healthcare assistant, 
female, age group: <30, ID number: 566] 
Both pharmacists and pharmacy staff also felt that the delivery of services increased their 
employability:  
I guess for me, personally, in offering the Umbrella services it does 
mean that you ll be more employable. So say if I went, so when I m an 
actual pharmacist, if I m locum-ing at, like, different pharmacies I guess 
the fact that you offer them services does, kind of, make you more 
employable to various pharmacies if you are trained in a number of 
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services. [Pharmacy healthcare assistant, female, age group: <30, ID 
number: 566] 
In summary, pharmacy staff were generally motivated to deliver pharmacy-based SRHS. 
Recognition for delivering services 
While pharmacy staff generally were motivated to deliver sexual and reproductive health services, 
many felt that they did not receive sufficient recognition for going beyond their traditional role.  
While pharmacists generally described that they were receiving a lot of recognition from 
pharmacy users, pharmacy healthcare assistants felt that they were not perceived by users as 
qualified healthcare providers:  
 I think when they come in, they just assume that, again, like I said with 
the, with the male figure working in the pharmacy, we re just a shop 
assistant or counter ... but, you know, so I think they, that s what 
happens a lot, cause we, we obviously, we take blood pressure as well 
and I say .... Oh, come on, I ll take your blood pressure,  cause I m 
quite ... and a lot of them are fine, but some of them sort of think, Oh,  
and they look and they expect (Pharmacist Name) to do it.  But this is 
the reason we get taken on these things, to free up (Pharmacist Name) s 
time.  You, do you know? And, yeah, I do think sometimes that the public 
don t realise that, not all of the staff within a pharmacy, but a majority of 
the staff within a pharmacy can do these things as well as a pharmacist. 
[Pharmacy healthcare assistant, female, age group: <50, ID number: 
593] 
In line with this, pharmacy users generally trusted pharmacists and felt they were qualified to 
provide the services they were offering. However, one user pointed out that the qualifications of 
the pharmacist hanging in the consultation room showed her that the pharmacist was qualified, 
possibly suggesting that the user needed to be ea ed of he pha maci  q alifica ion:  
They also have, like, all the certificates in there so you know, like, that 
your pharmacist s qualified.  [Pharmacy user, female, age group: 25-29, 
ID number: 1056] 
Pharmacy healthcare assistants reported feeling that pharmacy users trusted them less than 
pharmacists:  
Patients and customers don t see the pharmacy team as professionals, 
as they would the pharmacist.  So they ll trust more what the pharmacist 
is saying than the pharmacy advisor.   [Pharmacy healthcare assistant, 
female, age group: 30-39, ID number: 497] 
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However, pharmacy healthcare assistants felt that wearing an Umbrella name badge made users 
trust them more and made them more approachable:  
Because I ve got the name badge on, that sort of, like, breaks down the 
barrier that they, they re, I m approachable to for that information, so, 
because they, they know that I m aware of the, the things we can 
provide for them.  [Pharmacy healthcare assistant, male, age group:40-
49, ID number: 492] 
Overall, pharmacy healthcare assistants felt that they should get more recognition for what they 
were doing from pharmacy users:  
I mean we, we ve got access to all these records, to all, to, to lots of 
things, we re messing with controlled drugs all the time, we re obviously 
doing these services, especially the sexual health services as well.  So 
I do think, you know, yeah, there should be a bit more recognition, you 
know, but, and also for people that are, that are coming into the 
pharmacy and using the pharmacy, so, like I say, again, that they realise 
we re not just gonna take their blood pressure and not know what we re 
doing, or we re not gonna offer them a, a service and not know what 
we re doing.  I want them to be confident that they can come in to us 
and speak to us ...  [Pharmacy healthcare assistant, female, age group: 
<50, ID number: 593] 
Pharmacy healthcare assistants also felt that they should get some financial recognition for 
working outside their role:  
I guess the worst thing in general would be, kind of, there s not any 
real recognition for it.  You re offering these services but it s not 
reflected in, kind of, the pay.  [Pharmacy healthcare assistant, female, 
age group: <30, ID number: 566] 
However, pharmacy healthcare assistants did not expect to be paid for providing the services, but 
did feel that they should be reimbursed for the time they spent getting trained:  
Just for the training. If you re being trained then you ve got to commit, 
it s a part of the service, you know what I mean?  That's, that s my job, I 
don t feel like, that I should be personally given any more money 
because somebody is coming in, I ve give them the right information.  
That s part of my job.  [Pharmacy healthcare assistant, female, age 
group: >50, ID number: 567] 
More recognition was also something mentioned by pharmacists who felt that they were providing 
services but were not being asked for feedback about delivering the services:  
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But there, there isn't a real big feedback mechanism. Other than you 
talking to me today, I've not had the chance to speak to anybody about 
.... the services that we re able to offer 'cause they don t actually seek 
feedback from us.  They're only interested in feedback for the, the 
service users, not actually ... the providers of the services.  [Pharmacist, 
male, age group: 30-39, ID number: 86] 
And even those pharmacists who felt that they could give feedback in refresher trainings stated 
that they would like to be more involved in decisions regarding the delivery of sexual and 
reproductive health services:  
So, yeah, it would be nice, maybe, to get more chances to give our 
feedback and get more involved in the, kind of, service as well: how, 
what, kind of, for example, if they decide on providing new services, 
getting our, our opinions on it first, engaging with us as well, a bit more.  
So that s definitely something to improve on, I think.  It can feel like 
we re, we re far away from the, kind of, decision making process.  
[Pharmacist, male, age group: <30, ID number: 24] 
Not being asked for feedback was also something that pharmacy healthcare assistants identified:  
Because we ve never been asked for feedback.  I mean, we get 
mystery shopped.  But we don t really get asked, like, you know, what 
else could we possibly do to improve the services, or, you know, what 
do you think.  We don t really get asked that, to be honest.  [Pharmacy 
healthcare assistant, female, age group: 30-39, ID number: 497] 
However, one pharmacist stated that she believed that the annual awards, organised by Umbrella 
every September, would provide staff, and particularly pharmacy healthcare assistants, with 
recognition for their work:  
You know, that type of thing, or the counter staff can engage more 
'cause they feel that, Oh, at the end of it we are going to get a 
certificate, or an award, or something like that.   I think that, I think that s 
quite good.  [Pharmacist, female, age group: 30-39, ID number: 71] 
In summary, while pharmacists found that their efforts were recognised by pharmacy users, this 
was less the case for pharmacy healthcare assistants. Both pharmacists and pharmacy healthcare 
assistants lacked recognition by their health provider and felt that they should have more 
opportunity to provide feedback. Pharmacy healthcare assistants also wanted financial 
recognition for going beyond their role. Events were pharmacy staff efforts were acknowledged 
were positively perceived by pharmacy staff. 
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8.5. Interpretation of the results 
As outlined in section 2.6.4, Normalisation Process Theory (NPT) was used as a lens through 
which to interpret the findings from the qualitative study (C. R. May et al., 2009). As described in 
section 7.10, the findings from the thematic analysis were mapped onto the four NPT constructs: 
Coherence, Cognitive Participation, Collective Action, and Reflexive Monitoring where applicable. 
The NPT toolkit was used to support the process.  
Using NPT suggested that pharmacy-based SRHS have great potential but are not yet embedded 
into routine practice. The results of the NPT toolkit (C. May et al., 2015) are attached in Appendix 
12. Figure 11 illustrates which subthemes captured the four constructs of NPT. The results of the 
interpretation are now presented along the four NPT concepts. 
 
 
FIGURE 11 SUBTHEMES RELATING TO THE FOUR NPT CONSTRUCTS 
8.5.1. Coherence 
Coherence explored the findings in terms of whether people involved in the delivery of pharmacy-
based sexual and reproductive health services demonstrated understanding of its value, benefits 
and importance. It also looked at whether people involved in the provision of SRHS understand 
their specific tasks and responsibilities around a set of practices.  
Participants collectively agreed about the purpose of pharmacy-based SRHS and had a good 
understanding of the aims and objectives and expected benefits of the intervention. As captured 
under the subtheme Staff motivation to deliver services  pharmacy staff were aware that they 
were providing the services to help people, to take pressure off the healthcare system and to 
contribute to the prevention of STIs and unwanted pregnancies. 
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However, as the theme Need for Physical Privacy  showed, a few pharmacy healthcare assistants 
seemed not to have a strong understanding that discreteness was important when delivering 
sexual and reproductive health services to pharmacy users for reasons of privacy. Further, as 
shown in the sub-theme Awareness of pharmacy services , one pharmacy healthcare assistant 
was found not to be familiar with the criteria that pharmacy users had to fulfil in order to be allowed 
to access an Umbrella service.  
8.5.2. Cognitive Participation 
Cognitive participation explored whether people involved in the delivery of services appear to be 
driving its provision forward. In context of this study this could mean that staff engage with each 
other to deliver services or reorganise themselves in order to collectively contribute to the delivery 
of SRHS. Cognitive participation is also about whether people define actions and procedures to 
sustain a practice and to stay involved. This may involve rethinking individual and group 
relationships. Another important component of cognitive participation is whether other people 
involved in the delivery of pharmacy-based SRHS believed it is right for them to be involved.  
Pharmacy staff were reorganising themselves to contribute to the work involved in the delivery of 
SRHS. For example, as shown in the subtheme Sex of staff , male pharmacists involved female 
pharmacy healthcare assistants in the delivery of services. Female pharmacy healthcare 
assistants were asked to chaperone consultations with women and to convince women to conduct 
a consultation with a male pharmacist. By these strategies, pharmacy staff were driving pharmacy-
based sexual health services forward.  
Further, as shown in the subtheme motivation, pharmacy staff were supportive of the continuation 
of pharmacy-based SRHS and expressed that Umbrella is a great service. While pharmacists felt 
trusted by pharmacy users, pharmacy healthcare assistants sometimes felt that pharmacy users 
did not feel that it was appropriate for pharmacy healthcare assistants to be involved in the delivery 
of SRHS and that pharmacy users did not trust them as much as they trusted pharmacists. In 
terms of how this could be managed in the pharmacy, some pharmacy healthcare assistants felt 
that wearing an Umbrella badge inc ea ed pha mac  e   in hem and made hem mo e 
approachable.  
Although only two subthemes were identified to be relevant to cognitive participation, both were 
found to be highly relevant in the delivery of sexual and reproductive health services. Possibly, 
this area needs more depth in future studies. 
8.5.3. Collective Action 
Collective action explored how pharmacy-based SRHS appeared to have been operationalised in 
practice by pharmacy staff, whether the allocation of work seemed appropriate and whether they 
were sufficiently supported by their commissioner. 
As shown in the sub-theme Impact on workload , pharmacists generally felt that the workload was 
feasible.  
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However, some felt under pressure and found it difficult to manage the workload, especially where 
staffing levels were low. This indicates that services have not been fully normalised to become 
part of the routine pharmacy practice. However, none of the pharmacy staff interviewed indicated 
that work pressure would be a reason to discontinue delivering Umbrella s services. However, for 
ome pha maci  deli e ing Tie  1  e ice , o k p essure and lack of staff was a reason why 
he mo e e ended Tie  2  pha mac  e ice co ld no  be deli e ed.  
While some pharmacists found that the work allocated to pharmacy healthcare assistants was 
appropriate, others felt they could be more involved and take pressure off the pharmacist. That 
pha mac  heal hca e a i an  co ld no  collec  pha mac  e  da a electronically but had to 
collect it on paper forms, and that pharmacists had to enter the data later onto the web based 
system was perceived as an unnecessary duplication of work.  
Further, while pharmacy staff were overall satisfied with their commissioner, they sometimes felt 
not adequately supported. As covered in the sub-theme Clinic support for pharmacies , staff 
experienced difficulties getting through to the Clinical Help Line and making copper coil 
appointments at the clinic for users presenting for emergency contraception. Further, the 
subtheme Need for trained pharmacy staff  howed that sometimes not having a trained 
pharmacist available created a barrier to the delivery of pharmacy-based sexual and reproductive 
health services.  
As outlined in the subtheme Language and literacy  pharmacy staff had developed strategies to 
get information across to pharmacy users who did not understand English or were illiterate. They 
used Google Images and Google Translate to enable the delivery of pharmacy-based SRHS. 
However, this was not always successful. Arguably, if the pharmacy staff had translation services 
or documents available in different language by the health provider this would help them to deliver 
SRHS.  
8.5.4. Reflective Monitoring 
Reflective Monitoring described whether staff construed value in pharmacy-based SRHS within 
their work, whether they were informed about the effects of the services, whether they collectively 
and individually felt that delivering services is worthwhile. It also looked at whether practices 
relating to SRHS were modified. 
As described in the subtheme Staff motivation to deliver services , pharmacy healthcare 
assistants felt that offering the services had a positive impact on their employability and job 
satisfaction. However, staff felt that they did not receive feedback on the delivery of services by 
the health provider, limiting the degree to which they were informed about the effects of SRHS 
and their perceived recognition by the health provider.  
Finally, while pharmacy staff were doing most work required by them, they modified some of the 
tasks. For example, as presented in the subtheme Collection and use of personal information , 
one pha maci  a ed ha  he o ld no  collec  pha mac  e  name and add e e . 
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Further, as shown in the subtheme Impact on workload  some pharmacists allowed pharmacy 
healthcare assistants to enter data on PharmOutcomes® although they were not supposed to do 
this. 
To sum up, pharmacy staff appear to feel that their work related to the delivery of sexual and 
reproductive health services is not being sufficiently acknowledged by their health provider. 
Further, pharmacy staff are modifying tasks without communicating this to the health provider. 
Both lack of perceived recognition and modification of tasks may inhibit the quality and 
consistency that services are delivered with.  
  




8.6.1. Summary of the main findings 
In total, 30 interviews, 15 with pharmacy staff and 15 with pharmacy users were included in the 
analysis. Four themes and several subthemes were identified: 1. Pharmacy as a venue for SRHS 
(need for physical privacy; convenience; need for trained staff), 2. Staff-user interaction (sex of 
staff; staff interpersonal skills; collection and use of personal information; language and literacy), 
3. Implementing SRHS into pharmacies (awareness of pharmacy services; clinic support for 
pharmacies; ease of use of STI self-sampling kits); 4. Impact of delivering SRHS on pharmacy staff 
(impact on workload; staff motivation to deliver services; recognition for delivering services). 
Convenience was commonly named as a valuable feature of pharmacies. Users liked that 
pharmacies were easy to get to and that no appointments needed to be scheduled. However, not 
always having trained staff available was found to be a disadvantage of pharmacies as a venue 
for SRHS. Pharmacy staff were aware that physical privacy, defined as not being able to be 
overheard or overseen presenting for a SRHS, was important to users. The need for physical 
privacy was caused by fear of stigmatisation by staff and other users being present in the 
pharmacy. While physical privacy was largely well addressed through consultation rooms during 
the service delivery, there was a lack of privacy when requesting SRHS at the counter. The 
busyness of the pharmacy, the physical layout of the pharmacy and pharmacy staff discretion 
impacted the level of privacy experienced by service users.  
With regards to the staff-user interaction, pharmacy users were largely satisfied with pharmacy 
staff interpersonal skills. However, where pharmacy staff were being less confident in the service 
deli e , j dgemen al o  no  e pec f l of e  choice , pharmacy users had a more negative 
experience. A difficulty for pharmacy staff was to deliver services to users who were not fluent in 
English or who were illiterate. Same sex delivery was found to be important to some users. 
However, preferences were not straightforward and could not be presumed. In one case, the 
p efe ence eemed o be ela ed o he pha mac  e  exuality. For some users, not having a 
pharmacy staff member of a certain sex was a barrier to service delivery. Personal information 
privacy was a concern for pharmacy users, and some felt that the data collection should be as 
anonymous as possible. However, other participants felt that patient data should be shared 
between pharmacies and other health providers to save them repeating the information after a 
prior visit to an Umbrella service. 
Delivering SRHS had an impact on pharmacy staff workload and their motivation. The consultation 
which included the collection of data on pharmacy users was time consuming and added to 
pha maci  o kload. Ha ing pha mac  e  p e-register themselves was mentioned as a 
possible solution to minimise the added workload. While staff were largely motivated to deliver 
SRHS, some staff, and pharmacy healthcare assistants in particular, felt that they did not receive 
sufficient recognition for their role.  
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With regards to the implementation of pharmacy-based SRHS, pharmacy staff and users felt that 
there was not sufficient awareness for pharmacy services and pharmacy users experienced 
difficulties finding out where they could obtain Umbrella  pha mac  e ice . Further, pharmacy 
staff felt that there was not sufficient support from clinics as they reported a lack of clinical 
appointments for the copper coil and difficulties to get through the clinical advice line. With 
regards to the services provided, many pharmacy users experienced difficulties conducting the 
STI self-sampling kits, particularly the blood test, and participants felt that it would be beneficial if 
pharmacy staff could provide support for the blood test.  
Interpreting the findings using the four constructs of NPT showed that there were several factors 
that required development, suggesting that pharmacy-based SRHS are not yet fully integrated 
into routine practice. Although pharmacy staff collectively agreed about the purpose of the 
intervention, some pharmacy healthcare assistants had a limited understanding of who is eligible 
for the services and how important it is to be discreet when delivering services. Pharmacy staff 
were driving the delivery of services proactively. However, some pharmacy staff, and pharmacy 
healthcare assistants in particular, did not feel trusted by pharmacy users. Further, pharmacy staff 
sometimes felt that they did not get sufficient support from collaborating clinics and lacked staff 
resources. Although the delivery of services was generally perceived as feasible, pharmacy staff 
felt that work allocation was not optimised. This indicates that there is potential to further improve 
pharmacy-based SRHS. Finally, staff considered the delivery of services to be valuable; however, 
they sometimes modified the tasks where they felt appropriate.  
8.6.2. Strengths and Limitations of the Interview Study 
A strength of this study is the rigorous manner in which it was conducted. A purposive approach 
to sampling was used and the topic guide for this study informed by a systematic review and 
experts in the area. To increase the rigour of the data analysis, 30% of transcripts were coded by 
more than one researcher. Further, the coding frameworks, themes and the interpretation by NPT 
was discussed amongst four researchers and the contrasting perspectives of the different 
researchers involved were considered as a strength of the study.  
A major strength of the study was that three participant groups: pharmacists, pharmacy healthcare 
assistants and pharmacy users were interviewed. Interviewing three groups involved in the 
delivery of sexual health services allowed a multi-perspective insight into pharmacy-based sexual 
health services. This study is also one of few that included the experiences of pharmacy 
healthcare assistants.  
Given that interviews were exclusively conducted with pharmacy staff and pharmacy users from 
Birmingham (West Midlands), it has to be acknowledged that some interview study findings may 
be more transferrable to other areas across the UK and beyond than others. 
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For example, language and communications barriers may also be a concern in areas with 
compa able o  high p opo ion  of people ho don  peak he local lang age b  be le  of a 
barrier in areas with lower proportions of people who are not native in the local language. Further, 
some problems regarding the service delivery, for example a lack of appointments for the copper 
IUD, may be unique to the way that services are delivered by the health provider Umbrella in 
Birmingham. However, other findings are likely to be transferrable to other areas, for example 
concerns around privacy and pharmacy workload. 
Data saturation was achieved for both pharmacy staff and pharmacy users, and clear themes were 
identified. However, no pharmacy users under the age of 21 and over the age of 34 years and no 
people f om o he  e hnic g o p  e e ec i ed fo  in e ie . F rther, while women from a large 
range of ethnic groups were interviewed, only one male who self-identified as Asian/Asian British 
and one male who identified as Mixed/Multiple ethnic group could be interviewed. Considering 
the results from the retrospective study, which showed that a range of patients with different 
demographics use Umbrella s pharmacy-based SRHS; the comparatively limited demographics 
of those interviewed in this study may indicate that certain demographic groups were more 
difficult to reach for involvement in this research. Since online recruitment was mainly used to 
recruit users, it could be that younger demographics were more successfully targeted by the 
recruitment material. However, as the retrospective study showed, younger people were also 
more likely to access pharmacy-based SRHS. Possibly, fewer men participated in the study as 
they did not want to talk to a female researcher about SRHS. However, as the retrospective 
quantitative study showed (see chapter 4), the males were generally less likely to access the 
pharmacy for sexual and reproductive health services. Further, while many females who had used 
the emergency contraception were interested in taking part in a study, it was more difficult to 
recruit users of other services such as for example the contraceptive injection. However, as the 
retrospective quantitative study showed (see chapter 4), emergency contraception is the most 
used Umbrella service. It is also likely that only the more confident pharmacy users might have 
been willing to take part in an interview. Further, as explained in the method section, under 16-
year olds, people lacking consent and people with communication needs were excluded from the 
study for several reasons.  
It cannot be ruled out that groups of people who were not interviewed in this study would have 
had different views or would have led to different finding.  
Another limitation is that non-pharmacy service users and non-pharmacy service providers were 
not included in the study. Including these groups may have enabled an understanding of the 
barriers to the uptake of pharmacy-based sexual and reproductive health services.  
Considering views of the healthcare professionals and the population who are eligible to access 
the service, rather than those who had access or were delivering services should be considered 
in future research.  
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As the systematic review showed (see chapter 6), this was only the second high-quality qualitative 
study on pharmacy based SRHS in England. However, it was the first study to date to explore a 
large range of pharmacy-based sexual and reproductive health services and this opportunity was 
unique to Birmingham, where the health service Umbrella provides various SRHS through 
pharmacies. The use of NPT in interpreting the findings of the interview study is a strength. NPT 
has been shown to be important in understanding the potential of embedding and integrating 
complex interventions. The interpretation of the qualitative findings showed that pharmacy-based 
SRHS are not fully integrated in pharmacy practice yet. For example, pharmacy staff felt under 
time pressure and found it difficult to manage the workload. However, NPT also highlighted 
aspects that contribute to normalisation of services. For example, it highlighted that pharmacy 
heal hca e a i an  ea ing an Umb ella badge ma  inc ea e pha mac  e   in hem.  
However, the application of the constructs of the NPT to the findings of the interview study is 
subjective. In order to limit this subjectivity of the application of NPT, the findings and 
interpretation was discussed within the research team.  
While p ima  da a on e  and aff e pe iences of pharmacy-based SRHS were only collected 
through the interview study, it may have been insightful to also conduct a survey of pharmacy 
e  and aff e pe ience , and iang la e he finding  i h da a f om he in e ie  d . In 
hindsight, demographic information could have been collected at the end of the survey and this 
information used to sample participants using maximum variation sampling. The interview study, 
ho e e , can info m f e e  on e  and aff e pe ience  ac o  a ide  geographical 
area and in larger samples. 
8.6.3. Comparisons with the existing literature 
In line with our systematic review, convenience was commonly named as reason why pharmacy 
users had accessed the pharmacy (Gauly et al., 2019). Amongst others, pharmacy users liked 
that they did not have to travel far to get to the pharmacy. As shown in previous research 
geographical proximity and long opening hours were aspects that mattered to pharmacy users 
the most (Watson et al., 2019). According to digital NHS data, there are more than 11,500 
pharmacies in England in 2018/2019, which is an 9.8% increase since 2008/2009 (NHS Digital, 
2020), suggesting that pharmacies have become even more physically accessible over the years. 
However, several issues and areas for improvement were identified.  
Stigma was identified as a reason why privacy was highly important to pharmacy users. Some 
pharmacy users reported that they did not want to be recognised by staff or users in the pharmacy.  
In line with this a recent systematic review on emergency contraception found that users did not 
want to use pharmacies where they knew the pharmacy staff or may run into someone they knew 
(Mooney-Somers et al., 2019).  
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While most pharmacy users felt that private consultation rooms were providing sufficient privacy 
during the service delivery, one pharmacy user found that the consultation room was not 
soundproof which limited the perceived level of privacy. That privacy issues can remain even 
when using private consultation rooms was also found in a previous study (Dhital et al., 2010). 
Further, the interviews conducted showed that privacy when requesting a service was a major 
concern for pharmacy users and that staff were aware of this. Pharmacy users stated that the 
busyness of the pharmacy and the layout of the pharmacy (e.g. queuing system; location of 
counter) impacted pharmacy users  experience of privacy. In line with this, a recent study on 
pharmacy-based opioid substitution treatment showed that the pharmacy layout could enhance 
or hinder the perceived level of privacy of pharmacy users (Le & Braunack-Mayer, 2019). Physical 
privacy in the pharmacy was also found to be a concern in a study on the utilisation of community 
pharmacy space to enhance privacy (H. Laetitia Hattingh et al., 2016). This study concluded that 
pha macie  la o  and em  o add e  p i ac  needed o be explored in the future (H. Laetitia 
Hattingh et al., 2016).  
Lack of trained staff was a concern for pharmacy staff and pharmacy healthcare assistants in 
particular and sometimes created a barrier to service access. Pharmacy staff stated that locums 
were sometimes untrained. Previous studies showed that locums did not get trained for extended 
sexual and reproductive health services due to difficulties accessing trained or working only little 
in the pharmacy (Braund et al., 2018; G. Thomas et al., 2009).  
With regards to interpersonal skills of pharmacy staff it was found that it was important to 
pharmacy users that their choices were respected, and that staff were confident and non-
judgemental. That perceived judgement negatively impacts the experience of users was also 
shown in a previous review on emergency contraception (Mooney-Somers et al., 2019). 
Respecting patient preferences has been found to be an important part of a patient-centred 
healthcare model (Elwyn et al., 2014) and workforce confidence in the patient experience has 
been linked to a positive patient experience (Owens & Keller, 2018). Further, a recent survey with 
the public showed that people would be more likely to use community pharmacy services if 
pharmacy staff had strong interpersonal skills (Ali Mawfek Khaled Hindi et al., 2019). This 
highlights the importance of staff interpersonal skills on the delivery and impact of pharmacy-
based SRHS.  
Many pharmacy users in this study expressed that they had preferences regarding the sex of 
pharmacy staff. Same sex delivery of pharmacy-based services appeared to be highly important, 
particularly to females. However, one male pharmacy user stated that he preferred to be delivered 
a service by female pharmacy staff as he was attracted to males. In line with this, research 
conducted by Poria and colleagues (2019) has shown also shown that participants relate their 
preferences to their sexuality. 
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However, in their study, preferences were related to situations where health care professionals 
would be required to conduct an examination of intimate areas of the body (Poria et al., 2019). 
Lesbian and gay participants stated that they preferred health care professionals of the opposite 
gender because they felt that heterosexual women were less friendly to lesbians and heterosexual 
males less friendly to gay men (Poria et al., 2019). Our study showed that gender preferences 
were not straightforward but that they were important to pharmacy users, even in situations where 
no physical examination but only consultations took place. It was suggested that there should be 
more transparency on whether female or male pharmacy staff are working at the pharmacy. 
Pharmacy staff in this study described that it was difficult to deliver SRHS to pharmacy users who 
were not fluent in English or who were illiterate. Some pharmacy users had to be referred to the 
sexual health clinic (Whittall Street Clinic) in Birmingham because of language barriers. Language 
barriers adversely affect patients in their comprehension and adherence, quality of care and 
patient and provider satisfaction (Schwei et al., 2016). Over the last decade, there have been 
growing numbers of immigrants in the UK, coming from more diverse backgrounds than ever 
before (Somerville, 2009); this is likely to increase the incidence of language barriers. A study 
from America showed that almost half of pharmacists were dissatisfied with their communication 
with pharmacy users with limited English proficiency but that community pharmacies using 
telephone interpreting services were more likely to be able to verbally communicate in non-
English languages (Bradshaw et al., 2007). Language barriers were also identified to be a concern 
in an A alian d  on pha maci  e pe ience of he concep  of c l e  in hei  e e da  
practice environment (Fejzic & Barker, 2019). Hence, language barriers can negatively impact the 
delivery of pharmacy service.  
Pharmacy staff collectively agreed that the delivery of services added workload through the 
consultation time and data collection. It was suggested that allowing pharmacy users to pre-
register themselves would save time. With regards to the collection of personal information, this 
study found that it made many pharmacy users uncomfortable and that data privacy was a major 
concern for many. However, some pharmacy staff and pharmacy users felt that data should be 
shared with clinics. This is supported by a systematic review on extended pharmacy services, 
where not having access to patients records was perceived as a barrier to providing extended 
services (Ali M.K. Hindi et al., 2019). Access to health records was also deemed to be important 
to make patient care decisions in a recent study (Famiyeh et al., 2019). Concerns about time 
constraint  e e al o iden ified in a d  on pha maci  a i de  o a d  he implemen a ion 
of pharmacy based SRHS (Hilverding & Mager, 2017) and various further studies on pharmacy-
based SRHS (Deeks et al., 2014; Gudka et al., 2009, 2014; Hussainy et al., 2011; Parker et al., 
2015; Whelan et al., 2013). This study also showed that it was difficult to deliver sexual and 
reproductive health services, particularly when pharmacies had staffing difficulties, for example 
when pharmacists were alone in the pharmacy. 
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Lack of staffing to cover other pharmacist responsibilities while the consultation was occurring 
was also found to be an issue in a previous study (Whelan et al., 2013).  
Overall pharmacy staff in this study were motivated to deliver sexual and reproductive health 
services. However, some pharmacy staff and pharmacy healthcare assistants in particular, felt 
that they did not receive sufficient recognition for working outside their traditional role. It also 
emerged that both pharmacists and pharmacy healthcare assistants wanted to be asked for their 
feedback by the health providers and be more involved in decisions on pharmacy-based SRHS. 
Pharmacy staff also wanted financial recognition for their extended role. This finding is supported 
by a recent review on extended pharmacy services (Ali M.K. Hindi et al., 2019). Hence, a perceived 
lack of financial recognition is not unique for SRHS but extended pharmacy services in general.  
Both pharmacy users and pharmacy staff in the current study felt that there was not sufficient 
awareness of pharmacy services. In line with this, a recent systematic review on patient and public 
perspectives of pharmacies in the UK showed that public or patient awareness of extended 
pharmacy services was low (Ali M.K. Hindi et al., 2018). Hence, while this study is not the first to 
show that extended pharmacy services lack public awareness, it is the first to show that this is 
true for a large range of SRHS.  
Pharmacy users in this study reported that they had difficulties completing the blood test which is 
part of the STI self-sampling kits. Difficulty in drawing the blood sample was also the most 
commonly reported reason for not returning HIV self-sampling kits in another UK study (L. J. 
Brown et al., 2018). However, a Dutch study in which dried blood spot testing was used to screen 
for syphilis, HIV and hepatitis B showed that the majority of participants found the finger-prick test 
easy to complete (van Loo et al., 2017). This suggests that the collection of blood samples is 
generally feasible if a user-friendly self-sampling kit is provided.  
While a previous study showed that many pharmacists did not know where women could get a 
copper coil inserted (Wong et al., 2017), Umbrella offers a clear pathway for women. However, 
pharmacy staff felt that there were not sufficient appointments available. Increased availability of 
appointments is important to enable women get the copper coil, the most effective method of 
emergency contraception, inserted.  
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8.7. Chapter summary 
Overall, 15 pharmacy staff members and 15 pharmacy users were interviewed for this study. This 
chapter presented the results of the interview study. It gave an overview of pharmacy e  and 
staff characteristics. An overview of all four themes was provided: 1. Pharmacy as a venue for 
SRHS, 2. Staff-user interaction, 3. Implementing SRHS into pharmacies and 4. Impact of delivering 
SRHS on pharmacy staff. Findings were then interpreted using Normalisation Process Theory. 
This highlighted that there is still room for improvement for SRHS to become embedded in 
pharmacy practice.  
In the discussion, the main findings were summarised, the strength and limitations of the study 
discussed and comparisons to existing literature made. In the next chapter (chapter 9) the findings 
of all three studies: the systematic review, the quantitative study and this qualitative study are 
synthesised based on the Pillar Integration Process.  
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9. Data Synthesis: Methods & Results  
9.1. Chapter overview 
The fourth and final objective of this thesis was to synthesise all findings to develop 
recommendations for service optimisation. The objective is addressed in the current and 
subsequent chapter 10. In the current chapter, all results from this thesis are synthesised. In the 
following chapter (chapter 10), recommendations for service optimisation are developed based 
on the discussion of the integrated findings.  
The current chapter is split into three major sections: In the section 9.2, the method utilised to 
integrate all results is introduced. In section 9.3, the findings from the data synthesis are 
presented. In section 9.4, the strengths and weaknesses of the method used to integrate the 
different study components are discussed.  
9.2. Data synthesis Method 
As justified in section six of the second thesis chapter, the data synthesis was based on the Pillar 
Integration Process (PIP), a technique to integrate mixed methods research, (R. E. Johnson et al., 
2017). It is now briefly introduced to familiarise the reader with the methods of PIP.  
9.2.1. Pillar Integration Process 
The Pillar Integration Process (PIP) uses a joint display, which is a table or matrix used to draw 
out new insights by bringing data together through visual means (Fetters et al., 2013; R. E. 
Johnson et al., 2017). The joint display used in the PIP consists of five columns (see Figure 12). 
The PIP is carried out in four stages: 1. Listing, 2. Matching, 3. Checking and 4. Pillar Building.  
The Pillar Integration Process (PIP) was adapted in order to allow the integration of three (instead 
of two) data sources. The development was conducted by J.G. and discussed with and approved 
by Dr Amy Grove, Assistant Professor at Warwick Medical School and co-developer of the PIP. 
Hence, as the changes made to the PIP have been approved by one of the co-developers, it can 
be considered an appropriate adaption to PIP and fit for this thesis. 
 
FIGURE 12 PILLAR INTEGRATION PROCESS AS DESCRIBED BY JOHNSON ET AL. (R. E. JOHNSON ET AL., 2017, 
P. 305) 
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The differences between the original PIP and the adapted PIP are shown in Table 16.  






Pillar Integration Process as 
outlined by Johnson et al. 
(2017) 
Adapted Pillar Integration Process 
(developed by the PhD candidate 
for this thesis) 
Joint display x Usage of a joint 
display consisting of 
five columns 
x Two columns for each 
data source to be 
integrated (raw data / 
categorised data) 
x Central column for 
themes developed in 
the final stage of PIP 
x Usage of a joint display 
x One column for each data 
source integrated 
x Pillars are entered in the 
first column from the right 
and developed iteratively 
Stage 1 Listing  x Listing of findings 
from the first data 
source/dataset in 
form of raw data and 
categorised data  
x Listing of findings from the 
first data source in form of 
text (only exception being 
the retrospective study for 
which raw data was 
occasionally added) 
x Listing of preliminary pillars 
alongside the findings 
Stage 2 Matching x Listing of findings 
from the second data 
source/ dataset: raw 
data and categorised 
data is entered into 
two neighbouring 
columns; data not 
matching which 
findings from the 
previous dataset/ 
study is presented in 
a new row 
x Listing of findings from the 
second data source in form 
of text into one column; 
listing and refining of 
preliminary pillars (data not 
matching is presented in a 
new row) 
x Listing of findings from the 
third data source in form of 
text into one column; listing 
and refining of preliminary 
pillars; data not matching 
findings from the other 
studies is presented in a 
new row 
Stage 3 Checking x Reviewing of joint display; checking of all rows and columns 
for completeness and accuracy 
Stage 4  Pillar 
Building 
x Themes are 
developed based on 
the listing and 
matching of 
data/findings, and 













The stages of the adapted PIP are described in the following section (9.2.2). 
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9.2.2. Adapted Pillar Integration Process 
A visualisation of the adapted PIP developed for this thesis is presented in Figure 13. The different 
stages of the adapted PIP are explained in detail below.  
 
FIGURE 13 ADAPTED PILLAR INTEGRATION PROCESS 
Listing 
In line with the original PIP, findings from the first data source were listed in the first column of the 
joint display from the left. In this case, the systematic review findings were listed in the left column 
of the joint display. As the complete findings from all three data sources were listed in the joint 
display, the order in which the findings from the three data sources were listed was not expected 
to impact the results of the integration. In contrast to the original PIP, where quotes and 
percentages are listed alongside categorised data (e.g. themes/categories), only the text output 
of the findings were listed for the systematic review findings. The rationale for this was, that as 
raw data for the systematic review had already been presented in a previous chapter (chapter 8), 
listing the raw data from the original studies included in the review was deemed to be repetitive 
and unnecessary. Another benefit of only listing the findings in form of text was that the table was 
more manageable in terms of its size. 
When trialling the adapted PIP, it was found to be difficult to match data in the second stage 
without having an overview of the pillars relating to the listed findings. In contrast to the Pillar 
Integration Process, where pillars are only developed and listed in the final stage, preliminary 
pillars were listed and adapted iteratively throughout the different stages. An example for the 
listing of the systematic review findings can be found in Table 17. 
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TABLE 17 EXAMPLE LISTING SYSTEMATIC REVIEW FINDINGS 
 
Matching 
As specified in the original PIP, findings from the second data source were listed and matched in 
the second stage. The findings from the interview study were entered before the those from the 
retrospective study. Findings that matched or related to the findings from the systematic review 
were listed in the neighbouring column (second column from the left) in the same row (see Table 
18). 
TABLE 18 EXAMPLE MATCHING QUALITATIVE STUDY FINDINGS 
 
Where findings from the second study did not match findings from the systematic review, they 
e e li ed in o a ne  o  of he econd col mn f om he lef . In hi  ca e, no  iden ified  a  
entered into the neighbouring row (first column from the left). An example for this is shown in 
Table 19.  
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TABLE 19 EXAMPLE MATCHING QUALITATIVE STUDY FINDINGS 
 
No raw data (in this case quotes) from the interview study were listed as these had been presented 
in chapter 8 of this thesis. The preliminary pillars developed as part of stage one (Listing) were 
adapted where appropriate. Once all findings from the interview study had been added into the 
joint display and all themes had been reviewed by J.G., findings from the retrospective study were 
added into the next column (third column from the left). In contrast to the systematic review and 
the interview study, the retrospective study aimed to explore the utilisation of pharmacy-based 
SRHS a he  han pha mac  aff and pha mac  e  a i de  and e pe ience . It was therefore 
not expected that findings from the retrospective study would match with findings from the other 
two studies. Where findings from the retrospective study had the potential to support or match 
findings from the other studies, they were listed in the same row in the third column from the left. 
However, as the retrospective study was conducted for a different purpose, the matches between 
the retrospective study findings and the other two findings have to be treated with caution. 
Retrospective study findings which were found to potentially explain or support findings from the 
other studies were therefore written down in italics (see Table 20). Findings that were identified 
to be unrelated to findings from the other two studies were listed in new rows.  
TABLE 20 EXAMPLE MATCHING RETROSPECTIVE STUDY FINDINGS 
 
  




Once all findings were listed in the joint display and all pillars had been refined, the third stage 
(Checking) was conducted as specified by Johnson et al (2017). To check for completeness, 
accuracy and to ensure that integrated pillars appropriately represented the PhD findings, the 
joint display was discussed and refined iteratively through deliberation with the research team 
(H.A. and J.R.). The final version of the joint display was also reviewed by Dr Amy Grove, co-
developer of the Pillar Integration Process.  
Overarching Pillars  
The final stage of the original PIP is the Pilla  B ilding . However, since the pillars had been 
developed iteratively in the first two stages and had been checked in stage three, this stage was 
not needed for the adapted PIP. Instead, the pillars were grouped into overarching themes based 
on the principles of thematic analysis (see section 7.9). The rationale for this was that overarching 
themes made it easier to keep an overview of all pillars and hence, more easily identify 
relationships between the pillars. The overarching themes were refined over numerous weeks 
through deliberation with the research team to ensure robust and justified themes (H.A. and J.R). 
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9.3. Results of the Data Synthesis 
9.3.1. Overview 
Section 9.2 introduced the original Pillar Integration Process (PIP) and described how it was 
adapted to integrate the results from this PhD thesis. This section now presents the integrated 
findings which were derived from the retrospective quantitative study (chapter 4), the systematic 
review (chapter 6) and the interview study (chapter 8). 
Convergence among the multiple data sources (the systematic review, the retrospective 
quantitative study and the interview study) was searched. Integrating data from the three data 
sources was highly valuable as it allowed for the identification of common themes. When data 
from one data source confirms a pattern from a different data source, the findings are better 
substantiated (Creswell & Clark, 2017). Grouping all pillars into overarching themes allows the 
presentation of findings to be more structured and to identify relationships between all pillars.  
In total, eighteen different pillars were identified through the synthesis of all PhD findings. The 
pillars were then grouped into four overarching themes to structure the narrative of integrated 
findings. Table 21 shows from which study component the individual pillars were derived from.  
The listing of the systematic review findings led to the identification of twelve different preliminary 
pillars. Findings from the interview study matched eleven pillars that had been identified through 
the listing of the systematic review results. One of the pillars that was identified through the listing 
of the systematic review results could not be matched with the findings from the interview study. 
However, two new pillars were identified through the listing of the interview study findings. Next, 
findings from the retrospective study were added to the joint display. Findings from the 
retrospective study were found to have the potential to support eight out the fourteen pillars 
identified through the systematic review and/or the interview study results. Four new pillars were 
identified through the retrospective study. The complete joint display can be found in Appendix 
13. 
The overarching themes and pillars which were identified through the adapted Pillar Integration 
Process (PIP) are illustrated in Figure 14 and presented in following section (section 9.3.2.).  
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TABLE 21 OVERVIEW OF OVERARCHING THEMES AND PILLARS IDENTIFIED THROUGH THE SYNTHESIS OF ALL 
FINDINGS 
Overview of integrated overarching themes and pillars derived from the data synthesis3  
Overarching 
themes 















   
Need for trained 
pharmacy staff 
  Not identified 
Need for physical 
privacy in the pharmacy 
  Not identified 
Uptake of pharmacy-



















based SRHS by the day 











   
Pharmacist-assisted 
contraceptive injection 













obtaining SRHS  
Pharmacy staff-user 
interaction 
   
Collection and use of 
personal information  
  Not identified 
 
 
3 Dark blue: Theme/Matching theme; light blue: potentially matching theme; grey: no 
matching/relating theme identified 




the sex of pharmacy 
staff 
  Not identified 
Language and 
communication barriers 
between pharmacy staff 
and users 
  Not identified  
Consultation outcomes 
of pharmacy-based 















  Not identified 
 





FIGURE 14 INTEGRATED OVERARCHING THEMES AND PILLARS 
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9.3.2. Pharmacy as a venue for SRHS 
Convenience of pharmacy-based SRHS 
Both the systematic review and the interview study found that convenience was a key reason for 
people to use the pharmacy for SRHS. One important aspect that made pharmacies convenient 
for users was accessibility. Pharmacy users found it easy to get to a pharmacy and liked that they 
could typically access a pharmacy without having to travel a long distance. Further, pharmacies  
long opening hours and quick service delivery were identified as being convenient for pharmacy 
users. Not having to book an appointment for a SRHS in advance was also reported to be a major 
advantage of pharmacies over other SRH providers. Being able to attend the pharmacy for several 
health issues in one visit was perceived as another benefit of using pharmacies for SRHS. 
Moreover, pharmacy users liked that they could not only get the consultation for the SRHS at the 
pharmacy but also the required medication or product in a single visit.   
The retrospective study showed that there were more than 60,000 pharmacy-based service 
requests between August 2015 and August 2018. Given that this thesis is the first research of its 
kind, there were no comparable studies on the uptake of pharmacy-based SRHS elsewhere 
available to put this number in context. However, this finding could suggest that pharmacy-based 
SRHS are convenient for many people to use. 
Need for trained pharmacy staff  
The systematic review and the interview study found that lack of trained pharmacy staff could 
create a barrier to access. According to the systematic review, pharmacy staff were concerned 
about not being able to meet the demand for SRHS due to a lack of trained staff. Pharmacy 
healthcare assistants who participated in the interview study stated that not being able to deliver 
SRHS to users because no trained pharmacist was available was not only frustrating for them but 
also upsetting for pharmacy users who were presenting for time sensitive services such as the 
emergency contraceptive pill. No findings relating to this theme were identified in the 
retrospective study findings.  
Need for physical privacy in the pharmacy 
Both the systematic review and the interview study found that physical privacy was a concern 
when requesting a SRHS at the pharmacy.  
According to both the interview study and the systematic review, pharmacy users disliked being 
surrounded by other clients in the pharmacy. According to the interview study, some pharmacy 
users waited before entering the pharmacy or attending for a SRHS until the pharmacy was empty 
because they did not want to be overheard or overseen presenting for a SRHS. Some users stated 
that they did not want to attend pharmacies where they knew staff or were likely to meet someone 
they knew.  
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A study included in the systematic review, which compared people s experiences of privacy at 
he pha mac  i h people s experiences at the clinic, found that pharmacy users were less likely 
than clinic users to agree that they had experienced an adequate level of privacy. 
Relating to this finding, one pharmacy user in the interview study stated that he had experienced 
less privacy at the pharmacy than at the clinic due to the design of the queuing system. The 
pharmacy user reported that the pharmacy that he had attended had parallel queues which 
allowed those pharmacy clients in the queue next to him to overhear what he was presenting for. 
Another pharmacy user interviewed stated that having a separate counter for SRHS enabled 
p i ac . Hence, he pha mac  de ign a  ho n o impac  pha mac  e  pe cep ion of p i ac .  
Pharmacy users who participated in the interview study reported that they tried to speak quietly 
at the counter so that they could not be overheard by other people. Although both the systematic 
review and the interview study showed that staff were aware that privacy mattered to pharmacy 
users, instances where pharmacy staff had not been discreet were reported by both pharmacy 
users and pharmacy staff.  
One of the reasons pharmacy users required a high level of privacy was the stigma they 
associated with receiving SRHS. Users reported that they were scared to be judged by the 
pharmacy staff and other pharmacy clients. Many users stated feeling embarrassed when 
requesting a SRHS. 
Further, both the systematic review and the interview study showed that consultation rooms 
provided pharmacy users with sufficient privacy during the consultation on SRHS. The only 
exception was one pharmacy user who stated that the consultation room at the pharmacy that 
she had attended had not been soundproof. This negatively impacted her experience of privacy.  
No findings from the retrospective study related to the pillar of physical privacy in the pharmacy.  
Uptake of pharmacy-based SRHS by males  
One study included in the systematic review showed that some pharmacy staff members 
questioned whether pharmacies were the right place for condom distribution since they were 
used less by young males. This was corroborated by the retrospective study, which showed that 
females made up the large majority of pharmacy users, even for condoms and other services (STI 
self-sampling kits; chlamydia treatment) that were accessible to both men and women. This may 
suggest that males are indeed less likely to attend for pharmacy-based SRHS compared to 
females. None of the interview study findings related to this pillar.  
Uptake of pharmacy-based SRHS by age 
People in the 16-24 age group accounted for more than fifty percent of all SRHS requests. For all 
services consistently, 16-to 24-year old females and males accounted for the largest number of 
service requests. The median age across all SRHS was 24 years. 
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The median age was lowest for users who requested an STI self-sampling kit (median age: 21) 
and highest in women requesting emergency contraception (median age: 25). 
Uptake of pharmacy-based SRHS by ethnicity 
According to the available data, White/White British individuals were the largest group who 
accessed pharmacy services, followed by Asian/Asian British, Black/Black British, Mixed and 
other ethnic groups.  
Uptake of pharmacy-based SRHS by the day of the week 
All services except the contraceptive injection and chlamydia treatment were most frequently 
accessed on Monday, which was the most common day to present in a pharmacy for a SRHS. 
The uptake of SRHS was lowest on Sunday. Females were most likely to request emergency 
contraception, condoms and STI self-sampling kits on Mondays, and chlamydia treatment and the 
contraceptive injection on Wednesday. In contrast, males were most likely to obtain condoms and 
chlamydia treatment on Fridays and STI self-sampling kits on Tuesdays.  
No findings from the systematic review and the interview study related to this pillar. 
9.3.3. Requesting and obtaining SRHS 
Pharmacy staff-user interaction 
Both the systematic review and the interview study showed that pharmacy users generally had a 
positive experience when interacting with pharmacy staff, who they often described as friendly, 
supportive and sensitive. Vice versa, pharmacy staff reported that they generally felt comfortable 
in interacting with pharmacy users.  
The systematic review showed that most pharmacy users were comfortable discussing sexual 
and reproductive health matters with staff, the only exception being some of the young users. 
Both the systematic review and the interview study showed that pharmacy staff were aware that 
it was important for them to be confident, friendly and trained. Some pharmacy staff stated that 
they wanted to have more role playing in their training in order gain more confidence in delivering 
services. 
A smaller number of pharmacy users interviewed had a negative experience with pharmacy staff. 
Negative experiences were caused by staff who users perceived as judgemental, stigmatising or 
discriminatory or not confident. One pharmacy user who self-identified as a transgender woman 
felt discriminated against by staff and suggested that pharmacy staff should receive diversity 
training to include the use of the correct pronouns when delivering services to transgender 
people.  
The systematic review showed that pharmacy staff were concerned about providing SRHS to 
minors without parental consent. Further, staff were less likely to deliver emergency contraception 
to young women or to those who were not in need for emergency contraception themselves (e.g. 
male partners requesting emergency contraception for a partner).  
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Studies included in the systematic review compared e  e pe ience  a  he pha mac  i h 
e  e pe ience  a  he clinic. 
These studies showed that pharmacy users perceived their consultation as less comprehensive 
compared to users of clinical services. Further, pharmacy users were less likely than clinic users 
to agree that the consultation had helped them to understand the use of emergency contraception 
better. 
Collection and use of personal information  
Both the systematic review and the interview study identified problems relating to the collection 
and use of personal information on pharmacy users.  
The systematic review showed that pharmacy staff found it difficult to ask pharmacy users 
sensitive questions, for example, regarding a user  weight. Further, pharmacy staff who were 
collecting personal information from pharmacy users on paper felt that the data collection should 
be digitalised, and less information be collected in order to make pharmacy users more 
comfortable. While pharmacists in the interviews were recording information electronically, 
pharmacy healthcare assistants had to collect data on pharmacy users on paper forms. In line 
with the systematic review, pharmacy staff who participated in the interview study wanted the 
collection of personal information to be digitalised.  
Both the systematic review and the interview study indicated that some pharmacy users were 
hesitant or did not want to share their personal information. Pharmacists interviewed described 
that some pharmacy users preferred to buy emergency contraception rather than to obtain it for 
free through the Umbrella service because they did not want to provide their personal information. 
While some pharmacy users were more willing to provide their data after pharmacists had assured 
them of the confidentiality of the SRHS, others remained hesitant.  
To make the collection of personal data more comfortable for users, pharmacy staff suggested 
anonymising the collection of personal data as much as possible. Some pharmacists indicated 
that they were already not asking pharmacy users for their names although they were supposed 
to.  
While some pharmacy staff believed that pharmacy users would not want pharmacies to share 
their data with other providers of Umbrella s services, some pharmacy users wrongly believed 
that pharmacies were sharing it. These pharmacy users felt that it would be beneficial if 
pharmacies shared their data with other providers of Umbrella s services, as this would mean that 
they would not have to answer all the questions that they had already answered at a different 
health provider. 
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Preferences regarding the sex of pharmacy staff  
Both the systematic review and the interview study showed that pharmacy users sometimes had 
a preference regarding the sex of pharmacy staff delivering SRHS. According to the systematic 
review, young males did not want to be counselled by female staff whereas women seemed less 
comfortable being counselled by male staff. In line with this, the interview study also showed that 
many females preferred to be counselled by female staff. 
One female pharmacy user interviewed even stated that she would not attend a pharmacy for a 
SRHS if there was no female pharmacist available. According to pharmacy staff interviewed, some 
women presenting for a SRHS specifically asked for a female pharmacist at the pharmacy counter. 
To o e come pha mac  e  p efe ence , ome pha maci  le  hei  pha mac  heal hca e 
assistants act as chaperones or asked pharmacy healthcare assistants to reassure women that 
the male pharmacist was friendly and approachable. This strategy was successful in some cases. 
Some women interviewed stated that they did not know why they preferred a female pharmacist. 
However, one male pharmacy user who self-identified as gay stated that he would rather be 
counselled by a female as he was attracted to men.  
Pharmacy staff suggested that there should be more transparency on whether female or male 
pharmacists were available to deliver SRHS consultations.  
Communication and language barriers between pharmacy staff and users 
Both the systematic review and the interview study found that pharmacy staff experienced 
communication and language barriers with pharmacy users who were illiterate or not fluent in 
English. Although pharmacists who participated in the interview study tried to communicate with 
pharmacy users via Google Translate and Google Images, they sometimes had to refer people to 
the clinic due to communication and language barriers. Both the systematic review and the 
interview study found that having documents and information sheets available only in English 
created language barriers. To address this problem, pharmacy staff who were interviewed 
suggested developing information sheets in different languages. However, some pharmacy staff 
pointed out that information sheets would not be helpful when delivering services to illiterate 
people.  
No findings from the retrospective study related to this topic.  
Consultation outcomes for pharmacy-based chlamydia treatment and condoms 
Most people presenting for chlamydia treatment were provided with the antibiotic doxycycline 
rather than azithromycin. Most people attending for condoms were not provided with condom 
instructions. No findings from the systematic review and the interview study related to this pillar. 
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9.3.4. Implementing SRHS into pharmacies 
Pharmacy-based STI testing 
Both the systematic review and the interview study identified issues related to pharmacy-based 
STI testing. According to the systematic review, pharmacy users disliked that they had to return 
their STI samples to designated pathology laboratories, wait for the STI test results and call the 
hospital during working hours to receive the results. Umbrella s pathway of returning STI samples 
and receiving test results differs from those described in studies included in the systematic review. 
No issues with the return of samples and receipt of test results were reported in the interview 
study with Umbrella s service users. 
However, pharmacy users who participated in the interview study reported difficulties with 
completing the blood test which was part of the STI self-sampling kits testing for HIV and syphilis. 
Some pharmacy users therefore did not complete the STI sample or preferred to go to the clinic 
for STI testing. One dyslexic pharmacy user described difficulties in following the instructions for 
the STI self-sampling kits. 
The retrospective study showed that STI self-sampling kits accounted for 9.6% of all SRHS 
requests between August 2015 and August 2018. This was despite STI self-sampling being 
available from all Umbrella pharmacies. Possibly, this finding supports the findings from the 
systematic review and the interviews which suggest that there are barriers for some individuals to 
pharmacy-based STI testing. 
One study included in the systematic review showed that pharmacy users were comfortable with 
the pharmacist conducting a HIV rapid test and that there was no significant difference in 
satisfaction between people who got the HIV rapid testing at the pharmacy versus at the clinic. 
The Umbrella service does not offer pharmacist-assisted blood testing. However, pharmacy staff 
in the interview study were aware that users struggled with obtaining their own blood sample by 
using a lancet to prick their finger. Pharmacy staff felt that they were well placed to assist with the 
blood testing and this was welcomed by pharmacy users.  
Pharmacist-assisted contraceptive injection  
Only one study included in the systematic review gave insight into the delivery of the contraceptive 
injection in pharmacies. While some users were satisfied with the pharmacist-assisted 
contraceptive injection, others were concerned about pharmacy staff skills and some users 
reported that it took the pharmacist several attempts before providing the injection appropriately. 
Only one pharmacy user was interviewed on her experience of getting the contraceptive injection 
from an Umbrella pharmacy. This pharmacy user reported that getting the injection form the 
pharmacist was a quick and simple procedure and that she had not felt any pain or discomfort 
during the injection. The retrospective study showed that the contraceptive injection was the least 
accessed of Umbrella s SRHS.  
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Awareness for pharmacy-based SRHS 
Lack of awareness of SRHS provided in pharmacies was identified to be a barrier to access by 
both pharmacy users and pharmacy staff.  
In particular, pharmacy staff from smaller pharmacies felt that they were being overlooked by 
people in need of SRHS. Both pharmacy users and pharmacy staff felt that the SRHS should be 
better advertised.  
The interviews with users of Umbrella s services showed that even they were uncertain about the 
full range of services Umbrella was offering, where services could be accessed and by whom (in 
terms of gender and age).  
Pharmacy staff described that men sometimes presented for emergency contraception for their 
female partners although Umbrella pharmacies are not giving out emergency contraception to 
anyone except the person in need of emergency contraception themselves. Pharmacy staff felt 
that this confusion existed because it was not clearly advertised who could access emergency 
contraception.  
In some cases, even pharmacy staff seemed not to be aware of the eligibility criteria for the SRHS. 
For example, one pharmacy user interviewed described that she was charged for the emergency 
contraception in an Umbrella pharmacy because the pharmacy healthcare assistant wrongly 
believed that it was only free for users of a certain age.  
Moreover, pharmacy users described difficulties in obtaining information on pharmacy-based 
SRHS online. They stated that the pharmacy service information on the Umbrella website 
sometimes was not up to date and that it was not always clear whether a service was available 
from a pharmacy. Pharmacy users therefore called the pharmacy in advance to ensure that the 
pharmacy was able to deliver the service. In line with this, pharmacy staff also reported that users 
called in advance to check the service availability.  
The retrospective study showed that emergency contraception and condoms were overall the 
most commonly requested pharmacy-based SRHS. Emergency contraception and condoms have 
been available from pharmacies for a long period of time. Possibly, those services have been 
requested more in comparison to other services (such as for example contraceptive injection and 
chlamydia treatment) because people are more aware that they are available from pharmacies.  
The systematic review did not have any findings relating to this pillar.  
Clinical support for pharmacies delivering SRHS 
Pharmacists interviewed felt that pharmacies did not get sufficient support from the sexual health 
clinic collaborating with Umbrella pharmacies. For example, while pharmacists appreciated having 
a clinical support line, they experienced difficulties accessing the line for help.  
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Further, pharmacists complained that there were not sufficient clinical appointments available for 
women wishing to get a copper coil referral or appointment as emergency contraception and that 
those appointments that were available did not always suit pharmacy users.  
The retrospective study showed that the majority of women presenting for emergency 
contraception were provided with an emergency contraceptive pill. Less than one percent of 
women presenting for emergency contraception were provided with a copper coil appointment 
or referral. The low percentage of copper coil appointments may be an indicator for an insufficient 
number of clinical appointments. 
However, it is also possible that women were not interested in getting the copper coil or were not 
offered the copper coil as emergency contraception by pharmacy staff.  
Pharmacists felt that it was impractical that they had to call the clinic to schedule an appointment 
for the copper coil and some pharmacy staff members wanted to have direct access to the clinical 
appointment system.  
No findings from the systematic review related to this pillar.  
9.3.5. Impact of delivering SRHS on pharmacy staff 
Pharmacy staff workload  
Both the systematic review and the qualitative study showed that the delivery of SRHS affected 
pharmacy staff workload.  
Whether workload was perceived as a burden for staff was found to be related to several factors. 
First of all, pharmacists were found to be more affected by added workload than pharmacy 
healthcare assistants. Further, the burden of workload was dependent on the demand of SRHS. 
The systematic review showed that pharmacy staff found it more difficult to deliver services at 
times such as the weekend or evenings where demand was higher. Some pharmacy staff felt 
pressure from some pharmacy users to deliver services quickly rather than thoroughly.  
Pharmacy staff described that it was sometimes challenging to deliver SRHS in addition to all the 
other tasks that needed to be completed due to time pressure. They therefore often had to 
multitask during the delivery of SRHS. Pharmacy users reported that this multitasking impacted 
negatively on their experience of the consultation. 
It was found that time pressure was not related to the number of SRHS offered in the pharmacy 
(Tier 1 or Tier 2 services), rather it was related to the level of staffing in the pharmacy. Pharmacists 
who worked at pharmacies with lower staffing levels were more likely to experience the workload 
related to SRHS as difficult or stressful than those pharmacists working in pharmacies were 
several pharmacists and pharmacy healthcare assistants were employed. One pharmacist 
interviewed stated that low staffing levels were the reason why his pharmacy could not deliver the 
extended range of services (Tier 2 services). 
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Those pharmacists who were working alone found it particularly difficult to provide services as 
there was no one to cover the pharmacy counter during the consultation on a SRHS. While 
pharmacy staff felt that having more staff members would take pressure from staff, they believed 
that this was not likely to happen due to financial constraints. To reduce pressure on pharmacists, 
some pharmacy staff members suggested that some tasks could be shifted to pharmacy 
healthcare assistants. However, some pharmacists felt that pharmacy healthcare assistants were 
not paid enough and were underqualified to deliver a larger range of SRHS. However, pharmacy 
healthcare assistants themselves were largely willing to take on a bigger role. 
Pharmacy staff collectively agreed that it would take pressure off the pharmacist if pharmacy 
healthcare assistants could electronically enter data collected on pharmacy users. This would 
prevent pharmacists from having to enter data collected by pharmacy healthcare assistants on 
paper onto the PharmOutcomes® software package. According to pharmacy healthcare 
assistants, some pharmacists were already letting them enter data on the electronic platform 
PharmOutcomes®, although they were not supposed to.  
Pharmacists also felt that the collection of personal information on pharmacy users should be 
reduced. One pharmacist suggested that pharmacy users should be allowed to pre-register 
themselves in advance of the consultation. In his opinion, this would not only shorten the 
consultation, but also allo  pha maci  o e plo e pha mac  e  health needs in the 
consultation and provide pharmacy users with more reassurance.  
No retrospective study findings were identified to relate to this pillar.  
Pharmacy staff motivation and recognition  
Both the systematic review and the interview study found that pharmacy staff were willing to take 
on extra workload to deliver SRHS. Pharmacy staff were motivated to provide SRHS as they 
believed that hi  con ib ed o f eeing p doc o  ime and removing pressure from the 
healthcare system. Further, they enjoyed increasing access to SRHS, helping people and 
contributing to the reduction of unwanted pregnancy. Pharmacy staff also found that delivering 
the services enhanced their profession, increased their employability and aided them in 
developing their professional role as primary health care providers.  
Both the systematic review and the interview study found that pharmacy healthcare assistants 
wanted financial recognition for working beyond their traditional role. According to the systematic 
review, pharmacy healthcare assistants wanted financial recognition for their added workload, 
although pharmacy healthcare assistants that took part in the interview study indicated that they 
would expect to be paid for the time they spent getting trained on the delivery of SRHS but not 
for delivering the extra services.  
The interview study also showed that pharmacy healthcare assistants felt that pharmacy users did 
not perceive them as healthcare professionals and did not trust them to deliver services as much 
as they trusted the pharmacist. 
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However, some pharmacy healthcare assistants reported that wearing the Umbrella badge made 
them more approachable to pharmacy users as it showed that they could be asked for advice on 
SRHS. Pharmacists felt that pharmacy users did trust them and although this was supported by 
interviews with the majority of pharmacy users, one pharmacy user pointed out that the 
pha maci s qualifications displayed in the consultation room reassured her that the pharmacist 
was qualified for the delivery of SRHS. This need to be reassured of the pha maci  q alifica ions 
possibly suggests that some users did not initially trust pharmacists to deliver SRHS.  
Both pharmacists and pharmacy healthcare assistants felt that they should get more recognition 
for working beyond their traditional role from the health provider Umbrella. For example, they 
wanted to be asked for feedback and be involved in decisions regarding the delivery of pharmacy-
based SRHS. However, one pharmacist pointed out that an annual award event for pharmacy staff 
provided some sense of recognition.  
No findings from the retrospective study related to this topic.  
9.4. Strengths and limitations of the data synthesis methods 
The data synthesis was based on the Pillar Integration Process (PIP), a method that has been 
published in a peer reviewed journal (R. E. Johnson et al., 2017). A strength of the PIP is that it is 
flexible in its ability to synthesise findings from different study designs (R. E. Johnson et al., 2017), 
making i  ell i ed o hi  he i  mi ed me hod  approach. Another strength of the PIP is that 
clear steps are outlined which makes the data integration transparent and systematic. However, 
a limitation of the original PIP approach is that the stages described are only provided for the 
synthesis of two datasets. This limitation was addressed by the PhD candidate, as she adapted 
the PIP to allow for the integration of findings from three different data sources (the systematic 
review, the retrospective quantitative study, the interview study). In order to provide the reader 
with an understanding of the process and the findings, it was clearly described how and why the 
different PIP stages were adapted, increasing the reliability of the adapted PIP. The method used 
to integrate findings for this thesis was discussed with one of the co-developers of the original PIP 
to ensure that the adaption of the model was appropriate.  
However, there were also some limitations regarding the data synthesis. First, as shown in section 
6.4, almost half of the studies included in the systematic review were not of high quality or at least 
not reported as being of high-quality. This may not only affect the quality of the systematic review 
results but also the quality of the integrated findings. It is important to view the findings in light of 
this.  
There is also a risk that the data synthesis oversimplifies the level of convergence occurring 
across different studies, and in some cases may force data together which in reality does not 
match (Fitzpatrick, 2014). This may be true particularly for the retrospective study, which was not 
conducted to explore pharmacy staff and pha mac  e  experiences but to describe the 
utilisation of pharmacy-based SRHS.  
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It is therefore questionable whether the findings from the retrospective study can truly make sense 
of the systematic review and interview study findings, and so the interpretation needs to be viewed 
with caution.  
However, research using different study methodologies can result in more reliable findings than 
research using a single method (Dabae Lee, 2018). Comparing and contrasting the results of the 
three different studies allowed a more sophisticated understanding of all the findings generated 
from this thesis. It was shown that there were several patterns between the three studies, which 
strengthens the key thesis findings. 
9.5. Chapter summary 
This chapter described the methods used to synthesise the findings from this PhD thesis. The 
Pillar Integration Process, a method to integrate findings from different study designs, was 
adapted to synthesise the results from the systematic review, the interview study and the 
retrospective study. Following this, the results from the integration of all the findings were 
presented. Eighteen pillars were identified and grouped into four overarching themes: 1. 
Pharmacy as a venue for SRHS (need for physical privacy in the pharmacy; availability of trained 
staff; uptake of pharmacy-based SRHS by males; convenience of pharmacy-based SRHS; uptake 
of pharmacy-based SRHS by age; uptake of pharmacy-based SRHS by ethnicity; uptake of 
pharmacy-based SRHS by the day of the week),  2. Requesting and obtaining SRHS (pharmacy 
staff-user interaction; collection and use of personal information; preference regarding the sex of 
pharmacy staff; language and communication barriers between pharmacy staff and users), 3. 
Impact of delivering SRHS on pharmacy staff (pharmacy staff workload; pharmacy staff motivation 
and recognition) and 4. Implementing SRHS into pharmacies (awareness of pharmacy-based 
SRHS; pharmacy-based STI testing; clinical support for pharmacies delivering SRHS; pharmacist-
assisted contraceptive injection). The following and final chapter of the thesis offers a discussion 
of the integrated findings.  
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10. Discussion, Recommendations & Conclusion 
10.1. Chapter overview 
This thesis focused on pharmacy-based sexual and reproductive health services (SRHS). To 
address the overall aim of the thesis, which was to develop recommendations for the service 
optimisation of pharmacy-based sexual and reproductive health services in England (UK), two 
approaches were taken: (1) service utilisation was described, and (2) pharmacy staff and 
pha mac  e  e pe ience  and a i de  e e e plo ed. 
Routinely collected data from Umbrella, a sexual health provider in Birmingham (England), was 
analysed for the time period August 2015 to August 2018 to describe the utilisation of SRHS. It 
was the first study to analyse service utilisation across a wide range of SRHS. 
To e plo e e  and staff experiences and attitudes of pharmacy-based SRHS, two studies were 
cond c ed. U ing a ema ic e ie , e i ing e idence on e  and aff e pe ience  and 
attitudes of pharmacy-based SRHS were summarised. The systematic review revealed that there 
was limited (high quality) qualitative research (from England) exploring staff and particularly 
pha mac  e  e pe ience  of pha mac -based SRHS. It also showed that research capturing 
pha mac  heal hca e a i an  e pe ience  on deli e ing SRHS a  limited and that for some 
pharmacy-ba ed SRHS (e.g. chlam dia ea men ) no e idence on e  o  aff e pe ience  a  
a ailable. Hence, i  a  highl  impo an  and imel  o cond c  a q ali a i e d  e plo ing e  
and staff experiences in-depth. Based on the findings of the review and the retrospective study, 
semi-structured interviews with pharmacists, pharmacy healthcare assistants and pharmacy users 
were conducted in Birmingham (England), where the pharmacy service Umbrella delivers a wide 
range of services related to contraception and sexually transmitted infections across multiple 
pharmacies.  
The results from all three studies were first analysed and discussed separately and then 
synthesised using an adapted version of the Pillar Integration Process (R. E. Johnson et al., 2017) 
in the previous chapter (chapter 9).  
In this chapter, the integrated findings derived from the data synthesis are now summarised and 
discussed using the four overarching themes presented in section 9.3. Based on this discussion, 
recommendations for service optimisation are developed to complete the final objective of this 
he i  hich a  o n he i e all finding  o de elop ecommenda ion  fo  e ice op imi a ion . 
An overview of all recommendations is provided in section 10.6. Following this, the key strengths 
and weaknesses of this PhD thesis are discussed (see 10.7). In section 10.8, the dissemination 
plan for the findings and recommendations is presented. The chapter ends with the conclusion, 
which highlights the key contributions of this thesis (see section 10.9).  
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10.2. Pharmacy as venue for SRHS  
10.2.1. Convenience of pharmacy-based SRHS  
Both the systematic review and the interview study found that convenience was the key reason 
for service users to access SRHS via a pharmacy. Pharmacy users felt that it was easy to get to 
the pharmacy without having to travel a long distance. Further, pharmacy users liked that they did 
not have to schedule an appointment for a pharmacy-based SRHS in advance, that the service 
delivery was quick and that the pharmacies had long opening times. Moreover, being able to 
attend for several health services at one visit and the possibility to get both the consultation and 
the SRH product or medication from the pharmacy were features perceived as convenient by 
pharmacy users.  
These findings are in line with previous systematic reviews on pharmacy-based sexual and 
reproductive health services (Gonsalves & Hindin, 2017) and other extended pharmacy services 
(Ali M.K. Hindi et al., 2018). This would suggest that convenience is not only important to people 
seeking sexual and reproductive health services but for users of pharmacy services in general. It 
can therefore be recommended that pharmacies should maintain features, such as walk-in 
services and long opening times, which were found to be perceived as convenient. However, a 
recent study showed that the introduction of an appointment system to provide vaccinations in 
the pharmacy led to a higher overall rate of vaccinations per pharmacy store compared to 
pharmacies without appointments and that pharmacy users and staff appreciated having 
dedicated time to discuss vaccinations (Luder et al., 2018). While appointment-based systems 
may be appropriate for pharmacy services such as vaccinations, which can be planned in 
advance, services such as the emergency contraception don  lend themselves to an 
appointment-based system as women do not typically plan using emergency contraception in 
advance but request it after eme gencie  such as contraceptive failure. As access to emergency 
contraception is highly time-sensitive it is important for pharmacies and sexual health providers 
to offer walk-in services.  
Not having to schedule appointments was found to be a key advantage over other health providers 
in this thesis. Keeping walk-in services and long opening times can therefore be considered as an 
important key pharmacy attribute compared to some other health providers (see Table 22).  
TABLE 22 RECOMMENDATIONS RELATING TO CONVENIENCE OF PHARMACY-BASED SRHS 
Addressee of 
Recommendation(s) 
Recommendation(s) relating to convenience of pharmacy-based SRHS 
Practice  x Pharmacies should continue to offer walk-in consultations and 
long opening hours as convenience is perceived as a key 
strength of pharmacies  
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10.2.2. Need for physical privacy in the pharmacy 
Both the systematic review and the interview study showed that many pharmacy users felt that 
privacy was insufficiently addressed when requesting a SRHS. A major concern identified for 
pharmacy users was to be overheard or seen presenting for a SRHS. While some pharmacy users 
did not want to have anyone physically around them when requesting a SRHS, others were more 
concerned about requesting a SRHS at a pharmacy where they knew pharmacy staff or other 
pharmacy clients. Some pharmacy users waited outside or inside the pharmacy until it was quiet 
before approaching pharmacy staff for a SRHS, while others tried to whisper at the counter in 
order not to be o e hea d. Pha mac  e  e pe ience of p i ac  a  nega i el  impac ed if 
pharmacy staff were not discreet when discussing or delivering a service.  
Next to indiscreet staff, parallel queuing systems in the pharmacy caused negative experiences 
of privacy as pharmacy clients in the parallel queue could overhear what was being discussed. In 
contrast, pharmacy counters located in a separate area of the pharmacy appeared to improve 
pha mac  e  e pe ience of p i ac . With regards to the service delivery, the consultation room 
was found to provide sufficient privacy according to almost all pharmacy staff and pharmacy 
users.  
There is agreement in the wider literature that a lack of privacy when requesting a service is also 
a concern for users of pharmacy services other than SRHS (Bednarczyk et al., 2010; Hendrika 
Laetitia Hattingh et al., 2015; Ali M.K. Hindi et al., 2018; Krska & Mackridge, 2014; D. C. Stewart 
et al., 2011; J. Taylor et al., 2012; Tucker & Stewart, 2015; K. Wood et al., 2015). Hence, privacy 
is not only a concern for users of SRHS but users of various pharmacy services, although it might 
be a particular concern when discussing topics relating to sexual health.  
Indiscreetness of pharmacy staff has also been identified to be an issue in a previous study 
(Hendrika Laetitia Hattingh et al., 2015). The authors of this study suggested that better staff 
training concerning the importance of privacy and confidentiality was needed and the findings of 
this thesis support this recommendation (Hendrika Laetitia Hattingh et al., 2015). It may also be 
important to monitor or audit whether staff training on the delivery of SRHS, including training on 
discreetness, has been effective, for example through mystery shoppers organised by service 
commissioners (Moriarty et al., 2003).  
Since 2005, pharmacies increasingly have private consultation rooms available (Rapport et al., 
2009). In line with previous research (Hendrika Laetitia Hattingh et al., 2015), this thesis found that 
consultation rooms provided privacy during the service delivery. Having a consultation room in 
pharmacies has also been found to be associated with higher sales of incontinence and asthma 
products (Pike, 2007). This suggests that advertising the availability of consultation rooms may 
enable access to a broad range of pharmacy services, and so may be financially beneficial for 
pharmacies. However, one pharmacy user interviewed as part of this PhD project complained that 
the pharmacy consultation room was not soundproof. 
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According to the guidance from NHS England, it should not be possible to be overheard in the 
pharmacy consultation room when speaking at a normal volume (NHS England, 2019). 
Pharmacies should ensure that their consultation rooms are in line with this guidance to ensure 
that pharmacy users can discuss their health concerns in privacy. While consultation rooms 
appear to be enablers to pharmacy access, participants in a previous study found that being asked 
into the consultation room by pharmacy staff was singling them out from other clients and 
contributed to a feeling of embarrassment and stigma (Hendrika Laetitia Hattingh et al., 2015). 
This suggests that consultation rooms are not the total solution to create sufficient comfort and 
privacy in the pharmacy.  
Research on design solutions to enable privacy is limited despite many publications showing that 
a lack of privacy is a concern to pharmacy users. Participants in a recent study which aimed to 
explore pharmacy design suggested having a phone booth inside the pharmacy from which 
pharmacy users could call the pharmacist to speak in private (Reddy et al., 2019). However, if the 
phone booth is an optional choice, pharmacy users may still feel singled out entering the phone 
booth to talk to the pharmacist. It may therefore be better to create equal privacy for all pharmacy 
users.  
When developing solutions to address privacy in the pharmacy, the occurrence of pandemics 
such as the current (as of July 2020) COVID-19 pandemic, should be considered. A recently 
published COVID-19 guideline for pharmacy teams recommends to maintaining a 1-m distance 
to the pharmacy client (Bukhari et al., 2020). Having to maintain this distance, is likely to make it 
more difficult to be discreet as staff and users may have to speak louder to communicate with 
each other, especially when wearing face masks. Further, NHS England does not have any 
minimum requirements regarding the size of consultation rooms (Buisson, 2005). It may therefore 
be possible that some pharmacies are currently not able to utilise their consultation rooms due to 
a lack of space. Not being able to share their health concerns and not receive treatment as a result 
of a lack of privacy in the pharmacy ma  ha e nega i e con eq ence  on people s health. 
Guidance on how to deliver services in privacy, especially during times of pandemics such as 
COVID-19, are therefore urgently needed.  
The challenge of providing guidance on how to deliver pharmacy services privately is further 
complicated by large variations in the available space and configuration of pharmacies. Further 
required changes to ensure more privacy may lead to increased costs for pharmacies, which they 
may not be able to afford. Hence, more research on innovative and cost-effective solutions to 
address privacy in pharmacies which have different layouts is highly important to ensure that 
pharmacy users can safely and privately share their concerns with pharmacy staff. An overview 
of the recommendations relating to physical privacy are provided in Table 23.  
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TABLE 23 RECOMMENDATIONS RELATING TO NEED FOR PHYSICAL PRIVACY IN THE PHARMACY 
Addressee of 
Recommendation(s) 
Recommendation(s) relating to need for physical privacy in the 
pharmacy 
Practice  x Pharmacies should ensure that their consultation rooms meet 
the privacy requirements by NHS England, e.g. in terms of 
being soundproof 
x More effective training for pharmacy staff on the importance of 
the discreet delivery of services is needed;  
x Monitoring of adherence to guidelines and training relating to 
privacy is needed 
Policymakers x NHS England should provide guidelines on how to deliver 
pharmacy-based SRHS while ensuring privacy, including 
during pandemics such as COVID-19 
Research  x Future research should explore innovative and cost-effective 
solutions to provide privacy to pharmacy clients 
 
10.2.3. Need for trained pharmacy staff 
In both the systematic review and the interview study, a lack of availability of trained staff was 
identified to be a barrier to pharmacy-based SRHS. Not being able to deliver services because no 
trained pharmacist was available was frustrating and concerning for pharmacy staff and upsetting 
for pharmacy users presenting for time-sensitive services such as emergency contraception. 
In line with this finding, a recent systematic review from the US found that the absence of a trained 
pharmacist was a barrier to receiving emergency contraception (Moore et al., 2019). Several 
studies have identified barriers to pharmacy staff training. These included time constraints, lack 
of funding, having to travel to training and lack of relevant local training courses (Braund et al., 
2018; Smith & Watson, 2004). For locum pharmacists (those who are employed through an 
agency and choose their own hours and pay) not working enough hours in the pharmacy to make 
the training worthwhile was also cited as barrier (Braund et al., 2018). Ho e e , in B a nd e  al. s 
study, reasons such as not believing that pharmacies were appropriate to deliver sildenafil 
(medication for erectile dysfunction) were barriers to training (2018). Female staff in the study 
were also concerned about the sensitivity of the topic and preferred male pharmacist to deliver 
the service on erectile dysfunction (Braund et al., 2018). Hence, possibly staff attitudes towards 
specific services may be a barrier to deliver sensitive services such as SRHS. 
To increase uptake of training, barriers need to be removed. Umbrella is already partly providing 
training on sexual and reproductive health services online. Possibly, if full training was available 
in the form of an online course, this may make training more accessible for pharmacy staff as they 
could get trained in their own time. It may also reduce training costs in the long-term as no costs 
for travelling, the training location, the hiring of an educator or refreshments need to be paid. 
However, online courses and online tests have to be set up and content updated regularly. Online 
training would also make it more difficult to practice consultations skills in role plays. How to 
overcome barriers to training while ensuring its quality and effectiveness should be further 
explored in future research. 
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As there is only limited evidence showing how frequently services are unavailable due to lack of 
trained staff, more research is needed to explore the impact of this factor.  
Being sent away because no trained pharmacist is available is evidently upsetting for pharmacy 
users. Pharmacies should therefore try to ensure that all their pharmacists, including locum 
pharmacists, are trained on the delivery of SRHS. Further, pharmacies should be able to refer 
users presenting for SRHS to other SRH providers when no pharmacist is available. Umbrella has 
had mechanisms and training for referrals between Umbrella pharmacies in place since 2015. 
However, whether Umbrella pharmacies are making use of them in practice has not been explored 
yet and should be monitored or audited regularly to ensure pharmacy users get the healthcare 
they need. In cases where pharmacies can foresee at which times trained staff are available in the 
pharmacy, this information should be made accessible to pharmacy users, e.g. on their respective 
websites. An overview of the recommendations relating to the availability of trained pharmacy 
staff is provided in Table 24.  
TABLE 24 RECOMMENDATIONS RELATING TO THE NEED FOR TRAINED PHARMACY STAFF 
Addressee of 
Recommendation(s) 
Recommendation(s) relating to the need for trained pharmacy staff 
Practice  x Pharmacies should ensure that there are trained staff available 
at all times or ensure that there is information available for 
pharmacy users to check when trained staff are available 
x Pharmacies should have referral plan in place to ensure that 
pharmacy users can be directed to another health provider if 
no pharmacy staff are available 
Research  x Future research should explore the impact of not having 
trained staff available and reasons for staff not to obtain 
training 
x Future research should explore how to overcome barriers to 
training 
 
10.2.4. Uptake of pharmacy-based SRHS by males 
In the systematic review, some pharmacy staff questioned whether pharmacies were well placed 
to deliver condoms. They felt that pharmacies were not frequently visited by young males. The 
retrospective study showed that males attended those pharmacy-based SRHS that were 
accessible to both sexes less frequently than females. The gap in attendance by gender can be 
explained by a range of factors. Linking o he opic p efe ence  ega ding he e  of pha mac  
aff (described in section 9.3.3), the difference in attendance by gender may be partially 
explained by pharmacy counter staff being predominantly female (Schafheutle et al., 2008) and 
many males not wanting to approach females to discuss issues relating to sexual and reproductive 
health. However, research has shown that males are less likely to attend healthcare in general 
(Galdas et al., 2005). With regards to sexual and reproductive health services, males are also less 
likely than females to take part in STI testing (Banerjee et al., 2018; Götz et al., 2005; Goulet et al., 
2010; Kong et al., 2011; Macleod et al., 2005; Novak & Karlsson, 2006; Paudyal et al., 2015; 
Williamson et al., 2007). 
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Hence, the low uptake of pharmacy-based SRHS by men is likely not to be specific to this setting. 
Research has started to explore why men are engaging less in SRHS. Deficits in knowledge about 
SRHS has been shown to be a barrier to young men accessing services (Bersamin et al., 2017). 
Further, a study from Australia showed that stigma and discrimination, and concerns about privacy 
and anonymity were barriers for gay men to access sexual and reproductive health services (T. 
Lea et al., 2019). Linking to the topic of need for physical privacy in he pha mac  (described in 
section 9.3.2), improving privacy and anonymity may increase the service uptake of males. Linking 
to the topic of awareness (described in section 9.3.4), raising awareness and increasing 
advertisement of SRHS may also encourage men to attend SRHS. In line with this, a recent study 
has shown that advertising campaigns can increase STI testing amongst males in a university 
setting (E. A. Anderson et al., 2016). Further, one study from America found that multilevel 
interventions such as staff training, clinic environmental changes (e.g. incorporating male-
appropriate brochures etc), in-reach (encouraging male partners, friends, relatives about 
reproductive health services), outreach (promoting available male reproductive health services in 
community-based organisations), and efficiency assessment (e.g. reducing waiting times), 
increased male client volume and STI testing in family planning clinics (Fine et al., 2017). A study 
from South Africa found that establishing specific men  clinic  can inc ea e engagemen  in HIV 
services (Lekhotsa et al., 2018). There is also an ongoing randomised controlled trial exploring 
whether using mobile apps can increase STI screening uptake by males (Teo et al., 2019), 
although the findings from the trial have not yet been published.  
Hence, there is research indicating that male engagement in SRHS can be increased. Currently, 
there are limited data on the uptake of various SRHS from pharmacies in men. Future studies 
should compare the uptake of services in different settings (e.g. General Practices, sexual health 
clinics and pharmacies) by gender to better understand how the different settings contribute to 
reaching males. There is currently no research exploring barriers to pharmacy access by males. 
This should be considered for future research. Recommendations relating to the uptake of 
pharmacy-based SRHS by males are summarised in Table 25.  
TABLE 25 RECOMMENDATION(S) RELATING TO THE UPTAKE OF PHARMACY-BASED SRHS BY MALES 
Addressee of 
Recommendation(s) 
Recommendation(s) relating to the uptake of pharmacy-based SRHS by 
males 
Practice  x Pharmacies should try to improve privacy as this may increase 
the uptake of males 
x Health providers should use multilevel interventions to 
increase the uptake of males  
Research  x Research should explore barriers to pharmacy-based SRHS 
for males 
x Research should compare the uptake of services by different 
sexual and reproductive health providers (e.g. pharmacies, 
clinics and General Practices) and by gender  
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10.3. Requesting and obtaining SRHS 
10.3.1. Language and communication barriers between pharmacy staff and users  
The ema ic e ie  and he in e ie  d  ho ed ha  pha mac  e  inabili  to read, write 
or speak fluent English can create a barrier to pharmacy-based SRHS. Pharmacy staff were trying 
to explain services using Google Images and Google Translate. However, in some cases where 
pharmacy staff were unable to communicate information on SRHS, users needed to be referred 
to the sexual health clinic (Whittall Street Clinic, Birmingham). Not having documents such as 
information sheets in languages other than English was perceived as a barrier to service delivery 
by pharmacy staff. However, some pharmacy staff identified that information sheets were also not 
helpful with users who spoke English but were illiterate.  
Not being able to communicate with non-English speakers was also found to be a problem in 
several other studies evaluating a variety of pharmacy services in English speaking countries 
(Bellamy et al., 2017, 2019; Bradshaw et al., 2007; Chang et al., 2011; Cleland et al., 2012; Devraj 
& Young, 2017; Fejzic & Barker, 2019). A study from New Zealand gave an insight into the 
frequency that pharmacy staff were dealing with non-English speakers (Chang et al., 2011). It was 
found that at least 65% of pharmacists included in the study counselled non-English speakers at 
least once a week (Chang et al., 2011). Strategies to address language barriers in this study 
included hiring bilingual staff and using translated information sheets (Chang et al., 2011). While 
none of the pharmacies reported using professional translating services (Chang et al., 2011), the 
majority of pharmacy staff stated that they would like to have access to telephone interpreting 
services (Chang et al., 2011).  
In another study from the US, language-assistance telephone lines were perceived to be easier 
to use and more helpful in comparison to paper-based resources and bilingual personnel (Devraj 
& Young, 2017). Telephone translating services were also found to be beneficial in another study 
(Bradshaw et al., 2007). Pha macie  in A alia ha e acce  o A alia  T an la ing and 
Interpreting Service, a service which provides access to phone and on-site interpreting services 
in over 150 languages (Fejzic & Barker, 2019). Introducing access to translating and interpreting 
services for pharmacy staff should also be considered by policymakers in England in order to 
overcome communication barriers. However, this would not solve communication problems with 
deaf pharmacy users. Recent research has shown that it is difficult to deliver services to deaf 
pharmacy users for whom written material was identified to be crucial (M. C. Ferguson & Shan, 
2016).  
Language and communication barriers are not only unique to pharmacy-based SRHS but apply 
to pharmacy services in general. There is consistent international evidence on the risks of 
language barriers to impact on quality of care and patient safety (De Moissac & Bowen, 2019). It 
is therefore important to explore solutions which address communication barriers. 
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Translation telephone services may be feasible to address problems when communicating with 
non-English speakers. However, this will not be effective when communicating to deaf people. 
Having materials in different languages in addition to translating services may be effective in 
addressing language and communication needs.  
Acco ding o he la e  cen  da a, 2.4% of Bi mingham  pop la ion aged h ee ea  o  mo e 
do not speak English well or at all (Birmingham City Council, 2013). This was more than twice the 
national average. Hence, language and communication barriers in pharmacies are likely to be 
more prevalent in areas with a higher proportion of people who do not speak the national 
language. 
A summary of the recommendations relating to language and communication barriers between 
pharmacy staff and users is provided in Table 26.  
TABLE 26 RECOMMENDATIONS RELATING TO LANGUAGE AND COMMUNICATION BARRIERS BETWEEN 
PHARMACY STAFF AND USERS 
Addressee of 
Recommendation(s) 
Recommendation(s) relating to language and communication barriers 
between pharmacy staff and users 
Practice  x Pharmacies should consider providing access to translation 
services/ translated material for services 
Policymakers x Policymakers in England should consider of establishing a 
translating service following the Australian Translating and 
Interpreting services  
Research  x Future research should explore solutions to address language 
barriers (e.g. translating services, resources translated in 
several languages) 
 
10.3.2. Preferences regarding the sex of pharmacy staff  
Both the systematic review and the interview study showed that many pharmacy users have a 
preference regarding the sex of pharmacy staff delivering SRHS. Most female pharmacy users 
seemed to prefer being counselled by someone of the same sex. One male pharmacy user who 
self-identified as homosexual, stated that he would prefer to be counselled by a woman as he was 
attracted to males. For some women, not being able to be counselled by a female pharmacist was 
a barrier to access. Some pharmacy staff in our interview study stated that they offered female 
pharmacy users a female healthcare assistant chaperone when only a male pharmacist was 
available for the consultation. 
In line with the PhD findings, previous research has shown that females generally prefer to be 
seen by a female healthcare professional (Makam et al., 2010; Schmittdiel et al., 2000; Stanford 
et al., 2017). However, as shown by Schmittdiel et al. being seen by a healthcare professional of 
the preferred sex is not necessarily associated with higher satisfaction (2000). In fact, those 
women who took part in the study and chose a female doctor were the least satisfied with their 
experience (Schmittdiel et al., 2000). Reasons for this were, however, not reported. 
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Research has shown that being chaperoned is preferred by some but not all patients and that 
patients want to be involved in the decision whether or not to be chaperoned (Baber et al., 2007). 
Pharmacies could consider asking pharmacy users whether they would prefer to speak to a male 
or female pharmacist (where both are available) or would like to be chaperoned by a pharmacy 
healthcare assistant (where available). However, this would be an additional cost for the pharmacy 
as a member of staff needed for chaperoning consultations cannot cover the sales counter at the 
same time. Further, since pharmacy healthcare assistants are more likely to be female 
(Schafheutle et al., 2008), it is more difficult to provide a male chaperone for men who want to be 
chaperoned by a someone of the same sex. However, research has shown that men are less likely 
to have a preference regarding the sex of staff than females and are less willing to be chaperoned 
(Baber et al., 2007; Stanford et al., 2017). To date, there is no literature on chaperoning in 
pharmacies. Future research should explore pharmacy e  and aff attitudes towards 
introducing chaperoning in the pharmacy. Further, where possible, pharmacies should consider 
providing information online on whether female or male pharmacy staff is available and at which 
times. This would help pharmacy users to attend those pharmacies where they feel more 
comfortable to be delivered with SRHS.  
That homosexual people prefer to be counselled by health care professionals of the opposite sex 
has also been found in previous research where a physical examination was required (Poria et al., 
2019). The PhD findings suggest, however, that sex of staff not only matters where a physical 
examination is being performed but also when only a consultation is provided. Since, the PhD 
findings are based on a relatively small number of interviews, this has to be interpreted with 
caution and needs further exploration.  
Table 27 provides an overview of all recommendations relating to preferences regarding the sex 
of pharmacy staff.  
TABLE 27 RECOMMENDATIONS RELATING TO PREFERENCES REGARDING THE SEX OF PHARMACY STAFF 
Addressee of 
Recommendation(s) 
Recommendation(s) relating to preferences regarding the sex of 
pharmacy staff 
Practice  x Pharmacies should ask users whether they want to talk to a 
male or female pharmacist and could consider letting 
pharmacy healthcare assistants chaperone consultations if 
preferred by the pharmacy user; Pharmacies should also make 
information available online on whether and when female/male 
pharmacists are available  
Research  x F e e ea ch ho ld e plo e pha mac  e  and 
pharmacy staff attitudes towards introducing chaperoning for 
the delivery of sexual and reproductive health services  
x Future research ho ld al o e plo e pha mac  e  
preferences with regards to the sex of pharmacy staff 
delivering SRHS  
 
PhD Thesis | Discussion, Recommendations & Conclusion | Julia Gauly 
194 
 
10.3.3. Pharmacy staff user-interaction 
Both the systematic review and the interview study found that both staff and users perceived the 
interaction between them as largely positive. Most pharmacy users found that staff provided 
appropriate advice, were friendly, professional and polite. However, according to the systematic 
review, users perceived pharmacy consultations as less informative than clinic consultations. The 
ema ic e ie  al o ho ed ha  e  cha ac e i ic  ch a  age infl enced pha mac  aff 
willingness to offer services such as STI self-sampling kits and emergency contraception. A few 
pharmacy users in the interview study detailed negative experiences with pharmacy staff. These 
experiences were caused by staff lacking confidence, or being judgemental, discriminatory or 
di e pec f l of e  choice . According to the retrospective study, only a small number of 
people self-identifying as transgender accessed the services, suggesting that this group may face 
barriers to access or prefers to access other services available to them. For example, Umbrella 
has set up the first commissioned Trans Clinic in the country, in Birmingham (Umbrella, 2019) and 
possibly transgender people prefer accessing a clinic targeted to their needs over pharmacies.  
Further, it is also possible that transgender people were not captured in the data as only gender 
and not sex was recorded. Health providers should consider collecting both, details on the sex 
and gender to ensure that transgender people are identified in the dataset.  
One transgender woman who participated in the interview study stated that pharmacy staff should 
be trained in delivering services to transgender people, including the correct use of pronouns. In 
the UK, the pharmacy curriculum is firmly based on the European required syllabus (Sosabowski 
& Gard, 2008) and education on transgender care is currently not part of the pharmacy curriculum 
and training for pharmacy staff (Knockel et al., 2019). Since pharmacies are likely to be accessed 
by diverse populations, including transgender people, diversity training may be worth considering 
integrating into the pharmacy curriculum.  
The interaction between pharmacy staff and pharmacy users has also been identified as generally 
satisfying in previous research at another pharmacy service (Morrissey, 2017). However, as the 
systematic review showed, there is little research comparing experiences of pharmacy-based 
SRHS with the delivery of SRHS in clinics or General Practices. Further research on this should 
be conducted with large and diverse samples.  
The interview study showed that judgement of a e  choice  b  pharmacy staff negatively 
impac ed pha mac  e  e pe ience . J dgemen  f om heal hca e p ofe ional  ha  al o been 
found to be a concern for patients in different settings and services such as mental health services 
(Brooks et al., 2017). In contrast, non-judgemental attitudes were found to be associated with 
patients feeling reassured and cared for (N. Ferguson et al., 2019). Judgemental attitudes instead 
can lead to difficulty in providing emotional and psychological care for patients (Jittitaworn et al., 
2020) and result in negative patient experiences (N. Ferguson et al., 2019). 
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The importance of non-judgemental services has also been highlighted in research from the UK 
(Warren et al., 2016). Hence, pharmacy staff may benefit from training to ensure a non-
judgemental approach towards their patients.  
Patient-centred care (PCC) has emerged as a primary approach to health care (Jo Delaney, 2018). 
As part of this, the importance of respecting pa ien  choice  and deci ion  is increasingly 
recognised (Jo Delaney, 2018). In ol ing pa ien  in deci ion  can inc ea e pa ien   and 
confidence in healthcare professionals (Croker et al., 2013).  
Role-play training, which simulate situations in the pharmacy, can increase confidence when 
counselling patients and decrease the perception of the difficulty of completing tasks (Corelli et 
al., 2005; James et al., 2001; Rao, 2011). It should therefore be used in training. This was 
suggested by pharmacy staff interviewed as part of this PhD project.  
The recommendations relating to pharmacy staff-users interaction are provided in Table 28.  
TABLE 28 RECOMMENDATION(S) RELATING TO PHARMACY STAFF-USER INTERACTION 
Addressee of 
Recommendation(s) 
Recommendation(s) relating to pharmacy staff-user interaction 
Practice  x Pharmacies and commissioners should ensure pharmacy staff 
receives training including role-playing to increase staff 
confidence and a patient-centred approach (respectfulness of 
choice; non-judgemental attitude) 
x Pharmacies should record both sex and gender to capture 
transgender people in the data 
Research  x Research should explore consultation experiences on the 
same service from different providers on large and diverse 
samples 
 
10.3.4. P i ac  of pha mac  e  pe onal info ma ion 
Both the systematic review and the interview study identified that pharmacy users were 
uncomfortable or reluctant to share their personal information. According to the interview study, 
some pharmacy users were more likely to provide their personal information if the pharmacist 
assured them of the confidentiality of the service. However, for some users having to provide 
personal information was a barrier to access. Interview participants had mixed views on whether 
data should be shared with other health providers such as sexual health clinics. Some felt it would 
be beneficial as users would not have to provide information that they had shared previously at 
another sexual health providers.  
There is little information available on pharmacy users  experiences of being asked for personal 
information as part of a consultation in the pharmacy. However, one study from 2003 also showed 
that pharmacy users were reluctant to share their data (Seston et al., 2003). With regards to the 
discussion on information sharing with other health providers, a study from New Zealand explored 
pa ien  a i de o a d  info ma ion ha ing. I  ho ed ha  pa ien  an ed o be in ol ed in 
the discussion around sharing their information (Hunter et al., 2014). 
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The study also found that sharing patient information may create barriers to the attendance of 
SRHS (Hunter et al., 2014). A study from the UK showed, that 68% of sexual health clinic users 
found it important that sexual health clinic records were kept separate from GP and hospital 
records (Warren et al., 2016). Thi  o ld gge  ha  ha ing pha mac  e  da a widely is not 
acceptable to the general public. Future research should further explore the views of the public 
and of healthcare professionals regarding the risks and benefits of sharing personal information.  
Staff interviewed suggested that if pharmacy users could enter their details outside the 
consultation, e.g. via an app, this may make them more comfortable as they did not have to give 
their information out loud or face-to-face. Whether this would indeed help pharmacy users 
overcome their reluctance to provide data should be further explored.  
Recommenda ion  ela ing o p i ac  of pha mac  e  pe onal info ma ion i  p o ided in 
Table 29.  
TABLE 29 RECOMMENDATION(S) RELATING TO PRIVACY OF PHARMACY USERS' PERSONAL INFORMATION 
Addressee of 
Recommendation(s) 
Recommendation(s) relating to p i ac  of pha mac  e  pe onal 
information  
Research  x F e e ea ch ho ld e plo e he p blic  and heal h 
p ofe ional  a i de  o a d  ha ing da a be een 
healthcare providers or sexual health providers 
x Research should e plo e pha mac  e  pe cep ions about 
being asked for personal information when attending a 
pharmacy for SRHS 
 
10.3.5. Consultation outcomes of pharmacy-based chlamydia treatment and condoms  
The retrospective study found that most people attending for chlamydia treatment were provided 
with the antibiotic doxycycline rather than azithromycin. The retrospective study also showed that 
the majority of people attending for condoms were not provided with condom instructions. 
In contrast to the findings of this thesis, an earlier study on pharmacy-based delivery of chlamydia 
treatment, which was conducted in England and Wales between 2006 and 2008 found that the 
large majority of people (93.2%) were provided with azithromycin instead of doxycycline (C. 
Anderson & Thornley, 2011). The recommendation for first line treatment for chlamydia infections 
changed from azithromycin to doxycycline between 2010 and 2015; this possibly explains the 
difference in proportion of supply of doxycycline and azithromycin (Lanjouw et al., 2010; Nwokolo 
et al., 2016). 
Condom failure is a common problem (D. Greene et al., 2006; Shawe et al., 2001; Thompson et 
al., 1993) and condom instructions might positively contribute to safer sex. 
However, a recent study from the US showed that discussing the usage of condoms made men 
feel embarrassed and emasculated since they felt it was expected that they knew how to use them 
(Wilson, 2018); this may have caused users not to ask for or accept condom instructions in the 
PhD Thesis | Discussion, Recommendations & Conclusion | Julia Gauly 
197 
 
pharmacy. Pharmacy staff should record whether they asked pharmacy users for condom 
instructions and whether pharmacy users accepted or declined them.  
Table 30 provides an overview of recommendations relating to the consultation outcomes of 
pharmacy-based chlamydia treatment and condoms.  
TABLE 30 RECOMMENDATION(S) RELATING TO THE CONSULTATION OUTCOMES OF PHARMACY-BASED 
CHLAMYDIA TREATMENT AND CONDOMS 
Addressee of 
Recommendation(s) 
Recommendation(s) relating to the consultation outcomes of 
pharmacy-based chlamydia treatment and condoms 
Practice  x Pharmacies should record whether they asked pharmacy 
users if they wanted condom instructions and whether 
pharmacy users accepted or declined to receive them 
 
10.4. Implementing SRHS into pharmacies 
10.4.1. Pharmacy-based STI testing 
Both the systematic review and the interview study identified issues with pharmacy-based STI 
testing. According to the systematic review, pharmacy users found it inconvenient that they had 
to return their samples to designated pathology laboratories, had to wait for the test results and 
had to call the hospital during working hours to receive the STI test results. While pharmacy users 
interviewed as part of the PhD project also had to post the sample to a designated laboratory and 
to wait for the test results, they did not have to call for the test results. Instead, Umbrella  
pharmacy users are sent a text message via phone once the test result has been confirmed. 
Pharmacy users interviewed did not complain about this process, indicating that texting the test 
results is more acceptable. One of the studies included in the systematic review, showed that 
users of pharmacy-based HIV testing were comfortable with pharmacy staff conducting a finger 
prick test and that the pharmacist was able to obtain the blood sample on the first attempt.  
The blood sample which is part of Umbrella s STI self-sampling kits does not only test for HIV but 
also for syphilis. However, to test for syphilis, larger volumes of blood are required. Participants 
of the interview study who had obtained Umbrella  elf-sampling kit at the pharmacy expressed 
that they had difficulties with conducting the blood drawing. Users were required to take a lancet 
to draw blood into a tube. Some users therefore did not complete and return the test kit.  
Further, one dyslexic pharmacy user complained that the instructions for the STI self-sampling 
kits were difficult to follow. Pharmacy staff were aware that pharmacy users had difficulties with 
the blood test for STI self-sampling kits and suggested that they could assist with the blood testing. 
This idea was supported by pharmacy users. The retrospective study found that STI self-sampling 
kits accounted for about 10% of all service requests. 
Given that STI self-sampling kits were in contrast to other Umbrella services (e.g. chlamydia 
treatment, oral contraception, contraceptive injection) available in all Umbrella pharmacies ( Tie  
1  and Tie  2  pha macie ), the uptake was relatively low. It also needs to be considered that those 
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women in need for emergency contraception are potentially at risk of contracting an STI due to 
unprotected sexual intercourse and should therefore ideally be offered an STI self-sampling kit. 
Given that 30464 women were provided emergency contraception in Umbrella pharmacies 
between August 2015 and August 2018 but only 5830 STI self-sampling kits dispensed, there 
appears to be a missed opportunity for STI testing. It is possible that women presenting for 
emergency contraception were not offered or declined STI self-sampling kits. To make sure those 
who were at risk of contracting an STI are tested, it should be recorded whether women were 
offered a STI self-sampling kit and, where relevant, why they declined.  
Difficulties with drawing blood samples were also found to be an issue in another study on STI 
self-sampling kits (L. J. Brown et al., 2018). However, a Dutch study in which dried spot testing 
was used, reported that service users felt that the STI testing was easy to conduct (van Loo et al., 
2017). Further, in a study from the US, an oral test (OraQuick©) with comparable accuracy to 
provider-assisted testing in clinical setting was used to test for HIV and the large majority of users 
found it easy to conduct it (John et al., 2019). The large majority of participants in this study were 
able to correctly self-test the STI results in the correct time window (John et al., 2019). Hence, 
other ways of self-sampling or self-testing such as the dried spot test or an oral test may be more 
feasible to conduct for users and sexual health providers could consider using these rather than 
samples where blood needs to be drawn into tubes. Low uptake and return rates of STI self-
sampling kits due to problems with or fear of the blood test are not cost-effective and inefficient 
in addressing STI rates.  
Further, another study in which pharmacist assisted with a dry blood spot syphilis screening in 
the pharmacy was found to be acceptable to pharmacy users (Buchanan et al., 2016). Pharmacist-
assisted STI testing was also supported by staff and users interviewed for this thesis. However, 
pharmacist-assisted screening requires commitment and training for the pharmacist and also 
potentially puts the pharmacist at risk as they have to handle blood from pharmacy users who 
may carry a blood-borne infection (H. Wood & Gudka, 2018). Hence, while a pharmacist assisted 
STI testing scheme may be accepted by staff and users, staff safety must be considered. Evidence 
on pharmacist assisted STI testing is still limited and more evidence is needed. Further, how 
labelling and instructions for STI self-sampling kits could be improved, particularly for dyslexic 
people should be explored. Recommendation(s) relating to pharmacy-based STI testing are 
provided in Table 31. 
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TABLE 31 RECOMMENDATION(S) TO PHARMACY-BASED STI TESTING 
Addressee of 
Recommendation(s) 
Recommendation(s) relating to pharmacy-based STI testing  
Practice  x Sexual health providers should consider replacing collecting 
the blood sample test using a lancet by a more acceptable 
method (e.g. oral testing, dry blood spot testing) or consider 
introducing pharmacist assistance with the testing (with 
appropriate additional training) 
Research  x More research on pharmacist assisted STI testing is needed to 
explore how to make STI self-sampling kits more acceptable 
and easier to use -including for people with a disability and 
other disadvantaged groups 
 
10.4.2. Pharmacist-assisted contraceptive injection 
Only one study included in the systematic review and one pharmacy user interviewed gave insight 
into the experience of pharmacy-assisted contraceptive injection. While the pharmacy user 
interviewed had a positive experience and remarked that the injection was painless and quick, 
mixed experiences were reported from the study included in the systematic review. The 
contraceptive injection was also found to be the least requested of all SRHS offered by Umbrella 
offers. 
Evidence on pharmacist-assisted contraceptive injection is scarce. In line with findings from this 
current thesis, mixed experiences were also reported in this study and the authors concluded that 
pharmacie  service quality needed to be improved and training for pharmacy staff be expanded 
(Gonsalves et al., 2019).  
A recent study from the UK showed that only 33% (66/191) of those women who were not 
currently using the contraceptive injection would consider getting the contraceptive injection from 
a pharmacy (Rebecca Heller & Cameron, 2016). Hence, a lack of interest may explain the low 
uptake of pharmacy-based contraceptive injection. However, it also possible that the uptake was 
relatively low because women were not aware that the service was available. 
More research on access to pharmacist-assisted contraceptive injection is needed. Different 
aspects such as experience, awareness, satisfaction and uptake should be explored. The 
recommendation relating to pharmacist-assisted contraceptive injection is provided in Table 32.  
TABLE 32 RECOMMENDATION(S) RELATING TO PHARMACIST-ASSISTED CONTRACEPTIVE INJECTION 
Addressee of 
Recommendation(s) 
Recommendation(s) relating to pharmacist-assisted contraceptive 
injection  
Research  x More research on the provision of pharmacist-assisted and 
self-administered contraceptive injection from pharmacies 
should be performed (e.g. experiences, awareness, 
satisfaction, uptake) 
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10.4.3. Awareness of pharmacy-based SRHS 
According to both staff and users, people were not aware of the full range of SRHS, the eligibility 
criteria for the services (e.g. age and gender), and the availability of services in terms of which 
pharmacies offered the services. Further, the interview study found that one pharmacy user was 
charged for the Umbrella service by a pharmacy healthcare assistant who wrongly believed that 
Umbrella  SRHS e e onl  f ee fo  a ce ain age g o p. The e o pec i e d  ho ed ha  
emergency contraception, condoms and STI self-sampling kits were the most requested services. 
In line with the findings from the PhD project, several studies have shown that there is a lack of 
awareness for the range of extended pharmacy services (Cooper & Tsoneva, 2017; Ali M.K. Hindi 
et al., 2018; Maclure et al., 2018; Ramsbottom et al., 2016; R. M. Rodgers et al., 2016). While out 
of scope of this PhD, i  i  po ible ha  a a ene  fo  e ice  i  linked o people  ocioeconomic 
status. Heal h li e ac , defined a  pe on  abili  o acce  heal h info ma ion(Sørensen et al., 
2012), has been found to be lower in people from lower educational levels in a recent review 
(Stormacq et al., 2019).  
A study from the US showed that there was a significant positive correlation between awareness 
and the utilisation of pharmacy services (Dooda et al., 2017). Hence, increasing awareness may 
lead to an increase in uptake of SRHS. The retrospective study has shown that emergency 
contraception, condoms and STI self-sampling kits have been the most requested services over 
the past three years. Possibly, this was because these three services have been available from 
the pharmacy without prescription for a longer time, whereas prescription-free oral contraception, 
contraceptive injection and chlamydia treatment are novel services, which are not available in all 
areas in England. However, it is also possible that those women presenting for emergency 
contraception were additionally provided with condoms (to prevent STIs and pregnancy in the 
future) and STI self-sampling kits (to test for STIs after unprotected sexual intercourse). More data 
on the uptake of pharmacy-based SRHS is needed to provide context to these findings.  
Participants in the interview study suggested increasing awareness through more advertising. In 
Uganda, researchers are exploring whether mobile phone applications may increase awareness 
and the uptake of sexual and reproductive health services using a randomised controlled trial 
(Nuwamanya et al., 2018). However, the results have not been published yet. A recent study has 
shown that advertising campaigns can increase the uptake of STI testing amongst males in a 
university setting (E. A. Anderson et al., 2016). However, more research on this is needed. 
Exploring the relationship between awareness and uptake and how these relate to user 
characteristics (e.g. age, ethnicity, socioeconomic status) would also contribute to understanding 
whether the delivery of services is likely to be cost-effective. 
 
Further, studies comparing awareness and uptake of SRHS by health providers such as 
pharmacies, General Practices and Sexual Health or Family Planning Clinic are needed to better 
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nde and pha macie  con ib ion o an integrated system of healthcare delivery at a local, 
regional or national level.  
Pharmacy users complained that it was difficult to find out where and which types of services 
could be accessed. Pharmacies should ensure that their online information is clear and up to date. 
Further, the case where a pharmacy user interviewed was wrongly charged for a service highlights 
the importance of staff training. It is recommended that pharmacies train all pharmacy staff, 
including pharmacy healthcare assistants, on the services that the pharmacy provides in order to 
prevent misinformation being passed on to pharmacy users. Currently, Umbrella s training is only 
compulsory for pharmacists.  
An overview of the recommendations relating to awareness of pharmacy-based SRHS are 
provided in Table 33. 
TABLE 33 AWARENESS OF PHARMACY-BASED SRHS 
Addressee of 
Recommendation(s) 
Recommendation(s) relating to awareness of pharmacy-based SRHS 
Practice  x Pharmacies should include compulsory training for pharmacy 
healthcare assistants 
x Pharmacies should ensure their online information on available 
services is clear and up to date 
Research  x Future research should explore the association between 
awareness, advertising and uptake of services in pharmacies 
and other service providers (e.g. General Practices, Clinics) 
and how these relate to characteristics of the user (e.g. 
ethnicity, age, socioeconomic status)  
 
10.4.4. Clinical support for pharmacies 
According to the interview study, pharmacy staff sometimes experienced difficulties in getting 
through to the clinical advice line, which was set up to support Umbrella pharmacists in clinical 
decision making. Further, pharmacists complained that there were insufficient clinical 
appointments for women presenting for the copper coil available. The retrospective study showed 
that less than one percent of women presenting for emergency contraception were provided with 
a copper coil appointment or referral.  
While it can be perceived positively that pharmacies were provided with a clinical advice line, 
health providers should ensure that pharmacies are provided with sufficient support. Health 
providers could for example sent out feedback forms to pharmacies to evaluate their satisfaction 
with the clinical advice line.  
Pharmacists in the interview study complained about a lack of clinical appointments for the copper 
coil for women presenting for emergency contraception. 
Possibly, lack of appointments was the reason why the number of copper coil appointments 
identified through the retrospective study was low. Lack of availability of IUD appointments due to 
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few appointments with a trained provider has also been shown to be a barrier to its use in a study 
from the US where mystery callers contacted primary care, family planning and Ob/Gyn clinics to 
get an appointment (Schubert et al., 2016). However, it is also possible that women were reluctant 
to accept the copper IUD. Previous research showed that the interest of emergency contraception 
users in the copper coil is low (Turok et al., 2011) and that women have concerns about the long-
acting nature and safety of intrauterine contraception (S. Walker et al., 2016). Further, it may also 
be that women were not offered the copper coil by pharmacy staff.  
Research should explore how many women are offered and accept or decline the copper coil 
IUD, and the reasons for their decision. Further, the number of those who agreed to get a copper 
coil IUD and subsequently get an appointment should be measured. This will help to assess 
whether clinical appointments are indeed a barrier to access. For this research to be conducted, 
pharmacies have to ensure that the relevant data is recorded.  
The list of recommendations is provided in Table 34.  
TABLE 34 RECOMMENDATION(S) RELATING TO THE COLLECTION AND USE OF PERSONAL INFORMATION 
Addressee of 
Recommendation(s) 
Recommendation(s) relating to collection and use of personal 
information  
Practice  x Health providers should evaluate how many women attending 
for emergency contraception are offered the copper coil IUD, 
and how many accept 
Research  x Future research should explore the reasons why women 
attending for emergency contraception accept or decline the 
copper coil as IUD and the effectiveness of pathways to insert 
an IUD  
 
10.5. Impact of delivering SRHS on pharmacy staff 
10.5.1. Pharmacy staff workload 
Both the systematic review and the interview study showed that the delivery of SRHS added 
workload and was sometimes stressful for pharmacy staff. The collection of data relating to the 
consultation was the most commonly named factor contributing to the increased workload. Both 
the systematic review and the interview study suggested that collecting data electronically (rather 
than on paper forms) would contribute to greater time efficiency. Further, creating an opportunity 
for pharmacy users to pre-register themselves for the service was identified to have potential to 
shorten and use the consultation time more effectively. The key factor associated with the 
perception of workload was the level of staffing. Pharmacy staff working in pharmacies where 
several pharmacists and pharmacy healthcare assistants were employed experienced a lower 
workload compared to those working in pharmacies where only a single pharmacist and less 
pharmacy healthcare assistants were employed. Pharmacy staff in the interview study described 
that they sometimes had to multitask. 
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For example, some pharmacists described that they were labelling medications at the same time 
as delivering the consultation on SRHS due to time pressure. There were mixed views on whether 
workload could be allocated to pharmacy healthcare assistants to take pressure from pharmacists, 
who were more affected by the added workload than pharmacy healthcare assistants. 
Several studies found that the workload for pharmacy staff has increased over time (W. Gidman, 
2011; W. K. Gidman et al., 2007). Concerns about workload and time constrains have also been 
identified in several studies on pharmacy staff attitude towards the implementation of extended 
services (Family et al., 2014; W. Gidman, 2011; Hilverding & Mager, 2017). Further, research from 
England has shown that satisfaction levels with workload were low (Morrissey, 2017). In line with 
findings from this thesis, completing administrative work has also been identified to be a 
contributor to added workload in a previous study (Pumtong et al., 2008). 
Insufficient staffing levels causing pharmacy staff to feel under pressure to deliver services quickly 
has also been reported in another study on pharmacy services (Barnes et al., 2018). Further, a 
previous study has shown that pharmacy staff were concerned that having to multitask would 
increase the risk of errors (Family et al., 2014; W. Gidman, 2011).  
A study from England found that delegating tasks to support staff could indeed improve the 
management of workload (V. M. Lea et al., 2016). However, it also reported that some pharmacists 
were reluctant to delegate work (V. M. Lea et al., 2016). More research should explore 
pha maci  and pha mac  heal hca e a i an  a i de  o a d  hif ing sexual and 
reproductive healthcare tasks to pharmacy healthcare assistants.  
A recent study showed that pharmacists believed that mobile apps could hold a role in modern 
day pharmacy practice (Davies et al., 2014). However, the option to let pharmacy users pre-
register themselves and provide relevant data (e.g. age, gender, ethnicity, information relevant to 
deliver service) has not yet been explored. However, using apps for this purpose could reduce 
the consultation time in pharmacies. Further, linking to topic of p o i ion of pha mac  e  
personal information (described in section 9.3.3) pre-registration may also make pharmacy users 
who are reluctant to provide personal information face-to-face more comfortable. Research 
should explore e  and aff attitudes towards options for pharmacy users to pre-register 
themselves. 
Given that workload is evidently a concern for many pharmacy staff members, policymakers and 
health providers should not introduce new pharmacy services without exploring their feasibility in 
terms of workload in advance. Further, providing guidance on how many pharmacy staff members 
are necessary to run certain services should be considered. Finally, pharmacies should move 
towards the use of electronic records to increase work efficiency. Recommendations relating to 
pharmacy staff workload are provided in Table 35.  
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TABLE 35 RECOMMENDATIONS RELATING TO PHARMACY STAFF WORKLOAD 
Addressee of 
Recommendation(s) 
Recommendation(s) relating to pharmacy staff workload 
Practice  x Commissioners could specify in their commissioning brief that 
electronic patient records are needed; equally, pharmacies 
should use electronic records; this should include pharmacy 
healthcare assistants being allowed to securely record data 
electronically 
Policymakers x Policymakers should test the feasibility of adding more 
pharmacy services in terms of workload; guidance on the 
number of staff members needed to deliver services are 
required 
Research  x Future research should explore pharmacy e  and staff 
attitudes towards pre-registration for pharmacy services  
x The feasibility and acceptability of training pharmacy 
healthcare assistants to deliver more services should be 
further explored 
 
10.5.2. Pharmacy staff motivation and recognition  
Both the systematic review and the interview study showed that pharmacy staff were generally 
motivated to expand their role and deliver SRHS. Financial benefits (e.g. from an increase in 
footfall in the pharmacy and the remuneration for delivering Umbrella s services) were not 
mentioned by pharmacy staff members interviewed as motivating factor to deliver SRHS. In fact, 
according to the systematic review and interview study, some pharmacy staff felt they did not 
receive sufficient financial recognition for delivering services. However, pharmacy staff were not 
directly asked in the interviews whether financial benefits from Umbrella s services motivated 
them to deliver the SRHS as this question would have been leading.  
Motivation has been found to be an important consideration when planning to deliver new services 
(S. Michie et al., 2011). When staff are motivated they are more likely to deliver new services (T. 
Greenhalgh et al., 2016). Equally, evidence on extended pharmacy services other than SRHS 
show that the delivery of new services can increase staff motivation and satisfaction (L. Hattingh 
et al., 2020; Luetsch, 2017; Thomson et al., 2019). However, in line with findings from this thesis, 
dissatisfaction with remuneration has previously been found to be a concern in previous research 
on extended services from England (Ali M.K. Hindi et al., 2019; Morrissey, 2017). Hence, lack of 
financial compensation is not unique to SRHS but for a range of extended pharmacy services. 
Policymakers and pharmacies should consider offering more attractive financial incentives in 
order to keep staff motivated and make them feel recognised. If financial payment is not feasible 
then other ways to show appreciation might be considered, for example providing staff feedback 
or award events may contribute to a feeling of recognition.  
An overview of the recommendations relating to pharmacy staff motivation and recognition are 
presented in Table 36. 
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TABLE 36 RECOMMENDATION(S) RELATING TO PHARMACY STAFF MOTIVATION AND RECOGNITION 
Addressee of 
Recommendation(s) 
Recommendation(s) relating to pharmacy staff motivation and 
recognition 
Practice  Pharmacies should consider offering more attractive financial 
compensation or other incentives for delivering extended services to 
their staff  
Policymakers Policymakers should consider whether to regulate how pharmacy staff 
should be incentivised for going beyond their traditional role 
 
10.5.3. Uptake of pharmacy-based SRHS by age 
The retrospective study showed that those between 16 and 24 accounted for more than 50% of 
SRHS requests.  
Young people are particularly vulnerable to poor sexual health outcomes (Gonsalves & Hindin, 
2017; Slater & Robinson, 2014). This was also shown in a study from the Netherlands where the 
positivity rate for chlamydia was higher in the 15-24 age group compared to the overall average 
(14% versus 5%) (van Bergen et al., 2004).  
The finding from the retrospective study suggests that pharmacies are reaching young people 
who are at high need for SRHS. When comparing the findings from the retrospective study to a 
recent study from Birmingham (Banerjee et al., 2018), a higher proportion of young people 
between 16 and 24 were accessing the pharmacy rather than sexual health clinics for STI 
screening (62.9% versus 50%). This suggests, that pharmacy-based STI testing is more 
acceptable to this demographic than clinic-based testing. Future research should explore how 
young people decide where to access SRHS. Further, more data on the uptake of pharmacy-
ba ed SRHS in e m  of e  cha ac e i ic  i  needed o p o ide con e  o o  finding . 
Recommendations relating to the uptake of pharmacy-based SRHS are presented in Table 37.  
TABLE 37 RECOMMENDATION(S) RELATING TO THE UPTAKE OF PHARMACY-BASED SRHS BY AGE 
Addressee of 
Recommendation(s) 
Recommendation(s) relating to the uptake of pharmacy-based SRHS 
by age 
Research  x Research should explore what factors affect how young people 
decide where to access SRHS  
x The use of pharmacy-based SRHS acco ding o e  
demographic and behavioural data should be analysed further 
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10.5.4. Uptake of pharmacy-based SRSH by ethnicity 
According to the retrospective study, White/White British individuals were the largest group who 
accessed pharmacy services (43.3%), followed by Asian/Asian British (23.1%), Black/Black British 
(15.1%), mixed (6.4%) and other ethnic groups (2.0%). 
When comparing the findings to the latest census data from Birmingham, ethnic groups were 
represented approximately proportionally to their prevalence (Birmingham City Council, 2011)  
White/White British (census 57.9% cf. study population 43.4%), Asian/Asian British (census 23.7% 
cf. study population 23.1%), Black/Black British (census 7.2% cf. study population 15.1%), 
Mixed/Mixed British (census 4.4% cf. study population 2.0%) and other ethnic groups (census 
6.7% cf. study population 5.8%). Black/Black British appeared to be over-represented in 
comparison to the local population, suggesting that pharmacies may reach those associated with 
potentially poor sexual health outcomes (Fenton, 2001). However, in comparison to 2018 sexual 
health clinic data from Birmingham (Umbrella, 2018), people from Black/Black British or other 
ethnic groups appeared to be less likely to attend the pharmacy rather than the clinic for SRHS 
(clinic: 25% cf. pharmacy: 15.1%). In contrast, Asian/Asian British people appeared to be more 
likely (clinic: 18% cf. pharmacy: 23.1%) and White/White people as likely to attend the pharmacy 
(clinic: 43% cf. pharmacy: 43.4%) for SRHS. This suggests that ethnic minorities prefer different 
healthcare settings for SRHS. However, due to limitations of the dataset, available data identified 
only the number of service requests rather than the number of individual patients. Hence, this 
finding has to be treated with caution. Exploring differences in SRHS attendance of different 
settings by ethnicity and reasons for preferences should be further explored in the future.  
Health providers should collect data in a way that allows analysis of service requests on an 
individual level to better understand whether the uptake of services is representative of the 
population in Birmingham. This would help to identify people who are not currently reached by 
pharmacy-based SRHS.  
TABLE 38 RECOMMENDATION(S) RELATING TO THE UPTAKE OF PHARMACY-BASED SRHS BY ETHNICITY 
Addressee of 
Recommendation(s) 
Recommendation(s) relating to uptake of pharmacy-based SRHS by 
ethnicity 
Practice  x Pharmacies should collect demographic and behavioural data 
at the level of the individual to better understand whether the 
service is reaching higher risk groups 
 
10.5.5. Uptake of pharmacy-based SRHS by the day of the week  
The retrospective study showed that the uptake of services was the highest overall on Mondays 
and the lowest on Sundays. Attendance patterns by the day of the week varied by gender. 
Emergency contraception, condoms and STI self-sampling kits were most commonly requested 
by women on Mondays. Men were most likely to obtain condoms from pharmacies on Fridays. 
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In line with this, previous studies on emergency contraception also found that the uptake of 
emergency contraception was highest on Monday (Killick & Irving, 2004; Mantzourani et al., 2019). 
This suggests that sexual activity is more likely to occur on the weekend. This could also explain 
why males are most likely to attend for condoms on Fridays. This assumption is supported by a 
study from Singapore which found that sexual activity occurs more frequently on the weekend 
(Tan, 2020). However, more research exploring when sexual activity is most likely to occur is 
needed as this could inform health providers in preparing their stock and in deciding when to have 
a pharmacist trained in the provision of emergency contraception available.  
Policymakers have increasingly tried to deliver integrated sexual health services, where several 
sexual health and contraceptive needs can be addressed at one site visit (PHE & DH, 2018). It 
was found that emergency contraception, STI self-sampling kits and condoms were most 
frequently requested on Mondays. It is likely that those women attending on Mondays were 
additionally provided with STI self-sampling kits (as they had been at risk of contracting an STI 
through unprotected sexual intercourse) and condoms (to prevent unwanted pregnancy and STI 
contraction in the future). This would suggest that principles of integrated sexual and reproductive 
health services in the pharmacy are working. However, as no dates of attendance were available, 
it was not possible to analyse whether women were indeed provided with all three services in one 
day (rather than in three different visits). For future research, it would be important that the date 
of attendance (day/month/year) is included so that research can explore whether the integrated 
sexual and reproductive health service delivery, where several sexual and reproductive health 
needs are addressed in one visit, is indeed working. Data on the date of service request within the 
PhD quantitative analysis was not provided d e o conce n  abo  pha mac  e  anon mi . 
Having access to the date of attendance would also have allowed for the analysis of service uptake 
over time. It was also not possible to analyse service uptake at an individual level because 
pharmacy users obtained a new identification number whenever they entered a different 
pharmacy. Health providers should try to create a system where uptake of services can be 
tracked. This would help analyse what proportion of different types of pharmacy users (e.g. in 
terms of demographics) were provided with further services.  
In line with previous research on emergency contraception (Killick & Irving, 2004; Mantzourani et 
al., 2019), the retrospective study showed that service requests for emergency contraception 
were lowest on Sundays. This could be explained by less demand on Sunday but also by less 
uptake due to barriers to access. According to current data provided by Umbrella, the majority of 
Umbrella  pha macie  a e clo ed on S nda  (76.7%, 122/159), gge ing ha  limi ed S nda  
access was the main reason for low uptake. However, historic data is not available on the opening 
times of Umbrella pharmacies. Hence, it could be that opening times varied in the past. Health 
providers should ideally keep track of opening times of pharmacies and availability of trained staff. 
Demand, service uptake and opening times should be further explored in future research to 
understand whether Sunday access is a barrier to pharmacy-based SRHS. 
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An overview of the recommendations relating to the uptake of pharmacy-based SRSH by the day 
of the week are provided in Table 39.  
TABLE 39 RECOMMENDATION(S) RELATING TO UPTAKE OF SERVICES BY THE DAY OF THE WEEK 
 Addressee of 
Recommendation(s) 
Recommendation(s) relating to uptake of services by the day of the 
week 
Practice  x Health providers and pharmacies should record pharmacy 
opening times 
Research  x Future research should explore when sexual activity is most 
likely to occur as this can inform sexual healthcare provision 
x Demand and service provision for time sensitive services such 
as emergency contraception should be further explored 
 
10.6. Overview of Recommendations  
In section 10.2 to 10.5, recommendations were developed along the discussion of the integrated 
findings. In this section, the recommendations are briefly summarised according to the addressee 
(practice, policymakers or future researchers).  
10.6.1. Recommendations for practice 
Many of the recommendations for practice were for pharmacies to extend or improve the way that 
pharmacy staff are trained on the SRHS in order to increase the service quality (e.g. adding more 
roleplaying to training to make staff more confident, training on the discreet delivery of services). 
Recommendations relating to training have the potential to improve service quality for pharmacy 
users (e.g. by making training on SRHS compulsory for pharmacy healthcare assistants; by 
moni o ing/ a di  he he  aining fo  pha mac  aff i  effec i e). Rela ing o pha mac  e  
experience, further recommendations to make services more user-friendly (e.g. by changing way 
that STI blood samples are collected; making information on whether and when male/female staff 
and trained are available in the pharmacy) or keep them user friendly (e.g. keeping walk-in 
services and long opening times). Other recommendations aimed to improve pharmacy staff 
satisfaction (e.g. providing pharmacy staff with incentives or remuneration for service delivery). 
Further, recommendations for pharmacies were made to meet NHS guidelines (e.g. ensuring sure 
that the consultation room is soundproof). By increasing service quality and making services more 
user- and staff-f iendl , i  i  likel  ha  pha mac  e  and aff e pe ience  of the service will 
increase. 
Other recommendations for practice aimed to facilitate research on pharmacies (e.g. collecting 
da a on bo h e  and gende  of pha mac  e ; collec ing da a on he he  condom 
instructions/copper coil appointment where provided; collect data in a way that allows to analyse 
data on individual level). By facilitating research, more evidence understanding how pharmacies 
contribute to the delivery of SRHS and other services can be conducted, which again can help to 
optimise services. An overview of all recommendations for practice is provided in Table 40.  
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TABLE 40 RECOMMENDATIONS FOR PRACTICE 
Recommendations for Practice 
Recommendation Theme 
x Pharmacies should continue to offer walk-in consultations 
and long opening hours as convenience is perceived as a 
key strength of pharmacies 
Recommendation(s) relating 
to convenience of pharmacy-
based SRHS 
x Pharmacies should ensure that their consultation rooms 
meet the privacy requirements by NHS England, e.g. in 
terms of being soundproof 
x More effective training for pharmacy staff on the 
importance of the discreet delivery of services is needed; 
x Monitoring of adherence to guidelines and training relating 
to privacy is needed 
Recommendation(s) relating 
to need for physical privacy 
in the pharmacy 
x Pharmacies should ensure that there are trained staff 
available at all times or ensure that there is information 
available for pharmacy users to check when trained staff 
are available 
x Pharmacies should have referral plan in place to ensure 
that pharmacy users can be directed to another health 
provider if no pharmacy staff are available 
Recommendation(s) relating 
to the need for trained 
pharmacy staff 
x Pharmacies should try to improve privacy as this may 
increase the uptake of males 
x Health providers should use multilevel interventions to 
increase the uptake of males 
Recommendation(s) relating 
to the uptake of pharmacy-
based SRHS by males 
x Pharmacies should consider providing access to 
translation services/ translated material for services 
Recommendation(s) relating 
to language and 
communication barriers 
between pharmacy staff and 
users 
x Pharmacies should ask users whether they want to talk to a 
male or female pharmacist and could consider letting 
pharmacy healthcare assistants chaperone consultations if 
preferred by the pharmacy user; Pharmacies should also 
make information available online on whether and when 
female/male pharmacists are available 
Recommendation(s) relating 
to preferences regarding the 
sex of pharmacy staff 
x Pharmacies and commissioners should ensure pharmacy 
staff receives training including role-playing to increase 
staff confidence and a patient-centred approach 
(respectfulness of choice; non-judgemental attitude) 
x Pharmacies should record both sex and gender to capture 
transgender people in the data 
Recommendation(s) relating 
to pharmacy staff-user 
interaction 
x Pharmacies should record whether they asked pharmacy 
users if they wanted condom instructions and whether 
pharmacy users accepted or declined to receive them 
Recommendation(s) relating 
to the consultation outcomes 
of pharmacy-based 
chlamydia treatment and 
condoms 
x Sexual health providers should consider replacing 
collecting the blood sample test using a lancet by a more 
acceptable method (e.g. oral testing, dry blood spot 
testing) or consider introducing pharmacist assistance with 
the testing (with appropriate additional training) 
Recommendation(s) relating 
to pharmacy-based STI 
testing 
x Pharmacies should include compulsory training for 
pharmacy healthcare assistants 
x Pharmacies should ensure their online information on 
available services is clear and up to date 
Recommendation(s) relating 
to awareness of pharmacy-
based SRHS 
x Health providers should evaluate how many women 
attending for emergency contraception are offered the 
copper coil IUD, and how many accept 
Recommendation(s) relating 
to collection and use of 
personal information 
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x Pharmacies should digitalise the collection of data; this 
should include pharmacy healthcare assistants being 
allowed to securely record data electronically 
Recommendation(s) relating 
to pharmacy staff workload 
x Pharmacies should consider offering more attractive 
financial compensation or other incentives for delivering 
extended services to their staff 
Recommendation(s) relating 
to pharmacy staff motivation 
and recognition 
x Pharmacies should collect demographic and behavioural 
data at the level of the individual to better understand 
whether the service is reaching higher risk groups 
Recommendation(s) relating 
to uptake of pharmacy-based 
SRHS by ethnicity 
x Health providers and pharmacies should record pharmacy 
opening times 
Recommendation(s) relating 
to uptake of services by the 
day of the week 
 
10.6.2. Recommendations for policymakers 
A few recommendations for policymakers were made. Some aimed to improve pharmacy staff 
experience (e.g. by considering testing that workload for extended pharmacy services is feasible 
for staff before implementation; by considering whether to provide staff with a financial incentive 
to deliver services). One recommendation aimed to improve communication between staff and 
users (e.g. by considering whether to offer pharmacies the possibility to get access to translating 
services). One recommendation is considering the current COVID-19 pandemic and therefore be 
considered to more urgent to address than others. An overview of all recommendations for 
policymakers can be found in Table 41.  
TABLE 41 RECOMMENDATIONS FOR POLICYMAKERS 
Recommendations for Policymakers 
Recommendation Theme 
x NHS England should provide guidelines 
on how to deliver pharmacy-based SRHS 
while ensuring privacy, including during 
pandemics such as COVID-19 
Recommendation(s) relating to need for 
physical privacy in the pharmacy 
x Policymakers in England should consider 
of establishing a translating services 
following the Australian Translating and 
Interpreting services 
Recommendation(s) relating to language and 
communication barriers between pharmacy 
staff and users 
x Policymakers should test the feasibility of 
adding more pharmacy services in terms 
of workload; guidance on the number of 
staff members needed to deliver services 
are required 
Recommendation(s) relating to pharmacy staff 
workload 
x Policymakers should consider whether to 
regulate how pharmacy staff should be 
incentivised for going beyond their 
traditional role 
Recommendation(s) relating to pharmacy staff 
motivation and recognition 
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10.6.3. Recommendations for future research 
In this section, recommendations for future research which were identified through the integration 
of findings are summarised. Additionally, further considerations for future research are 
highlighted.  
Recommendations for future research based on the integrated findings 
The findings from the systematic review and interview study showed that privacy is a concern for 
pharmacy users. However, little research address privacy in the pharmacy. Possibly, a workshops 
or Ideas Café with pharmacy staff, designers, and members from the public could be used to 
explore solutions (Ulahannan et al., 2018). Many recommendations were made, which could be 
explored through pharmacy staff (e.g. barriers to SRHS training; attitude towards letting pharmacy 
users pre-register themselves before the consultation) and pharmacy users (e.g. pharmacy users 
attitude towards data sharing, attitude towards having opportunity to pre-register themselves, 
preferences regarding sex of pharmacy staff, attitudes towards being chaperoned in the 
pha mac ). S e  co ld al o be ed o compa e people  e pe ience i h diffe en  pe  of 
STI self-sampling kits. In order to explore how best to address language barriers, different 
interventions could be trialled in different pharmacies (e.g. translating services versus translated 
material versus both translating services and translated material) to explore how best to overcome 
language barriers in areas with high proportions how cannot speak English (well). In order to 
explore the impact of not having trained staff available mystery shoppers could be used to test 
the availability of staff at different times of the day and the week. (Secondary) analysis of data 
would be appropriate to address other research questions (e.g. uptake of contraceptive injection 
and the copper coil; uptake of SRHS between different providers). The list of recommendations 
for future research is provided in Table 42.  
TABLE 42 RECOMMENDATIONS FOR FUTURE RESEARCH (BASED ON THE INTEGRATED FINDINGS) 
Recommendations for future research 
Recommendation Theme 
x Future research should explore innovative 
and cost-effective solutions to provide 
privacy to pharmacy clients 
Recommendation(s) relating to need for  
physical privacy in the pharmacy 
x Future research should explore the 
impact of not having trained staff 
available and reasons for staff not to 
obtain training 
x Future research should explore how to 
overcome barriers to training 
Recommendation(s) relating to the need for 
trained pharmacy staff 
x Research should explore barriers to 
pharmacy-based SRHS for males 
x Research should compare the uptake of 
services by different sexual and 
reproductive health providers (e.g. 
pharmacies, clinics and General 
Practices) and by gender 
Recommendation(s) relating to the uptake of 
pharmacy-based SRHS by males 
x Future research should explore solutions 
to address language barriers (e.g. 
Recommendation(s) relating to language and 
communication barriers between pharmacy 
staff and users 
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translating services, resources translated 
in several languages) 
x Future research should explore 
pha mac  e  and pha mac  aff 
attitudes towards introducing 
chaperoning for the delivery of sexual 
and reproductive health services  
x Future research should also explore 
pha mac  e  p efe ence  i h ega d  
to the sex of pharmacy staff delivering 
SRHS 
Recommendation(s) relating to preferences 
regarding the sex of pharmacy staff 
x Research should explore consultation 
experiences on the same service from 
different providers on large and diverse 
samples 
Recommendation(s) relating to pharmacy 
staff-user interaction 
x Future research should explore the 
p blic  and heal h p ofe ional  
attitudes towards sharing data between 
healthcare providers or sexual health 
providers 
x Re ea ch ho ld e plo e pha mac  e  
perceptions about being asked for 
personal information when attending a 
pharmacy for SRHS 
Recommendation(s) relating to privacy of 
pha mac  e  pe onal info ma ion 
x More research on pharmacist assisted STI 
testing is needed to explore how to make 
STI self-sampling kits more acceptable 
and easier to use -including for people 
with a disability and other disadvantaged 
groups 
Recommendation(s) relating to pharmacy-
based STI testing 
x More research on the provision of 
pharmacist-assisted and self-
administered contraceptive injection from 
pharmacies should be performed (e.g. 
experiences, awareness, satisfaction, 
uptake) 
Recommendation(s) relating to pharmacist-
assisted contraceptive injection 
x Future research should explore the 
association between awareness, 
advertising and uptake of services in 
pharmacies and other service providers 
(e.g. General Practices, Clinics) and how 
these relate to characteristics of the user 
(e.g. ethnicity, age, socioeconomic status) 
Recommendation(s) relating to awareness of 
pharmacy-based SRHS 
x Future research should explore the 
reasons why women attending for 
emergency contraception accept or 
decline the copper IUD, and the 
effectiveness of referral pathways to insert 
an IUD 
Recommendation(s) relating to collection and 
use of personal information 
x Future research should explore 
pharmacy e  and staff attitudes 
towards pre-registration for pharmacy 
services  
x The feasibility and acceptability of training 
pharmacy healthcare assistants to deliver 
more services should be further explored 
Recommendation(s) relating to pharmacy 
staff workload 
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x Research should explore what factors 
affect how young people decide where to 
access SRHS  
x The use of pharmacy-based SRHS 
acco ding o e  demog aphic and 
behavioural data should be analysed 
further 
Recommendation(s) relating to the uptake of 
pharmacy-based SRHS by age 
x Future research should explore when 
sexual activity is most likely to occur as 
this can inform sexual healthcare 
provision 
x Demand and service provision for time 
sensitive services such as emergency 
contraception should be further explored 
Recommendation(s) relating to uptake of 
services by the day of the week 
 
Further considerations for future research 
The systematic review showed that evidence on pharmacy-based sexual and reproductive health 
services was limited to evaluation of pharmacy services which only provided one or two different 
sexual and reproductive health services. It also showed that studies on pharmacy-based sexual 
and reproductive health were often not of high-quality reporting. Only few studies allowed for a 
multi-perspective exploration of pharmacy-based sexual and reproductive health services, and 
particularly pharmacy healthcare assistants were rarely involved in research in this field although 
they are usually the first contact to pharmacy users. It was also found in the systematic review 
ha  he e a  a lack of e ea ch e plo ing e  and aff e pe ience  of ome e ice  ch a  
chlamydia treatment, partner notification, hepatitis B vaccine or testing for STIs such as syphilis 
and gonorrhoea. The novel methodological approach of this PhD, in combining qualitative and 
quantitative methods and the use of PIP, has highlighted the need for more high-quality research 
giving multi-perspective insight into staff and user  e pe ience  of a a ie  of pha mac -based 
sexual and reproductive health services.  
A limitation of this project is that most data analysed was based only on one pharmacy service 
(Umbrella). However, to allow for findings to be more transferrable, future research should 
consider the collection and analysis of data from several pharmacy services, e.g. through a survey. 
Another limitation was that non- e ice e  and non- e ice p o ide  ie  e e no  
considered although this may have revealed further barriers to service access. Hence, future 
research should consider views of both non-service users and non-service providers to explore 
how uptake of sexual and reproductive health services could be increased. 
  
PhD Thesis | Discussion, Recommendations & Conclusion | Julia Gauly 
214 
 
10.7. Strengths and Limitations 
The strengths and limitations of each of the three studies (systematic review, retrospective study, 
interview study) were outlined in the individual chapters. In this section, key strengths and 
limitations of the thesis as a whole are considered:  
10.7.1. Key strengths of this PhD project  
The PhD thesis had four clear objectives, and all of these were addressed by using different study 
designs. The combination of multiple methods to address the overall research questions can be 
perceived as a strength as it allowed for an in-depth exploration of different aspects (e.g. utilisation 
and experiences) of pharmacy-based sexual and reproductive health services. 
Before this PhD project, no research had explored a pharmacy service delivering a large range of 
pharmacy-based sexual and reproductive health. The insights gained from the research has 
extended the existing knowledge on the experiences and the utilisation of a large range of 
pharmacy-based sexual and reproductive health services. The findings are likely to be interesting 
to those delivering and planning pharmacy-based sexual and reproductive health services.  
Another strength of this thesis was that the experiences of pharmacists, pharmacy healthcare 
assistants and pharmacy users were explored. This allowed for an in-depth multi-perspective 
exploration of pharmacy-based sexual and reproductive health services. Pharmacy staff and 
pha mac  e  e pe ience  a e clo el  linked and he efo e i  a  impo an  o anal e da a 
e plo ing ho  o imp o e bo h e  and staff experiences of service delivery. 
Finally, the PhD project not only generated new knowledge on pharmacy-based sexual and 
reproductive health services but also on integration of data from mixed methods research. The 
method used to synthesise data in this thesis may be applied by other researchers wishing to 
integrate findings from different data sources. 
10.7.2. Key limitations of this PhD project 
One of the limitations of this research was that the data analysed and collected to explore 
pharmacy-based sexual and reproductive health services was limited to only one pharmacy 
service in Birmingham (Umbrella). While some findings may be transferrable to other settings in 
the UK and beyond, others may be unique to the pharmacy service evaluated or to the setting in 
Birmingham. However, the aim of this project was to explore a large range of pharmacy-based 
sexual and reproductive health services and this opportunity was unique to Birmingham where 
the pharmacy services Umbrella is delivering a large range of sexual and reproductive health 
services related to contraception and sexually transmitted infections. 
A further limitation of this project was that only users and staff who had obtained or were delivering 
pharmacy-based sexual and reproductive health services were captured. Interviewing non-users 
and non-providers may have revealed further barriers to access and provide sexual and 
reproductive health services.  
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For this project it was considered that exploring experiences of those who had obtained or 
delivered SRHS from a pharmacy would generate more applicable findings for service 
improvement. However, the views of non-users and non-providers are important to be considered 
in future research in order to explore how the uptake of pharmacy-based sexual and reproductive 
health services by health providers and the public could be increased.  
10.8. Dissemination of PhD Findings 
To make an impact in the real world, it is important for the PhD findings and recommendations to 
be disseminated to different target audiences: academics, service users, the public, sexual health 
providers, commissioners and national policy makers. The PhD candidate has been awarded with 
a six months Early Career Fellowship at the University of Warwick, providing her with the time and 
resources to disseminate PhD findings in the future. This section describes what has been 
disseminated to date and is planned to be disseminated in the future. 
10.8.1. Disseminating findings to Academic audiences 
Research findings are commonly shared with academic audiences through journal papers and 
conference presentation/publications.  
Dissemination to date 
To date, both the systematic review and the retrospective study have been published in the high 
impact peer reviewed BMJ journal Sexually Transmitted Infections (Gauly et al., 2019, 2020). The 
systematic review has also been presented as a poster at the BASHH (British Association for 
Se al Heal h and HIV) confe ence in Bi mingham in 2018, he UK  leading p ofe ional 
organisation dealing with all aspects of sexual health care. In 2019, the retrospective study was 
presented in Shanghai at the conference of IUSTI (International Union against Sexually 
Transmitted Infections), the oldest international organisation in the field. The interview study has 
been written up for publication and is currently (as of September 2020) under review at the MDPI 
journal Pharmacy.  
Dissemination plans for the future 
The adapted version of the Pillar Integration Process will be written up for publication in the journal 
for mixed methods research to guide researchers wishing to integrate data from more than two 
data sources. Further, the integrated findings of the thesis will be shared in form of a presentation 
at a Warwick Medical School research seminar.  
10.8.2. Disseminating findings to the public and study participants  
Those who participated in a study deserve to be informed about the knowledge they have made 
possible. The interview study will therefore be written up as lay report and shared with those 
participants who expressed an interest in receiving the study report. However, it is also important 
to share the findings with the local community and the wider public.  
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Dissemination to date 
In 2018, he PhD finding  e e ha ed i h he p blic a  he ann al cience fe i al Pin  of 
Science  and Da abee , a mmi  open o e e one i h an in e e  in da a cience in Co en  
at Warwick University.  
Dissemination plans for the future  
The PhD candidate has established contacts with the Warwick Medical School media relations 
manager, Peter Thorley. Together with his help, she will write a press release to be published in 
a na ional o  local ne pape . Wi h he a i ance of Wa ick  Comm nications Team, findings 
will also be shared through social media, radio interviews and other channels to maximise the 
research impact. 
10.8.3. Sexual health providers 
Dissemination to date 
The findings of the interview study were also presented at Umbrella s stakeholder event in 
September 2019. The stakeholder event was attended by 34 pharmacy team members and 
Umbrella employees.  
Dissemination plans for the future 
The PhD candidate will also present her findings and recommendations at an Umbrella webinar 
in October 2020. She will also develop a short report and infographic summarising all findings 
and recommendation relevant to pharmacies. This can be shared via Umbrella with all the 
community pharmacies that Umbrella is collaborating with. As part of the project, the PhD 
candidate has established contacts with large pharmacy chains in the UK. She will contact the 
pharmacy chains and offer to share her findings at the R&D departments. 
10.8.4. Commissioners and national policy makers 
Dissemination plans for the future 
A  pa  of he PhD p ojec , he PhD candida e ha  a ended e e al mee ing  of Bi mingham  
local pharmaceutical committee. The local pharmaceutical committee (LPC) is an independent 
and representative group of all community pharmacists and community pharmacy owners which 
work locally with NHS England Area Teams, Clinical Commissioning Groups, local authorities and 
other healthcare professionals to help plan healthcare services. The PhD candidate will seek an 
opportunity to present and discuss her findings at the local pharmaceutical committee. Possibly, 
Bi mingham  LPC and Umb ella  b ine  manage  can a i  he PhD candida e in ha ing and 
di c ing finding  i h Bi mingham  Ci  Council. Additional opportunities to present at regional 
and national meetings, such as the Royal Pharmaceutical Society English Pharmacy Board 
Meeting, a meeting to provide professional leadership, advocacy and support for pharmacy 
practice in England across all sectors, will be sought. 
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The PhD candidate has recently attended webinars from the All Party Parliamentary Group on 
Sexual and Reproductive Health in the UK (APPG SRH), a group of MPs and peers seeking to 
raise awareness in Parliament for sexual and reproductive health issues. The PhD candidate will 
contact the group and offer to share her findings in written form or in form of an oral presentation. 
10.9. Conclusion 
The current thesis provides a rigorous and innovative exploration of pharmacy-based sexual and 
reproductive health services (SRHS). A mixed methods approach was taken in order to develop 
recommendations for service optimisation.  
The thesis made a number of unique contributions to the existing literature on pharmacy-based 
sexual and reproductive health services. Through a retrospective study of three-years of routinely 
collected data from a large sexual and reproductive health provider from Birmingham (England), 
the utilisation of pharmacy-based sexual and reproductive health services was explored. It was 
the first study of its kind. This research was also the first to compile a substantial body of literature 
ing a ema ic e ie  o nde and pha mac  aff and pha mac  e  e pe ience  and 
attitudes when providing or being delivered with a large range of pharmacy-based SRHS. The 
review found that there was lack of high-quality qualitative evidence which assessed the views of 
pharmacists, pharmacy healthcare assistants and pharmacy users in England. This gap in 
knowledge was addressed by conducting semi-structured interviews with pharmacists, pharmacy 
healthcare assistants and pharmacy users in a service providing a wide range of SRHS via 
pharmacies in Birmingham (England). Findings from all three components of the thesis were 
synthesised using the Pillar Integration Process (PIP) which was further developed by the PhD 
candidate to allow the data integration of three datasets. The development of the Pillar Integration 
Process in this way will be applicable for future research and a further original contribution. 
This thesis identified several barriers to the delivery of pharmacy-based SRHS, which should be 
addressed to further optimise its delivery. Considering these exceptional times as a result of the 
current COVID-19 pandemic, where General Practices and clinics have had to limit the provision 
of healthcare services, including sexual and reproductive health services; pharmacies have 
remained open and continued to deliver services. Therefore, pharmacies have evidently become 
an even more important point of access to healthcare than ever before.  
Based on the results of this thesis, there is evidence to suggest that health care providers should 
recognise the potential of pharmacies to deliver SRHS and consider increasing service provision 
through pharmacies. When implementing sexual and reproductive health services in pharmacies, 
the recommendations outlined in this thesis should be considered.  
Key recommendations from this thesis include exploring how to: adequately address physical 
privacy, overcome language and communication barriers (e.g. through the use of phone 
translation services) and reduce barriers to pharmacy-based STI testing (e.g. through pharmacy-
assisted STI testing or alternative blood test methods).  
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Pharmacies and health providers should also assess the additional workload for pharmacists as a 
result of delivering SRHS and how this can be integrated with existing pharmacy work (e.g. by 
allocating work to other healthcare professionals and the use of electronic systems). Moreover, 
health providers should ensure that data is collected in a way that allows analysis of pharmacy-
based SRHS at an individual level and over time. Work must also be done to raise awareness for 
the SRHS availability and eligibility criteria, in order for them to be utilised appropriately. 
By improving the service delivery of SRHS through pharmacies, health providers can contribute 
to ensuring that people  e al and ep od c i e heal h need  can con in e o be add e ed.  
As evidenced in this thesis, pharmacies offer notable advantages over other health providers, and 
there is an opportunity to build on these. For example, convenience was found to be a key feature 
that made pharmacies ideal for the delivery of SRHS. Further, that no appointments needed to be 
made and that pharmacies have long opening times were perceived as further advantages of 
pharmacies over other health providers. Pharmacies can also provide both a consultation and the 
medication on a sexual and reproductive health services in a single visit, and this was also found 
to be a key strength of pharmacies over other health providers.  
According to recent data, pharmacies in England carry out one million consultations a week, 
showing their strong contribution to the delivery of healthcare. The recommendations developed 
in this thesis through the mixed methods methodology, can now be taken forward to build on the 
strengths of pharmacies, to ensure that they can continue to provide stronger and more 
accessible sexual and reproductive health services in the future. 
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APPENDIX 4 ELECTRONIC DATABASES  SEARCH TERMS  
SEARCH TERMS - ELECTRONIC DATABASES 
Embase  
Database: Embase Classic+Embase <1947 to 2018 Week 38> 
Search Strategy: 
-------------------------------------------------------------------------------- 
1     Pharmacy.mp. or exp pharmacy/ (121392) 
2     Pharmacies.mp. (17129) 
3     1 or 2 (124739) 
4     exp contraception/ or exp long-acting reversible contraception/ or exp barrier contraception/ or exp 
hormonal 
contraception/ or Contraception.mp. or exp oral contraception/ (173978) 
5     Contraceptive.mp. or exp contraceptive agent/ (182698) 
6     exp sexually transmitted disease/ or Sexually Transmitted Infection*.mp. (108345) 
7     STI.mp. (15159) 
8     STD.mp. (13576) 
9     exp Chlamydia rapid test/ or exp Chlamydia trachomatis test kit/ or exp Chlamydia/ or 
Chlamydia.mp. (35825) 
10     Gonorrhoea.mp. or exp gonorrhea/ (21929) 
11     Syphilis.mp. or exp syphilis/ (45923) 
12     HIV.mp. or exp Human immunodeficiency virus/ (389480) 
13     rapid test.mp. or exp rapid test/ (12279) 
14     (self-sampling test* or self-sampling kit*).mp. [mp=title, abstract, heading word, drug trade name, 
original 
title, device manufacturer, drug manufacturer, device trade name, keyword, floating subheading word, 
candidate term 
word] (63) 
15     Hepatitis B vaccine.mp. or exp hepatitis B vaccine/ (21082) 
16     (Hepatitis B vaccination or Hepatitis B).mp. [mp=title, abstract, heading word, drug trade name, 
original title, 
device manufacturer, drug manufacturer, device trade name, keyword, floating subheading word, 
candidate term word] 
(150262) 
17     Emergency Hormonal Contraception.mp. or exp emergency contraception/ (2787) 
18     Morning after pill.mp. or exp postcoitus contraceptive agent/ (50221) 
19     EHC.mp. (706) 
20     Condom*.mp. or exp condom/ (28035) 
21     exp sexual health/ or Sexual Health Service.mp. (13309) 
22     contact tracing.mp. (1975) 
23     Partner notification.mp. (1227) 
24     4 or 5 or 6 or 7 or 8 or 9 or 10 or 11 or 12 or 13 or 14 or 15 or 16 or 17 or 18 or 19 or 20 or 21 or 22 
or 23 
(958793) 
25     3 and 24 (4723)  
  




Database: Ovid MEDLINE(R) <1946 to September Week 1 2018> 
Search Strategy: 
-------------------------------------------------------------------------------- 
1     pharmacy.mp. or exp PHARMACY/ (51805) 
2     pharmacies.mp. or exp PHARMACIES/ (13208) 
3     1 or 2 (56571) 
4     Contraception.mp. or exp CONTRACEPTION, BARRIER/ or exp CONTRACEPTION/ or exp 
CONTRACEPTION BEHAVIOR/ or exp 
LONG-ACTING REVERSIBLE CONTRACEPTION/ (49292) 
5     Contraceptive.mp. or exp Contraceptive Agents/ (90752) 
6     Sexually Transmitted infection.mp. or exp Sexually Transmitted Diseases/ (321054) 
7     STI.mp. (6936) 
8     STD.mp. (8706) 
9     Chlamydia.mp. or exp CHLAMYDIA INFECTIONS/ or exp CHLAMYDIA/ or exp CHLAMYDIA 
TRACHOMATIS/ (30567) 
10     exp Gonorrhea/ or Gonorrhoea.mp. (14740) 
11     Syphilis.mp. or exp SYPHILIS/ (32561) 
12     Human Immunodeficiency Virus.mp. or exp HIV/ (139482) 
13     rapid test.mp. (2579) 
14     (self-sampling test* or self-sampling kit*).mp. [mp=title, abstract, original title, name of substance 
word, 
subject heading word, floating sub-heading word, keyword heading word, protocol supplementary 
concept word, rare disease 
supplementary concept word, unique identifier, synonyms] (41) 
15     Hepatitis B vaccine.mp. or exp Hepatitis B Vaccines/ (9808) 
16     (Hepatitis B vaccination or Hepatitis B).mp. [mp=title, abstract, original title, name of substance 
word, subject 
heading word, floating sub-heading word, keyword heading word, protocol supplementary concept word, 
rare disease 
supplementary concept word, unique identifier, synonyms] (85547) 
17     Emergency Hormonal Contraception.mp. (56) 
18     Emergency Contraception.mp. or exp Contraception, Postcoital/ (2092) 
19     (Morning after Pill or EHC).mp. [mp=title, abstract, original title, name of substance word, subject 
heading 
word, floating sub-heading word, keyword heading word, protocol supplementary concept word, rare 
disease supplementary 
concept word, unique identifier, synonyms] (581) 
20     exp CONDOMS/ or Condom*.mp. (19649) 
21     (sexual health service or sexual health).mp. [mp=title, abstract, original title, name of substance 
word, subject 
heading word, floating sub-heading word, keyword heading word, protocol supplementary concept word, 
rare disease 
supplementary concept word, unique identifier, synonyms] (6907) 
22     Partner notification.mp. or exp Contact Tracing/ (4209) 
23     4 or 5 or 6 or 7 or 8 or 9 or 10 or 11 or 12 or 13 or 14 or 15 or 16 or 17 or 18 or 19 or 20 or 21 or 22 
(585340) 
24     3 and 23 (1908)  
  




Database: PsycINFO <1806 to September Week 2 2018> 
Search Strategy: 
-------------------------------------------------------------------------------- 
1     Pharmacy.mp. or exp PHARMACY/ (3774) 
2     pharmacies.mp. (1229) 
3     1 or 2 (4387) 
4     Contraception.mp. or exp Birth Control/ (9933) 
5     exp CONTRACEPTIVE DEVICES/ or exp Oral Contraceptives/ or Contraceptive.mp. (8436) 
6     exp Sexually Transmitted Diseases/ or Sexually Transmitted Infection.mp. (43630) 
7     STI.mp. (2589) 
8     STD.mp. (2110) 
9     Chlamydia.mp. (856) 
10     exp Gonorrhea/ or Gonorrhoea.mp. (287) 
11     Syphilis.mp. or exp SYPHILIS/ (1747) 
12     Human Immunodeficiency VIrus.mp. or exp HIV/ (41236) 
13     exp HIV Testing/ or Rapid test.mp. or exp Testing/ (131233) 
14     (self-sampling kit* or self-sampling test*).mp. [mp=title, abstract, heading word, table of contents, 
key 
concepts, original title, tests & measures] (2) 
15     Hepatitis B vaccine.mp. (74) 
16     (Hepatitis B vaccination or Hepatitis B).mp. [mp=title, abstract, heading word, table of contents, key 
concepts, 
original title, tests & measures] (1121) 
17     Emergency Contraception.mp. (247) 
18     (Morning after pill or EHC or Emergency Hormonal Contraception).mp. [mp=title, abstract, heading 
word, table of 
contents, key concepts, original title, tests & measures] (69) 
19     exp CONDOMS/ or Condom*.mp. (9683) 
20     Sexual health service.mp. (51) 
21     sexual health.mp. (5297) 
22     partner notification.mp. (188) 
23     contact tracing.mp. (95) 
24     4 or 5 or 6 or 7 or 8 or 9 or 10 or 11 or 12 or 13 or 14 or 15 or 16 or 17 or 18 or 19 or 20 or 21 or 22 
or 23 
(189773) 
25     3 and 24 (399)  
Scopus  
(TITLE-ABS-KEY ( Pharmacy  OR Pharmacies ) AND TITLE-ABS-KEY ( Contraception  OR 
Contraceptive ) OR TITLE-ABS-KEY ( Sexually Transmitted Infection  OR SEXUALLY TRANSMITTED 
DISEASE  OR STI  OR STD ) OR TITLE-ABS-KEY ( Chlamydia  OR Gonorrhoea  OR Gonorrhea  OR 
Syphilis  OR HIV  OR Human Immunodeficiency Virus ) OR TITLE-ABS-KEY ( Self-sampling test  OR 
Self-sampling kit  OR rapid test ) OR TITLE-ABS-KEY ( Hepatitis B vaccination  OR Hepatitis B ) OR 
TITLE-ABS-KEY ( Emergency Hormonal Contraception  OR Emergency Contraception  OR EHC  OR 
Morning After Pill ) OR TITEL ABS-KEY ( Condom  OR sexual health  OR sexual health service ) OR 
TITLE ABS-KEY ( Contact Tracing  OR Partner notification )) 
Web of Science  
TS=(Pharmacy OR Pharmacies) AND TS=(Contraceptive OR Contraception OR "Sexually Transmitted 
Infection*" OR "Sexually Transmitted Disease*" OR STI OR STD OR Chlamydia OR Gonorrhoea OR 
gonorrhea OR Syphilis OR HIV OR "Human Immunodeficiency Virus" OR "Self-sampling kit*" OR "self-
sampling test*" OR "Hepatitis B vaccine*" OR "Hepatitis B vaccination" OR "Hepatitis B" OR "Emergency 
Hormonal Contraception" OR "Emergency Contraception" OR EHC OR "Morning-After Pill" OR "Condom*" 
OR "Sexual health service*" OR "sexual health" OR "Partner notification" OR "contact tracing") 
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Cochrane Library  
Search Name: Cochrane Library 17092018  1194  References 
Last Saved: 17/09/2018 15:46:38 
Comment: 1194 References (17092018 Cochrane Library)  
 
ID Search 
#1 MeSH descriptor: [Pharmacies] explode all trees 
#2 Pharmacy OR Pharmacies 
#3 #1 OR #2 
#4 MeSH descriptor: [Contraception] explode all trees 
#5 Contraception OR Contraceptive 
#6 MeSH descriptor: [Sexually Transmitted Diseases] 4 tree(s) exploded 
#7 Sexually Transmitted Infection* OR Sexually Transmitted Disease OR STI OR STD 
#8 MeSH descriptor: [Chlamydia] explode all trees 
#9 Chlamydia 
#10 MeSH descriptor: [Gonorrhea] 5 tree(s) exploded 
#11 Gonorrhoea OR Gonorrhea 
#12 Syphilis 
#13 MeSH descriptor: [Syphilis] 6 tree(s) exploded 
#14 MeSH descriptor: [HIV] explode all trees 
#15 HIV OR Human Immunodeficiency Virus 
#16 Self-sampling kit OR self-sampling test OR rapid test 
#17 MeSH descriptor: [Hepatitis B Vaccines] explode all trees 
#18 Hepatitis B vaccine OR Hepatitis B vaccination OR Hepatitis B 
#19 MeSH descriptor: [Contraception, Postcoital] explode all trees 
#20 Emergency Hormonal Contraception OR Emergency Contraception OR EHC OR Morning 
after pill 
#21 MeSH descriptor: [Condoms] explode all trees 
#22 Condom 
#23 MeSH descriptor: [Sexual Health] explode all trees 
#24 Sexual Health Service OR sexual Health 
#25 MeSH descriptor: [Contact Tracing] explode all trees 
#26 Partner notification OR Contact Tracing 
#27 #4 OR #5 OR #6 OR #7 OR #8 OR #9 OR #10 OR #11 OR #12 OR #13 OR #14 OR #15 OR 
#16 OR #17 OR #18 OR #19 OR #20 OR #21 OR #22 OR #23 OR #24 OR #25 OR #26 
#28 #3 AND #27  
Popline  
(Pharmacy or Pharmacies) AND (Contraception OR Sexually Transmitted Infection* OR Sexually 
Transmitted Disease* OR Contraceptive OR STI OR STD OR Chlamydia OR Gonorrhoea OR Gonorrhea 
OR Syphilis OR HIV OR Human Immunodeficiency Virus OR Self-sampling it OR Self-sampling test OR 
rapid test OR Hepatitis B vaccine OR Hepatitis B vaccination OR Hepatitis B OR Emergency Contraception 
OR EHC OR Morning after pill OR Condom* OR Sexual health service* OR Sexual health OR partner 
Notification OR Contact Tracing 




APPENDIX 5 QUALITY ASSESMENT MMAT 
Categorisation into High, Medium and Low Quality  
There are five MMAT-criteria each for qualitative and quantitative studies; and JG categorised studies as high, medium, or low quality if they met 4-5, 3, 1-2 
criteria respectively. For mixed methods studies with 15 (or in one case 20) criteria, JG divided them into high, medium and low quality if they fulfilled 11-15 
(12-20), 8-10 (9-12), 1-7 (1-8) criteria. 
Overview Quality Assessment (MMAT) 













Are there clear research questions? Yes Yes Yes Yes Yes 
Do the collected data allow to address the research 
questions? 




1) Is the qualitative approach appropriate to 
answer the research question? 
Yes Yes Yes Yes Yes 
2) Are the qualitative data collection methods 
adequate to address the research question? 
Yes No Yes Yes Yes 
3) Are the findings adequately derived from the 
data? 
Yes Yes Yes Yes Yes 
4) Is the interpretation of results sufficiently 
substantiated by data? 
Yes Yes Yes Yes Yes 
5) Is there coherence between qualitative data 
sources, collection, analysis and 
interpretation? 
Yes Not clear Yes Yes Yes 
Quality Overall  High (5/5) Medium (3/5) High (5/5) High (5/5) High (5/5) 
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Are there clear research questions? Yes Yes Yes Yes Yes Yes Yes 
Do the collected data allow to address the research 
questions? 






1) Is the sampling strategy relevant to address 
the research question? 
Not clear No Yes Yes Yes Yes Yes 
2) Is the sample representative of the target 
population? 
Not clear Not clear Not clear Yes Not clear Yes Yes 
3) Are the measurements appropriate? Yes Yes Yes Yes Yes Yes Yes 
4) Is the risk of nonresponse bias low? 
(acceptable response rate is 60% or above) 
Not clear Not clear No No No No No 
5) Is the statistical analysis appropriate to 
answer the research question? 
Yes Yes Yes Yes Yes Yes Yes 
Quality Overall Low (2/5) Low (2/5) Medium 
(3/5) 
High (4/5) Medium 
(3/5) 
High (4/5) High 
(4/5) 
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Are there clear research questions? Yes Not clear Yes Yes Yes Yes Yes 
Do the collected data allow to address the 
research questions? 
Yes Not clear Yes Yes Yes Yes Yes 
Criteria for the 
qualitative part of 
the study  
1) Is the qualitative approach 
appropriate to answer the research 
question? 
Yes Not clear Yes Yes Yes Yes Yes 
2) Are the qualitative data collection 
methods adequate to address the 
research question? 
Yes Not clear Yes Not 
clear 
Yes Yes Yes 
3) Are the findings adequately derived 
from the data? 
Yes No Yes No Yes Not 
clear 
Yes 
4) Is the interpretation of results 
sufficiently substantiated by data? 
Yes No Yes No Yes Not 
clear 
Yes 
5) Is there coherence between 
qualitative data sources, collection, 
analysis and interpretation? 







controlled trials (if 
appropriate) 
1) Are the participants representative of 
the target population? 
 Yes      
2) Are measurements appropriate 
regarding both the outcome and 
intervention (or exposure)? 
 Yes      
3) Are there complete outcome data? 
(80% or above) 
 No      
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4) Are the confounders accounted for in 
the design and analysis? 
 Not 
applicable 
     
5) During the study period, is the 
intervention administered (or 
exposure occurred) as intended? 
 Not 
applicable 





1) Is the sampling strategy relevant to 
address the research question? 
Yes Yes Yes Yes Yes Yes Yes 
2) Is the sample representative of the 
target population? 





3) Are the measurements appropriate? Yes Not clear Yes Yes Yes Not 
clear 
Yes 
4) Is the risk of nonresponse bias low? 
(acceptable response rate is 60% or 
above) 
No No No No No No Yes 
5) Is the statistical analysis appropriate 
to answer the research question? 





Criteria on the 
mixed methods 
study components 
1) Is there an adequate rationale for 
using a mixed methods design to 
address the research question? 
Yes Not clear Not clear Yes Yes No Not clear 
2) Are the different components of the 
study effectively integrated to answer 
the research question? 
Not clear Not clear Yes Not 
clear 
No No Not clear 
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3) Are the results adequately brought 
together into overall interpretations? 
No No No Not 
clear 
No No Yes 
4) Are divergences and inconsistencies 
between quantitative and qualitative 
results adequately addressed? 
Yes No Yes No Not clear No Yes 
5) Do the different components of the 
study adhere to the quality criteria of 
each tradition of the methods 
involved? 
Yes No No No Yes No Not clear 
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APPENDIX 6 FLYER 
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APPENDIX 7 INFORMATION SHEETS 
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APPENDIX 8 CONSENT FORM 
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APPENDIX 9 AMENDMENT LOG 
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APPENDIX 10 TIMELINE (ETHICAL) APPROVALS AND AMENDMENTS 
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APPENDIX 11 INTERVIEW TOPIC GUIDE 
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APPENDIX 12 NPT TOOLKIT RESULTS 
 












APPENDIX 13 JOINT DISPLAY  
Joint Display 
Acronyms: PU= Pharmacy user(s); P(s)=Pharmacist(s); Ps= Pharmacists; PS= Pharmacy staff; 








x PU found it easy to 
get to the 
pharmacy 
x PU liked that there 
was no need to 
travel long 
distance 
x PU found it easier 
to get to pharmacy 
than to a clinic 
x PU liked the 
speedy service 
delivery at the 
pharmacy 
x PU liked the walk-
in nature of 
pharmacies (no 
need to schedule 
appointment)  
x PU liked that they 
could attend for 
several health 
issues in one visit 
x PU liked that they 
could get both 
consultation and 
medication in one 
visit 
x PS felt that 
pharmacies were 
convenient to use 




hours and quicker 
appointments 
(compared to 
x Convenience was 
most commonly 
named as reason why 
PU used the 
pharmacy 
x PU found pharmacies 
easy to get to from 
work/home; 
x Pu found pharmacies 
accessible as they 
had long opening 
hours and there was 
no need to schedule 
appointments 
60498 service 
requests were made 
between August 










x PU experienced 
lack of trained staff 
as barrier to 
service 
x A few PS were 
concerned/anxious 
about not being 
able to meet 
demand due to 
lack of trained staff 
x Not having trained 
staff at all times 
limited service 
availability  
x PHA stated that they 
often had to send 
people away as they 
didn  ha e ained 
pharmacist in 
pharmacy (this was 
sometimes frustrating 
for PHA and upsetting 
for PU presenting for 
time sensitive 
services)  




x PU found it 
inconvenient that 
STI samples had 
to be returned to 
designated places, 
that they had to 
wait for test results 
and that they had 
to call the hospital 
during working 
hours to receive 
test results  




rapid testing (there 
was no significant 
difference in 
comfort compared 
to clinic users) 
x Many pharmacy users 
experienced 
difficulties in 
conducting the blood 
test for the STI self-
sampling kits: PU 
found it difficult to fill 
the tube; PU felt that 
there were not 
enough lancets 
provided; dyslexic PU 
found it difficult to 
follow the instructions  
x Due to the difficulties 
with the self-sampling 
kits, some users left 
the kit uncompleted 
or decided to get 
tested at a clinic 
instead 
x PS were aware that 
PU had problems 
conducting the blood 
test and suggested 
that they could 
support the conduct 
of the blood sample in 
the pharmacy; this 
idea was welcomed 
by users 
x STI self-sampling 
kits accounted for 
only 9.6% of all 
service requests 
made between 





x While some PU 
liked privacy about 
pharmacy and 
stated that privacy 
was not a concern 
for them, others 
experienced lack 
of privacy as a 
barrier to access 
x Physical privacy (not 
being overheard or 
being overseen 
presenting for SRHS) 
was highly important 
to PU  
x Fear of stigma is a 
reason for high 
privacy requirements 
(PU are worried about 
being judged by staff 
Not identified Need for 
physical 
privacy in the 
pharmacy 
 
PhD Thesis | Appendix | Julia Gauly 
333 
 
x Some PU feared 
being surrounded 
by other PU  
x PU were less likely 
than clinical users 
to agree that 
adequate privacy 
had been provided 
x PS were aware 
that privacy was 
highly important to 
PU  
x Discreteness of PS 
enabled the 
service delivery  
x Having private 
consultation rooms 
helped Ps to 
interact with 
pharmacy users 
and other pharmacy 
clients)  
x PU who entered 
emptier pharmacies 
had a better 
experience of privacy 
than those presenting 
in busy pharmacies 
x According to PS, 
some PU intentionally 
waited until the 
pharmacy was empty 
before entering the 
pharmacy for SRHS 
due to privacy 
concerns 
x PU tried to speak 
quietly at the counter 
for privacy reasons 
x Discreteness of staff 
impac ed PU  
perceived privacy 





privacy; having a 
counter at separate 
area enabled privacy 
x PU intentionally 
visited pharmacies 
where they did not 
know staff and were 
unlikely to meet 
people that they knew 
x Discreet packaging of 
SRH products 
enabled privacy 
x Consultation rooms 
provided sufficient 
privacy during the 
service delivery (with 
the exception of one 
pharmacy user who 
complaint that the 
consultation room 
was not soundproof) 









x PU largely had a 
positive experiences 
interacting with PS 
(PS were often 
described as friendly, 
sensitive) 
x However, a few users 
made negative 
experiences with PS 
who were: not 




the pharmacy for 
SRHS between 
August 2015 and 
August 2018 
Pharmacy 
Staff  user 
interaction 
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x PU were largely 
comfortable 
discussing sexual 
health with PS 
(with the exception 
of younger users) 




x PS were aware 
that whether they 
were trained, 
confident and 
friendly had an 
impact on the 
interaction with PU 
x PS were generally 
comfortable 
interacting with PU 
x While PS felt that 







x PU felt that 
appropriate advice 
was provided 
x The consultation at 
the pharmacy was 
perceived as less 
comprehensive 
than at clinic 
x PU were less likely 
to agree than 
clinic users that 
consultation 
helped them to 
understand EC 
use better in the 
future 
x Pharmacy staff 
were concerned 
about providing 
SRHS to minors 
without parental 
consent 
x Staff were less 
likely to deliver EC 
to young users 
and women that 
were not those in 
need for the 
service 
respectful of the 




discriminating PU (in 
the case of one 
transgender woman, 
who suggested that 
PS should have to 
obtain diversity 
training) 
x PS were aware that 
being confident is 
highly important and 
some PS wished that 
they had more role 
playing in the training 
to make them more 
confident when 
delivering services  
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x PS found it difficult 
to ask PU for their 
weight  
x PS felt that 
administrative 
work should be 
simplified and 
digitalised 
x Some PU did not 
want to share their 
personal 
information  
x While some PU felt 
that all information 
requested by PS was 
relevant, others felt 
uncomfortable having 
to provide personal 
information for 
privacy reasons and 
were not sure why the 
questions were being 
asked 
x While some PU were 
more willing to 
provide details after 
Ps had reassured 
them of the 
confidentiality of the 




x According to PS, 
some PU chose to 
buy EC rather than 
get the free Umbrella 
service because they 
did not want to 
provide their personal 
information 
x Ps were aware of how 
uncomfortable some 




collected as much as 
possible 
x Some Ps were 
already not asking for 
PU  name although 
this was against the 
policy 
x Ps believed that PU 
did not want their data 
to be shared with 
other health 
providers; however, 
some PU actually 
wanted their data to 
be shared with other 
health providers so 
that they did not have 
to answer questions in 
pharmacy again 
Not identified Collection 
and use of 
personal 
information 
x PU had mixed 
experiences with 
PS providing the 
contraceptive 
injection: Some 
x One pharmacy 
described that she 
had a positive 
experience being 
provided with the 
x The 
contraceptive 













skills and some 
users reported 
that it took the 
pharmacist several 
attempts in some 







injection by the 
pharmacist 




the right place for 
condom 
distribution as they 
were used less by 
young males 
Not identified x Males accessed 
pharmacy-based 
SRHS that were 
accessible for 








x Some pharmacy 
staff noted that 
pharmacy users 
had a preference 
regarding the sex 
of pharmacy staff 
(e.g. young males 






male staff)  
x Many PU had 
preferences regarding 
the sex of PU 
x Several females 
expressed that they 
preferred to be 
counselled by a 
female  
x For one PU 
interviewed not 
having staff of 
preferred sex was a 
barrier to access 
x According to PS, 
some female PU 
specifically asked to 
be delivered a service 
by a female  
x According to PS, they 
let female PHA 
chaperone 
consultations and let 
them convince 
females to get a 
consultation by a male 
pharmacist 
x Same sex delivery 
was important, 
particularly to 
females, one male PU 
preferred to be 
counselled by a 
woman because he 
was attracted to men 
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x Ps felt there should 
be more transparency 
on whether a male or 
female pharmacist 
were working in 
pharmacy 
x The majority of PS 
felt that the 
delivery of SRHS 
was feasible within 
their practice 
x Consultation and 
administrative 
work added 
workload for PS 
x The service 
delivery was more 
difficult when the 
demand was 
higher (particularly 
on the weekends 
and in the 
evenings) 
x Some PS felt 
pressured by 
users to deliver 
services fast rather 
than thorough 
x Staff collectively 
agreed that the 
consultation and the 
collection of personal 
information added to 
their workload; Ps 
were more affected 
by the added 
workload than PHA 
x One P suggested to 
let pharmacy users 
pre-register 
themselves prior to 
the consultation in 
order to use 
consultation time 
more effectively 
x Ps felt it that it took 
too much time to 
collect data for some 
services such as 
condoms 
x PS felt that PHA 
should be able to 
record services 
electronically rather 
than on paper forms; 
having to enter the 
data collected by PHA 
on PharmOutcomes® 
duplicated work for Ps 
x Some Ps were 




although they were 
not supposed to 
x Ps felt that there was 
sometimes time 
pressure because the 
Umbrella services 
were only one of the 
jobs that they needed 
to complete; Ps 
sometimes found it 
difficult to multitask; 
PU did not like it when 
Ps were multitasking 
during the 
consultation 
x Overall, less 
services were 




on the weekend 
where driven by 
requests for EC 
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x Workload was not 
associated with the 
level of services 
provided (Tier 1 or 2) 
but with staffing 
levels; low levels of 
staff made it more 
difficult to provide 
services and in one 
case prevented a 
pharmacist from 
delivering the more 
comprehensive Tier 2 
service level; The 
delivery of services 
was difficult where 
there was only PHA 
and one P in the 
pharmacy; even more 
difficult was it, when 
Ps were alone in the 
pharmacy and no one 
was there to cover the 
counter 
x Ps felt that having 
more staff would be 
helpful but were 
aware that this was 
not possible due to 
financial constrains 
x Some PS felt that 
shifting workload to 
PHA could take 
pressure of the P; 
however, Ps felt that 
some things had to be 
done by a P; Ps also 
felt that PHA were not 
paid enough/qualified 
enough to provide a 
larger range of 
services; however 
most PHA were willing 
to take on a larger 
role 
x Some Ps felt it was 
not feasible for them 
to take on additional 
services 
x Most pharmacists 
were willing to 
take on extra 
workload as part 
of their routine 
work and deliver 
SRHS 
x Pharmacy staff 
liked contributing 
to freeing up 
x PS were generally 
highly motivated to 
deliver services and 
positive about 
Umbrella  
x PS were happy to 
take on a bigger role 
and felt it increased 
their job satisfaction 
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doc o  ime, 
increasing access 
to SRHS and 
helping to reduce 
unintended 
pregnancy 




aided them in 
developing their 
professional role 
as primary health 
providers 





x PS felt grateful to be 
able to help other 
people by offering 
services; PS liked to 
take pressure of the 
healthcare system; PS 
felt that delivering 
SRHS increased their 
employability 
x PS felt that they did 
not get sufficient 
financial recognition 
for going beyond their 
traditional role 
x While Ps felt they did 
get recognition for 
their work from PU, 
PHA felt that PU did 
not perceive them as 
healthcare 
professionals and 
trusted them less than 
the pharmacist 
x PU stated they trusted 
Ps; however, one PU 
stated that she felt 
reassured that the 
pha maci  
qualifications were 
hanging in the 
consultation room  
x PHA felt that wearing 
an Umbrella badge 
made them more 
approachable to users 
as it showed that they 
could provide 
information 
x PHA wanted more 
recognition from 




x PS felt that they 
should get more 
recognition from 
health providers for 
their work, e.g. by 
being asked for 
feedback and being 
involved in decisions 
on pharmacy-based 
SRHS 
x Pharmacist felt that 
annual awards for 
staff made staff feel 
appreciated for their 
work 
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x Having documents 
such as the 
protocol for EC 
only in English was 
found to create a 
language barrier 
x Many pharmacists 
experienced 
difficulties delivering 
services to people 
who were not fluent in 
English 




to PU but sometimes 
they had to refer PU 
to clinic due to 
communication/langu
age barriers 
x PS felt that having 
information leaflets in 
different languages 
may be helpful; 
however, only with PU 









Not identified x PU and PS felt that 
lack of awareness for 
the range of services 
created a barrier to 
services  
x PS from smaller 
pharmacies felt that 
they were being 
overlooked by PU 
x PU and PS felt that 
there should be more 
advertisement for the 
services 
x Even PU who had 
used Umbrella service 
were not fully aware 
which services 
Umbrella was offering, 
where and for whom 
(e.g. age, gender) 
x PS described that 
men presented for EC 
and were upset when 
he  co ldn  ge  i  fo  
their female partners; 
staff felt that it should 
be more transparent 
who was eligible to 
receive services  
x One PU was wrongly 
charged for an 
Umbrella service by a 
PHA who believed 
that Umbrella services 
were only free for 
certain demographics 
x EC and condoms 





based SRHS  
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x PU described 
difficulties when trying 
to find an Umbrella 
pharmacy offering the 
services they needed; 
PU felt that  
information was not 
updated; PU were 
therefore calling the 
pharmacy in advance 
to find out whether 
service is available 
and trained staff 
present to provide 
service) 
Not identified x Ps appreciated that 
Umbrella has a 
clinical advice line but 
sometimes 
experienced 
difficulties to get 
through the line 
x Ps reported that there 
were not sufficient 
clinical appointments 
available for women 
wishing to get the 
copper coil (and those 
appointments 
available sometimes 
did not suit the PU) 
x Ps felt that it was 
impractical that they 
needed to call the 
clinics to arrange 
appointment as they 
did not have direct 
access to the 
appointment system 
but  














Not identified Not identified x More than 50% 




(median age: 24)  
x The median age 
was lowest for 
STI self-sampling 
kit users (median 
age: 21) and 
highest for users 






Not identified Not identified x White/White 
British individuals 
















and other ethnic 
groups 
Not identified Not identified x Monday was the 
most common 
day to present 
for pharmacy-
based SRHS 













x Females were 










x Males were most 










by the day of 
the week  
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provided with 
condom 
instructions 
 
 
